,category,over_represented_pvalue,under_represented_pvalue,numDEInCat,numInCat,term,ontology,foreground_genes
1396,GO:0030258,0.00800180997067792,0.998293339137283,11,18,lipid modification,BP,HACL1;ACAT1;ACADVL;ABCG1;ECI1;ETFDH;DECR1;FGF18;CPT1C;ZFYVE21;ETFB
780,GO:0009062,0.0118838282571997,0.99801309681902,8,12,fatty acid catabolic process,BP,HACL1;ACAT1;ACADVL;ECI1;ETFDH;DECR1;CPT1C;ETFB
511,GO:0006635,0.0126739771230775,0.998207118198718,7,10,fatty acid beta-oxidation,BP,ACAT1;ACADVL;ECI1;ETFDH;DECR1;CPT1C;ETFB
2313,GO:0046488,0.0210656397831065,1,4,4,phosphatidylinositol metabolic process,BP,PLA2G16;FGF18;ZFYVE21;DPM3
865,GO:0009888,0.0219838283846338,0.99644252125878,7,10,tissue development,BP,ACAT1;RBP4;ACADVL;KRT10;PSMB10;PLA2G16;FGF18
2975,GO:0072329,0.0227497864229002,0.995250043647354,8,13,monocarboxylic acid catabolic process,BP,HACL1;ACAT1;ACADVL;ECI1;ETFDH;DECR1;CPT1C;ETFB
2397,GO:0048193,0.0309758395289052,1,3,3,Golgi vesicle transport,BP,CNIH4;USE1;TBC1D14
1683,GO:0033539,0.0359029290693521,1,3,3,fatty acid beta-oxidation using acyl-CoA dehydrogenase,BP,ACADVL;ETFDH;ETFB
1260,GO:0019395,0.0376124143452802,0.990679387785688,8,14,fatty acid oxidation,BP,HACL1;ACAT1;ACADVL;ECI1;ETFDH;DECR1;CPT1C;ETFB
1743,GO:0034440,0.0376124143452802,0.990679387785688,8,14,lipid oxidation,BP,HACL1;ACAT1;ACADVL;ECI1;ETFDH;DECR1;CPT1C;ETFB
2797,GO:0061448,0.0428680791376412,1,3,3,connective tissue development,BP,ACAT1;PLA2G16;FGF18
348,GO:0005515,0.046780661339568,0.980942859497252,29,72,protein binding,MF,HACL1;ACAT1;PXMP2;PXK;RBP4;CNIH4;ARL6IP4;NUDT7;TSFM;ABCG1;BOLA1;USE1;FADD;DEPTOR;PSMB10;LAGE3;TBC1D14;NUDT6;HNF1A;PTS;PLA2G16;LINGO1;FGF18;CPT1C;ZFYVE21;DPM3;PEPD;ETFB;IFI30
378,GO:0005759,0.0498652792922149,0.985210122089923,9,17,mitochondrial matrix,CC,ACAT1;MRPL14;ACADVL;PUS1;TSFM;ECI1;ETFDH;DECR1;ETFB
2020,GO:0043234,0.0506215957816342,0.98864085092926,7,11,protein complex,CC,PXMP2;PXK;RBP4;ETFDH;FADD;PSMB10;HNF1A
1095,GO:0016197,0.0560140774479436,1,2,2,endosomal transport,BP,TBC1D14;ZFYVE21
1120,GO:0016482,0.0560140774479436,1,2,2,cytosolic transport,BP,TBC1D14;ZFYVE21
1879,GO:0042147,0.0560140774479436,1,2,2,retrograde transport, endosome to Golgi,BP,TBC1D14;ZFYVE21
864,GO:0009887,0.056628195286387,1,3,3,animal organ morphogenesis,BP,RBP4;PSMB10;FGF18
370,GO:0005654,0.0751693131012016,0.981015042739492,6,11,nucleoplasm,CC,MSRA;ARL6IP4;PSMB10;LAGE3;TBC1D14;DECR1
5,GO:0000045,0.0776349160121906,1,1,1,autophagosome assembly,BP,TBC1D14
314,GO:0005096,0.0776349160121906,1,1,1,GTPase activator activity,MF,TBC1D14
595,GO:0006906,0.0776349160121906,1,1,1,vesicle fusion,BP,TBC1D14
901,GO:0010507,0.0776349160121906,1,1,1,negative regulation of autophagy,BP,TBC1D14
1076,GO:0016050,0.0776349160121906,1,1,1,vesicle organization,BP,TBC1D14
1099,GO:0016236,0.0776349160121906,1,1,1,macroautophagy,BP,TBC1D14
1100,GO:0016241,0.0776349160121906,1,1,1,regulation of macroautophagy,BP,TBC1D14
1430,GO:0030695,0.0776349160121906,1,1,1,GTPase regulator activity,MF,TBC1D14
1490,GO:0031338,0.0776349160121906,1,1,1,regulation of vesicle fusion,BP,TBC1D14
2088,GO:0044088,0.0776349160121906,1,1,1,regulation of vacuole organization,BP,TBC1D14
2172,GO:0044801,0.0776349160121906,1,1,1,single-organism membrane fusion,BP,TBC1D14
2402,GO:0048284,0.0776349160121906,1,1,1,organelle fusion,BP,TBC1D14
2772,GO:0060589,0.0776349160121906,1,1,1,nucleoside-triphosphatase regulator activity,MF,TBC1D14
2783,GO:0061025,0.0776349160121906,1,1,1,membrane fusion,BP,TBC1D14
2877,GO:0070925,0.0776349160121906,1,1,1,organelle assembly,BP,TBC1D14
2961,GO:0071955,0.0776349160121906,1,1,1,recycling endosome to Golgi transport,BP,TBC1D14
3019,GO:0090174,0.0776349160121906,1,1,1,organelle membrane fusion,BP,TBC1D14
3046,GO:0090630,0.0776349160121906,1,1,1,activation of GTPase activity,BP,TBC1D14
3222,GO:1902115,0.0776349160121906,1,1,1,regulation of organelle assembly,BP,TBC1D14
3353,GO:1905037,0.0776349160121906,1,1,1,autophagosome organization,BP,TBC1D14
3414,GO:2000785,0.0776349160121906,1,1,1,regulation of autophagosome assembly,BP,TBC1D14
2141,GO:0044446,0.0814763326363059,0.963169319542906,28,74,intracellular organelle part,CC,HACL1;MSRA;ACAT1;MRPL14;PXMP2;PXK;ACADVL;ARL6IP4;PUS1;NUDT7;TSFM;ABCG1;ALG5;USE1;KRT10;ECI1;ETFDH;PSMB10;LAGE3;TBC1D14;PLA2G16;DECR1;FGF18;CPT1C;ZFYVE21;DPM3;ETFB;IFI30
2104,GO:0044260,0.0867919894277644,0.960938788164835,17,40,cellular macromolecule metabolic process,BP,MSRA;MRPL14;ARL6IP4;PUS1;TSFM;ABCG1;ALG5;KRT10;LYPLAL1;FADD;DEPTOR;PSMB10;LAGE3;HNF1A;FGF18;DPM3;ETFB
1532,GO:0031974,0.0878058116620543,0.959884775842602,18,43,membrane-enclosed lumen,CC,HACL1;MSRA;ACAT1;MRPL14;ACADVL;ARL6IP4;PUS1;NUDT7;TSFM;ECI1;ETFDH;PSMB10;LAGE3;TBC1D14;DECR1;FGF18;ETFB;IFI30
2019,GO:0043233,0.0878058116620543,0.959884775842602,18,43,organelle lumen,CC,HACL1;MSRA;ACAT1;MRPL14;ACADVL;ARL6IP4;PUS1;NUDT7;TSFM;ECI1;ETFDH;PSMB10;LAGE3;TBC1D14;DECR1;FGF18;ETFB;IFI30
2809,GO:0070013,0.0878058116620543,0.959884775842602,18,43,intracellular organelle lumen,CC,HACL1;MSRA;ACAT1;MRPL14;ACADVL;ARL6IP4;PUS1;NUDT7;TSFM;ECI1;ETFDH;PSMB10;LAGE3;TBC1D14;DECR1;FGF18;ETFB;IFI30
2763,GO:0060429,0.0910884955575541,0.985290026603194,4,6,epithelium development,BP,ACAT1;ACADVL;KRT10;PSMB10
2012,GO:0043226,0.0938476942170653,0.977529153238404,39,110,organelle,CC,HACL1;MSRA;ACAT1;MRPL14;PXMP2;PXK;RBP4;ACADVL;TMEM160;CNIH4;ARL6IP4;PUS1;NUDT7;TSFM;ABCG1;ALG5;BOLA1;USE1;KRT10;ECI1;ETFDH;LYPLAL1;CCDC51;FADD;PSMB10;LAGE3;TBC1D14;NUDT6;HNF1A;PTS;PLA2G16;DECR1;FGF18;CPT1C;ZFYVE21;DPM3;PEPD;ETFB;IFI30
2013,GO:0043227,0.0972470295722014,0.971140512036718,38,106,membrane-bounded organelle,CC,HACL1;MSRA;ACAT1;MRPL14;PXMP2;RBP4;ACADVL;TMEM160;CNIH4;ARL6IP4;PUS1;NUDT7;TSFM;ABCG1;ALG5;BOLA1;USE1;KRT10;ECI1;ETFDH;LYPLAL1;CCDC51;FADD;PSMB10;LAGE3;TBC1D14;NUDT6;HNF1A;PTS;PLA2G16;DECR1;FGF18;CPT1C;ZFYVE21;DPM3;PEPD;ETFB;IFI30
2126,GO:0044422,0.0992723570657749,0.953511002966936,28,75,organelle part,CC,HACL1;MSRA;ACAT1;MRPL14;PXMP2;PXK;ACADVL;ARL6IP4;PUS1;NUDT7;TSFM;ABCG1;ALG5;USE1;KRT10;ECI1;ETFDH;PSMB10;LAGE3;TBC1D14;PLA2G16;DECR1;FGF18;CPT1C;ZFYVE21;DPM3;ETFB;IFI30
1075,GO:0016043,0.102446559162662,0.957345214920681,12,26,cellular component organization,BP,HACL1;ACAT1;MRPL14;PUS1;ABCG1;FADD;DEPTOR;TBC1D14;HNF1A;PLA2G16;DECR1;LINGO1
1080,GO:0016054,0.102500984688537,0.964918096710125,8,16,organic acid catabolic process,BP,HACL1;ACAT1;ACADVL;ECI1;ETFDH;DECR1;CPT1C;ETFB
2291,GO:0046395,0.102500984688537,0.964918096710125,8,16,carboxylic acid catabolic process,BP,HACL1;ACAT1;ACADVL;ECI1;ETFDH;DECR1;CPT1C;ETFB
364,GO:0005622,0.103100352911769,0.974914995240081,39,111,intracellular,CC,HACL1;MSRA;ACAT1;MRPL14;PXMP2;PXK;RBP4;ACADVL;TMEM160;CNIH4;ARL6IP4;PUS1;NUDT7;TSFM;ABCG1;ALG5;BOLA1;USE1;KRT10;ECI1;ETFDH;LYPLAL1;CCDC51;FADD;DEPTOR;PSMB10;LAGE3;TBC1D14;NUDT6;HNF1A;PTS;PLA2G16;DECR1;FGF18;CPT1C;ZFYVE21;DPM3;ETFB;IFI30
2127,GO:0044424,0.103100352911769,0.974914995240081,39,111,intracellular part,CC,HACL1;MSRA;ACAT1;MRPL14;PXMP2;PXK;RBP4;ACADVL;TMEM160;CNIH4;ARL6IP4;PUS1;NUDT7;TSFM;ABCG1;ALG5;BOLA1;USE1;KRT10;ECI1;ETFDH;LYPLAL1;CCDC51;FADD;DEPTOR;PSMB10;LAGE3;TBC1D14;NUDT6;HNF1A;PTS;PLA2G16;DECR1;FGF18;CPT1C;ZFYVE21;DPM3;ETFB;IFI30
2006,GO:0043170,0.107781100259819,0.948177279526734,19,47,macromolecule metabolic process,BP,MSRA;MRPL14;ARL6IP4;PUS1;TSFM;ABCG1;ALG5;USE1;KRT10;LYPLAL1;FADD;DEPTOR;PSMB10;LAGE3;HNF1A;FGF18;DPM3;PEPD;ETFB
2043,GO:0043412,0.10838501954593,0.957639182352415,10,21,macromolecule modification,BP,MSRA;PUS1;ALG5;KRT10;LYPLAL1;DEPTOR;PSMB10;FGF18;DPM3;ETFB
1223,GO:0018193,0.111655561548967,0.988171350800359,3,4,peptidyl-amino acid modification,BP,ALG5;FGF18;DPM3
1783,GO:0035295,0.115878713845627,0.987488509681523,3,4,tube development,BP,ACAT1;RBP4;FGF18
2947,GO:0071840,0.119386345589411,0.948064953263475,12,27,cellular component organization or biogenesis,BP,HACL1;ACAT1;MRPL14;PUS1;ABCG1;FADD;DEPTOR;TBC1D14;HNF1A;PLA2G16;DECR1;LINGO1
1335,GO:0022900,0.119462084362504,1,2,2,electron transport chain,BP,ETFDH;ETFB
1336,GO:0022904,0.119462084362504,1,2,2,respiratory electron transport chain,BP,ETFDH;ETFB
1534,GO:0031981,0.120499542799958,0.955910600346143,8,17,nuclear lumen,CC,MSRA;ACADVL;ARL6IP4;PSMB10;LAGE3;TBC1D14;DECR1;FGF18
2773,GO:0060612,0.121464288954362,1,2,2,adipose tissue development,BP,ACAT1;PLA2G16
477,GO:0006464,0.122118622913155,0.952824048428191,9,19,cellular protein modification process,BP,MSRA;ALG5;KRT10;LYPLAL1;DEPTOR;PSMB10;FGF18;DPM3;ETFB
1835,GO:0036211,0.122118622913155,0.952824048428191,9,19,protein modification process,BP,MSRA;ALG5;KRT10;LYPLAL1;DEPTOR;PSMB10;FGF18;DPM3;ETFB
2101,GO:0044255,0.123725299339329,0.941625856891055,15,36,cellular lipid metabolic process,BP,HACL1;ACAT1;RBP4;ACADVL;NUDT7;ABCG1;ECI1;ETFDH;PLA2G16;DECR1;FGF18;CPT1C;ZFYVE21;DPM3;ETFB
794,GO:0009109,0.127267165142932,1,2,2,coenzyme catabolic process,BP,ACAT1;NUDT7
1066,GO:0015936,0.127267165142932,1,2,2,coenzyme A metabolic process,BP,ACAT1;NUDT7
1692,GO:0033865,0.127267165142932,1,2,2,nucleoside bisphosphate metabolic process,BP,ACAT1;NUDT7
1695,GO:0033875,0.127267165142932,1,2,2,ribonucleoside bisphosphate metabolic process,BP,ACAT1;NUDT7
1699,GO:0034032,0.127267165142932,1,2,2,purine nucleoside bisphosphate metabolic process,BP,ACAT1;NUDT7
2285,GO:0046356,0.127267165142932,1,2,2,acetyl-CoA catabolic process,BP,ACAT1;NUDT7
2587,GO:0051187,0.127267165142932,1,2,2,cofactor catabolic process,BP,ACAT1;NUDT7
287,GO:0004620,0.127683116565834,1,2,2,phospholipase activity,MF,LYPLAL1;PLA2G16
1103,GO:0016298,0.127683116565834,1,2,2,lipase activity,MF,LYPLAL1;PLA2G16
341,GO:0005488,0.128415738767046,0.944706581697911,34,94,binding,MF,HACL1;ACAT1;MRPL14;PXMP2;PXK;RBP4;ACADVL;CNIH4;ARL6IP4;PUS1;NUDT7;TSFM;ABCG1;BOLA1;USE1;ETFDH;FADD;DEPTOR;PSMB10;LAGE3;TBC1D14;NUDT6;HNF1A;PTS;PLA2G16;DECR1;LINGO1;FGF18;CPT1C;ZFYVE21;DPM3;PEPD;ETFB;IFI30
1370,GO:0030145,0.133451488611397,1,2,2,manganese ion binding,MF,NUDT7;PEPD
1170,GO:0016790,0.133553428821735,1,2,2,thiolester hydrolase activity,MF,NUDT7;LYPLAL1
2342,GO:0046834,0.133655296986213,1,2,2,lipid phosphorylation,BP,FGF18;ZFYVE21
2345,GO:0046854,0.133655296986213,1,2,2,phosphatidylinositol phosphorylation,BP,FGF18;ZFYVE21
2696,GO:0055037,0.135363032034262,0.988198131423106,2,3,recycling endosome,CC,ABCG1;TBC1D14
1664,GO:0032991,0.135906360593306,0.943752330636447,10,21,macromolecular complex,CC,MRPL14;PXMP2;PXK;RBP4;ETFDH;FADD;PSMB10;HNF1A;CPT1C;DPM3
184,GO:0002699,0.136696597235142,1,2,2,positive regulation of immune effector process,BP,RBP4;FADD
695,GO:0008083,0.140680179220032,1,2,2,growth factor activity,MF,NUDT6;FGF18
1880,GO:0042157,0.140945024172778,0.983137098956721,3,4,lipoprotein metabolic process,BP,ABCG1;LYPLAL1;DPM3
1375,GO:0030163,0.143133464031176,0.982733193493265,3,4,protein catabolic process,BP,USE1;LYPLAL1;PSMB10
1074,GO:0016042,0.143362922907108,0.942167550463398,9,19,lipid catabolic process,BP,HACL1;ACAT1;ACADVL;ECI1;ETFDH;PLA2G16;DECR1;CPT1C;ETFB
1144,GO:0016667,0.143444441051043,1,2,2,oxidoreductase activity, acting on a sulfur group of donors,MF,MSRA;IFI30
2017,GO:0043231,0.1497090788918,0.933020281389661,34,93,intracellular membrane-bounded organelle,CC,HACL1;MSRA;ACAT1;MRPL14;PXMP2;ACADVL;TMEM160;CNIH4;ARL6IP4;PUS1;NUDT7;TSFM;ABCG1;ALG5;BOLA1;USE1;KRT10;ECI1;ETFDH;CCDC51;FADD;PSMB10;LAGE3;TBC1D14;NUDT6;HNF1A;PTS;PLA2G16;DECR1;FGF18;CPT1C;DPM3;ETFB;IFI30
2113,GO:0044282,0.150710602747251,0.94121779960946,8,17,small molecule catabolic process,BP,HACL1;ACAT1;ACADVL;ECI1;ETFDH;DECR1;CPT1C;ETFB
626,GO:0007049,0.151057097242332,1,2,2,cell cycle,BP,PSMB10;PLA2G16
2239,GO:0045786,0.151057097242332,1,2,2,negative regulation of cell cycle,BP,PSMB10;PLA2G16
2670,GO:0051726,0.151057097242332,1,2,2,regulation of cell cycle,BP,PSMB10;PLA2G16
1353,GO:0030054,0.151498513905802,0.97378817344876,3,5,cell junction,CC,CPT1C;ZFYVE21;IFI30
154,GO:0002474,0.156530668723064,1,2,2,antigen processing and presentation of peptide antigen via MHC class I,BP,PSMB10;IFI30
155,GO:0002478,0.156530668723064,1,2,2,antigen processing and presentation of exogenous peptide antigen,BP,PSMB10;IFI30
1291,GO:0019884,0.156530668723064,1,2,2,antigen processing and presentation of exogenous antigen,BP,PSMB10;IFI30
1939,GO:0042590,0.156530668723064,1,2,2,antigen processing and presentation of exogenous peptide antigen via MHC class I,BP,PSMB10;IFI30
523,GO:0006661,0.158020307766698,1,2,2,phosphatidylinositol biosynthetic process,BP,FGF18;DPM3
2097,GO:0044242,0.166710598087889,0.933002010313982,8,17,cellular lipid catabolic process,BP,HACL1;ACAT1;ACADVL;ECI1;ETFDH;DECR1;CPT1C;ETFB
483,GO:0006487,0.167130967309507,1,2,2,protein N-linked glycosylation,BP,ALG5;DPM3
1224,GO:0018196,0.167130967309507,1,2,2,peptidyl-asparagine modification,BP,ALG5;DPM3
1227,GO:0018279,0.167130967309507,1,2,2,protein N-linked glycosylation via asparagine,BP,ALG5;DPM3
519,GO:0006650,0.169442200420396,0.964170289687362,4,6,glycerophospholipid metabolic process,BP,PLA2G16;FGF18;ZFYVE21;DPM3
365,GO:0005623,0.171057635298014,0.968412193526256,40,117,cell,CC,HACL1;MSRA;ACAT1;MRPL14;PXMP2;PXK;RBP4;ACADVL;TMEM160;CNIH4;ARL6IP4;PUS1;NUDT7;TSFM;ABCG1;ALG5;BOLA1;USE1;KRT10;ECI1;ETFDH;LYPLAL1;CCDC51;FADD;DEPTOR;PSMB10;LAGE3;TBC1D14;NUDT6;HNF1A;PTS;PLA2G16;DECR1;LINGO1;FGF18;CPT1C;ZFYVE21;DPM3;ETFB;IFI30
2149,GO:0044464,0.171057635298014,0.968412193526256,40,117,cell part,CC,HACL1;MSRA;ACAT1;MRPL14;PXMP2;PXK;RBP4;ACADVL;TMEM160;CNIH4;ARL6IP4;PUS1;NUDT7;TSFM;ABCG1;ALG5;BOLA1;USE1;KRT10;ECI1;ETFDH;LYPLAL1;CCDC51;FADD;DEPTOR;PSMB10;LAGE3;TBC1D14;NUDT6;HNF1A;PTS;PLA2G16;DECR1;LINGO1;FGF18;CPT1C;ZFYVE21;DPM3;ETFB;IFI30
1269,GO:0019538,0.173825255668007,0.911595942194792,15,36,protein metabolic process,BP,MSRA;MRPL14;TSFM;ABCG1;ALG5;USE1;KRT10;LYPLAL1;FADD;DEPTOR;PSMB10;FGF18;DPM3;PEPD;ETFB
1992,GO:0043087,0.175893545201128,0.981709499180641,2,3,regulation of GTPase activity,BP,TBC1D14;FGF18
2062,GO:0043547,0.175893545201128,0.981709499180641,2,3,positive regulation of GTPase activity,BP,TBC1D14;FGF18
775,GO:0009056,0.177804968947548,0.908755003461085,15,37,catabolic process,BP,HACL1;ACAT1;ACADVL;NUDT7;USE1;ECI1;ETFDH;LYPLAL1;PSMB10;TBC1D14;PLA2G16;DECR1;CPT1C;PEPD;ETFB
1133,GO:0016604,0.18210779421495,0.980602322347834,2,3,nuclear body,CC,ARL6IP4;LAGE3
2143,GO:0044451,0.18210779421495,0.980602322347834,2,3,nucleoplasm part,CC,ARL6IP4;LAGE3
2015,GO:0043229,0.185861664115531,0.921293512893391,36,102,intracellular organelle,CC,HACL1;MSRA;ACAT1;MRPL14;PXMP2;PXK;ACADVL;TMEM160;CNIH4;ARL6IP4;PUS1;NUDT7;TSFM;ABCG1;ALG5;BOLA1;USE1;KRT10;ECI1;ETFDH;CCDC51;FADD;PSMB10;LAGE3;TBC1D14;NUDT6;HNF1A;PTS;PLA2G16;DECR1;FGF18;CPT1C;ZFYVE21;DPM3;ETFB;IFI30
3021,GO:0090181,0.189435526845365,0.979258166679733,2,3,regulation of cholesterol metabolic process,BP,ACADVL;ABCG1
383,GO:0005768,0.190939641741555,0.957102433074555,3,6,endosome,CC,ABCG1;TBC1D14;ZFYVE21
2474,GO:0050662,0.200786551303577,0.930932041972541,5,11,coenzyme binding,MF,HACL1;ACAT1;ACADVL;ETFDH;DECR1
2130,GO:0044429,0.205228246628416,0.901986573249593,10,24,mitochondrial part,CC,ACAT1;MRPL14;ACADVL;PUS1;TSFM;ECI1;ETFDH;DECR1;CPT1C;ETFB
3375,GO:2000026,0.206823478985334,0.923584088067888,6,12,regulation of multicellular organismal development,BP,RBP4;FADD;PSMB10;PLA2G16;LINGO1;FGF18
1448,GO:0030855,0.207890391898894,0.975686758096894,2,3,epithelial cell differentiation,BP,ACADVL;KRT10
2511,GO:0050793,0.213015134153987,0.910663207963484,7,16,regulation of developmental process,BP,RBP4;ABCG1;FADD;PSMB10;PLA2G16;LINGO1;FGF18
433,GO:0006091,0.213545916244111,0.9555740583085,3,5,generation of precursor metabolites and energy,BP,ACADVL;ETFDH;ETFB
1069,GO:0015980,0.213545916244111,0.9555740583085,3,5,energy derivation by oxidation of organic compounds,BP,ACADVL;ETFDH;ETFB
2464,GO:0048871,0.222044355341016,0.972765424615424,2,3,multicellular organismal homeostasis,BP,RBP4;ACADVL
220,GO:0003676,0.222341143974965,0.911053592381618,6,14,nucleic acid binding,MF,MRPL14;ARL6IP4;PUS1;NUDT7;TSFM;HNF1A
429,GO:0006084,0.223587844135064,0.972437199502944,2,3,acetyl-CoA metabolic process,BP,ACAT1;NUDT7
2107,GO:0044267,0.225992936672533,0.883268727932295,12,29,cellular protein metabolic process,BP,MSRA;MRPL14;TSFM;ALG5;KRT10;LYPLAL1;FADD;DEPTOR;PSMB10;FGF18;DPM3;ETFB
389,GO:0005777,0.22940975790324,0.929933479499181,4,8,peroxisome,CC,HACL1;PXMP2;NUDT7;PLA2G16
1937,GO:0042579,0.22940975790324,0.929933479499181,4,8,microbody,CC,HACL1;PXMP2;NUDT7;PLA2G16
2136,GO:0044438,0.22940975790324,0.929933479499181,4,8,microbody part,CC,HACL1;PXMP2;NUDT7;PLA2G16
2137,GO:0044439,0.22940975790324,0.929933479499181,4,8,peroxisomal part,CC,HACL1;PXMP2;NUDT7;PLA2G16
3157,GO:1901137,0.230264081381639,0.950006959716796,3,5,carbohydrate derivative biosynthetic process,BP,ACAT1;ALG5;DPM3
38,GO:0000975,0.230630915833593,1,1,1,regulatory region DNA binding,MF,HNF1A
39,GO:0000976,0.230630915833593,1,1,1,transcription regulatory region sequence-specific DNA binding,MF,HNF1A
40,GO:0000977,0.230630915833593,1,1,1,RNA polymerase II regulatory region sequence-specific DNA binding,MF,HNF1A
41,GO:0000981,0.230630915833593,1,1,1,RNA polymerase II transcription factor activity, sequence-specific DNA binding,MF,HNF1A
42,GO:0000982,0.230630915833593,1,1,1,transcription factor activity, RNA polymerase II core promoter proximal region sequence-specific binding,MF,HNF1A
45,GO:0001012,0.230630915833593,1,1,1,RNA polymerase II regulatory region DNA binding,MF,HNF1A
46,GO:0001067,0.230630915833593,1,1,1,regulatory region nucleic acid binding,MF,HNF1A
47,GO:0001071,0.230630915833593,1,1,1,nucleic acid binding transcription factor activity,MF,HNF1A
48,GO:0001077,0.230630915833593,1,1,1,transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding,MF,HNF1A
52,GO:0001228,0.230630915833593,1,1,1,transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding,MF,HNF1A
214,GO:0003014,0.230630915833593,1,1,1,renal system process,BP,HNF1A
222,GO:0003690,0.230630915833593,1,1,1,double-stranded DNA binding,MF,HNF1A
223,GO:0003700,0.230630915833593,1,1,1,transcription factor activity, sequence-specific DNA binding,MF,HNF1A
460,GO:0006352,0.230630915833593,1,1,1,DNA-templated transcription, initiation,BP,HNF1A
466,GO:0006367,0.230630915833593,1,1,1,transcription initiation from RNA polymerase II promoter,BP,HNF1A
1807,GO:0035623,0.230630915833593,1,1,1,renal glucose absorption,BP,HNF1A
2064,GO:0043565,0.230630915833593,1,1,1,sequence-specific DNA binding,MF,HNF1A
2093,GO:0044212,0.230630915833593,1,1,1,transcription regulatory region DNA binding,MF,HNF1A
2739,GO:0060260,0.230630915833593,1,1,1,regulation of transcription initiation from RNA polymerase II promoter,BP,HNF1A
2740,GO:0060261,0.230630915833593,1,1,1,positive regulation of transcription initiation from RNA polymerase II promoter,BP,HNF1A
2833,GO:0070293,0.230630915833593,1,1,1,renal absorption,BP,HNF1A
3372,GO:1990837,0.230630915833593,1,1,1,sequence-specific double-stranded DNA binding,MF,HNF1A
3386,GO:2000142,0.230630915833593,1,1,1,regulation of DNA-templated transcription, initiation,BP,HNF1A
3387,GO:2000144,0.230630915833593,1,1,1,positive regulation of DNA-templated transcription, initiation,BP,HNF1A
2008,GO:0043178,0.232213937036509,0.970567639297023,2,3,alcohol binding,MF,RBP4;ABCG1
1159,GO:0016746,0.235877155603361,0.94059423987634,3,6,transferase activity, transferring acyl groups,MF,ACAT1;PLA2G16;CPT1C
3178,GO:1901575,0.235895297147951,0.874089761427737,13,32,organic substance catabolic process,BP,HACL1;ACAT1;ACADVL;NUDT7;USE1;ECI1;ETFDH;LYPLAL1;PSMB10;PLA2G16;DECR1;CPT1C;ETFB
491,GO:0006520,0.239489554421335,0.911530634062638,5,11,cellular amino acid metabolic process,BP,MSRA;ACAT1;PSMB10;PTS;PEPD
376,GO:0005743,0.241030135539725,0.910724176831359,5,11,mitochondrial inner membrane,CC,ACAT1;MRPL14;ACADVL;ECI1;ETFDH
646,GO:0007267,0.243186389842156,0.919624954445615,4,9,cell-cell signaling,BP,PXK;RBP4;PSMB10;FGF18
10,GO:0000139,0.251922342842801,1,1,1,Golgi membrane,CC,ABCG1
357,GO:0005548,0.251922342842801,1,1,1,phospholipid transporter activity,MF,ABCG1
756,GO:0008565,0.251922342842801,1,1,1,protein transporter activity,MF,ABCG1
841,GO:0009593,0.251922342842801,1,1,1,detection of chemical stimulus,BP,ABCG1
853,GO:0009720,0.251922342842801,1,1,1,detection of hormone stimulus,BP,ABCG1
855,GO:0009726,0.251922342842801,1,1,1,detection of endogenous stimulus,BP,ABCG1
874,GO:0009897,0.251922342842801,1,1,1,external side of plasma membrane,CC,ABCG1
942,GO:0010742,0.251922342842801,1,1,1,macrophage derived foam cell differentiation,BP,ABCG1
943,GO:0010743,0.251922342842801,1,1,1,regulation of macrophage derived foam cell differentiation,BP,ABCG1
944,GO:0010745,0.251922342842801,1,1,1,negative regulation of macrophage derived foam cell differentiation,BP,ABCG1
961,GO:0010874,0.251922342842801,1,1,1,regulation of cholesterol efflux,BP,ABCG1
962,GO:0010875,0.251922342842801,1,1,1,positive regulation of cholesterol efflux,BP,ABCG1
964,GO:0010878,0.251922342842801,1,1,1,cholesterol storage,BP,ABCG1
965,GO:0010883,0.251922342842801,1,1,1,regulation of lipid storage,BP,ABCG1
966,GO:0010885,0.251922342842801,1,1,1,regulation of cholesterol storage,BP,ABCG1
967,GO:0010887,0.251922342842801,1,1,1,negative regulation of cholesterol storage,BP,ABCG1
968,GO:0010888,0.251922342842801,1,1,1,negative regulation of lipid storage,BP,ABCG1
1026,GO:0015197,0.251922342842801,1,1,1,peptide transporter activity,MF,ABCG1
1036,GO:0015399,0.251922342842801,1,1,1,primary active transmembrane transporter activity,MF,ABCG1
1037,GO:0015405,0.251922342842801,1,1,1,P-P-bond-hydrolysis-driven transmembrane transporter activity,MF,ABCG1
1118,GO:0016462,0.251922342842801,1,1,1,pyrophosphatase activity,MF,ABCG1
1176,GO:0016817,0.251922342842801,1,1,1,hydrolase activity, acting on acid anhydrides,MF,ABCG1
1177,GO:0016818,0.251922342842801,1,1,1,hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides,MF,ABCG1
1178,GO:0016820,0.251922342842801,1,1,1,hydrolase activity, acting on acid anhydrides, catalyzing transmembrane movement of substances,MF,ABCG1
1195,GO:0016887,0.251922342842801,1,1,1,ATPase activity,MF,ABCG1
1209,GO:0017111,0.251922342842801,1,1,1,nucleoside-triphosphatase activity,MF,ABCG1
1268,GO:0019534,0.251922342842801,1,1,1,toxin transporter activity,MF,ABCG1
1566,GO:0032370,0.251922342842801,1,1,1,positive regulation of lipid transport,BP,ABCG1
1569,GO:0032373,0.251922342842801,1,1,1,positive regulation of sterol transport,BP,ABCG1
1572,GO:0032376,0.251922342842801,1,1,1,positive regulation of cholesterol transport,BP,ABCG1
1702,GO:0034040,0.251922342842801,1,1,1,lipid-transporting ATPase activity,MF,ABCG1
1703,GO:0034041,0.251922342842801,1,1,1,sterol-transporting ATPase activity,MF,ABCG1
1728,GO:0034374,0.251922342842801,1,1,1,low-density lipoprotein particle remodeling,BP,ABCG1
1741,GO:0034436,0.251922342842801,1,1,1,glycoprotein transport,BP,ABCG1
1742,GO:0034437,0.251922342842801,1,1,1,glycoprotein transporter activity,MF,ABCG1
1943,GO:0042623,0.251922342842801,1,1,1,ATPase activity, coupled,MF,ABCG1
1944,GO:0042626,0.251922342842801,1,1,1,ATPase activity, coupled to transmembrane movement of substances,MF,ABCG1
1969,GO:0042982,0.251922342842801,1,1,1,amyloid precursor protein metabolic process,BP,ABCG1
1970,GO:0042987,0.251922342842801,1,1,1,amyloid precursor protein catabolic process,BP,ABCG1
2053,GO:0043492,0.251922342842801,1,1,1,ATPase activity, coupled to movement of substances,MF,ABCG1
2059,GO:0043531,0.251922342842801,1,1,1,ADP binding,MF,ABCG1
2079,GO:0043691,0.251922342842801,1,1,1,reverse cholesterol transport,BP,ABCG1
2132,GO:0044431,0.251922342842801,1,1,1,Golgi apparatus part,CC,ABCG1
2216,GO:0045542,0.251922342842801,1,1,1,positive regulation of cholesterol biosynthetic process,BP,ABCG1
2660,GO:0051606,0.251922342842801,1,1,1,detection of stimulus,BP,ABCG1
2711,GO:0055094,0.251922342842801,1,1,1,response to lipoprotein particle,BP,ABCG1
2712,GO:0055099,0.251922342842801,1,1,1,response to high density lipoprotein particle,BP,ABCG1
3014,GO:0090077,0.251922342842801,1,1,1,foam cell differentiation,BP,ABCG1
3028,GO:0090205,0.251922342842801,1,1,1,positive regulation of cholesterol metabolic process,BP,ABCG1
3086,GO:0098552,0.251922342842801,1,1,1,side of membrane,CC,ABCG1
3162,GO:1901264,0.251922342842801,1,1,1,carbohydrate derivative transport,BP,ABCG1
3172,GO:1901505,0.251922342842801,1,1,1,carbohydrate derivative transporter activity,MF,ABCG1
3185,GO:1901618,0.251922342842801,1,1,1,organic hydroxy compound transmembrane transporter activity,MF,ABCG1
3212,GO:1901998,0.251922342842801,1,1,1,toxin transport,BP,ABCG1
3266,GO:1902932,0.251922342842801,1,1,1,positive regulation of alcohol biosynthetic process,BP,ABCG1
3363,GO:1905954,0.251922342842801,1,1,1,positive regulation of lipid localization,BP,ABCG1
2454,GO:0048732,0.254060451307204,0.965562700695399,2,3,gland development,BP,ACAT1;FADD
322,GO:0005154,0.256551762895828,1,1,1,epidermal growth factor receptor binding,MF,LINGO1
941,GO:0010721,0.256551762895828,1,1,1,negative regulation of cell development,BP,LINGO1
946,GO:0010769,0.256551762895828,1,1,1,regulation of cell morphogenesis involved in differentiation,BP,LINGO1
947,GO:0010771,0.256551762895828,1,1,1,negative regulation of cell morphogenesis involved in differentiation,BP,LINGO1
989,GO:0010975,0.256551762895828,1,1,1,regulation of neuron projection development,BP,LINGO1
990,GO:0010977,0.256551762895828,1,1,1,negative regulation of neuron projection development,BP,LINGO1
1494,GO:0031345,0.256551762895828,1,1,1,negative regulation of cell projection organization,BP,LINGO1
2228,GO:0045664,0.256551762895828,1,1,1,regulation of neuron differentiation,BP,LINGO1
2229,GO:0045665,0.256551762895828,1,1,1,negative regulation of neuron differentiation,BP,LINGO1
2500,GO:0050768,0.256551762895828,1,1,1,negative regulation of neurogenesis,BP,LINGO1
2502,GO:0050770,0.256551762895828,1,1,1,regulation of axonogenesis,BP,LINGO1
2503,GO:0050771,0.256551762895828,1,1,1,negative regulation of axonogenesis,BP,LINGO1
2679,GO:0051961,0.256551762895828,1,1,1,negative regulation of nervous system development,BP,LINGO1
2369,GO:0046982,0.257139401724252,0.964825816022245,2,3,protein heterodimerization activity,MF,RBP4;ABCG1
482,GO:0006486,0.263316432084211,0.963323710410463,2,3,protein glycosylation,BP,ALG5;DPM3
792,GO:0009101,0.263316432084211,0.963323710410463,2,3,glycoprotein biosynthetic process,BP,ALG5;DPM3
2044,GO:0043413,0.263316432084211,0.963323710410463,2,3,macromolecule glycosylation,BP,ALG5;DPM3
2813,GO:0070085,0.263316432084211,0.963323710410463,2,3,glycosylation,BP,ALG5;DPM3
373,GO:0005739,0.26476761760342,0.846728606905676,17,44,mitochondrion,CC,MSRA;ACAT1;MRPL14;ACADVL;TMEM160;PUS1;TSFM;ABCG1;BOLA1;ECI1;ETFDH;CCDC51;NUDT6;PTS;DECR1;CPT1C;ETFB
194,GO:0002757,0.266689208525234,0.962490079006319,2,3,immune response-activating signal transduction,BP,FADD;PSMB10
195,GO:0002758,0.266689208525234,0.962490079006319,2,3,innate immune response-activating signal transduction,BP,FADD;PSMB10
198,GO:0002764,0.266689208525234,0.962490079006319,2,3,immune response-regulating signaling pathway,BP,FADD;PSMB10
2169,GO:0044767,0.26696410946531,0.851073392872543,13,35,single-organism developmental process,BP,ACAT1;RBP4;ACADVL;NUDT7;ABCG1;ALG5;KRT10;FADD;PSMB10;PTS;PLA2G16;LINGO1;FGF18
2084,GO:0043933,0.267466943806112,0.880735773179968,7,15,macromolecular complex subunit organization,BP,HACL1;ACAT1;MRPL14;ABCG1;FADD;HNF1A;DECR1
503,GO:0006577,0.268746130175697,1,1,1,amino-acid betaine metabolic process,BP,CPT1C
836,GO:0009437,0.268746130175697,1,1,1,carnitine metabolic process,BP,CPT1C
1409,GO:0030425,0.268746130175697,1,1,1,dendrite,CC,CPT1C
183,GO:0002697,0.270392017267868,0.961563871715751,2,3,regulation of immune effector process,BP,RBP4;FADD
21,GO:0000287,0.271538733706892,0.961274692417791,2,3,magnesium ion binding,MF,HACL1;NUDT7
1179,GO:0016829,0.272314430874841,0.897599031224455,5,10,lyase activity,MF,HACL1;ACAT1;PUS1;ECI1;PTS
2870,GO:0070851,0.273046452420333,0.960892784074211,2,3,growth factor receptor binding,MF,LINGO1;FGF18
2219,GO:0045595,0.274367080583733,0.903961663015221,4,9,regulation of cell differentiation,BP,ABCG1;FADD;LINGO1;FGF18
2472,GO:0050660,0.274867450379279,0.946810565428531,2,4,flavin adenine dinucleotide binding,MF,ACADVL;ETFDH
1182,GO:0016835,0.276395643045384,0.933181755774624,3,5,carbon-oxygen lyase activity,MF,PUS1;ECI1;PTS
1403,GO:0030323,0.280859551813811,0.95888279026615,2,3,respiratory tube development,BP,RBP4;FGF18
1404,GO:0030324,0.280859551813811,0.95888279026615,2,3,lung development,BP,RBP4;FGF18
2767,GO:0060541,0.280859551813811,0.95888279026615,2,3,respiratory system development,BP,RBP4;FGF18
71,GO:0001655,0.28423224372548,0.957999024507849,2,3,urogenital system development,BP,ACAT1;RBP4
2962,GO:0072001,0.28423224372548,0.957999024507849,2,3,renal system development,BP,ACAT1;RBP4
2358,GO:0046907,0.288312295345278,0.896605140853965,4,9,intracellular transport,BP,CNIH4;ABCG1;TBC1D14;ZFYVE21
2663,GO:0051649,0.288312295345278,0.896605140853965,4,9,establishment of localization in cell,BP,CNIH4;ABCG1;TBC1D14;ZFYVE21
463,GO:0006357,0.288596247446705,0.918423549590077,3,6,regulation of transcription from RNA polymerase II promoter,BP,FADD;PSMB10;HNF1A
2264,GO:0045944,0.291388181010517,0.941110681408148,2,4,positive regulation of transcription from RNA polymerase II promoter,BP,FADD;HNF1A
251,GO:0004174,0.302091075559756,1,1,1,electron-transferring-flavoprotein dehydrogenase activity,MF,ETFDH
1142,GO:0016649,0.302091075559756,1,1,1,oxidoreductase activity, acting on the CH-NH group of donors, quinone or similar compound as acceptor,MF,ETFDH
1154,GO:0016722,0.302091075559756,1,1,1,oxidoreductase activity, oxidizing metal ions,MF,ETFDH
1211,GO:0017133,0.302091075559756,1,1,1,mitochondrial electron transfer flavoprotein complex,CC,ETFDH
1475,GO:0031300,0.302091075559756,1,1,1,intrinsic component of organelle membrane,CC,ETFDH
1476,GO:0031301,0.302091075559756,1,1,1,integral component of organelle membrane,CC,ETFDH
1477,GO:0031304,0.302091075559756,1,1,1,intrinsic component of mitochondrial inner membrane,CC,ETFDH
1478,GO:0031305,0.302091075559756,1,1,1,integral component of mitochondrial inner membrane,CC,ETFDH
1600,GO:0032592,0.302091075559756,1,1,1,integral component of mitochondrial membrane,CC,ETFDH
2080,GO:0043783,0.302091075559756,1,1,1,oxidoreductase activity, oxidizing metal ions with flavin as acceptor,MF,ETFDH
2197,GO:0045251,0.302091075559756,1,1,1,electron transfer flavoprotein complex,CC,ETFDH
2388,GO:0048038,0.302091075559756,1,1,1,quinone binding,MF,ETFDH
2389,GO:0048039,0.302091075559756,1,1,1,ubiquinone binding,MF,ETFDH
2654,GO:0051539,0.302091075559756,1,1,1,4 iron, 4 sulfur cluster binding,MF,ETFDH
3087,GO:0098573,0.302091075559756,1,1,1,intrinsic component of mitochondrial membrane,CC,ETFDH
3110,GO:0098798,0.302091075559756,1,1,1,mitochondrial protein complex,CC,ETFDH
470,GO:0006399,0.302673348078603,0.952992640484558,2,3,tRNA metabolic process,BP,PUS1;LAGE3
690,GO:0008033,0.302673348078603,0.952992640484558,2,3,tRNA processing,BP,PUS1;LAGE3
2613,GO:0051260,0.303701529303017,0.952704747735507,2,3,protein homooligomerization,BP,ACAT1;DECR1
738,GO:0008328,0.304226635614076,0.973308038675996,1,2,ionotropic glutamate receptor complex,CC,CPT1C
1555,GO:0032281,0.304226635614076,0.973308038675996,1,2,AMPA glutamate receptor complex,CC,CPT1C
1764,GO:0034703,0.304226635614076,0.973308038675996,1,2,cation channel complex,CC,CPT1C
3111,GO:0098802,0.304226635614076,0.973308038675996,1,2,plasma membrane receptor complex,CC,CPT1C
3115,GO:0098878,0.304226635614076,0.973308038675996,1,2,neurotransmitter receptor complex,CC,CPT1C
1319,GO:0022607,0.305295929451495,0.862044301766289,6,14,cellular component assembly,BP,HACL1;ACAT1;FADD;TBC1D14;HNF1A;DECR1
73,GO:0001659,0.308623874641913,1,1,1,temperature homeostasis,BP,ACADVL
242,GO:0003995,0.308623874641913,1,1,1,acyl-CoA dehydrogenase activity,MF,ACADVL
270,GO:0004466,0.308623874641913,1,1,1,long-chain-acyl-CoA dehydrogenase activity,MF,ACADVL
615,GO:0006986,0.308623874641913,1,1,1,response to unfolded protein,BP,ACADVL
820,GO:0009266,0.308623874641913,1,1,1,response to temperature stimulus,BP,ACADVL
822,GO:0009295,0.308623874641913,1,1,1,nucleoid,CC,ACADVL
832,GO:0009409,0.308623874641913,1,1,1,response to cold,BP,ACADVL
1454,GO:0030968,0.308623874641913,1,1,1,endoplasmic reticulum unfolded protein response,BP,ACADVL
1751,GO:0034620,0.308623874641913,1,1,1,cellular response to unfolded protein,BP,ACADVL
1823,GO:0035966,0.308623874641913,1,1,1,response to topologically incorrect protein,BP,ACADVL
1824,GO:0035967,0.308623874641913,1,1,1,cellular response to topologically incorrect protein,BP,ACADVL
1845,GO:0036498,0.308623874641913,1,1,1,IRE1-mediated unfolded protein response,BP,ACADVL
1950,GO:0042645,0.308623874641913,1,1,1,mitochondrial nucleoid,CC,ACADVL
2278,GO:0046322,0.308623874641913,1,1,1,negative regulation of fatty acid oxidation,BP,ACADVL
396,GO:0005794,0.309142188795624,0.934660233502897,2,4,Golgi apparatus,CC,ABCG1;TBC1D14
372,GO:0005737,0.310234491434341,0.84876483147586,36,105,cytoplasm,CC,HACL1;MSRA;ACAT1;MRPL14;PXMP2;PXK;RBP4;ACADVL;TMEM160;CNIH4;PUS1;NUDT7;TSFM;ABCG1;ALG5;BOLA1;USE1;KRT10;ECI1;ETFDH;LYPLAL1;CCDC51;FADD;DEPTOR;PSMB10;TBC1D14;NUDT6;HNF1A;PTS;PLA2G16;DECR1;CPT1C;ZFYVE21;DPM3;ETFB;IFI30
366,GO:0005634,0.311473199982494,0.816193295511613,14,38,nucleus,CC,MSRA;ACADVL;ARL6IP4;PUS1;TSFM;KRT10;FADD;PSMB10;LAGE3;TBC1D14;NUDT6;HNF1A;DECR1;FGF18
325,GO:0005198,0.313674972677434,0.949863421836616,2,3,structural molecule activity,MF,MRPL14;KRT10
2942,GO:0071822,0.315887880810291,0.858238351063231,6,13,protein complex subunit organization,BP,HACL1;ACAT1;MRPL14;FADD;HNF1A;DECR1
2095,GO:0044237,0.317241142201246,0.816841492924922,31,90,cellular metabolic process,BP,HACL1;MSRA;ACAT1;MRPL14;RBP4;ACADVL;ARL6IP4;PUS1;NUDT7;TSFM;ABCG1;ALG5;KRT10;ECI1;ETFDH;LYPLAL1;FADD;DEPTOR;PSMB10;LAGE3;TBC1D14;HNF1A;PTS;PLA2G16;DECR1;FGF18;CPT1C;ZFYVE21;DPM3;PEPD;ETFB
1588,GO:0032502,0.317423256440041,0.813664529572032,13,36,developmental process,BP,ACAT1;RBP4;ACADVL;NUDT7;ABCG1;ALG5;KRT10;FADD;PSMB10;PTS;PLA2G16;LINGO1;FGF18
803,GO:0009150,0.318033673565329,0.948593702510678,2,3,purine ribonucleotide metabolic process,BP,ACAT1;NUDT7
815,GO:0009259,0.318033673565329,0.948593702510678,2,3,ribonucleotide metabolic process,BP,ACAT1;NUDT7
61,GO:0001533,0.318179134223174,1,1,1,cornified envelope,CC,KRT10
406,GO:0005882,0.318179134223174,1,1,1,intermediate filament,CC,KRT10
875,GO:0009913,0.318179134223174,1,1,1,epidermal cell differentiation,BP,KRT10
1222,GO:0018149,0.318179134223174,1,1,1,peptide cross-linking,BP,KRT10
1391,GO:0030216,0.318179134223174,1,1,1,keratinocyte differentiation,BP,KRT10
1399,GO:0030280,0.318179134223174,1,1,1,structural constituent of epidermis,MF,KRT10
1507,GO:0031424,0.318179134223174,1,1,1,keratinization,BP,KRT10
2188,GO:0045111,0.318179134223174,1,1,1,intermediate filament cytoskeleton,CC,KRT10
2830,GO:0070268,0.318179134223174,1,1,1,cornification,BP,KRT10
72,GO:0001656,0.31840415648911,1,1,1,metanephros development,BP,ACAT1
238,GO:0003985,0.31840415648911,1,1,1,acetyl-CoA C-acetyltransferase activity,MF,ACAT1
240,GO:0003988,0.31840415648911,1,1,1,acetyl-CoA C-acyltransferase activity,MF,ACAT1
496,GO:0006550,0.31840415648911,1,1,1,isoleucine catabolic process,BP,ACAT1
1067,GO:0015937,0.31840415648911,1,1,1,coenzyme A biosynthetic process,BP,ACAT1
1113,GO:0016407,0.31840415648911,1,1,1,acetyltransferase activity,MF,ACAT1
1117,GO:0016453,0.31840415648911,1,1,1,C-acetyltransferase activity,MF,ACAT1
1194,GO:0016885,0.31840415648911,1,1,1,ligase activity, forming carbon-carbon bonds,MF,ACAT1
1693,GO:0033866,0.31840415648911,1,1,1,nucleoside bisphosphate biosynthetic process,BP,ACAT1
1697,GO:0034030,0.31840415648911,1,1,1,ribonucleoside bisphosphate biosynthetic process,BP,ACAT1
1700,GO:0034033,0.31840415648911,1,1,1,purine nucleoside bisphosphate biosynthetic process,BP,ACAT1
2368,GO:0046952,0.31840415648911,1,1,1,ketone body catabolic process,BP,ACAT1
2791,GO:0061326,0.31840415648911,1,1,1,renal tubule development,BP,ACAT1
2963,GO:0072006,0.31840415648911,1,1,1,nephron development,BP,ACAT1
2964,GO:0072009,0.31840415648911,1,1,1,nephron epithelium development,BP,ACAT1
2965,GO:0072014,0.31840415648911,1,1,1,proximal tubule development,BP,ACAT1
2966,GO:0072019,0.31840415648911,1,1,1,proximal convoluted tubule development,BP,ACAT1
2967,GO:0072073,0.31840415648911,1,1,1,kidney epithelium development,BP,ACAT1
2968,GO:0072080,0.31840415648911,1,1,1,nephron tubule development,BP,ACAT1
2969,GO:0072170,0.31840415648911,1,1,1,metanephric tubule development,BP,ACAT1
2970,GO:0072207,0.31840415648911,1,1,1,metanephric epithelium development,BP,ACAT1
2971,GO:0072229,0.31840415648911,1,1,1,metanephric proximal convoluted tubule development,BP,ACAT1
2972,GO:0072234,0.31840415648911,1,1,1,metanephric nephron tubule development,BP,ACAT1
2973,GO:0072237,0.31840415648911,1,1,1,metanephric proximal tubule development,BP,ACAT1
2974,GO:0072243,0.31840415648911,1,1,1,metanephric nephron epithelium development,BP,ACAT1
3254,GO:1902858,0.31840415648911,1,1,1,propionyl-CoA metabolic process,BP,ACAT1
3255,GO:1902860,0.31840415648911,1,1,1,propionyl-CoA biosynthetic process,BP,ACAT1
473,GO:0006414,0.318439890453266,0.948474495286481,2,3,translational elongation,BP,MRPL14;TSFM
1593,GO:0032543,0.318439890453266,0.948474495286481,2,3,mitochondrial translation,BP,MRPL14;TSFM
2814,GO:0070125,0.318439890453266,0.948474495286481,2,3,mitochondrial translational elongation,BP,MRPL14;TSFM
468,GO:0006396,0.324241363395904,0.901687859905298,3,6,RNA processing,BP,ARL6IP4;PUS1;LAGE3
2460,GO:0048856,0.324290471736928,0.815639557620943,11,29,anatomical structure development,BP,ACAT1;RBP4;ACADVL;ALG5;KRT10;FADD;PSMB10;PTS;PLA2G16;LINGO1;FGF18
1455,GO:0030976,0.325863225582675,1,1,1,thiamine pyrophosphate binding,MF,HACL1
230,GO:0003746,0.329082795639584,1,1,1,translation elongation factor activity,MF,TSFM
461,GO:0006354,0.329082795639584,1,1,1,DNA-templated transcription, elongation,BP,TSFM
703,GO:0008135,0.329082795639584,1,1,1,translation factor activity, RNA binding,MF,TSFM
1639,GO:0032784,0.329082795639584,1,1,1,regulation of DNA-templated transcription, elongation,BP,TSFM
2816,GO:0070129,0.329082795639584,1,1,1,regulation of mitochondrial translation,BP,TSFM
388,GO:0005776,0.332139977018339,0.967572483102332,1,2,autophagosome,CC,TBC1D14
900,GO:0010506,0.332139977018339,0.967572483102332,1,2,regulation of autophagy,BP,TBC1D14
2569,GO:0051093,0.333647828565431,0.897031343151454,3,6,negative regulation of developmental process,BP,RBP4;ABCG1;LINGO1
2442,GO:0048646,0.335532808346948,0.943321861622773,2,3,anatomical structure formation involved in morphogenesis,BP,RBP4;FGF18
253,GO:0004177,0.336463365348732,1,1,1,aminopeptidase activity,MF,PEPD
254,GO:0004180,0.336463365348732,1,1,1,carboxypeptidase activity,MF,PEPD
255,GO:0004181,0.336463365348732,1,1,1,metallocarboxypeptidase activity,MF,PEPD
726,GO:0008235,0.336463365348732,1,1,1,metalloexopeptidase activity,MF,PEPD
728,GO:0008237,0.336463365348732,1,1,1,metallopeptidase activity,MF,PEPD
729,GO:0008238,0.336463365348732,1,1,1,exopeptidase activity,MF,PEPD
1173,GO:0016805,0.336463365348732,1,1,1,dipeptidase activity,MF,PEPD
1422,GO:0030574,0.336463365348732,1,1,1,collagen catabolic process,BP,PEPD
1659,GO:0032963,0.336463365348732,1,1,1,collagen metabolic process,BP,PEPD
2098,GO:0044243,0.336463365348732,1,1,1,multicellular organismal catabolic process,BP,PEPD
2103,GO:0044259,0.336463365348732,1,1,1,multicellular organismal macromolecule metabolic process,BP,PEPD
3130,GO:0102009,0.336463365348732,1,1,1,proline dipeptidase activity,MF,PEPD
126,GO:0002084,0.336755460191835,1,1,1,protein depalmitoylation,BP,LYPLAL1
288,GO:0004622,0.336755460191835,1,1,1,lysophospholipase activity,MF,LYPLAL1
750,GO:0008474,0.336755460191835,1,1,1,palmitoyl-(protein) hydrolase activity,MF,LYPLAL1
1806,GO:0035601,0.336755460191835,1,1,1,protein deacylation,BP,LYPLAL1
1882,GO:0042159,0.336755460191835,1,1,1,lipoprotein catabolic process,BP,LYPLAL1
3091,GO:0098599,0.336755460191835,1,1,1,palmitoyl hydrolase activity,MF,LYPLAL1
3100,GO:0098732,0.336755460191835,1,1,1,macromolecule deacylation,BP,LYPLAL1
3101,GO:0098734,0.336755460191835,1,1,1,macromolecule depalmitoylation,BP,LYPLAL1
1457,GO:0031090,0.339347058142216,0.80700741359378,10,28,organelle membrane,CC,ACAT1;MRPL14;PXMP2;ACADVL;ABCG1;ECI1;ETFDH;PLA2G16;CPT1C;ZFYVE21
85,GO:0001776,0.339742146774147,1,1,1,leukocyte homeostasis,BP,FADD
98,GO:0001906,0.339742146774147,1,1,1,cell killing,BP,FADD
99,GO:0001909,0.339742146774147,1,1,1,leukocyte mediated cytotoxicity,BP,FADD
100,GO:0001910,0.339742146774147,1,1,1,regulation of leukocyte mediated cytotoxicity,BP,FADD
101,GO:0001912,0.339742146774147,1,1,1,positive regulation of leukocyte mediated cytotoxicity,BP,FADD
102,GO:0001913,0.339742146774147,1,1,1,T cell mediated cytotoxicity,BP,FADD
103,GO:0001914,0.339742146774147,1,1,1,regulation of T cell mediated cytotoxicity,BP,FADD
104,GO:0001916,0.339742146774147,1,1,1,positive regulation of T cell mediated cytotoxicity,BP,FADD
117,GO:0001961,0.339742146774147,1,1,1,positive regulation of cytokine-mediated signaling pathway,BP,FADD
136,GO:0002260,0.339742146774147,1,1,1,lymphocyte homeostasis,BP,FADD
151,GO:0002449,0.339742146774147,1,1,1,lymphocyte mediated immunity,BP,FADD
152,GO:0002456,0.339742146774147,1,1,1,T cell mediated immunity,BP,FADD
153,GO:0002460,0.339742146774147,1,1,1,adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,BP,FADD
162,GO:0002573,0.339742146774147,1,1,1,myeloid leukocyte differentiation,BP,FADD
179,GO:0002691,0.339742146774147,1,1,1,regulation of cellular extravasation,BP,FADD
180,GO:0002693,0.339742146774147,1,1,1,positive regulation of cellular extravasation,BP,FADD
187,GO:0002703,0.339742146774147,1,1,1,regulation of leukocyte mediated immunity,BP,FADD
188,GO:0002705,0.339742146774147,1,1,1,positive regulation of leukocyte mediated immunity,BP,FADD
189,GO:0002706,0.339742146774147,1,1,1,regulation of lymphocyte mediated immunity,BP,FADD
190,GO:0002708,0.339742146774147,1,1,1,positive regulation of lymphocyte mediated immunity,BP,FADD
191,GO:0002709,0.339742146774147,1,1,1,regulation of T cell mediated immunity,BP,FADD
192,GO:0002711,0.339742146774147,1,1,1,positive regulation of T cell mediated immunity,BP,FADD
196,GO:0002761,0.339742146774147,1,1,1,regulation of myeloid leukocyte differentiation,BP,FADD
197,GO:0002763,0.339742146774147,1,1,1,positive regulation of myeloid leukocyte differentiation,BP,FADD
205,GO:0002822,0.339742146774147,1,1,1,regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,BP,FADD
206,GO:0002824,0.339742146774147,1,1,1,positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,BP,FADD
602,GO:0006924,0.339742146774147,1,1,1,activation-induced cell death of T cells,BP,FADD
1001,GO:0014072,0.339742146774147,1,1,1,response to isoquinoline alkaloid,BP,FADD
1362,GO:0030099,0.339742146774147,1,1,1,myeloid cell differentiation,BP,FADD
1393,GO:0030225,0.339742146774147,1,1,1,macrophage differentiation,BP,FADD
1418,GO:0030534,0.339742146774147,1,1,1,adult behavior,BP,FADD
1473,GO:0031265,0.339742146774147,1,1,1,CD95 death-inducing signaling complex,CC,FADD
1491,GO:0031341,0.339742146774147,1,1,1,regulation of cell killing,BP,FADD
1492,GO:0031343,0.339742146774147,1,1,1,positive regulation of cell killing,BP,FADD
1510,GO:0031638,0.339742146774147,1,1,1,zymogen activation,BP,FADD
1670,GO:0033077,0.339742146774147,1,1,1,T cell differentiation in thymus,BP,FADD
1811,GO:0035697,0.339742146774147,1,1,1,CD8-positive, alpha-beta T cell extravasation,BP,FADD
1812,GO:0035698,0.339742146774147,1,1,1,CD8-positive, alpha-beta cytotoxic T cell extravasation,BP,FADD
1841,GO:0036462,0.339742146774147,1,1,1,TRAIL-activated apoptotic signaling pathway,BP,FADD
1847,GO:0038034,0.339742146774147,1,1,1,signal transduction in absence of ligand,BP,FADD
1889,GO:0042220,0.339742146774147,1,1,1,response to cocaine,BP,FADD
1982,GO:0043029,0.339742146774147,1,1,1,T cell homeostasis,BP,FADD
2029,GO:0043278,0.339742146774147,1,1,1,response to morphine,BP,FADD
2190,GO:0045123,0.339742146774147,1,1,1,cellular extravasation,BP,FADD
2224,GO:0045637,0.339742146774147,1,1,1,regulation of myeloid cell differentiation,BP,FADD
2225,GO:0045639,0.339742146774147,1,1,1,positive regulation of myeloid cell differentiation,BP,FADD
2226,GO:0045649,0.339742146774147,1,1,1,regulation of macrophage differentiation,BP,FADD
2227,GO:0045651,0.339742146774147,1,1,1,positive regulation of macrophage differentiation,BP,FADD
2393,GO:0048148,0.339742146774147,1,1,1,behavioral response to cocaine,BP,FADD
2419,GO:0048535,0.339742146774147,1,1,1,lymph node development,BP,FADD
2420,GO:0048536,0.339742146774147,1,1,1,spleen development,BP,FADD
2421,GO:0048538,0.339742146774147,1,1,1,thymus development,BP,FADD
2465,GO:0048872,0.339742146774147,1,1,1,homeostasis of number of cells,BP,FADD
2747,GO:0060338,0.339742146774147,1,1,1,regulation of type I interferon-mediated signaling pathway,BP,FADD
2748,GO:0060340,0.339742146774147,1,1,1,positive regulation of type I interferon-mediated signaling pathway,BP,FADD
2755,GO:0060359,0.339742146774147,1,1,1,response to ammonium ion,BP,FADD
2769,GO:0060546,0.339742146774147,1,1,1,negative regulation of necroptotic process,BP,FADD
2777,GO:0060760,0.339742146774147,1,1,1,positive regulation of response to cytokine stimulus,BP,FADD
2820,GO:0070227,0.339742146774147,1,1,1,lymphocyte apoptotic process,BP,FADD
2821,GO:0070228,0.339742146774147,1,1,1,regulation of lymphocyte apoptotic process,BP,FADD
2822,GO:0070229,0.339742146774147,1,1,1,negative regulation of lymphocyte apoptotic process,BP,FADD
2823,GO:0070231,0.339742146774147,1,1,1,T cell apoptotic process,BP,FADD
2824,GO:0070232,0.339742146774147,1,1,1,regulation of T cell apoptotic process,BP,FADD
2825,GO:0070233,0.339742146774147,1,1,1,negative regulation of T cell apoptotic process,BP,FADD
2826,GO:0070235,0.339742146774147,1,1,1,regulation of activation-induced cell death of T cells,BP,FADD
2827,GO:0070236,0.339742146774147,1,1,1,negative regulation of activation-induced cell death of T cells,BP,FADD
2884,GO:0071214,0.339742146774147,1,1,1,cellular response to abiotic stimulus,BP,FADD
2892,GO:0071260,0.339742146774147,1,1,1,cellular response to mechanical stimulus,BP,FADD
2955,GO:0071887,0.339742146774147,1,1,1,leukocyte apoptotic process,BP,FADD
3005,GO:0072683,0.339742146774147,1,1,1,T cell extravasation,BP,FADD
3050,GO:0097049,0.339742146774147,1,1,1,motor neuron apoptotic process,BP,FADD
3059,GO:0097192,0.339742146774147,1,1,1,extrinsic apoptotic signaling pathway in absence of ligand,BP,FADD
3063,GO:0097202,0.339742146774147,1,1,1,activation of cysteine-type endopeptidase activity,BP,FADD
3078,GO:0097527,0.339742146774147,1,1,1,necroptotic signaling pathway,BP,FADD
3216,GO:1902043,0.339742146774147,1,1,1,positive regulation of extrinsic apoptotic signaling pathway via death domain receptors,BP,FADD
3379,GO:2000106,0.339742146774147,1,1,1,regulation of leukocyte apoptotic process,BP,FADD
3380,GO:2000107,0.339742146774147,1,1,1,negative regulation of leukocyte apoptotic process,BP,FADD
3402,GO:2000407,0.339742146774147,1,1,1,regulation of T cell extravasation,BP,FADD
3403,GO:2000409,0.339742146774147,1,1,1,positive regulation of T cell extravasation,BP,FADD
3404,GO:2000449,0.339742146774147,1,1,1,regulation of CD8-positive, alpha-beta T cell extravasation,BP,FADD
3405,GO:2000451,0.339742146774147,1,1,1,positive regulation of CD8-positive, alpha-beta T cell extravasation,BP,FADD
3406,GO:2000452,0.339742146774147,1,1,1,regulation of CD8-positive, alpha-beta cytotoxic T cell extravasation,BP,FADD
3407,GO:2000454,0.339742146774147,1,1,1,positive regulation of CD8-positive, alpha-beta cytotoxic T cell extravasation,BP,FADD
1200,GO:0017016,0.34026454452206,0.965773419639725,1,2,Ras GTPase binding,MF,TBC1D14
1212,GO:0017137,0.34026454452206,0.965773419639725,1,2,Rab GTPase binding,MF,TBC1D14
1474,GO:0031267,0.34026454452206,0.965773419639725,1,2,small GTPase binding,MF,TBC1D14
2555,GO:0051020,0.34026454452206,0.965773419639725,1,2,GTPase binding,MF,TBC1D14
219,GO:0003674,0.340730109291115,0.88236300972216,39,117,molecular_function,MF,HACL1;MSRA;ACAT1;MRPL14;PXMP2;PXK;RBP4;ACADVL;CNIH4;ARL6IP4;PUS1;NUDT7;TSFM;ABCG1;ALG5;BOLA1;USE1;KRT10;ECI1;ETFDH;LYPLAL1;FADD;DEPTOR;PSMB10;LAGE3;TBC1D14;NUDT6;HNF1A;PTS;PLA2G16;DECR1;LINGO1;FGF18;CPT1C;ZFYVE21;DPM3;PEPD;ETFB;IFI30
390,GO:0005778,0.341698012240881,0.921933929659442,2,4,peroxisomal membrane,CC,PXMP2;PLA2G16
1523,GO:0031903,0.341698012240881,0.921933929659442,2,4,microbody membrane,CC,PXMP2;PLA2G16
1288,GO:0019866,0.343744957382753,0.847275141387326,5,12,organelle inner membrane,CC,ACAT1;MRPL14;ACADVL;ECI1;ETFDH
2086,GO:0044085,0.343915336954026,0.834079913254467,6,15,cellular component biogenesis,BP,HACL1;ACAT1;FADD;TBC1D14;HNF1A;DECR1
250,GO:0004165,0.34538764295978,1,1,1,dodecenoyl-CoA delta-isomerase activity,MF,ECI1
741,GO:0008361,0.34538764295978,1,1,1,regulation of cell size,BP,DEPTOR
1525,GO:0031929,0.34538764295978,1,1,1,TOR signaling,BP,DEPTOR
1537,GO:0032006,0.34538764295978,1,1,1,regulation of TOR signaling,BP,DEPTOR
1538,GO:0032007,0.34538764295978,1,1,1,negative regulation of TOR signaling,BP,DEPTOR
2240,GO:0045792,0.34538764295978,1,1,1,negative regulation of cell size,BP,DEPTOR
764,GO:0008643,0.346994458119812,0.964237446503609,1,2,carbohydrate transport,BP,HNF1A
765,GO:0008645,0.346994458119812,0.964237446503609,1,2,hexose transport,BP,HNF1A
1049,GO:0015749,0.346994458119812,0.964237446503609,1,2,monosaccharide transport,BP,HNF1A
1050,GO:0015758,0.346994458119812,0.964237446503609,1,2,glucose transport,BP,HNF1A
2279,GO:0046323,0.346994458119812,0.964237446503609,1,2,glucose import,BP,HNF1A
476,GO:0006461,0.347258692443409,0.848859194186689,5,11,protein complex assembly,BP,HACL1;ACAT1;FADD;HNF1A;DECR1
2831,GO:0070271,0.347258692443409,0.848859194186689,5,11,protein complex biogenesis,BP,HACL1;ACAT1;FADD;HNF1A;DECR1
2305,GO:0046474,0.347275175528049,0.939624955704558,2,3,glycerophospholipid biosynthetic process,BP,FGF18;DPM3
2131,GO:0044430,0.349638869883503,0.9186490405898,2,4,cytoskeletal part,CC,PXK;KRT10
1290,GO:0019882,0.35194447924418,0.938118627128789,2,3,antigen processing and presentation,BP,PSMB10;IFI30
2380,GO:0048002,0.35194447924418,0.938118627128789,2,3,antigen processing and presentation of peptide antigen,BP,PSMB10;IFI30
2652,GO:0051536,0.352376829443614,0.962978724968815,1,2,iron-sulfur cluster binding,MF,ETFDH
2655,GO:0051540,0.352376829443614,0.962978724968815,1,2,metal cluster binding,MF,ETFDH
58,GO:0001522,0.352912403493782,1,1,1,pseudouridine synthesis,BP,PUS1
294,GO:0004730,0.352912403493782,1,1,1,pseudouridylate synthase activity,MF,PUS1
882,GO:0009982,0.352912403493782,1,1,1,pseudouridine synthase activity,MF,PUS1
1128,GO:0016556,0.352912403493782,1,1,1,mRNA modification,BP,PUS1
1190,GO:0016866,0.352912403493782,1,1,1,intramolecular transferase activity,MF,PUS1
1461,GO:0031119,0.352912403493782,1,1,1,tRNA pseudouridine synthesis,BP,PUS1
2876,GO:0070902,0.352912403493782,1,1,1,mitochondrial tRNA pseudouridine synthesis,BP,PUS1
3368,GO:1990481,0.352912403493782,1,1,1,mRNA pseudouridine synthesis,BP,PUS1
226,GO:0003723,0.353930422894628,0.840602704815501,5,12,RNA binding,MF,MRPL14;ARL6IP4;PUS1;NUDT7;TSFM
2162,GO:0044712,0.355861910695195,0.791683358438231,11,29,single-organism catabolic process,BP,HACL1;ACAT1;ACADVL;NUDT7;ECI1;ETFDH;PLA2G16;DECR1;CPT1C;PEPD;ETFB
1157,GO:0016740,0.356646658805989,0.813206282884879,7,19,transferase activity,MF,ACAT1;ALG5;PLA2G16;FGF18;CPT1C;ZFYVE21;DPM3
774,GO:0009055,0.357283317111887,0.915418306620192,2,4,electron carrier activity,MF,ETFDH;ETFB
2387,GO:0048037,0.359658059906127,0.833618959912978,5,13,cofactor binding,MF,HACL1;ACAT1;ACADVL;ETFDH;DECR1
374,GO:0005740,0.362139689254603,0.821432793064469,6,15,mitochondrial envelope,CC,ACAT1;MRPL14;ACADVL;ECI1;ETFDH;CPT1C
1528,GO:0031966,0.362139689254603,0.821432793064469,6,15,mitochondrial membrane,CC,ACAT1;MRPL14;ACADVL;ECI1;ETFDH;CPT1C
776,GO:0009057,0.362707655444785,0.8819980646311,3,6,macromolecule catabolic process,BP,USE1;LYPLAL1;PSMB10
54,GO:0001503,0.363724919732644,1,1,1,ossification,BP,FGF18
76,GO:0001667,0.363724919732644,1,1,1,ameboidal-type cell migration,BP,FGF18
113,GO:0001957,0.363724919732644,1,1,1,intramembranous ossification,BP,FGF18
114,GO:0001958,0.363724919732644,1,1,1,endochondral ossification,BP,FGF18
124,GO:0002062,0.363724919732644,1,1,1,chondrocyte differentiation,BP,FGF18
125,GO:0002063,0.363724919732644,1,1,1,chondrocyte development,BP,FGF18
291,GO:0004713,0.363724919732644,1,1,1,protein tyrosine kinase activity,MF,FGF18
312,GO:0005085,0.363724919732644,1,1,1,guanyl-nucleotide exchange factor activity,MF,FGF18
313,GO:0005088,0.363724919732644,1,1,1,Ras guanyl-nucleotide exchange factor activity,MF,FGF18
316,GO:0005104,0.363724919732644,1,1,1,fibroblast growth factor receptor binding,MF,FGF18
317,GO:0005105,0.363724919732644,1,1,1,type 1 fibroblast growth factor receptor binding,MF,FGF18
318,GO:0005111,0.363724919732644,1,1,1,type 2 fibroblast growth factor receptor binding,MF,FGF18
754,GO:0008543,0.363724919732644,1,1,1,fibroblast growth factor receptor signaling pathway,BP,FGF18
913,GO:0010594,0.363724919732644,1,1,1,regulation of endothelial cell migration,BP,FGF18
914,GO:0010595,0.363724919732644,1,1,1,positive regulation of endothelial cell migration,BP,FGF18
920,GO:0010631,0.363724919732644,1,1,1,epithelial cell migration,BP,FGF18
921,GO:0010632,0.363724919732644,1,1,1,regulation of epithelial cell migration,BP,FGF18
922,GO:0010634,0.363724919732644,1,1,1,positive regulation of epithelial cell migration,BP,FGF18
998,GO:0014065,0.363724919732644,1,1,1,phosphatidylinositol 3-kinase signaling,BP,FGF18
999,GO:0014066,0.363724919732644,1,1,1,regulation of phosphatidylinositol 3-kinase signaling,BP,FGF18
1105,GO:0016303,0.363724919732644,1,1,1,1-phosphatidylinositol-3-kinase activity,MF,FGF18
1452,GO:0030947,0.363724919732644,1,1,1,regulation of vascular endothelial growth factor receptor signaling pathway,BP,FGF18
1453,GO:0030949,0.363724919732644,1,1,1,positive regulation of vascular endothelial growth factor receptor signaling pathway,BP,FGF18
1544,GO:0032103,0.363724919732644,1,1,1,positive regulation of response to external stimulus,BP,FGF18
1557,GO:0032330,0.363724919732644,1,1,1,regulation of chondrocyte differentiation,BP,FGF18
1558,GO:0032332,0.363724919732644,1,1,1,positive regulation of chondrocyte differentiation,BP,FGF18
1773,GO:0035004,0.363724919732644,1,1,1,phosphatidylinositol 3-kinase activity,MF,FGF18
1814,GO:0035766,0.363724919732644,1,1,1,cell chemotaxis to fibroblast growth factor,BP,FGF18
1815,GO:0035767,0.363724919732644,1,1,1,endothelial cell chemotaxis,BP,FGF18
1816,GO:0035768,0.363724919732644,1,1,1,endothelial cell chemotaxis to fibroblast growth factor,BP,FGF18
1826,GO:0036072,0.363724919732644,1,1,1,direct ossification,BP,FGF18
1827,GO:0036075,0.363724919732644,1,1,1,replacement ossification,BP,FGF18
1828,GO:0036092,0.363724919732644,1,1,1,phosphatidylinositol-3-phosphate biosynthetic process,BP,FGF18
2060,GO:0043542,0.363724919732644,1,1,1,endothelial cell migration,BP,FGF18
2362,GO:0046934,0.363724919732644,1,1,1,phosphatidylinositol-4,5-bisphosphate 3-kinase activity,MF,FGF18
2382,GO:0048010,0.363724919732644,1,1,1,vascular endothelial growth factor receptor signaling pathway,BP,FGF18
2383,GO:0048015,0.363724919732644,1,1,1,phosphatidylinositol-mediated signaling,BP,FGF18
2384,GO:0048017,0.363724919732644,1,1,1,inositol lipid-mediated signaling,BP,FGF18
2449,GO:0048705,0.363724919732644,1,1,1,skeletal system morphogenesis,BP,FGF18
2543,GO:0050920,0.363724919732644,1,1,1,regulation of chemotaxis,BP,FGF18
2544,GO:0050921,0.363724919732644,1,1,1,positive regulation of chemotaxis,BP,FGF18
2594,GO:0051216,0.363724919732644,1,1,1,cartilage development,BP,FGF18
2689,GO:0052742,0.363724919732644,1,1,1,phosphatidylinositol kinase activity,MF,FGF18
2690,GO:0052813,0.363724919732644,1,1,1,phosphatidylinositol bisphosphate kinase activity,MF,FGF18
2744,GO:0060326,0.363724919732644,1,1,1,cell chemotaxis,BP,FGF18
2753,GO:0060349,0.363724919732644,1,1,1,bone morphogenesis,BP,FGF18
2754,GO:0060350,0.363724919732644,1,1,1,endochondral bone morphogenesis,BP,FGF18
2784,GO:0061035,0.363724919732644,1,1,1,regulation of cartilage development,BP,FGF18
2785,GO:0061036,0.363724919732644,1,1,1,positive regulation of cartilage development,BP,FGF18
3017,GO:0090130,0.363724919732644,1,1,1,tissue migration,BP,FGF18
3018,GO:0090132,0.363724919732644,1,1,1,epithelium migration,BP,FGF18
3035,GO:0090287,0.363724919732644,1,1,1,regulation of cellular response to growth factor stimulus,BP,FGF18
3347,GO:1904847,0.363724919732644,1,1,1,regulation of cell chemotaxis to fibroblast growth factor,BP,FGF18
3348,GO:1904849,0.363724919732644,1,1,1,positive regulation of cell chemotaxis to fibroblast growth factor,BP,FGF18
3410,GO:2000544,0.363724919732644,1,1,1,regulation of endothelial cell chemotaxis to fibroblast growth factor,BP,FGF18
3411,GO:2000546,0.363724919732644,1,1,1,positive regulation of endothelial cell chemotaxis to fibroblast growth factor,BP,FGF18
3418,GO:2001026,0.363724919732644,1,1,1,regulation of endothelial cell chemotaxis,BP,FGF18
3419,GO:2001028,0.363724919732644,1,1,1,positive regulation of endothelial cell chemotaxis,BP,FGF18
700,GO:0008113,0.365893932596744,1,1,1,peptide-methionine (S)-S-oxide reductase activity,MF,MSRA
1145,GO:0016671,0.365893932596744,1,1,1,oxidoreductase activity, acting on a sulfur group of donors, disulfide as acceptor,MF,MSRA
1359,GO:0030091,0.365893932596744,1,1,1,protein repair,BP,MSRA
2096,GO:0044238,0.368749605808223,0.777542276827708,31,90,primary metabolic process,BP,HACL1;MSRA;ACAT1;MRPL14;RBP4;ACADVL;ARL6IP4;PUS1;NUDT7;TSFM;ABCG1;ALG5;USE1;KRT10;ECI1;ETFDH;LYPLAL1;FADD;DEPTOR;PSMB10;LAGE3;HNF1A;PTS;PLA2G16;DECR1;FGF18;CPT1C;ZFYVE21;DPM3;PEPD;ETFB
1511,GO:0031647,0.369063160846118,0.932415957868494,2,3,regulation of protein stability,BP,DPM3;IFI30
20,GO:0000285,0.372772177382892,1,1,1,1-phosphatidylinositol-3-phosphate 5-kinase activity,MF,ZFYVE21
410,GO:0005912,0.372772177382892,1,1,1,adherens junction,CC,ZFYVE21
411,GO:0005924,0.372772177382892,1,1,1,cell-substrate adherens junction,CC,ZFYVE21
412,GO:0005925,0.372772177382892,1,1,1,focal adhesion,CC,ZFYVE21
1106,GO:0016307,0.372772177382892,1,1,1,phosphatidylinositol phosphate kinase activity,MF,ZFYVE21
1354,GO:0030055,0.372772177382892,1,1,1,cell-substrate junction,CC,ZFYVE21
2817,GO:0070161,0.372772177382892,1,1,1,anchoring junction,CC,ZFYVE21
2612,GO:0051259,0.373967400435791,0.875905501070259,3,6,protein oligomerization,BP,HACL1;ACAT1;DECR1
1134,GO:0016607,0.374083822349626,1,1,1,nuclear speck,CC,ARL6IP4
2129,GO:0044428,0.375966458942421,0.792265267916306,8,21,nuclear part,CC,MSRA;ACADVL;ARL6IP4;PSMB10;LAGE3;TBC1D14;DECR1;FGF18
851,GO:0009653,0.377703912756946,0.844214958551599,4,9,anatomical structure morphogenesis,BP,RBP4;PSMB10;LINGO1;FGF18
1745,GO:0034470,0.379729184250341,0.905536651771765,2,4,ncRNA processing,BP,PUS1;LAGE3
1083,GO:0016071,0.380352069650851,0.905253883355243,2,4,mRNA metabolic process,BP,ARL6IP4;PUS1
2311,GO:0046486,0.380598219110348,0.849390108697212,4,8,glycerolipid metabolic process,BP,PLA2G16;FGF18;ZFYVE21;DPM3
1015,GO:0015031,0.380656051385999,0.82254265545749,5,12,protein transport,BP,RBP4;CNIH4;ABCG1;USE1;TBC1D14
1055,GO:0015833,0.380656051385999,0.82254265545749,5,12,peptide transport,BP,RBP4;CNIH4;ABCG1;USE1;TBC1D14
1964,GO:0042886,0.380656051385999,0.82254265545749,5,12,amide transport,BP,RBP4;CNIH4;ABCG1;USE1;TBC1D14
2193,GO:0045184,0.380656051385999,0.82254265545749,5,12,establishment of protein localization,BP,RBP4;CNIH4;ABCG1;USE1;TBC1D14
769,GO:0008670,0.381556530480585,1,1,1,2,4-dienoyl-CoA reductase (NADPH) activity,MF,DECR1
1143,GO:0016651,0.381556530480585,1,1,1,oxidoreductase activity, acting on NAD(P)H,MF,DECR1
2840,GO:0070402,0.381556530480585,1,1,1,NADPH binding,MF,DECR1
1493,GO:0031344,0.382249913219809,0.955486439806076,1,2,regulation of cell projection organization,BP,LINGO1
289,GO:0004623,0.382475917512285,1,1,1,phospholipase A2 activity,MF,PLA2G16
522,GO:0006658,0.382475917512285,1,1,1,phosphatidylserine metabolic process,BP,PLA2G16
524,GO:0006662,0.382475917512285,1,1,1,glycerol ether metabolic process,BP,PLA2G16
621,GO:0007031,0.382475917512285,1,1,1,peroxisome organization,BP,PLA2G16
772,GO:0008970,0.382475917512285,1,1,1,phosphatidylcholine 1-acylhydrolase activity,MF,PLA2G16
1232,GO:0018904,0.382475917512285,1,1,1,ether metabolic process,BP,PLA2G16
1831,GO:0036149,0.382475917512285,1,1,1,phosphatidylinositol acyl-chain remodeling,BP,PLA2G16
1832,GO:0036150,0.382475917512285,1,1,1,phosphatidylserine acyl-chain remodeling,BP,PLA2G16
1833,GO:0036151,0.382475917512285,1,1,1,phosphatidylcholine acyl-chain remodeling,BP,PLA2G16
1834,GO:0036152,0.382475917512285,1,1,1,phosphatidylethanolamine acyl-chain remodeling,BP,PLA2G16
2310,GO:0046485,0.382475917512285,1,1,1,ether lipid metabolic process,BP,PLA2G16
2687,GO:0052739,0.382475917512285,1,1,1,phosphatidylserine 1-acylhydrolase activity,MF,PLA2G16
2688,GO:0052740,0.382475917512285,1,1,1,1-acyl-2-lysophosphatidylserine acylhydrolase activity,MF,PLA2G16
3332,GO:1904177,0.382475917512285,1,1,1,regulation of adipose tissue development,BP,PLA2G16
400,GO:0005829,0.382567100108094,0.75758208782719,15,42,cytosol,CC,MSRA;PXK;RBP4;ACADVL;KRT10;LYPLAL1;FADD;PSMB10;TBC1D14;PTS;PLA2G16;DECR1;ZFYVE21;ETFB;IFI30
1104,GO:0016301,0.383391260524177,0.892068402704533,2,5,kinase activity,MF,FGF18;ZFYVE21
1166,GO:0016773,0.383391260524177,0.892068402704533,2,5,phosphotransferase activity, alcohol group as acceptor,MF,FGF18;ZFYVE21
2221,GO:0045597,0.384166545731792,0.903512031597565,2,4,positive regulation of cell differentiation,BP,FADD;FGF18
282,GO:0004576,0.387356646245831,1,1,1,oligosaccharyl transferase activity,MF,ALG5
283,GO:0004581,0.387356646245831,1,1,1,dolichyl-phosphate beta-glucosyltransferase activity,MF,ALG5
657,GO:0007368,0.387356646245831,1,1,1,determination of left/right symmetry,BP,ALG5
658,GO:0007389,0.387356646245831,1,1,1,pattern specification process,BP,ALG5
862,GO:0009799,0.387356646245831,1,1,1,specification of symmetry,BP,ALG5
863,GO:0009855,0.387356646245831,1,1,1,determination of bilateral symmetry,BP,ALG5
1778,GO:0035251,0.387356646245831,1,1,1,UDP-glucosyltransferase activity,MF,ALG5
2319,GO:0046527,0.387356646245831,1,1,1,glucosyltransferase activity,MF,ALG5
622,GO:0007033,0.387955605086686,0.953954577672052,1,2,vacuole organization,BP,TBC1D14
481,GO:0006479,0.391562596710872,1,1,1,protein methylation,BP,ETFB
722,GO:0008213,0.391562596710872,1,1,1,protein alkylation,BP,ETFB
1405,GO:0030334,0.391956361189122,0.89989997050667,2,4,regulation of cell migration,BP,FADD;FGF18
1406,GO:0030335,0.391956361189122,0.89989997050667,2,4,positive regulation of cell migration,BP,FADD;FGF18
1858,GO:0040017,0.391956361189122,0.89989997050667,2,4,positive regulation of locomotion,BP,FADD;FGF18
2618,GO:0051272,0.391956361189122,0.89989997050667,2,4,positive regulation of cellular component movement,BP,FADD;FGF18
3390,GO:2000147,0.391956361189122,0.89989997050667,2,4,positive regulation of cell motility,BP,FADD;FGF18
2087,GO:0044087,0.392868051445395,0.887209503167654,2,5,regulation of cellular component biogenesis,BP,TBC1D14;HNF1A
649,GO:0007275,0.393444604296309,0.76588571763163,10,27,multicellular organism development,BP,ACAT1;RBP4;ALG5;KRT10;FADD;PSMB10;PTS;PLA2G16;LINGO1;FGF18
2220,GO:0045596,0.396241678778021,0.897881206321525,2,4,negative regulation of cell differentiation,BP,ABCG1;LINGO1
1292,GO:0019886,0.396505713112874,1,1,1,antigen processing and presentation of exogenous peptide antigen via MHC class II,BP,IFI30
2390,GO:0048144,0.396505713112874,1,1,1,fibroblast proliferation,BP,IFI30
2391,GO:0048145,0.396505713112874,1,1,1,regulation of fibroblast proliferation,BP,IFI30
2392,GO:0048147,0.396505713112874,1,1,1,negative regulation of fibroblast proliferation,BP,IFI30
2523,GO:0050821,0.396505713112874,1,1,1,protein stabilization,BP,IFI30
403,GO:0005856,0.397343309256956,0.853226518330553,3,7,cytoskeleton,CC,MSRA;PXK;KRT10
239,GO:0003986,0.39803402059112,1,1,1,acetyl-CoA hydrolase activity,MF,NUDT7
802,GO:0009132,0.39803402059112,1,1,1,nucleoside diphosphate metabolic process,BP,NUDT7
805,GO:0009154,0.39803402059112,1,1,1,purine ribonucleotide catabolic process,BP,NUDT7
817,GO:0009261,0.39803402059112,1,1,1,ribonucleotide catabolic process,BP,NUDT7
1068,GO:0015938,0.39803402059112,1,1,1,coenzyme A catabolic process,BP,NUDT7
1102,GO:0016289,0.39803402059112,1,1,1,CoA hydrolase activity,MF,NUDT7
1416,GO:0030515,0.39803402059112,1,1,1,snoRNA binding,MF,NUDT7
1694,GO:0033869,0.39803402059112,1,1,1,nucleoside bisphosphate catabolic process,BP,NUDT7
1698,GO:0034031,0.39803402059112,1,1,1,ribonucleoside bisphosphate catabolic process,BP,NUDT7
1701,GO:0034034,0.39803402059112,1,1,1,purine nucleoside bisphosphate catabolic process,BP,NUDT7
1324,GO:0022804,0.398836111659961,0.950940231601486,1,2,active transmembrane transporter activity,MF,ABCG1
6,GO:0000086,0.39995558892345,1,1,1,G2/M transition of mitotic cell cycle,BP,PSMB10
19,GO:0000278,0.39995558892345,1,1,1,mitotic cell cycle,BP,PSMB10
31,GO:0000502,0.39995558892345,1,1,1,proteasome complex,CC,PSMB10
81,GO:0001736,0.39995558892345,1,1,1,establishment of planar polarity,BP,PSMB10
82,GO:0001738,0.39995558892345,1,1,1,morphogenesis of a polarized epithelium,BP,PSMB10
119,GO:0002009,0.39995558892345,1,1,1,morphogenesis of an epithelium,BP,PSMB10
128,GO:0002220,0.39995558892345,1,1,1,innate immune response activating cell surface receptor signaling pathway,BP,PSMB10
130,GO:0002223,0.39995558892345,1,1,1,stimulatory C-type lectin receptor signaling pathway,BP,PSMB10
146,GO:0002429,0.39995558892345,1,1,1,immune response-activating cell surface receptor signaling pathway,BP,PSMB10
156,GO:0002479,0.39995558892345,1,1,1,antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent,BP,PSMB10
199,GO:0002768,0.39995558892345,1,1,1,immune response-regulating cell surface receptor signaling pathway,BP,PSMB10
258,GO:0004298,0.39995558892345,1,1,1,threonine-type endopeptidase activity,MF,PSMB10
401,GO:0005839,0.39995558892345,1,1,1,proteasome core complex,CC,PSMB10
489,GO:0006511,0.39995558892345,1,1,1,ubiquitin-dependent protein catabolic process,BP,PSMB10
492,GO:0006521,0.39995558892345,1,1,1,regulation of cellular amino acid metabolic process,BP,PSMB10
630,GO:0007164,0.39995558892345,1,1,1,establishment of tissue polarity,BP,PSMB10
656,GO:0007346,0.39995558892345,1,1,1,regulation of mitotic cell cycle,BP,PSMB10
895,GO:0010389,0.39995558892345,1,1,1,regulation of G2/M transition of mitotic cell cycle,BP,PSMB10
899,GO:0010498,0.39995558892345,1,1,1,proteasomal protein catabolic process,BP,PSMB10
911,GO:0010564,0.39995558892345,1,1,1,regulation of cell cycle process,BP,PSMB10
982,GO:0010948,0.39995558892345,1,1,1,negative regulation of cell cycle process,BP,PSMB10
988,GO:0010972,0.39995558892345,1,1,1,negative regulation of G2/M transition of mitotic cell cycle,BP,PSMB10
1081,GO:0016055,0.39995558892345,1,1,1,Wnt signaling pathway,BP,PSMB10
1130,GO:0016579,0.39995558892345,1,1,1,protein deubiquitination,BP,PSMB10
1299,GO:0019941,0.39995558892345,1,1,1,modification-dependent protein catabolic process,BP,PSMB10
1306,GO:0022402,0.39995558892345,1,1,1,cell cycle process,BP,PSMB10
1365,GO:0030111,0.39995558892345,1,1,1,regulation of Wnt signaling pathway,BP,PSMB10
1379,GO:0030177,0.39995558892345,1,1,1,positive regulation of Wnt signaling pathway,BP,PSMB10
1380,GO:0030178,0.39995558892345,1,1,1,negative regulation of Wnt signaling pathway,BP,PSMB10
1462,GO:0031145,0.39995558892345,1,1,1,anaphase-promoting complex-dependent catabolic process,BP,PSMB10
1463,GO:0031146,0.39995558892345,1,1,1,SCF-dependent proteasomal ubiquitin-dependent protein catabolic process,BP,PSMB10
1499,GO:0031397,0.39995558892345,1,1,1,negative regulation of protein ubiquitination,BP,PSMB10
1675,GO:0033238,0.39995558892345,1,1,1,regulation of cellular amine metabolic process,BP,PSMB10
1799,GO:0035567,0.39995558892345,1,1,1,non-canonical Wnt signaling pathway,BP,PSMB10
1848,GO:0038061,0.39995558892345,1,1,1,NIK/NF-kappaB signaling,BP,PSMB10
1849,GO:0038093,0.39995558892345,1,1,1,Fc receptor signaling pathway,BP,PSMB10
1850,GO:0038095,0.39995558892345,1,1,1,Fc-epsilon receptor signaling pathway,BP,PSMB10
1960,GO:0042787,0.39995558892345,1,1,1,protein ubiquitination involved in ubiquitin-dependent protein catabolic process,BP,PSMB10
2002,GO:0043161,0.39995558892345,1,1,1,proteasome-mediated ubiquitin-dependent protein catabolic process,BP,PSMB10
2069,GO:0043618,0.39995558892345,1,1,1,regulation of transcription from RNA polymerase II promoter in response to stress,BP,PSMB10
2070,GO:0043620,0.39995558892345,1,1,1,regulation of DNA-templated transcription in response to stress,BP,PSMB10
2074,GO:0043632,0.39995558892345,1,1,1,modification-dependent macromolecule catabolic process,BP,PSMB10
2170,GO:0044770,0.39995558892345,1,1,1,cell cycle phase transition,BP,PSMB10
2171,GO:0044772,0.39995558892345,1,1,1,mitotic cell cycle phase transition,BP,PSMB10
2174,GO:0044839,0.39995558892345,1,1,1,cell cycle G2/M phase transition,BP,PSMB10
2258,GO:0045930,0.39995558892345,1,1,1,negative regulation of mitotic cell cycle,BP,PSMB10
2452,GO:0048729,0.39995558892345,1,1,1,tissue morphogenesis,BP,PSMB10
2527,GO:0050851,0.39995558892345,1,1,1,antigen receptor-mediated signaling pathway,BP,PSMB10
2528,GO:0050852,0.39995558892345,1,1,1,T cell receptor signaling pathway,BP,PSMB10
2642,GO:0051436,0.39995558892345,1,1,1,negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle,BP,PSMB10
2643,GO:0051437,0.39995558892345,1,1,1,positive regulation of ubiquitin-protein ligase activity involved in regulation of mitotic cell cycle transition,BP,PSMB10
2644,GO:0051438,0.39995558892345,1,1,1,regulation of ubiquitin-protein transferase activity,BP,PSMB10
2645,GO:0051439,0.39995558892345,1,1,1,regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle,BP,PSMB10
2646,GO:0051443,0.39995558892345,1,1,1,positive regulation of ubiquitin-protein transferase activity,BP,PSMB10
2647,GO:0051444,0.39995558892345,1,1,1,negative regulation of ubiquitin-protein transferase activity,BP,PSMB10
2724,GO:0060070,0.39995558892345,1,1,1,canonical Wnt signaling pathway,BP,PSMB10
2725,GO:0060071,0.39995558892345,1,1,1,Wnt signaling pathway, planar cell polarity pathway,BP,PSMB10
2779,GO:0060828,0.39995558892345,1,1,1,regulation of canonical Wnt signaling pathway,BP,PSMB10
2796,GO:0061418,0.39995558892345,1,1,1,regulation of transcription from RNA polymerase II promoter in response to hypoxia,BP,PSMB10
2807,GO:0070003,0.39995558892345,1,1,1,threonine-type peptidase activity,MF,PSMB10
2854,GO:0070646,0.39995558892345,1,1,1,protein modification by small protein removal,BP,PSMB10
3016,GO:0090090,0.39995558892345,1,1,1,negative regulation of canonical Wnt signaling pathway,BP,PSMB10
3020,GO:0090175,0.39995558892345,1,1,1,regulation of establishment of planar polarity,BP,PSMB10
3032,GO:0090263,0.39995558892345,1,1,1,positive regulation of canonical Wnt signaling pathway,BP,PSMB10
3135,GO:0198738,0.39995558892345,1,1,1,cell-cell signaling by wnt,BP,PSMB10
3208,GO:1901987,0.39995558892345,1,1,1,regulation of cell cycle phase transition,BP,PSMB10
3209,GO:1901988,0.39995558892345,1,1,1,negative regulation of cell cycle phase transition,BP,PSMB10
3210,GO:1901990,0.39995558892345,1,1,1,regulation of mitotic cell cycle phase transition,BP,PSMB10
3211,GO:1901991,0.39995558892345,1,1,1,negative regulation of mitotic cell cycle phase transition,BP,PSMB10
3252,GO:1902749,0.39995558892345,1,1,1,regulation of cell cycle G2/M phase transition,BP,PSMB10
3253,GO:1902750,0.39995558892345,1,1,1,negative regulation of cell cycle G2/M phase transition,BP,PSMB10
3273,GO:1903047,0.39995558892345,1,1,1,mitotic cell cycle process,BP,PSMB10
3288,GO:1903321,0.39995558892345,1,1,1,negative regulation of protein modification by small protein conjugation or removal,BP,PSMB10
3341,GO:1904666,0.39995558892345,1,1,1,regulation of ubiquitin protein ligase activity,BP,PSMB10
3342,GO:1904667,0.39995558892345,1,1,1,negative regulation of ubiquitin protein ligase activity,BP,PSMB10
3343,GO:1904668,0.39995558892345,1,1,1,positive regulation of ubiquitin protein ligase activity,BP,PSMB10
3356,GO:1905330,0.39995558892345,1,1,1,regulation of morphogenesis of an epithelium,BP,PSMB10
3358,GO:1905368,0.39995558892345,1,1,1,peptidase complex,CC,PSMB10
3359,GO:1905369,0.39995558892345,1,1,1,endopeptidase complex,CC,PSMB10
3365,GO:1990111,0.39995558892345,1,1,1,spermatoproteasome complex,CC,PSMB10
3376,GO:2000027,0.39995558892345,1,1,1,regulation of organ morphogenesis,BP,PSMB10
3377,GO:2000058,0.39995558892345,1,1,1,regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process,BP,PSMB10
3378,GO:2000060,0.39995558892345,1,1,1,positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process,BP,PSMB10
518,GO:0006644,0.400671979107841,0.829253240288467,4,9,phospholipid metabolic process,BP,PLA2G16;FGF18;ZFYVE21;DPM3
236,GO:0003874,0.403188668822384,1,1,1,6-pyruvoyltetrahydropterin synthase activity,MF,PTS
1184,GO:0016838,0.403188668822384,1,1,1,carbon-oxygen lyase activity, acting on phosphates,MF,PTS
59,GO:0001523,0.403451835569179,1,1,1,retinoid metabolic process,BP,RBP4
70,GO:0001654,0.403451835569179,1,1,1,eye development,BP,RBP4
145,GO:0002377,0.403451835569179,1,1,1,immunoglobulin production,BP,RBP4
147,GO:0002440,0.403451835569179,1,1,1,production of molecular mediator of immune response,BP,RBP4
171,GO:0002637,0.403451835569179,1,1,1,regulation of immunoglobulin production,BP,RBP4
172,GO:0002639,0.403451835569179,1,1,1,positive regulation of immunoglobulin production,BP,RBP4
185,GO:0002700,0.403451835569179,1,1,1,regulation of production of molecular mediator of immune response,BP,RBP4
186,GO:0002702,0.403451835569179,1,1,1,positive regulation of production of molecular mediator of immune response,BP,RBP4
210,GO:0003007,0.403451835569179,1,1,1,heart morphogenesis,BP,RBP4
216,GO:0003205,0.403451835569179,1,1,1,cardiac chamber development,BP,RBP4
217,GO:0003206,0.403451835569179,1,1,1,cardiac chamber morphogenesis,BP,RBP4
343,GO:0005501,0.403451835569179,1,1,1,retinoid binding,MF,RBP4
664,GO:0007423,0.403451835569179,1,1,1,sensory organ development,BP,RBP4
665,GO:0007507,0.403451835569179,1,1,1,heart development,BP,RBP4
671,GO:0007586,0.403451835569179,1,1,1,digestion,BP,RBP4
676,GO:0007601,0.403451835569179,1,1,1,visual perception,BP,RBP4
859,GO:0009790,0.403451835569179,1,1,1,embryo development,BP,RBP4
861,GO:0009792,0.403451835569179,1,1,1,embryo development ending in birth or egg hatching,BP,RBP4
876,GO:0009914,0.403451835569179,1,1,1,hormone transport,BP,RBP4
937,GO:0010669,0.403451835569179,1,1,1,epithelial structure maintenance,BP,RBP4
1009,GO:0014855,0.403451835569179,1,1,1,striated muscle cell proliferation,BP,RBP4
1198,GO:0016918,0.403451835569179,1,1,1,retinal binding,MF,RBP4
1282,GO:0019840,0.403451835569179,1,1,1,isoprenoid binding,MF,RBP4
1283,GO:0019841,0.403451835569179,1,1,1,retinol binding,MF,RBP4
1315,GO:0022600,0.403451835569179,1,1,1,digestive system process,BP,RBP4
1342,GO:0023061,0.403451835569179,1,1,1,signal release,BP,RBP4
1357,GO:0030072,0.403451835569179,1,1,1,peptide hormone secretion,BP,RBP4
1358,GO:0030073,0.403451835569179,1,1,1,insulin secretion,BP,RBP4
1398,GO:0030277,0.403451835569179,1,1,1,maintenance of gastrointestinal epithelium,BP,RBP4
1420,GO:0030540,0.403451835569179,1,1,1,female genitalia development,BP,RBP4
1539,GO:0032024,0.403451835569179,1,1,1,positive regulation of insulin secretion,BP,RBP4
1591,GO:0032526,0.403451835569179,1,1,1,response to retinoic acid,BP,RBP4
1753,GO:0034632,0.403451835569179,1,1,1,retinol transporter activity,MF,RBP4
1754,GO:0034633,0.403451835569179,1,1,1,retinol transport,BP,RBP4
1776,GO:0035112,0.403451835569179,1,1,1,genitalia morphogenesis,BP,RBP4
1780,GO:0035265,0.403451835569179,1,1,1,organ growth,BP,RBP4
1935,GO:0042572,0.403451835569179,1,1,1,retinol metabolic process,BP,RBP4
1975,GO:0043009,0.403451835569179,1,1,1,chordate embryonic development,BP,RBP4
1976,GO:0043010,0.403451835569179,1,1,1,camera-type eye development,BP,RBP4
2256,GO:0045926,0.403451835569179,1,1,1,negative regulation of growth,BP,RBP4
2323,GO:0046620,0.403451835569179,1,1,1,regulation of organ growth,BP,RBP4
2324,GO:0046621,0.403451835569179,1,1,1,negative regulation of organ growth,BP,RBP4
2346,GO:0046864,0.403451835569179,1,1,1,isoprenoid transport,BP,RBP4
2347,GO:0046865,0.403451835569179,1,1,1,terpenoid transport,BP,RBP4
2350,GO:0046879,0.403451835569179,1,1,1,hormone secretion,BP,RBP4
2351,GO:0046883,0.403451835569179,1,1,1,regulation of hormone secretion,BP,RBP4
2352,GO:0046887,0.403451835569179,1,1,1,positive regulation of hormone secretion,BP,RBP4
2403,GO:0048305,0.403451835569179,1,1,1,immunoglobulin secretion,BP,RBP4
2423,GO:0048562,0.403451835569179,1,1,1,embryonic organ morphogenesis,BP,RBP4
2424,GO:0048568,0.403451835569179,1,1,1,embryonic organ development,BP,RBP4
2429,GO:0048592,0.403451835569179,1,1,1,eye morphogenesis,BP,RBP4
2430,GO:0048593,0.403451835569179,1,1,1,camera-type eye morphogenesis,BP,RBP4
2431,GO:0048598,0.403451835569179,1,1,1,embryonic morphogenesis,BP,RBP4
2439,GO:0048640,0.403451835569179,1,1,1,negative regulation of developmental growth,BP,RBP4
2450,GO:0048706,0.403451835569179,1,1,1,embryonic skeletal system development,BP,RBP4
2455,GO:0048738,0.403451835569179,1,1,1,cardiac muscle tissue development,BP,RBP4
2458,GO:0048807,0.403451835569179,1,1,1,female genitalia morphogenesis,BP,RBP4
2513,GO:0050796,0.403451835569179,1,1,1,regulation of insulin secretion,BP,RBP4
2545,GO:0050953,0.403451835569179,1,1,1,sensory perception of light stimulus,BP,RBP4
2556,GO:0051023,0.403451835569179,1,1,1,regulation of immunoglobulin secretion,BP,RBP4
2557,GO:0051024,0.403451835569179,1,1,1,positive regulation of immunoglobulin secretion,BP,RBP4
2585,GO:0051183,0.403451835569179,1,1,1,vitamin transporter activity,MF,RBP4
2691,GO:0055017,0.403451835569179,1,1,1,cardiac muscle tissue growth,BP,RBP4
2692,GO:0055021,0.403451835569179,1,1,1,regulation of cardiac muscle tissue growth,BP,RBP4
2693,GO:0055022,0.403451835569179,1,1,1,negative regulation of cardiac muscle tissue growth,BP,RBP4
2694,GO:0055024,0.403451835569179,1,1,1,regulation of cardiac muscle tissue development,BP,RBP4
2695,GO:0055026,0.403451835569179,1,1,1,negative regulation of cardiac muscle tissue development,BP,RBP4
2715,GO:0060038,0.403451835569179,1,1,1,cardiac muscle cell proliferation,BP,RBP4
2716,GO:0060041,0.403451835569179,1,1,1,retina development in camera-type eye,BP,RBP4
2717,GO:0060042,0.403451835569179,1,1,1,retina morphogenesis in camera-type eye,BP,RBP4
2718,GO:0060043,0.403451835569179,1,1,1,regulation of cardiac muscle cell proliferation,BP,RBP4
2719,GO:0060044,0.403451835569179,1,1,1,negative regulation of cardiac muscle cell proliferation,BP,RBP4
2721,GO:0060059,0.403451835569179,1,1,1,embryonic retina morphogenesis in camera-type eye,BP,RBP4
2722,GO:0060065,0.403451835569179,1,1,1,uterus development,BP,RBP4
2723,GO:0060068,0.403451835569179,1,1,1,vagina development,BP,RBP4
2730,GO:0060157,0.403451835569179,1,1,1,urinary bladder development,BP,RBP4
2750,GO:0060343,0.403451835569179,1,1,1,trabecula formation,BP,RBP4
2751,GO:0060347,0.403451835569179,1,1,1,heart trabecula formation,BP,RBP4
2761,GO:0060419,0.403451835569179,1,1,1,heart growth,BP,RBP4
2762,GO:0060420,0.403451835569179,1,1,1,regulation of heart growth,BP,RBP4
2788,GO:0061117,0.403451835569179,1,1,1,negative regulation of heart growth,BP,RBP4
2794,GO:0061383,0.403451835569179,1,1,1,trabecula morphogenesis,BP,RBP4
2795,GO:0061384,0.403451835569179,1,1,1,heart trabecula morphogenesis,BP,RBP4
3033,GO:0090276,0.403451835569179,1,1,1,regulation of peptide hormone secretion,BP,RBP4
3034,GO:0090277,0.403451835569179,1,1,1,positive regulation of peptide hormone secretion,BP,RBP4
3045,GO:0090596,0.403451835569179,1,1,1,sensory organ morphogenesis,BP,RBP4
2632,GO:0051347,0.404561093106324,0.893897032141609,2,4,positive regulation of transferase activity,BP,PSMB10;FGF18
2662,GO:0051641,0.40510581976454,0.820788881988394,4,10,cellular localization,BP,CNIH4;ABCG1;TBC1D14;ZFYVE21
1180,GO:0016830,0.406575405995037,0.892919366266435,2,4,carbon-carbon lyase activity,MF,HACL1;ACAT1
11,GO:0000165,0.407305541285509,0.892563727688475,2,4,MAPK cascade,BP,PSMB10;FGF18
1337,GO:0023014,0.407305541285509,0.892563727688475,2,4,signal transduction by protein phosphorylation,BP,PSMB10;FGF18
495,GO:0006549,0.407899124947193,0.94833406333061,1,2,isoleucine metabolic process,BP,ACAT1
592,GO:0006890,0.408038810083564,1,1,1,retrograde vesicle-mediated transport, Golgi to ER,BP,USE1
623,GO:0007034,0.408038810083564,1,1,1,vacuolar transport,BP,USE1
625,GO:0007041,0.408038810083564,1,1,1,lysosomal transport,BP,USE1
337,GO:0005319,0.409712338466481,0.891386647153301,2,4,lipid transporter activity,MF,RBP4;ABCG1
462,GO:0006355,0.410566872660546,0.794728195831066,5,14,regulation of transcription, DNA-templated,BP,TSFM;ABCG1;FADD;PSMB10;HNF1A
465,GO:0006366,0.411968784271712,0.844188532881183,3,7,transcription from RNA polymerase II promoter,BP,FADD;PSMB10;HNF1A
1160,GO:0016747,0.41313911880224,0.876421769181021,2,5,transferase activity, transferring acyl groups other than amino-acyl groups,MF,ACAT1;CPT1C
1162,GO:0016758,0.414288073066858,0.889128563562269,2,4,transferase activity, transferring hexosyl groups,MF,ALG5;DPM3
509,GO:0006631,0.415581008127976,0.758412479771024,8,23,fatty acid metabolic process,BP,HACL1;ACAT1;ACADVL;ECI1;ETFDH;DECR1;CPT1C;ETFB
1295,GO:0019901,0.420032303468567,0.928497732067473,1,3,protein kinase binding,MF,TBC1D14
2173,GO:0044802,0.422567474156062,0.943926855870458,1,2,single-organism membrane organization,BP,TBC1D14
2782,GO:0061024,0.422567474156062,0.943926855870458,1,2,membrane organization,BP,TBC1D14
1372,GO:0030154,0.423248879024642,0.760715779671973,7,20,cell differentiation,BP,ACADVL;NUDT7;ABCG1;KRT10;FADD;LINGO1;FGF18
2462,GO:0048869,0.423248879024642,0.760715779671973,7,20,cellular developmental process,BP,ACADVL;NUDT7;ABCG1;KRT10;FADD;LINGO1;FGF18
1082,GO:0016070,0.423279675232233,0.753568486018672,8,22,RNA metabolic process,BP,ARL6IP4;PUS1;TSFM;ABCG1;FADD;PSMB10;LAGE3;HNF1A
395,GO:0005793,0.423503613822761,1,1,1,endoplasmic reticulum-Golgi intermediate compartment,CC,CNIH4
591,GO:0006888,0.423503613822761,1,1,1,ER to Golgi vesicle-mediated transport,BP,CNIH4
1516,GO:0031730,0.423503613822761,1,1,1,CCR5 chemokine receptor binding,MF,CNIH4
1908,GO:0042379,0.423503613822761,1,1,1,chemokine receptor binding,MF,CNIH4
2385,GO:0048020,0.423503613822761,1,1,1,CCR chemokine receptor binding,MF,CNIH4
2094,GO:0044236,0.423648819529038,0.943592501227619,1,2,multicellular organism metabolic process,BP,PEPD
2111,GO:0044273,0.423774206407286,0.884361850811917,2,4,sulfur compound catabolic process,BP,ACAT1;NUDT7
3355,GO:1905114,0.42935755671637,0.941805410458526,1,2,cell surface receptor signaling pathway involved in cell-cell signaling,BP,PSMB10
2200,GO:0045333,0.429787562271858,0.88127978135845,2,4,cellular respiration,BP,ETFDH;ETFB
391,GO:0005782,0.430403215319848,0.880961564742038,2,4,peroxisomal matrix,CC,HACL1;NUDT7
1524,GO:0031907,0.430403215319848,0.880961564742038,2,4,microbody lumen,CC,HACL1;NUDT7
1057,GO:0015850,0.43050153147467,0.880910701285743,2,4,organic hydroxy compound transport,BP,RBP4;ABCG1
2158,GO:0044707,0.431626560845692,0.717733033372002,14,41,single-multicellular organism process,BP,ACAT1;RBP4;ACADVL;ABCG1;ALG5;KRT10;FADD;PSMB10;HNF1A;PTS;PLA2G16;LINGO1;FGF18;PEPD
2939,GO:0071705,0.432679732215768,0.781163723383712,5,13,nitrogen compound transport,BP,RBP4;CNIH4;ABCG1;USE1;TBC1D14
1682,GO:0033500,0.433242839536577,0.86517820450856,2,5,carbohydrate homeostasis,BP,RBP4;HNF1A
1941,GO:0042593,0.433242839536577,0.86517820450856,2,5,glucose homeostasis,BP,RBP4;HNF1A
1317,GO:0022603,0.433509852825082,0.879348200714008,2,4,regulation of anatomical structure morphogenesis,BP,PSMB10;LINGO1
3122,GO:0099513,0.43368780053607,0.940425004621419,1,2,polymeric cytoskeletal fiber,CC,KRT10
2,GO:0000030,0.434435076548239,1,1,1,mannosyltransferase activity,MF,DPM3
284,GO:0004582,0.434435076548239,1,1,1,dolichyl-phosphate beta-D-mannosyltransferase activity,MF,DPM3
484,GO:0006493,0.434435076548239,1,1,1,protein O-linked glycosylation,BP,DPM3
485,GO:0006497,0.434435076548239,1,1,1,protein lipidation,BP,DPM3
486,GO:0006505,0.434435076548239,1,1,1,GPI anchor metabolic process,BP,DPM3
487,GO:0006506,0.434435076548239,1,1,1,GPI anchor biosynthetic process,BP,DPM3
814,GO:0009247,0.434435076548239,1,1,1,glycolipid biosynthetic process,BP,DPM3
1219,GO:0018103,0.434435076548239,1,1,1,protein C-linked glycosylation,BP,DPM3
1225,GO:0018211,0.434435076548239,1,1,1,peptidyl-tryptophan modification,BP,DPM3
1228,GO:0018317,0.434435076548239,1,1,1,protein C-linked glycosylation via tryptophan,BP,DPM3
1229,GO:0018406,0.434435076548239,1,1,1,protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan,BP,DPM3
1508,GO:0031501,0.434435076548239,1,1,1,mannosyltransferase complex,CC,DPM3
1672,GO:0033185,0.434435076548239,1,1,1,dolichol-phosphate-mannose synthase complex,CC,DPM3
1781,GO:0035268,0.434435076548239,1,1,1,protein mannosylation,BP,DPM3
1782,GO:0035269,0.434435076548239,1,1,1,protein O-linked mannosylation,BP,DPM3
1881,GO:0042158,0.434435076548239,1,1,1,lipoprotein biosynthetic process,BP,DPM3
2303,GO:0046467,0.434435076548239,1,1,1,membrane lipid biosynthetic process,BP,DPM3
3077,GO:0097502,0.434435076548239,1,1,1,mannosylation,BP,DPM3
662,GO:0007417,0.435978665398606,0.878056975732637,2,4,central nervous system development,BP,ACAT1;PTS
358,GO:0005575,0.437177142843419,1,41,123,cellular_component,CC,HACL1;MSRA;ACAT1;MRPL14;PXMP2;PXK;RBP4;ACADVL;TMEM160;CNIH4;ARL6IP4;PUS1;NUDT7;TSFM;ABCG1;ALG5;BOLA1;USE1;KRT10;ECI1;ETFDH;LYPLAL1;CCDC51;FADD;DEPTOR;PSMB10;LAGE3;TBC1D14;NUDT6;HNF1A;PTS;PLA2G16;DECR1;LINGO1;FGF18;CPT1C;ZFYVE21;DPM3;PEPD;ETFB;IFI30
398,GO:0005815,0.440038011872254,0.938361329338592,1,2,microtubule organizing center,CC,PXK
1040,GO:0015630,0.440038011872254,0.938361329338592,1,2,microtubule cytoskeleton,CC,PXK
2685,GO:0052689,0.44162107675555,0.875075432079521,2,4,carboxylic ester hydrolase activity,MF,LYPLAL1;PLA2G16
1284,GO:0019842,0.442646929193956,0.8745287718011,2,4,vitamin binding,MF,HACL1;RBP4
767,GO:0008654,0.444252006081335,0.823260030730485,3,7,phospholipid biosynthetic process,BP,PLA2G16;FGF18;DPM3
1107,GO:0016310,0.445140942748821,0.787663295452752,4,11,phosphorylation,BP,DEPTOR;PSMB10;FGF18;ZFYVE21
2370,GO:0046983,0.446057231157598,0.77088308287463,5,13,protein dimerization activity,MF,ACAT1;RBP4;ABCG1;HNF1A;PTS
3171,GO:1901363,0.446157905136058,0.713975823103744,11,34,heterocyclic compound binding,MF,HACL1;MRPL14;ACADVL;ARL6IP4;PUS1;NUDT7;TSFM;ABCG1;ETFDH;HNF1A;DECR1
1220,GO:0018108,0.447420769349515,0.935902318250716,1,2,peptidyl-tyrosine phosphorylation,BP,FGF18
1226,GO:0018212,0.447420769349515,0.935902318250716,1,2,peptidyl-tyrosine modification,BP,FGF18
2039,GO:0043405,0.447420769349515,0.935902318250716,1,2,regulation of MAP kinase activity,BP,FGF18
2040,GO:0043406,0.447420769349515,0.935902318250716,1,2,positive regulation of MAP kinase activity,BP,FGF18
2959,GO:0071902,0.447420769349515,0.935902318250716,1,2,positive regulation of protein serine/threonine kinase activity,BP,FGF18
247,GO:0004095,0.447875408488201,0.935748760922566,1,2,carnitine O-palmitoyltransferase activity,MF,CPT1C
743,GO:0008374,0.447875408488201,0.935748760922566,1,2,O-acyltransferase activity,MF,CPT1C
1112,GO:0016406,0.447875408488201,0.935748760922566,1,2,carnitine O-acyltransferase activity,MF,CPT1C
1115,GO:0016409,0.447875408488201,0.935748760922566,1,2,palmitoyltransferase activity,MF,CPT1C
1116,GO:0016416,0.447875408488201,0.935748760922566,1,2,O-palmitoyltransferase activity,MF,CPT1C
430,GO:0006085,0.449796567945293,0.935097125718296,1,2,acetyl-CoA biosynthetic process,BP,ACAT1
127,GO:0002218,0.450403503476059,0.870349346167677,2,4,activation of innate immune response,BP,FADD;PSMB10
1497,GO:0031349,0.450403503476059,0.870349346167677,2,4,positive regulation of defense response,BP,FADD;PSMB10
2187,GO:0045089,0.450403503476059,0.870349346167677,2,4,positive regulation of innate immune response,BP,FADD;PSMB10
451,GO:0006163,0.452023797146291,0.86946594688527,2,4,purine nucleotide metabolic process,BP,ACAT1;NUDT7
706,GO:0008152,0.452439035477898,0.721515023900159,33,99,metabolic process,BP,HACL1;MSRA;ACAT1;MRPL14;RBP4;ACADVL;ARL6IP4;PUS1;NUDT7;TSFM;ABCG1;ALG5;USE1;KRT10;ECI1;ETFDH;LYPLAL1;FADD;DEPTOR;PSMB10;LAGE3;TBC1D14;HNF1A;PTS;PLA2G16;DECR1;FGF18;CPT1C;ZFYVE21;DPM3;PEPD;ETFB;IFI30
2625,GO:0051338,0.457203017394119,0.8144749463646,3,7,regulation of transferase activity,BP,DEPTOR;PSMB10;FGF18
176,GO:0002684,0.457773519912311,0.814082714706485,3,7,positive regulation of immune system process,BP,RBP4;FADD;PSMB10
2802,GO:0065003,0.459245124990805,0.764666042776666,5,12,macromolecular complex assembly,BP,HACL1;ACAT1;FADD;HNF1A;DECR1
1141,GO:0016645,0.460254040111159,0.931471106129297,1,2,oxidoreductase activity, acting on the CH-NH group of donors,MF,ETFDH
342,GO:0005496,0.46082058707938,0.931270805484985,1,2,steroid binding,MF,ABCG1
969,GO:0010893,0.46082058707938,0.931270805484985,1,2,positive regulation of steroid biosynthetic process,BP,ABCG1
1029,GO:0015248,0.46082058707938,0.931270805484985,1,2,sterol transporter activity,MF,ABCG1
1038,GO:0015485,0.46082058707938,0.931270805484985,1,2,cholesterol binding,MF,ABCG1
1210,GO:0017127,0.46082058707938,0.931270805484985,1,2,cholesterol transporter activity,MF,ABCG1
1562,GO:0032366,0.46082058707938,0.931270805484985,1,2,intracellular sterol transport,BP,ABCG1
1563,GO:0032367,0.46082058707938,0.931270805484985,1,2,intracellular cholesterol transport,BP,ABCG1
1653,GO:0032934,0.46082058707938,0.931270805484985,1,2,sterol binding,MF,ABCG1
2982,GO:0072359,0.461455149247756,0.864251996921904,2,4,circulatory system development,BP,RBP4;FGF18
2215,GO:0045540,0.461714592028704,0.930953917921391,1,2,regulation of cholesterol biosynthetic process,BP,ABCG1
3265,GO:1902930,0.461714592028704,0.930953917921391,1,2,regulation of alcohol biosynthetic process,BP,ABCG1
2499,GO:0050767,0.464180376063006,0.93007470773793,1,2,regulation of neurogenesis,BP,LINGO1
2678,GO:0051960,0.464180376063006,0.93007470773793,1,2,regulation of nervous system development,BP,LINGO1
2741,GO:0060284,0.464180376063006,0.93007470773793,1,2,regulation of cell development,BP,LINGO1
2252,GO:0045893,0.465416660678716,0.846008259173843,2,5,positive regulation of transcription, DNA-templated,BP,FADD;HNF1A
2610,GO:0051254,0.465416660678716,0.846008259173843,2,5,positive regulation of RNA metabolic process,BP,FADD;HNF1A
3251,GO:1902680,0.465416660678716,0.846008259173843,2,5,positive regulation of RNA biosynthetic process,BP,FADD;HNF1A
3298,GO:1903508,0.465416660678716,0.846008259173843,2,5,positive regulation of nucleic acid-templated transcription,BP,FADD;HNF1A
845,GO:0009612,0.469755305488369,0.928058552166385,1,2,response to mechanical stimulus,BP,FADD
3088,GO:0098588,0.475482189346414,0.741229629664891,5,15,bounding membrane of organelle,CC,PXMP2;ABCG1;PLA2G16;CPT1C;ZFYVE21
1183,GO:0016836,0.475575948303746,0.856212166593224,2,4,hydro-lyase activity,MF,PUS1;ECI1
1502,GO:0031400,0.477045851234847,0.855358892752911,2,4,negative regulation of protein modification process,BP,DEPTOR;PSMB10
2633,GO:0051348,0.477045851234847,0.855358892752911,2,4,negative regulation of transferase activity,BP,DEPTOR;PSMB10
1853,GO:0040008,0.482055159012036,0.923468617468691,1,2,regulation of growth,BP,RBP4
2437,GO:0048638,0.482055159012036,0.923468617468691,1,2,regulation of developmental growth,BP,RBP4
1072,GO:0016021,0.483865267494335,0.677275075885493,12,36,integral component of membrane,CC,PXMP2;TMEM160;CNIH4;ABCG1;ALG5;USE1;ETFDH;CCDC51;PLA2G16;LINGO1;CPT1C;DPM3
697,GO:0008104,0.484894732676048,0.739809885591352,5,13,protein localization,BP,RBP4;CNIH4;ABCG1;USE1;TBC1D14
1774,GO:0035091,0.486873938449083,0.921616027284462,1,2,phosphatidylinositol binding,MF,PXK
2453,GO:0048731,0.487547181955968,0.691404862234477,9,25,system development,BP,ACAT1;RBP4;KRT10;FADD;PSMB10;PTS;PLA2G16;LINGO1;FGF18
2099,GO:0044248,0.490611904681709,0.67607093844144,11,32,cellular catabolic process,BP,HACL1;ACAT1;ACADVL;NUDT7;ECI1;ETFDH;PSMB10;TBC1D14;DECR1;CPT1C;ETFB
2050,GO:0043487,0.491261489472866,0.919902031963141,1,2,regulation of RNA stability,BP,PSMB10
2051,GO:0043488,0.491261489472866,0.919902031963141,1,2,regulation of mRNA stability,BP,PSMB10
2988,GO:0072521,0.491583352527511,0.829298420745315,2,5,purine-containing compound metabolic process,BP,ACAT1;NUDT7
1587,GO:0032501,0.492879814459987,0.662771010562011,14,42,multicellular organismal process,BP,ACAT1;RBP4;ACADVL;ABCG1;ALG5;KRT10;FADD;PSMB10;HNF1A;PTS;PLA2G16;LINGO1;FGF18;PEPD
659,GO:0007399,0.493535419427364,0.780065182785491,3,8,nervous system development,BP,ACAT1;PTS;LINGO1
3054,GO:0097159,0.494243370797735,0.670640178506589,11,35,organic cyclic compound binding,MF,HACL1;MRPL14;ACADVL;ARL6IP4;PUS1;NUDT7;TSFM;ABCG1;ETFDH;HNF1A;DECR1
354,GO:0005543,0.49450599474077,0.827367226449108,2,5,phospholipid binding,MF,PXK;ABCG1
2366,GO:0046950,0.495074509889569,0.918391151747376,1,2,cellular ketone body metabolic process,BP,ACAT1
2367,GO:0046951,0.495074509889569,0.918391151747376,1,2,ketone body biosynthetic process,BP,ACAT1
3227,GO:1902224,0.495074509889569,0.918391151747376,1,2,ketone body metabolic process,BP,ACAT1
897,GO:0010467,0.496431139712127,0.68104382145121,9,27,gene expression,BP,MRPL14;ARL6IP4;PUS1;TSFM;ABCG1;FADD;PSMB10;LAGE3;HNF1A
2145,GO:0044455,0.497222618494045,0.917531155762949,1,2,mitochondrial membrane part,CC,ETFDH
3296,GO:1903506,0.500219402047787,0.720437825389312,5,15,regulation of nucleic acid-templated transcription,BP,TSFM;ABCG1;FADD;PSMB10;HNF1A
315,GO:0005102,0.500641068129326,0.699903613820247,7,18,receptor binding,MF,HACL1;CNIH4;NUDT7;FADD;NUDT6;LINGO1;FGF18
1243,GO:0019218,0.500824317283005,0.823146676844039,2,5,regulation of steroid metabolic process,BP,ACADVL;ABCG1
2139,GO:0044444,0.50089535975095,0.686492043284685,34,101,cytoplasmic part,CC,HACL1;MSRA;ACAT1;MRPL14;PXMP2;PXK;RBP4;ACADVL;TMEM160;CNIH4;PUS1;NUDT7;TSFM;ABCG1;ALG5;BOLA1;USE1;KRT10;ECI1;ETFDH;LYPLAL1;CCDC51;FADD;PSMB10;TBC1D14;NUDT6;PTS;PLA2G16;DECR1;CPT1C;ZFYVE21;DPM3;ETFB;IFI30
3036,GO:0090304,0.500961647564763,0.685753764015609,8,23,nucleic acid metabolic process,BP,ARL6IP4;PUS1;TSFM;ABCG1;FADD;PSMB10;LAGE3;HNF1A
3112,GO:0098805,0.501483186509914,0.719355085658656,5,15,whole membrane,CC,PXMP2;FADD;PLA2G16;CPT1C;ZFYVE21
1139,GO:0016627,0.502660018421005,0.821908676168403,2,5,oxidoreductase activity, acting on the CH-CH group of donors,MF,ACADVL;DECR1
1297,GO:0019915,0.504465728902618,0.914583865553693,1,2,lipid storage,BP,ABCG1
917,GO:0010608,0.506151932107142,0.819538962991951,2,5,posttranscriptional regulation of gene expression,BP,TSFM;PSMB10
508,GO:0006629,0.508467422320547,0.646340122983365,15,44,lipid metabolic process,BP,HACL1;ACAT1;RBP4;ACADVL;NUDT7;ABCG1;ECI1;ETFDH;PLA2G16;DECR1;FGF18;CPT1C;ZFYVE21;DPM3;ETFB
2938,GO:0071704,0.508606379390752,0.660648128819957,31,93,organic substance metabolic process,BP,HACL1;MSRA;ACAT1;MRPL14;RBP4;ACADVL;ARL6IP4;PUS1;NUDT7;TSFM;ABCG1;ALG5;USE1;KRT10;ECI1;ETFDH;LYPLAL1;FADD;DEPTOR;PSMB10;LAGE3;HNF1A;PTS;PLA2G16;DECR1;FGF18;CPT1C;ZFYVE21;DPM3;PEPD;ETFB
663,GO:0007420,0.509055453088208,0.91267778441578,1,2,brain development,BP,ACAT1
2743,GO:0060322,0.509055453088208,0.91267778441578,1,2,head development,BP,ACAT1
1073,GO:0016032,0.515214416528927,0.813297702556074,2,5,viral process,BP,FADD;PSMB10
2122,GO:0044403,0.515214416528927,0.813297702556074,2,5,symbiosis, encompassing mutualism through parasitism,BP,FADD;PSMB10
2123,GO:0044419,0.515214416528927,0.813297702556074,2,5,interspecies interaction between organisms,BP,FADD;PSMB10
2167,GO:0044764,0.515214416528927,0.813297702556074,2,5,multi-organism cellular process,BP,FADD;PSMB10
1408,GO:0030424,0.517683131769202,0.909012241563077,1,2,axon,CC,CPT1C
97,GO:0001894,0.518779996773787,0.908538393363488,1,2,tissue homeostasis,BP,RBP4
2737,GO:0060249,0.518779996773787,0.908538393363488,1,2,anatomical structure homeostasis,BP,RBP4
1942,GO:0042594,0.519545577067126,0.882521546996775,1,3,response to starvation,BP,ACAT1
7,GO:0000096,0.520880431925388,0.907626005230048,1,2,sulfur amino acid metabolic process,BP,MSRA
497,GO:0006555,0.520880431925388,0.907626005230048,1,2,methionine metabolic process,BP,MSRA
783,GO:0009066,0.520880431925388,0.907626005230048,1,2,aspartate family amino acid metabolic process,BP,MSRA
1114,GO:0016408,0.522231870712072,0.907035479769748,1,2,C-acyltransferase activity,MF,ACAT1
129,GO:0002221,0.523025766153794,0.906687299990636,1,2,pattern recognition receptor signaling pathway,BP,FADD
131,GO:0002224,0.523025766153794,0.906687299990636,1,2,toll-like receptor signaling pathway,BP,FADD
193,GO:0002756,0.523025766153794,0.906687299990636,1,2,MyD88-independent toll-like receptor signaling pathway,BP,FADD
1810,GO:0035666,0.523025766153794,0.906687299990636,1,2,TRIF-dependent toll-like receptor signaling pathway,BP,FADD
3070,GO:0097342,0.523025766153794,0.906687299990636,1,2,ripoptosome,CC,FADD
2030,GO:0043279,0.524530207974236,0.906024888668562,1,2,response to alkaloid,BP,FADD
2639,GO:0051402,0.524530207974236,0.906024888668562,1,2,neuron apoptotic process,BP,FADD
2881,GO:0070997,0.524530207974236,0.906024888668562,1,2,neuron death,BP,FADD
736,GO:0008289,0.525032404700944,0.755396144970984,3,8,lipid binding,MF,PXK;RBP4;ABCG1
1855,GO:0040012,0.528268766802131,0.804071477416402,2,5,regulation of locomotion,BP,FADD;FGF18
2616,GO:0051270,0.528268766802131,0.804071477416402,2,5,regulation of cellular component movement,BP,FADD;FGF18
3388,GO:2000145,0.528268766802131,0.804071477416402,2,5,regulation of cell motility,BP,FADD;FGF18
2014,GO:0043228,0.528853659662843,0.670072218852173,7,20,non-membrane-bounded organelle,CC,MSRA;MRPL14;PXK;ACADVL;ARL6IP4;KRT10;FGF18
2018,GO:0043232,0.528853659662843,0.670072218852173,7,20,intracellular non-membrane-bounded organelle,CC,MSRA;MRPL14;PXK;ACADVL;ARL6IP4;KRT10;FGF18
2125,GO:0044421,0.530116839955403,0.639517840042542,11,32,extracellular region part,CC,MSRA;ACAT1;RBP4;KRT10;ECI1;LYPLAL1;DECR1;LINGO1;FGF18;PEPD;ETFB
1467,GO:0031224,0.53235202495232,0.63167716021789,12,37,intrinsic component of membrane,CC,PXMP2;TMEM160;CNIH4;ABCG1;ALG5;USE1;ETFDH;CCDC51;PLA2G16;LINGO1;CPT1C;DPM3
1161,GO:0016757,0.533882945226859,0.800016244231742,2,5,transferase activity, transferring glycosyl groups,MF,ALG5;DPM3
2929,GO:0071496,0.53472113395196,0.874090825634861,1,3,cellular response to external stimulus,BP,FADD
1165,GO:0016772,0.536055196095558,0.786632958323065,2,6,transferase activity, transferring phosphorus-containing groups,MF,FGF18;ZFYVE21
825,GO:0009308,0.536348983138348,0.900700523372074,1,2,amine metabolic process,BP,PSMB10
2092,GO:0044106,0.536348983138348,0.900700523372074,1,2,cellular amine metabolic process,BP,PSMB10
1361,GO:0030098,0.537861776531846,0.900003322723636,1,2,lymphocyte differentiation,BP,FADD
1392,GO:0030217,0.537861776531846,0.900003322723636,1,2,T cell differentiation,BP,FADD
3219,GO:1902107,0.537861776531846,0.900003322723636,1,2,positive regulation of leukocyte differentiation,BP,FADD
3321,GO:1903708,0.537861776531846,0.900003322723636,1,2,positive regulation of hemopoiesis,BP,FADD
791,GO:0009100,0.54041308831956,0.795231985062502,2,5,glycoprotein metabolic process,BP,ALG5;DPM3
2194,GO:0045202,0.54045007156995,0.870799280361835,1,3,synapse,CC,CPT1C
2411,GO:0048513,0.541510944909617,0.660508436307038,7,19,animal organ development,BP,ACAT1;RBP4;KRT10;FADD;PSMB10;PLA2G16;FGF18
2118,GO:0044344,0.541918910014519,0.898115598485441,1,2,cellular response to fibroblast growth factor stimulus,BP,FGF18
2869,GO:0070848,0.541918910014519,0.898115598485441,1,2,response to growth factor,BP,FGF18
2909,GO:0071363,0.541918910014519,0.898115598485441,1,2,cellular response to growth factor stimulus,BP,FGF18
2941,GO:0071774,0.541918910014519,0.898115598485441,1,2,response to fibroblast growth factor,BP,FGF18
1489,GO:0031334,0.544428371334041,0.896934802311427,1,2,positive regulation of protein complex assembly,BP,HNF1A
2089,GO:0044089,0.544428371334041,0.896934802311427,1,2,positive regulation of cellular component biogenesis,BP,HNF1A
2575,GO:0051130,0.544428371334041,0.896934802311427,1,2,positive regulation of cellular component organization,BP,HNF1A
1760,GO:0034660,0.545666407775521,0.791329844636921,2,5,ncRNA metabolic process,BP,PUS1;LAGE3
1274,GO:0019693,0.546559495949307,0.790661685631312,2,5,ribose phosphate metabolic process,BP,ACAT1;NUDT7
2414,GO:0048519,0.546922569198684,0.62886786862662,10,29,negative regulation of biological process,BP,RBP4;ACADVL;ABCG1;FADD;DEPTOR;PSMB10;TBC1D14;PLA2G16;LINGO1;IFI30
2416,GO:0048523,0.546922569198684,0.62886786862662,10,29,negative regulation of cellular process,BP,RBP4;ACADVL;ABCG1;FADD;DEPTOR;PSMB10;TBC1D14;PLA2G16;LINGO1;IFI30
1946,GO:0042632,0.547123523773911,0.895655294860013,1,2,cholesterol homeostasis,BP,ABCG1
2704,GO:0055081,0.547123523773911,0.895655294860013,1,2,anion homeostasis,BP,ABCG1
2708,GO:0055088,0.547123523773911,0.895655294860013,1,2,lipid homeostasis,BP,ABCG1
2709,GO:0055091,0.547123523773911,0.895655294860013,1,2,phospholipid homeostasis,BP,ABCG1
2710,GO:0055092,0.547123523773911,0.895655294860013,1,2,sterol homeostasis,BP,ABCG1
778,GO:0009059,0.547543125094404,0.641281287463736,8,24,macromolecule biosynthetic process,BP,MRPL14;TSFM;ABCG1;ALG5;FADD;PSMB10;HNF1A;DPM3
1757,GO:0034645,0.547543125094404,0.641281287463736,8,24,cellular macromolecule biosynthetic process,BP,MRPL14;TSFM;ABCG1;ALG5;FADD;PSMB10;HNF1A;DPM3
90,GO:0001822,0.547875537804042,0.895296171597294,1,2,kidney development,BP,ACAT1
95,GO:0001889,0.547875537804042,0.895296171597294,1,2,liver development,BP,ACAT1
2781,GO:0061008,0.547875537804042,0.895296171597294,1,2,hepaticobiliary system development,BP,ACAT1
848,GO:0009628,0.548693186908777,0.735867711215146,3,8,response to abiotic stimulus,BP,ACADVL;FADD;PSMB10
1186,GO:0016853,0.548925457264001,0.78888484794692,2,5,isomerase activity,MF,PUS1;ECI1
1940,GO:0042592,0.551078876104555,0.675233152350682,5,15,homeostatic process,BP,RBP4;ACADVL;ABCG1;FADD;HNF1A
3233,GO:1902494,0.552377476964133,0.742533662628304,3,7,catalytic complex,CC,FADD;PSMB10;DPM3
360,GO:0005578,0.555856802121661,0.891427281187052,1,2,proteinaceous extracellular matrix,CC,LINGO1
1456,GO:0031012,0.555856802121661,0.891427281187052,1,2,extracellular matrix,CC,LINGO1
371,GO:0005730,0.555954360075918,0.729696220071178,3,8,nucleolus,CC,ACADVL;ARL6IP4;FGF18
221,GO:0003677,0.558352846303088,0.86011374403674,1,3,DNA binding,MF,HNF1A
3039,GO:0090407,0.559340365550411,0.693581606320378,4,11,organophosphate biosynthetic process,BP,ACAT1;PLA2G16;FGF18;DPM3
135,GO:0002253,0.559976450967004,0.780454098636918,2,5,activation of immune response,BP,FADD;PSMB10
2506,GO:0050778,0.559976450967004,0.780454098636918,2,5,positive regulation of immune response,BP,FADD;PSMB10
3055,GO:0097164,0.564991306305708,0.776555767129623,2,5,ammonium ion metabolic process,BP,PLA2G16;CPT1C
290,GO:0004672,0.565123090745807,0.855910151674785,1,3,protein kinase activity,MF,FGF18
2630,GO:0051345,0.565158288218351,0.721749726925381,3,8,positive regulation of hydrolase activity,BP,FADD;TBC1D14;FGF18
599,GO:0006914,0.56524457370434,0.855833887599805,1,3,autophagy,BP,TBC1D14
64,GO:0001561,0.565702786520664,0.88650668998577,1,2,fatty acid alpha-oxidation,BP,HACL1
478,GO:0006468,0.568079384861014,0.711980572317273,3,9,protein phosphorylation,BP,DEPTOR;PSMB10;FGF18
513,GO:0006637,0.569021216531854,0.760512486562369,2,6,acyl-CoA metabolic process,BP,ACAT1;NUDT7
1793,GO:0035383,0.569021216531854,0.760512486562369,2,6,thioester metabolic process,BP,ACAT1;NUDT7
755,GO:0008544,0.569542964778368,0.884542163627918,1,2,epidermis development,BP,KRT10
2065,GO:0043588,0.569542964778368,0.884542163627918,1,2,skin development,BP,KRT10
3105,GO:0098773,0.569542964778368,0.884542163627918,1,2,skin epidermis development,BP,KRT10
612,GO:0006959,0.569686862039669,0.884468046860616,1,2,humoral immune response,BP,PSMB10
1772,GO:0034976,0.570640903852275,0.883975726735506,1,2,response to endoplasmic reticulum stress,BP,ACADVL
2213,GO:0045471,0.570712905963332,0.883938505749535,1,2,response to ethanol,BP,RBP4
3067,GO:0097305,0.570712905963332,0.883938505749535,1,2,response to alcohol,BP,RBP4
1071,GO:0016020,0.573717531139058,0.576987376691454,21,65,membrane,CC,MSRA;ACAT1;MRPL14;PXMP2;PXK;ACADVL;TMEM160;CNIH4;ABCG1;ALG5;USE1;KRT10;ECI1;ETFDH;CCDC51;FADD;PLA2G16;LINGO1;CPT1C;ZFYVE21;DPM3
881,GO:0009968,0.577182348774643,0.711155594320283,3,8,negative regulation of signal transduction,BP,FADD;DEPTOR;PSMB10
927,GO:0010648,0.577182348774643,0.711155594320283,3,8,negative regulation of cell communication,BP,FADD;DEPTOR;PSMB10
1341,GO:0023057,0.577182348774643,0.711155594320283,3,8,negative regulation of signaling,BP,FADD;DEPTOR;PSMB10
2608,GO:0051252,0.577598344009066,0.647465480207119,5,16,regulation of RNA metabolic process,BP,TSFM;ABCG1;FADD;PSMB10;HNF1A
3422,GO:2001141,0.577598344009066,0.647465480207119,5,16,regulation of RNA biosynthetic process,BP,TSFM;ABCG1;FADD;PSMB10;HNF1A
959,GO:0010872,0.577992418870667,0.880127646993048,1,2,regulation of cholesterol esterification,BP,ABCG1
1048,GO:0015748,0.577992418870667,0.880127646993048,1,2,organophosphate ester transport,BP,ABCG1
1061,GO:0015914,0.577992418870667,0.880127646993048,1,2,phospholipid transport,BP,ABCG1
1564,GO:0032368,0.577992418870667,0.880127646993048,1,2,regulation of lipid transport,BP,ABCG1
1567,GO:0032371,0.577992418870667,0.880127646993048,1,2,regulation of sterol transport,BP,ABCG1
1570,GO:0032374,0.577992418870667,0.880127646993048,1,2,regulation of cholesterol transport,BP,ABCG1
1678,GO:0033344,0.577992418870667,0.880127646993048,1,2,cholesterol efflux,BP,ABCG1
1690,GO:0033700,0.577992418870667,0.880127646993048,1,2,phospholipid efflux,BP,ABCG1
1725,GO:0034367,0.577992418870667,0.880127646993048,1,2,macromolecular complex remodeling,BP,ABCG1
1726,GO:0034368,0.577992418870667,0.880127646993048,1,2,protein-lipid complex remodeling,BP,ABCG1
1727,GO:0034369,0.577992418870667,0.880127646993048,1,2,plasma lipoprotein particle remodeling,BP,ABCG1
1729,GO:0034375,0.577992418870667,0.880127646993048,1,2,high-density lipoprotein particle remodeling,BP,ABCG1
1738,GO:0034433,0.577992418870667,0.880127646993048,1,2,steroid esterification,BP,ABCG1
1739,GO:0034434,0.577992418870667,0.880127646993048,1,2,sterol esterification,BP,ABCG1
1740,GO:0034435,0.577992418870667,0.880127646993048,1,2,cholesterol esterification,BP,ABCG1
2943,GO:0071825,0.577992418870667,0.880127646993048,1,2,protein-lipid complex subunit organization,BP,ABCG1
2945,GO:0071827,0.577992418870667,0.880127646993048,1,2,plasma lipoprotein particle organization,BP,ABCG1
3048,GO:0097006,0.577992418870667,0.880127646993048,1,2,regulation of plasma lipoprotein particle levels,BP,ABCG1
3361,GO:1905952,0.577992418870667,0.880127646993048,1,2,regulation of lipid localization,BP,ABCG1
3362,GO:1905953,0.577992418870667,0.880127646993048,1,2,negative regulation of lipid localization,BP,ABCG1
2752,GO:0060348,0.578178533010006,0.880028963959747,1,2,bone development,BP,FGF18
454,GO:0006195,0.578951235688773,0.879618581015871,1,2,purine nucleotide catabolic process,BP,NUDT7
604,GO:0006935,0.579978392951904,0.879071371387417,1,2,chemotaxis,BP,FGF18
1901,GO:0042330,0.579978392951904,0.879071371387417,1,2,taxis,BP,FGF18
1270,GO:0019637,0.581148603788273,0.633310614019096,6,17,organophosphate metabolic process,BP,ACAT1;NUDT7;PLA2G16;FGF18;ZFYVE21;DPM3
324,GO:0005164,0.583277829451436,0.877300526535924,1,2,tumor necrosis factor receptor binding,MF,FADD
760,GO:0008625,0.583277829451436,0.877300526535924,1,2,extrinsic apoptotic signaling pathway via death domain receptors,BP,FADD
1472,GO:0031264,0.583277829451436,0.877300526535924,1,2,death-inducing signaling complex,CC,FADD
2189,GO:0045121,0.583277829451436,0.877300526535924,1,2,membrane raft,CC,FADD
2768,GO:0060544,0.583277829451436,0.877300526535924,1,2,regulation of necroptotic process,BP,FADD
2932,GO:0071550,0.583277829451436,0.877300526535924,1,2,death-inducing signaling complex assembly,BP,FADD
3065,GO:0097296,0.583277829451436,0.877300526535924,1,2,activation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway,BP,FADD
3089,GO:0098589,0.583277829451436,0.877300526535924,1,2,membrane region,CC,FADD
3108,GO:0098796,0.583277829451436,0.877300526535924,1,2,membrane protein complex,CC,FADD
3109,GO:0098797,0.583277829451436,0.877300526535924,1,2,plasma membrane protein complex,CC,FADD
3113,GO:0098857,0.583277829451436,0.877300526535924,1,2,membrane microdomain,CC,FADD
3214,GO:1902041,0.583277829451436,0.877300526535924,1,2,regulation of extrinsic apoptotic signaling pathway via death domain receptors,BP,FADD
3215,GO:1902042,0.583277829451436,0.877300526535924,1,2,negative regulation of extrinsic apoptotic signaling pathway via death domain receptors,BP,FADD
3436,GO:2001267,0.583277829451436,0.877300526535924,1,2,regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway,BP,FADD
3437,GO:2001269,0.583277829451436,0.877300526535924,1,2,positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway,BP,FADD
1535,GO:0031982,0.583662329047696,0.581474554560012,12,37,vesicle,CC,MSRA;ACAT1;RBP4;ABCG1;KRT10;ECI1;LYPLAL1;TBC1D14;DECR1;ZFYVE21;PEPD;ETFB
2570,GO:0051094,0.583865187162897,0.748100747142868,2,6,positive regulation of developmental process,BP,FADD;FGF18
319,GO:0005123,0.587927510842383,0.874770705820146,1,2,death receptor binding,MF,FADD
1645,GO:0032845,0.587927510842383,0.874770705820146,1,2,negative regulation of homeostatic process,BP,FADD
1819,GO:0035877,0.587927510842383,0.874770705820146,1,2,death effector domain binding,MF,FADD
2770,GO:0060547,0.587927510842383,0.874770705820146,1,2,negative regulation of necrotic cell death,BP,FADD
3012,GO:0089720,0.587927510842383,0.874770705820146,1,2,caspase binding,MF,FADD
2186,GO:0045088,0.592293902223223,0.7545075984288,2,5,regulation of innate immune response,BP,FADD;PSMB10
2509,GO:0050790,0.592938796574596,0.621736013328202,6,17,regulation of catalytic activity,BP,FADD;DEPTOR;PSMB10;TBC1D14;PTS;FGF18
1561,GO:0032365,0.593881717726169,0.837001864919817,1,3,intracellular lipid transport,BP,ABCG1
884,GO:0009987,0.593936395097674,0.615721748800109,35,107,cellular process,BP,HACL1;MSRA;ACAT1;MRPL14;PXK;RBP4;ACADVL;ARL6IP4;PUS1;NUDT7;TSFM;ABCG1;ALG5;USE1;KRT10;ECI1;ETFDH;LYPLAL1;FADD;DEPTOR;PSMB10;LAGE3;TBC1D14;HNF1A;PTS;PLA2G16;DECR1;LINGO1;FGF18;CPT1C;ZFYVE21;DPM3;PEPD;ETFB;IFI30
459,GO:0006351,0.593991304743807,0.631481705516143,5,16,transcription, DNA-templated,BP,TSFM;ABCG1;FADD;PSMB10;HNF1A
3080,GO:0097659,0.593991304743807,0.631481705516143,5,16,nucleic acid-templated transcription,BP,TSFM;ABCG1;FADD;PSMB10;HNF1A
788,GO:0009083,0.594356124974901,0.871205752714635,1,2,branched-chain amino acid catabolic process,BP,ACAT1
724,GO:0008233,0.596746938359894,0.750775080018108,2,5,peptidase activity,MF,PSMB10;PEPD
2808,GO:0070011,0.596746938359894,0.750775080018108,2,5,peptidase activity, acting on L-amino acid peptides,MF,PSMB10;PEPD
1974,GO:0043005,0.597596074334146,0.736241761319451,2,6,neuron projection,CC,FADD;CPT1C
3194,GO:1901681,0.597656135859225,0.869344889948699,1,2,sulfur compound binding,MF,HACL1
472,GO:0006412,0.598174274952008,0.749570344293686,2,5,translation,BP,MRPL14;TSFM
259,GO:0004300,0.600552386213971,0.86769418018037,1,2,enoyl-CoA hydratase activity,MF,ECI1
452,GO:0006164,0.600641435939219,0.867643164845175,1,2,purine nucleotide biosynthetic process,BP,ACAT1
804,GO:0009152,0.600641435939219,0.867643164845175,1,2,purine ribonucleotide biosynthetic process,BP,ACAT1
816,GO:0009260,0.600641435939219,0.867643164845175,1,2,ribonucleotide biosynthetic process,BP,ACAT1
2289,GO:0046390,0.600641435939219,0.867643164845175,1,2,ribose phosphate biosynthetic process,BP,ACAT1
1885,GO:0042176,0.602390991189121,0.86663768351905,1,2,regulation of protein catabolic process,BP,PSMB10
2102,GO:0044257,0.602390991189121,0.86663768351905,1,2,cellular protein catabolic process,BP,PSMB10
2106,GO:0044265,0.602390991189121,0.86663768351905,1,2,cellular macromolecule catabolic process,BP,PSMB10
2235,GO:0045732,0.602390991189121,0.86663768351905,1,2,positive regulation of protein catabolic process,BP,PSMB10
2658,GO:0051603,0.602390991189121,0.86663768351905,1,2,proteolysis involved in cellular protein catabolic process,BP,PSMB10
3274,GO:1903050,0.602390991189121,0.86663768351905,1,2,regulation of proteolysis involved in cellular protein catabolic process,BP,PSMB10
3275,GO:1903052,0.602390991189121,0.86663768351905,1,2,positive regulation of proteolysis involved in cellular protein catabolic process,BP,PSMB10
3290,GO:1903362,0.602390991189121,0.86663768351905,1,2,regulation of cellular protein catabolic process,BP,PSMB10
3291,GO:1903364,0.602390991189121,0.86663768351905,1,2,positive regulation of cellular protein catabolic process,BP,PSMB10
1529,GO:0031967,0.603177599939649,0.608932292948586,6,18,organelle envelope,CC,ACAT1;MRPL14;ACADVL;ECI1;ETFDH;CPT1C
1533,GO:0031975,0.603177599939649,0.608932292948586,6,18,envelope,CC,ACAT1;MRPL14;ACADVL;ECI1;ETFDH;CPT1C
1763,GO:0034702,0.605058377148576,0.829169838401671,1,3,ion channel complex,CC,CPT1C
3234,GO:1902495,0.605058377148576,0.829169838401671,1,3,transmembrane transporter complex,CC,CPT1C
3367,GO:1990351,0.605058377148576,0.829169838401671,1,3,transporter complex,CC,CPT1C
2937,GO:0071702,0.605464833747584,0.60439570705658,6,19,organic substance transport,BP,RBP4;CNIH4;ABCG1;USE1;TBC1D14;HNF1A
2147,GO:0044459,0.605928110597538,0.671267842035794,3,10,plasma membrane part,CC,ABCG1;FADD;CPT1C
1039,GO:0015629,0.606808660896279,0.864071619000311,1,2,actin cytoskeleton,CC,MSRA
1716,GO:0034308,0.606939956712112,0.863994752890181,1,2,primary alcohol metabolic process,BP,RBP4
745,GO:0008380,0.609553384241557,0.862457455469668,1,2,RNA splicing,BP,ARL6IP4
133,GO:0002250,0.609640372252285,0.862406046978584,1,2,adaptive immune response,BP,FADD
177,GO:0002685,0.609640372252285,0.862406046978584,1,2,regulation of leukocyte migration,BP,FADD
178,GO:0002687,0.609640372252285,0.862406046978584,1,2,positive regulation of leukocyte migration,BP,FADD
203,GO:0002819,0.609640372252285,0.862406046978584,1,2,regulation of adaptive immune response,BP,FADD
204,GO:0002821,0.609640372252285,0.862406046978584,1,2,positive regulation of adaptive immune response,BP,FADD
1605,GO:0032609,0.609640372252285,0.862406046978584,1,2,interferon-gamma production,BP,FADD
1611,GO:0032637,0.609640372252285,0.862406046978584,1,2,interleukin-8 production,BP,FADD
1616,GO:0032649,0.609640372252285,0.862406046978584,1,2,regulation of interferon-gamma production,BP,FADD
1621,GO:0032677,0.609640372252285,0.862406046978584,1,2,regulation of interleukin-8 production,BP,FADD
1627,GO:0032729,0.609640372252285,0.862406046978584,1,2,positive regulation of interferon-gamma production,BP,FADD
1632,GO:0032757,0.609640372252285,0.862406046978584,1,2,positive regulation of interleukin-8 production,BP,FADD
1686,GO:0033612,0.609640372252285,0.862406046978584,1,2,receptor serine/threonine kinase binding,MF,FADD
1870,GO:0042104,0.609640372252285,0.862406046978584,1,2,positive regulation of activated T cell proliferation,BP,FADD
2266,GO:0046006,0.609640372252285,0.862406046978584,1,2,regulation of activated T cell proliferation,BP,FADD
2514,GO:0050798,0.609640372252285,0.862406046978584,1,2,activated T cell proliferation,BP,FADD
2541,GO:0050900,0.609640372252285,0.862406046978584,1,2,leukocyte migration,BP,FADD
3003,GO:0072676,0.609640372252285,0.862406046978584,1,2,lymphocyte migration,BP,FADD
3004,GO:0072678,0.609640372252285,0.862406046978584,1,2,T cell migration,BP,FADD
3398,GO:2000401,0.609640372252285,0.862406046978584,1,2,regulation of lymphocyte migration,BP,FADD
3399,GO:2000403,0.609640372252285,0.862406046978584,1,2,positive regulation of lymphocyte migration,BP,FADD
3400,GO:2000404,0.609640372252285,0.862406046978584,1,2,regulation of T cell migration,BP,FADD
3401,GO:2000406,0.609640372252285,0.862406046978584,1,2,positive regulation of T cell migration,BP,FADD
2990,GO:0072523,0.60993163176786,0.825665851104691,1,3,purine-containing compound catabolic process,BP,NUDT7
2232,GO:0045717,0.610312951920381,0.862008040236553,1,2,negative regulation of fatty acid biosynthetic process,BP,ACADVL
2244,GO:0045833,0.610312951920381,0.862008040236553,1,2,negative regulation of lipid metabolic process,BP,ACADVL
2254,GO:0045922,0.610312951920381,0.862008040236553,1,2,negative regulation of fatty acid metabolic process,BP,ACADVL
2565,GO:0051055,0.610312951920381,0.862008040236553,1,2,negative regulation of lipid biosynthetic process,BP,ACADVL
1221,GO:0018130,0.610724940556273,0.586965078709386,7,22,heterocycle biosynthetic process,BP,ACAT1;TSFM;ABCG1;FADD;PSMB10;HNF1A;PTS
1264,GO:0019438,0.610724940556273,0.586965078709386,7,22,aromatic compound biosynthetic process,BP,ACAT1;TSFM;ABCG1;FADD;PSMB10;HNF1A;PTS
871,GO:0009894,0.611346883757604,0.723987959673087,2,6,regulation of catabolic process,BP,PSMB10;TBC1D14
1485,GO:0031329,0.611346883757604,0.723987959673087,2,6,regulation of cellular catabolic process,BP,PSMB10;TBC1D14
2519,GO:0050810,0.613150986314906,0.823320728198575,1,3,regulation of steroid biosynthetic process,BP,ABCG1
36,GO:0000959,0.615093522188232,0.859152191736395,1,2,mitochondrial RNA metabolic process,BP,PUS1
37,GO:0000963,0.615093522188232,0.859152191736395,1,2,mitochondrial RNA processing,BP,PUS1
471,GO:0006400,0.615093522188232,0.859152191736395,1,2,tRNA modification,BP,PUS1
839,GO:0009451,0.615093522188232,0.859152191736395,1,2,RNA modification,BP,PUS1
2845,GO:0070525,0.615093522188232,0.859152191736395,1,2,tRNA threonylcarbamoyladenosine metabolic process,BP,PUS1
2874,GO:0070900,0.615093522188232,0.859152191736395,1,2,mitochondrial tRNA modification,BP,PUS1
3047,GO:0090646,0.615093522188232,0.859152191736395,1,2,mitochondrial tRNA processing,BP,PUS1
3148,GO:1900864,0.615093522188232,0.859152191736395,1,2,mitochondrial RNA modification,BP,PUS1
3180,GO:1901605,0.61657351012626,0.709760618153803,2,7,alpha-amino acid metabolic process,BP,MSRA;ACAT1
1280,GO:0019752,0.616591126454666,0.547177250973023,12,38,carboxylic acid metabolic process,BP,HACL1;MSRA;ACAT1;ACADVL;ECI1;ETFDH;PSMB10;PTS;DECR1;CPT1C;PEPD;ETFB
1168,GO:0016787,0.618865756605715,0.58035029829622,7,21,hydrolase activity,MF,NUDT7;ABCG1;LYPLAL1;PSMB10;NUDT6;PLA2G16;PEPD
2745,GO:0060333,0.61941471595787,0.856529671368568,1,2,interferon-gamma-mediated signaling pathway,BP,IFI30
2021,GO:0043235,0.619540211370791,0.801208076167799,1,4,receptor complex,CC,CPT1C
12,GO:0000166,0.619999860236755,0.62060965423882,4,15,nucleotide binding,MF,ACADVL;ABCG1;ETFDH;DECR1
3163,GO:1901265,0.619999860236755,0.62060965423882,4,15,nucleoside phosphate binding,MF,ACADVL;ABCG1;ETFDH;DECR1
2260,GO:0045935,0.620224315083545,0.715869576441103,2,6,positive regulation of nucleobase-containing compound metabolic process,BP,FADD;HNF1A
60,GO:0001525,0.620471724015149,0.855882155457198,1,2,angiogenesis,BP,FGF18
2412,GO:0048514,0.620471724015149,0.855882155457198,1,2,blood vessel morphogenesis,BP,FGF18
14,GO:0000209,0.621610030240996,0.855182167123218,1,2,protein polyubiquitination,BP,PSMB10
2837,GO:0070371,0.623960287323769,0.853728090464402,1,2,ERK1 and ERK2 cascade,BP,FGF18
2838,GO:0070372,0.623960287323769,0.853728090464402,1,2,regulation of ERK1 and ERK2 cascade,BP,FGF18
2839,GO:0070374,0.623960287323769,0.853728090464402,1,2,positive regulation of ERK1 and ERK2 cascade,BP,FGF18
1640,GO:0032787,0.624176177557253,0.561035089068163,8,27,monocarboxylic acid metabolic process,BP,HACL1;ACAT1;ACADVL;ECI1;ETFDH;DECR1;CPT1C;ETFB
1634,GO:0032768,0.626254558935591,0.852297107666011,1,2,regulation of monooxygenase activity,BP,PTS
2550,GO:0050999,0.626254558935591,0.852297107666011,1,2,regulation of nitric-oxide synthase activity,BP,PTS
2016,GO:0043230,0.627784373174856,0.553089158907998,9,27,extracellular organelle,CC,MSRA;ACAT1;RBP4;KRT10;ECI1;LYPLAL1;DECR1;PEPD;ETFB
2811,GO:0070062,0.627784373174856,0.553089158907998,9,27,extracellular exosome,CC,MSRA;ACAT1;RBP4;KRT10;ECI1;LYPLAL1;DECR1;PEPD;ETFB
3308,GO:1903561,0.627784373174856,0.553089158907998,9,27,extracellular vesicle,CC,MSRA;ACAT1;RBP4;KRT10;ECI1;LYPLAL1;DECR1;PEPD;ETFB
1852,GO:0040007,0.62849123918865,0.811805459513365,1,3,growth,BP,RBP4
2428,GO:0048589,0.62849123918865,0.811805459513365,1,3,developmental growth,BP,RBP4
2615,GO:0051262,0.630061509214286,0.849897183853977,1,2,protein tetramerization,BP,DECR1
2622,GO:0051289,0.630061509214286,0.849897183853977,1,2,protein homotetramerization,BP,DECR1
883,GO:0009986,0.630980091765224,0.791824796089127,1,4,cell surface,CC,ABCG1
434,GO:0006094,0.632523730825312,0.84832786982682,1,2,gluconeogenesis,BP,RBP4
1250,GO:0019319,0.632523730825312,0.84832786982682,1,2,hexose biosynthetic process,BP,RBP4
1294,GO:0019900,0.635000331272902,0.788447046493636,1,4,kinase binding,MF,TBC1D14
1838,GO:0036294,0.63602480363721,0.846072973755874,1,2,cellular response to decreased oxygen levels,BP,PSMB10
2925,GO:0071453,0.63602480363721,0.846072973755874,1,2,cellular response to oxygen levels,BP,PSMB10
2926,GO:0071456,0.63602480363721,0.846072973755874,1,2,cellular response to hypoxia,BP,PSMB10
320,GO:0005126,0.63612888404462,0.715983863666811,2,5,cytokine receptor binding,MF,CNIH4;FADD
925,GO:0010646,0.636338270070303,0.572455386138247,6,19,regulation of cell communication,BP,PXK;RBP4;FADD;DEPTOR;PSMB10;FGF18
2457,GO:0048806,0.637883978083253,0.844864234383715,1,2,genitalia development,BP,RBP4
666,GO:0007517,0.638166075171555,0.844680137705913,1,2,muscle organ development,BP,RBP4
1003,GO:0014706,0.638166075171555,0.844680137705913,1,2,striated muscle tissue development,BP,RBP4
1096,GO:0016202,0.638166075171555,0.844680137705913,1,2,regulation of striated muscle tissue development,BP,RBP4
2246,GO:0045843,0.638166075171555,0.844680137705913,1,2,negative regulation of striated muscle tissue development,BP,RBP4
2435,GO:0048634,0.638166075171555,0.844680137705913,1,2,regulation of muscle organ development,BP,RBP4
2436,GO:0048635,0.638166075171555,0.844680137705913,1,2,negative regulation of muscle organ development,BP,RBP4
2765,GO:0060537,0.638166075171555,0.844680137705913,1,2,muscle tissue development,BP,RBP4
2787,GO:0061061,0.638166075171555,0.844680137705913,1,2,muscle structure development,BP,RBP4
3201,GO:1901861,0.638166075171555,0.844680137705913,1,2,regulation of muscle tissue development,BP,RBP4
3202,GO:1901862,0.638166075171555,0.844680137705913,1,2,negative regulation of muscle tissue development,BP,RBP4
2045,GO:0043414,0.638307042070809,0.844588074137819,1,2,macromolecule methylation,BP,ETFB
426,GO:0006066,0.63928398426116,0.644148800035467,3,9,alcohol metabolic process,BP,RBP4;ACADVL;ABCG1
1293,GO:0019899,0.639349334984312,0.63796657015124,3,10,enzyme binding,MF,ACAT1;FADD;TBC1D14
2714,GO:0055114,0.642412387177393,0.529167455051239,10,32,oxidation-reduction process,BP,HACL1;MSRA;ACAT1;ACADVL;ECI1;ETFDH;DECR1;CPT1C;ETFB;IFI30
25,GO:0000313,0.642570737415965,0.841781795148778,1,2,organellar ribosome,CC,MRPL14
26,GO:0000315,0.642570737415965,0.841781795148778,1,2,organellar large ribosomal subunit,CC,MRPL14
229,GO:0003735,0.642570737415965,0.841781795148778,1,2,structural constituent of ribosome,MF,MRPL14
379,GO:0005761,0.642570737415965,0.841781795148778,1,2,mitochondrial ribosome,CC,MRPL14
380,GO:0005762,0.642570737415965,0.841781795148778,1,2,mitochondrial large ribosomal subunit,CC,MRPL14
402,GO:0005840,0.642570737415965,0.841781795148778,1,2,ribosome,CC,MRPL14
474,GO:0006415,0.642570737415965,0.841781795148778,1,2,translational termination,BP,MRPL14
1065,GO:0015934,0.642570737415965,0.841781795148778,1,2,large ribosomal subunit,CC,MRPL14
2121,GO:0044391,0.642570737415965,0.841781795148778,1,2,ribosomal subunit,CC,MRPL14
2815,GO:0070126,0.642570737415965,0.841781795148778,1,2,mitochondrial translational termination,BP,MRPL14
734,GO:0008285,0.642640546922791,0.709907015797151,2,5,negative regulation of cell proliferation,BP,RBP4;IFI30
2176,GO:0045017,0.642726798918686,0.70982587599987,2,5,glycerolipid biosynthetic process,BP,FGF18;DPM3
546,GO:0006729,0.643127526465268,0.841412202073584,1,2,tetrahydrobiopterin biosynthetic process,BP,PTS
1932,GO:0042558,0.643127526465268,0.841412202073584,1,2,pteridine-containing compound metabolic process,BP,PTS
1933,GO:0042559,0.643127526465268,0.841412202073584,1,2,pteridine-containing compound biosynthetic process,BP,PTS
2274,GO:0046146,0.643127526465268,0.841412202073584,1,2,tetrahydrobiopterin metabolic process,BP,PTS
157,GO:0002495,0.643524713998766,0.84114810694467,1,2,antigen processing and presentation of peptide antigen via MHC class II,BP,IFI30
158,GO:0002504,0.643524713998766,0.84114810694467,1,2,antigen processing and presentation of peptide or polysaccharide antigen via MHC class II,BP,IFI30
3381,GO:2000112,0.643627384971515,0.578067453115214,5,17,regulation of cellular macromolecule biosynthetic process,BP,TSFM;ABCG1;FADD;PSMB10;HNF1A
1666,GO:0033002,0.644396994701705,0.840566813699137,1,2,muscle cell proliferation,BP,RBP4
1501,GO:0031399,0.646563087735591,0.636681563188476,3,9,regulation of protein modification process,BP,DEPTOR;PSMB10;FGF18
2535,GO:0050873,0.647747480294874,0.838317276592628,1,2,brown fat cell differentiation,BP,NUDT7
787,GO:0009081,0.648444855208447,0.795943869315056,1,3,branched-chain amino acid metabolic process,BP,ACAT1
3117,GO:0099080,0.649520762705414,0.795058921367093,1,3,supramolecular complex,CC,KRT10
3118,GO:0099081,0.649520762705414,0.795058921367093,1,3,supramolecular polymer,CC,KRT10
3121,GO:0099512,0.649520762705414,0.795058921367093,1,3,supramolecular fiber,CC,KRT10
907,GO:0010557,0.65418236545354,0.672999466159718,2,7,positive regulation of macromolecule biosynthetic process,BP,FADD;HNF1A
918,GO:0010628,0.654893577827965,0.672273625584008,2,7,positive regulation of gene expression,BP,FADD;HNF1A
872,GO:0009895,0.655091469119727,0.790426691952998,1,3,negative regulation of catabolic process,BP,TBC1D14
1486,GO:0031330,0.655091469119727,0.790426691952998,1,3,negative regulation of cellular catabolic process,BP,TBC1D14
885,GO:0009991,0.655200498588774,0.770816501561331,1,4,response to extracellular stimulus,BP,ACAT1
1513,GO:0031667,0.655200498588774,0.770816501561331,1,4,response to nutrient levels,BP,ACAT1
888,GO:0010008,0.656278800880393,0.789428383980647,1,3,endosome membrane,CC,ZFYVE21
2138,GO:0044440,0.656278800880393,0.789428383980647,1,3,endosomal part,CC,ZFYVE21
1990,GO:0043085,0.658488688837486,0.590662782562247,4,12,positive regulation of catalytic activity,BP,FADD;PSMB10;TBC1D14;FGF18
53,GO:0001501,0.658557830598514,0.678832110603826,2,6,skeletal system development,BP,RBP4;FGF18
105,GO:0001932,0.658631424034231,0.67875776006549,2,6,regulation of protein phosphorylation,BP,DEPTOR;FGF18
1898,GO:0042325,0.658631424034231,0.67875776006549,2,6,regulation of phosphorylation,BP,DEPTOR;FGF18
2063,GO:0043549,0.658631424034231,0.67875776006549,2,6,regulation of kinase activity,BP,DEPTOR;FGF18
2247,GO:0045859,0.658631424034231,0.67875776006549,2,6,regulation of protein kinase activity,BP,DEPTOR;FGF18
2573,GO:0051128,0.659285992651838,0.617078549566837,3,10,regulation of cellular component organization,BP,TBC1D14;HNF1A;LINGO1
710,GO:0008194,0.662176395789504,0.784411435877216,1,3,UDP-glycosyltransferase activity,MF,ALG5
74,GO:0001664,0.662801449808039,0.827872522447081,1,2,G-protein coupled receptor binding,MF,CNIH4
2277,GO:0046320,0.663380658400249,0.783374941748355,1,3,regulation of fatty acid oxidation,BP,ACADVL
583,GO:0006869,0.663842743073869,0.673459737820131,2,6,lipid transport,BP,RBP4;ABCG1
1636,GO:0032774,0.663882661271479,0.556148099177474,5,17,RNA biosynthetic process,BP,TSFM;ABCG1;FADD;PSMB10;HNF1A
3366,GO:1990234,0.666148713911767,0.825472661176592,1,2,transferase complex,CC,DPM3
1244,GO:0019219,0.666467316973956,0.553301888260079,5,17,regulation of nucleobase-containing compound metabolic process,BP,TSFM;ABCG1;FADD;PSMB10;HNF1A
1119,GO:0016477,0.667004639858155,0.670213130015519,2,6,cell migration,BP,FADD;FGF18
1651,GO:0032879,0.667569565893421,0.554706136596767,5,16,regulation of localization,BP,RBP4;ABCG1;FADD;TBC1D14;FGF18
1644,GO:0032844,0.668361405656919,0.779043938690674,1,3,regulation of homeostatic process,BP,FADD
469,GO:0006397,0.669693142728454,0.777873760983603,1,3,mRNA processing,BP,ARL6IP4
359,GO:0005576,0.67051249460154,0.489904053824496,12,37,extracellular region,CC,MSRA;ACAT1;RBP4;KRT10;ECI1;LYPLAL1;DECR1;LINGO1;FGF18;PEPD;ETFB;IFI30
926,GO:0010647,0.670984799932167,0.57275335816968,4,13,positive regulation of cell communication,BP,RBP4;FADD;PSMB10;FGF18
1340,GO:0023056,0.670984799932167,0.57275335816968,4,13,positive regulation of signaling,BP,RBP4;FADD;PSMB10;FGF18
1689,GO:0033674,0.671166179133699,0.776573382007856,1,3,positive regulation of kinase activity,BP,FGF18
2248,GO:0045860,0.671166179133699,0.776573382007856,1,3,positive regulation of protein kinase activity,BP,FGF18
1191,GO:0016874,0.672665524573738,0.77524321984548,1,3,ligase activity,MF,ACAT1
616,GO:0006996,0.673280705212867,0.608344667168829,3,9,organelle organization,BP,PUS1;TBC1D14;PLA2G16
534,GO:0006695,0.673323788154296,0.7746571330516,1,3,cholesterol biosynthetic process,BP,ABCG1
1087,GO:0016126,0.673323788154296,0.7746571330516,1,3,sterol biosynthetic process,BP,ABCG1
2275,GO:0046165,0.673323788154296,0.7746571330516,1,3,alcohol biosynthetic process,BP,ABCG1
3248,GO:1902653,0.673323788154296,0.7746571330516,1,3,secondary alcohol biosynthetic process,BP,ABCG1
2041,GO:0043408,0.674200864508597,0.773874225837153,1,3,regulation of MAPK cascade,BP,FGF18
2042,GO:0043410,0.674200864508597,0.773874225837153,1,3,positive regulation of MAPK cascade,BP,FGF18
2957,GO:0071900,0.674200864508597,0.773874225837153,1,3,regulation of protein serine/threonine kinase activity,BP,FGF18
2427,GO:0048585,0.675378771527522,0.606055432728514,3,9,negative regulation of response to stimulus,BP,FADD;DEPTOR;PSMB10
1169,GO:0016788,0.675927189001584,0.605455463289113,3,9,hydrolase activity, acting on ester bonds,MF,NUDT7;LYPLAL1;PLA2G16
232,GO:0003824,0.676595955519262,0.469404030092249,22,69,catalytic activity,MF,HACL1;MSRA;ACAT1;ACADVL;PUS1;NUDT7;ABCG1;ALG5;ECI1;ETFDH;LYPLAL1;PSMB10;NUDT6;PTS;PLA2G16;DECR1;FGF18;CPT1C;ZFYVE21;DPM3;PEPD;IFI30
1094,GO:0016192,0.678372906574559,0.564542120544819,4,13,vesicle-mediated transport,BP,CNIH4;USE1;TBC1D14;ZFYVE21
1719,GO:0034340,0.678646958748296,0.769870052770753,1,3,response to type I interferon,BP,FADD
2746,GO:0060337,0.678646958748296,0.769870052770753,1,3,type I interferon signaling pathway,BP,FADD
2908,GO:0071357,0.678646958748296,0.769870052770753,1,3,cellular response to type I interferon,BP,FADD
2004,GO:0043168,0.679574412151885,0.51991824914264,6,22,anion binding,MF,HACL1;PXK;ACADVL;ABCG1;ETFDH;DECR1
2504,GO:0050776,0.680042275244264,0.656563900012111,2,6,regulation of immune response,BP,FADD;PSMB10
675,GO:0007600,0.68423477578638,0.764752374913237,1,3,sensory perception,BP,RBP4
3181,GO:1901606,0.685519786925104,0.763561832292691,1,3,alpha-amino acid catabolic process,BP,ACAT1
732,GO:0008283,0.686117599969463,0.560193225207928,4,12,cell proliferation,BP,RBP4;FADD;FGF18;IFI30
1877,GO:0042127,0.686117599969463,0.560193225207928,4,12,regulation of cell proliferation,BP,RBP4;FADD;FGF18;IFI30
1378,GO:0030176,0.687814325614856,0.761423118133255,1,3,integral component of endoplasmic reticulum membrane,CC,DPM3
1470,GO:0031227,0.687814325614856,0.761423118133255,1,3,intrinsic component of endoplasmic reticulum membrane,CC,DPM3
2598,GO:0051235,0.69181853057329,0.757650915776377,1,3,maintenance of location,BP,ABCG1
2473,GO:0050661,0.692850397939509,0.756670519655771,1,3,NADP binding,MF,DECR1
2048,GO:0043436,0.693292459876181,0.462694650914431,12,40,oxoacid metabolic process,BP,HACL1;MSRA;ACAT1;ACADVL;ECI1;ETFDH;PSMB10;PTS;DECR1;CPT1C;PEPD;ETFB
1062,GO:0015918,0.697233352539489,0.752467689151548,1,3,sterol transport,BP,ABCG1
1401,GO:0030301,0.697233352539489,0.752467689151548,1,3,cholesterol transport,BP,ABCG1
2263,GO:0045940,0.697233352539489,0.752467689151548,1,3,positive regulation of steroid metabolic process,BP,ABCG1
2128,GO:0044425,0.699348294535064,0.452561310190432,13,43,membrane part,CC,PXMP2;TMEM160;CNIH4;ABCG1;ALG5;USE1;ETFDH;CCDC51;FADD;PLA2G16;LINGO1;CPT1C;DPM3
1549,GO:0032268,0.700016192776504,0.51797350233123,5,16,regulation of cellular protein metabolic process,BP,TSFM;FADD;DEPTOR;PSMB10;FGF18
2829,GO:0070266,0.700097249474612,0.749687398695377,1,3,necroptotic process,BP,FADD
3066,GO:0097300,0.700097249474612,0.749687398695377,1,3,programmed necrotic cell death,BP,FADD
3155,GO:1901135,0.701465603003073,0.538183043575601,4,13,carbohydrate derivative metabolic process,BP,ACAT1;NUDT7;ALG5;DPM3
1318,GO:0022604,0.702137037592037,0.747690498922973,1,3,regulation of cell morphogenesis,BP,LINGO1
2211,GO:0045444,0.702139300333311,0.747688276004682,1,3,fat cell differentiation,BP,NUDT7
660,GO:0007409,0.702769489789951,0.747068506045855,1,3,axonogenesis,BP,LINGO1
1464,GO:0031175,0.702769489789951,0.747068506045855,1,3,neuron projection development,BP,LINGO1
1663,GO:0032990,0.702769489789951,0.747068506045855,1,3,cell part morphogenesis,BP,LINGO1
2459,GO:0048812,0.702769489789951,0.747068506045855,1,3,neuron projection morphogenesis,BP,LINGO1
2461,GO:0048858,0.702769489789951,0.747068506045855,1,3,cell projection morphogenesis,BP,LINGO1
2799,GO:0061564,0.702769489789951,0.747068506045855,1,3,axon development,BP,LINGO1
1121,GO:0016485,0.705450623630445,0.744416668527339,1,3,protein processing,BP,FADD
2659,GO:0051604,0.705450623630445,0.744416668527339,1,3,protein maturation,BP,FADD
408,GO:0005887,0.705490262485054,0.609569337246206,2,8,integral component of plasma membrane,CC,ABCG1;CPT1C
1469,GO:0031226,0.705490262485054,0.609569337246206,2,8,intrinsic component of plasma membrane,CC,ABCG1;CPT1C
1000,GO:0014070,0.707084938496538,0.615594395188509,2,7,response to organic cyclic compound,BP,ACAT1;FADD
633,GO:0007167,0.707308242548515,0.719750819179101,1,4,enzyme linked receptor protein signaling pathway,BP,FGF18
634,GO:0007169,0.707308242548515,0.719750819179101,1,4,transmembrane receptor protein tyrosine kinase signaling pathway,BP,FGF18
606,GO:0006950,0.708343408999134,0.465954056074303,8,29,response to stress,BP,MSRA;ACAT1;PXK;ACADVL;ETFDH;FADD;PSMB10;IFI30
475,GO:0006417,0.709785969315902,0.740076577138432,1,3,regulation of translation,BP,TSFM
1711,GO:0034248,0.709785969315902,0.740076577138432,1,3,regulation of cellular amide metabolic process,BP,TSFM
363,GO:0005615,0.709862460744449,0.528327586834479,4,13,extracellular space,CC,RBP4;KRT10;LINGO1;FGF18
50,GO:0001101,0.710193030192697,0.739665725061022,1,3,response to acid chemical,BP,RBP4
1794,GO:0035384,0.710212212362702,0.716643436294928,1,4,thioester biosynthetic process,BP,ACAT1
2936,GO:0071616,0.710212212362702,0.716643436294928,1,4,acyl-CoA biosynthetic process,BP,ACAT1
2738,GO:0060255,0.713113522825411,0.46891985173201,7,26,regulation of macromolecule metabolic process,BP,TSFM;ABCG1;FADD;DEPTOR;PSMB10;HNF1A;FGF18
873,GO:0009896,0.713946146090555,0.735850233630188,1,3,positive regulation of catabolic process,BP,PSMB10
1487,GO:0031331,0.713946146090555,0.735850233630188,1,3,positive regulation of cellular catabolic process,BP,PSMB10
906,GO:0010556,0.714475165902883,0.495978401681246,5,18,regulation of macromolecule biosynthetic process,BP,TSFM;ABCG1;FADD;PSMB10;HNF1A
2091,GO:0044093,0.716055848687886,0.520962061869233,4,13,positive regulation of molecular function,BP,FADD;PSMB10;TBC1D14;FGF18
3075,GO:0097458,0.716227058800927,0.604921959675277,2,7,neuron part,CC,FADD;CPT1C
3134,GO:0120025,0.716227058800927,0.604921959675277,2,7,plasma membrane bounded cell projection,CC,FADD;CPT1C
1338,GO:0023051,0.716325574368543,0.480733620595739,6,20,regulation of signaling,BP,PXK;RBP4;FADD;DEPTOR;PSMB10;FGF18
544,GO:0006721,0.718142364986986,0.7315249150238,1,3,terpenoid metabolic process,BP,RBP4
1085,GO:0016101,0.718142364986986,0.7315249150238,1,3,diterpenoid metabolic process,BP,RBP4
2025,GO:0043254,0.718631736444941,0.731016352228328,1,3,regulation of protein complex assembly,BP,HNF1A
89,GO:0001819,0.719197671192278,0.730427137401705,1,3,positive regulation of cytokine production,BP,FADD
1612,GO:0032640,0.719197671192278,0.730427137401705,1,3,tumor necrosis factor production,BP,FADD
1622,GO:0032680,0.719197671192278,0.730427137401705,1,3,regulation of tumor necrosis factor production,BP,FADD
1633,GO:0032760,0.719197671192278,0.730427137401705,1,3,positive regulation of tumor necrosis factor production,BP,FADD
2940,GO:0071706,0.719197671192278,0.730427137401705,1,3,tumor necrosis factor superfamily cytokine production,BP,FADD
3306,GO:1903555,0.719197671192278,0.730427137401705,1,3,regulation of tumor necrosis factor superfamily cytokine production,BP,FADD
3307,GO:1903557,0.719197671192278,0.730427137401705,1,3,positive regulation of tumor necrosis factor superfamily cytokine production,BP,FADD
174,GO:0002682,0.721302965121285,0.546650435881119,3,10,regulation of immune system process,BP,RBP4;FADD;PSMB10
2989,GO:0072522,0.721701945027234,0.727805784495541,1,3,purine-containing compound biosynthetic process,BP,ACAT1
160,GO:0002521,0.723534685357815,0.725872704624476,1,3,leukocyte differentiation,BP,FADD
3217,GO:1902105,0.723534685357815,0.725872704624476,1,3,regulation of leukocyte differentiation,BP,FADD
3319,GO:1903706,0.723534685357815,0.725872704624476,1,3,regulation of hemopoiesis,BP,FADD
1758,GO:0034654,0.723997561834629,0.469744800282224,6,21,nucleobase-containing compound biosynthetic process,BP,ACAT1;TSFM;ABCG1;FADD;PSMB10;HNF1A
1720,GO:0034341,0.727149725535646,0.722022960045445,1,3,response to interferon-gamma,BP,IFI30
2904,GO:0071346,0.727149725535646,0.722022960045445,1,3,cellular response to interferon-gamma,BP,IFI30
1129,GO:0016567,0.727867137235323,0.72125310582551,1,3,protein ubiquitination,BP,PSMB10
1498,GO:0031396,0.727867137235323,0.72125310582551,1,3,regulation of protein ubiquitination,BP,PSMB10
1500,GO:0031398,0.727867137235323,0.72125310582551,1,3,positive regulation of protein ubiquitination,BP,PSMB10
1582,GO:0032446,0.727867137235323,0.72125310582551,1,3,protein modification by small protein conjugation,BP,PSMB10
2855,GO:0070647,0.727867137235323,0.72125310582551,1,3,protein modification by small protein conjugation or removal,BP,PSMB10
3287,GO:1903320,0.727867137235323,0.72125310582551,1,3,regulation of protein modification by small protein conjugation or removal,BP,PSMB10
3289,GO:1903322,0.727867137235323,0.72125310582551,1,3,positive regulation of protein modification by small protein conjugation or removal,BP,PSMB10
3058,GO:0097191,0.727926036219853,0.602521198041955,2,6,extrinsic apoptotic signaling pathway,BP,FADD;DEPTOR
3427,GO:2001233,0.727926036219853,0.602521198041955,2,6,regulation of apoptotic signaling pathway,BP,FADD;DEPTOR
3430,GO:2001236,0.727926036219853,0.602521198041955,2,6,regulation of extrinsic apoptotic signaling pathway,BP,FADD;DEPTOR
628,GO:0007155,0.72801939082575,0.721089470844568,1,3,cell adhesion,BP,FADD
629,GO:0007159,0.72801939082575,0.721089470844568,1,3,leukocyte cell-cell adhesion,BP,FADD
1109,GO:0016337,0.72801939082575,0.721089470844568,1,3,single organismal cell-cell adhesion,BP,FADD
1309,GO:0022407,0.72801939082575,0.721089470844568,1,3,regulation of cell-cell adhesion,BP,FADD
1310,GO:0022409,0.72801939082575,0.721089470844568,1,3,positive regulation of cell-cell adhesion,BP,FADD
1320,GO:0022610,0.72801939082575,0.721089470844568,1,3,biological adhesion,BP,FADD
1373,GO:0030155,0.72801939082575,0.721089470844568,1,3,regulation of cell adhesion,BP,FADD
1867,GO:0042098,0.72801939082575,0.721089470844568,1,3,T cell proliferation,BP,FADD
1869,GO:0042102,0.72801939082575,0.721089470844568,1,3,positive regulation of T cell proliferation,BP,FADD
1873,GO:0042110,0.72801939082575,0.721089470844568,1,3,T cell activation,BP,FADD
1878,GO:0042129,0.72801939082575,0.721089470844568,1,3,regulation of T cell proliferation,BP,FADD
2238,GO:0045785,0.72801939082575,0.721089470844568,1,3,positive regulation of cell adhesion,BP,FADD
2529,GO:0050863,0.72801939082575,0.721089470844568,1,3,regulation of T cell activation,BP,FADD
2533,GO:0050870,0.72801939082575,0.721089470844568,1,3,positive regulation of T cell activation,BP,FADD
3092,GO:0098602,0.72801939082575,0.721089470844568,1,3,single organism cell adhesion,BP,FADD
3093,GO:0098609,0.72801939082575,0.721089470844568,1,3,cell-cell adhesion,BP,FADD
3271,GO:1903037,0.72801939082575,0.721089470844568,1,3,regulation of leukocyte cell-cell adhesion,BP,FADD
3272,GO:1903039,0.72801939082575,0.721089470844568,1,3,positive regulation of leukocyte cell-cell adhesion,BP,FADD
808,GO:0009166,0.728202105978825,0.720892980659718,1,3,nucleotide catabolic process,BP,NUDT7
3164,GO:1901292,0.728202105978825,0.720892980659718,1,3,nucleoside phosphate catabolic process,BP,NUDT7
65,GO:0001568,0.72836968422706,0.720712656681487,1,3,blood vessel development,BP,FGF18
112,GO:0001944,0.72836968422706,0.720712656681487,1,3,vasculature development,BP,FGF18
2981,GO:0072358,0.72836968422706,0.720712656681487,1,3,cardiovascular system development,BP,FGF18
1247,GO:0019222,0.729305427568575,0.428156669202992,10,36,regulation of metabolic process,BP,ACADVL;TSFM;ABCG1;FADD;DEPTOR;PSMB10;TBC1D14;HNF1A;PTS;FGF18
1246,GO:0019221,0.729795968059968,0.536298923638286,3,10,cytokine-mediated signaling pathway,BP,FADD;PSMB10;IFI30
715,GO:0008203,0.732236241987357,0.585646177174487,2,7,cholesterol metabolic process,BP,ACADVL;ABCG1
3247,GO:1902652,0.732236241987357,0.585646177174487,2,7,secondary alcohol metabolic process,BP,ACADVL;ABCG1
1479,GO:0031323,0.732322420980626,0.43068843111422,9,32,regulation of cellular metabolic process,BP,ACADVL;TSFM;ABCG1;FADD;DEPTOR;PSMB10;TBC1D14;HNF1A;FGF18
428,GO:0006082,0.73393097804242,0.414946454774191,12,41,organic acid metabolic process,BP,HACL1;MSRA;ACAT1;ACADVL;ECI1;ETFDH;PSMB10;PTS;DECR1;CPT1C;PEPD;ETFB
2250,GO:0045862,0.73894120101591,0.58913576507248,2,6,positive regulation of proteolysis,BP,FADD;PSMB10
614,GO:0006979,0.739841973306417,0.576215184545384,2,7,response to oxidative stress,BP,MSRA;ETFDH
2896,GO:0071310,0.740051840798034,0.46484783486659,5,18,cellular response to organic substance,BP,ACADVL;FADD;PSMB10;FGF18;IFI30
979,GO:0010939,0.741251051013208,0.706523929317105,1,3,regulation of necrotic cell death,BP,FADD
1641,GO:0032813,0.741251051013208,0.706523929317105,1,3,tumor necrosis factor receptor superfamily binding,MF,FADD
3428,GO:2001234,0.741251051013208,0.706523929317105,1,3,negative regulation of apoptotic signaling pathway,BP,FADD
3431,GO:2001237,0.741251051013208,0.706523929317105,1,3,negative regulation of extrinsic apoptotic signaling pathway,BP,FADD
1189,GO:0016863,0.742423406075579,0.705199685763364,1,3,intramolecular oxidoreductase activity, transposing C=C bonds,MF,ECI1
869,GO:0009892,0.743223110100021,0.487640682036331,4,13,negative regulation of metabolic process,BP,ACADVL;DEPTOR;PSMB10;TBC1D14
1480,GO:0031324,0.743223110100021,0.487640682036331,4,13,negative regulation of cellular metabolic process,BP,ACADVL;DEPTOR;PSMB10;TBC1D14
632,GO:0007166,0.743438250786521,0.460625335197016,5,18,cell surface receptor signaling pathway,BP,FADD;DEPTOR;PSMB10;FGF18;IFI30
393,GO:0005789,0.744266319501649,0.461907537389557,5,17,endoplasmic reticulum membrane,CC,ABCG1;ALG5;USE1;CPT1C;DPM3
1884,GO:0042175,0.744266319501649,0.461907537389557,5,17,nuclear outer membrane-endoplasmic reticulum membrane network,CC,ABCG1;ALG5;USE1;CPT1C;DPM3
2133,GO:0044432,0.744266319501649,0.461907537389557,5,17,endoplasmic reticulum part,CC,ABCG1;ALG5;USE1;CPT1C;DPM3
106,GO:0001933,0.744695219734206,0.702617466830634,1,3,negative regulation of protein phosphorylation,BP,DEPTOR
479,GO:0006469,0.744695219734206,0.702617466830634,1,3,negative regulation of protein kinase activity,BP,DEPTOR
1688,GO:0033673,0.744695219734206,0.702617466830634,1,3,negative regulation of kinase activity,BP,DEPTOR
1899,GO:0042326,0.744695219734206,0.702617466830634,1,3,negative regulation of phosphorylation,BP,DEPTOR
445,GO:0006139,0.744747124639164,0.410807099298409,10,34,nucleobase-containing compound metabolic process,BP,ACAT1;ARL6IP4;PUS1;NUDT7;TSFM;ABCG1;FADD;PSMB10;LAGE3;HNF1A
889,GO:0010033,0.747718218558262,0.420699301894378,8,27,response to organic substance,BP,ACAT1;RBP4;ACADVL;ABCG1;FADD;PSMB10;FGF18;IFI30
3242,GO:1902580,0.74811691775758,0.673188498166977,1,4,single-organism cellular localization,BP,ABCG1
3243,GO:1902582,0.74811691775758,0.673188498166977,1,4,single-organism intracellular transport,BP,ABCG1
2603,GO:0051246,0.749246227511355,0.455645744094266,5,17,regulation of protein metabolic process,BP,TSFM;FADD;DEPTOR;PSMB10;FGF18
231,GO:0003779,0.75176900894526,0.694438802311053,1,3,actin binding,MF,PXK
963,GO:0010876,0.752428387405389,0.560201538688233,2,7,lipid localization,BP,RBP4;ABCG1
3236,GO:1902531,0.752715312325046,0.502068442447218,3,11,regulation of intracellular signal transduction,BP,FADD;DEPTOR;FGF18
2166,GO:0044763,0.752907353430968,0.393728657210506,28,89,single-organism cellular process,BP,HACL1;MSRA;ACAT1;MRPL14;PXK;RBP4;ACADVL;NUDT7;ABCG1;ALG5;USE1;KRT10;ECI1;ETFDH;FADD;DEPTOR;PSMB10;TBC1D14;PTS;PLA2G16;DECR1;LINGO1;FGF18;CPT1C;ZFYVE21;DPM3;PEPD;ETFB
912,GO:0010565,0.753123151139242,0.559302378039594,2,7,regulation of cellular ketone metabolic process,BP,ACADVL;PSMB10
2627,GO:0051341,0.753503611807023,0.692400646813402,1,3,regulation of oxidoreductase activity,BP,PTS
2407,GO:0048471,0.753945729684411,0.691879069738524,1,3,perinuclear region of cytoplasm,CC,PLA2G16
1348,GO:0030030,0.754269282183533,0.665588875143974,1,4,cell projection organization,BP,LINGO1
375,GO:0005741,0.754401465537426,0.691340534577611,1,3,mitochondrial outer membrane,CC,CPT1C
2463,GO:0048870,0.754563945037544,0.557432523234272,2,7,cell motility,BP,FADD;FGF18
2664,GO:0051674,0.754563945037544,0.557432523234272,2,7,localization of cell,BP,FADD;FGF18
2333,GO:0046660,0.754649012381334,0.691047632172664,1,3,female sex differentiation,BP,RBP4
1503,GO:0031401,0.756759722147797,0.554569312032999,2,7,positive regulation of protein modification process,BP,PSMB10;FGF18
1077,GO:0016051,0.757672623211551,0.687448263554564,1,3,carbohydrate biosynthetic process,BP,RBP4
2286,GO:0046364,0.757672623211551,0.687448263554564,1,3,monosaccharide biosynthetic process,BP,RBP4
120,GO:0002020,0.757767776357922,0.687334333971392,1,3,protease binding,MF,FADD
898,GO:0010468,0.759627083030472,0.436358125773237,5,20,regulation of gene expression,BP,TSFM;ABCG1;FADD;PSMB10;HNF1A
3237,GO:1902532,0.759879279408892,0.684795749552122,1,3,negative regulation of intracellular signal transduction,BP,DEPTOR
1592,GO:0032535,0.761357274409121,0.683006860669759,1,3,regulation of cellular component size,BP,DEPTOR
3013,GO:0090066,0.761357274409121,0.683006860669759,1,3,regulation of anatomical structure size,BP,DEPTOR
33,GO:0000904,0.762499556218247,0.655162533608921,1,4,cell morphogenesis involved in differentiation,BP,LINGO1
1381,GO:0030182,0.762499556218247,0.655162533608921,1,4,neuron differentiation,BP,LINGO1
2446,GO:0048666,0.762499556218247,0.655162533608921,1,4,neuron development,BP,LINGO1
2447,GO:0048667,0.762499556218247,0.655162533608921,1,4,cell morphogenesis involved in neuron differentiation,BP,LINGO1
852,GO:0009719,0.762592197548814,0.456018703500965,4,15,response to endogenous stimulus,BP,ACAT1;ABCG1;FADD;FGF18
846,GO:0009615,0.762873901365905,0.654681043033013,1,4,response to virus,BP,FADD
2661,GO:0051607,0.762873901365905,0.654681043033013,1,4,defense response to virus,BP,FADD
3085,GO:0098542,0.762873901365905,0.654681043033013,1,4,defense response to other organism,BP,FADD
589,GO:0006886,0.764946613723097,0.652003427079364,1,4,intracellular protein transport,BP,TBC1D14
2582,GO:0051173,0.7649848055536,0.535193155659164,2,8,positive regulation of nitrogen compound metabolic process,BP,FADD;HNF1A
2517,GO:0050804,0.765353839591022,0.651475024232493,1,4,modulation of synaptic transmission,BP,PXK
607,GO:0006952,0.766138997610625,0.451365086242714,4,15,defense response,BP,PXK;FADD;PSMB10;IFI30
525,GO:0006664,0.767141105652939,0.675910116578511,1,3,glycolipid metabolic process,BP,DPM3
3299,GO:1903509,0.767141105652939,0.675910116578511,1,3,liposaccharide metabolic process,BP,DPM3
2600,GO:0051239,0.767914734948346,0.414987447583803,6,21,regulation of multicellular organismal process,BP,RBP4;FADD;PSMB10;PLA2G16;LINGO1;FGF18
3432,GO:2001238,0.768977612693246,0.673624078097048,1,3,positive regulation of extrinsic apoptotic signaling pathway,BP,FADD
2159,GO:0044708,0.770316537096454,0.644973228903833,1,4,single-organism behavior,BP,FADD
563,GO:0006796,0.770511113730035,0.392092197579637,8,27,phosphate-containing compound metabolic process,BP,ACAT1;NUDT7;DEPTOR;PSMB10;PLA2G16;FGF18;ZFYVE21;DPM3
1547,GO:0032259,0.770748329655203,0.671404758428692,1,3,methylation,BP,ETFB
1543,GO:0032101,0.771139015818172,0.628752554887178,1,5,regulation of response to external stimulus,BP,FGF18
880,GO:0009967,0.771917707389482,0.476675418637983,3,11,positive regulation of signal transduction,BP,FADD;PSMB10;FGF18
1973,GO:0042995,0.772007442657293,0.525657127671934,2,8,cell projection,CC,FADD;CPT1C
3238,GO:1902533,0.774648481729022,0.522025176938784,2,8,positive regulation of intracellular signal transduction,BP,FADD;FGF18
2601,GO:0051240,0.774763251472777,0.521866770833986,2,8,positive regulation of multicellular organismal process,BP,FADD;FGF18
647,GO:0007268,0.777474391284106,0.620041252681481,1,5,chemical synaptic transmission,BP,PXK
3116,GO:0098916,0.777474391284106,0.620041252681481,1,5,anterograde trans-synaptic signaling,BP,PXK
3123,GO:0099536,0.777474391284106,0.620041252681481,1,5,synaptic signaling,BP,PXK
3124,GO:0099537,0.777474391284106,0.620041252681481,1,5,trans-synaptic signaling,BP,PXK
545,GO:0006725,0.777667166923403,0.364849536953121,11,38,cellular aromatic compound metabolic process,BP,ACAT1;ARL6IP4;PUS1;NUDT7;TSFM;ABCG1;FADD;PSMB10;LAGE3;HNF1A;PTS
1312,GO:0022411,0.779750737722082,0.659885377686777,1,3,cellular component disassembly,BP,MRPL14
1661,GO:0032984,0.779750737722082,0.659885377686777,1,3,macromolecular complex disassembly,BP,MRPL14
2022,GO:0043241,0.779750737722082,0.659885377686777,1,3,protein complex disassembly,BP,MRPL14
2072,GO:0043624,0.779750737722082,0.659885377686777,1,3,cellular protein complex disassembly,BP,MRPL14
1962,GO:0042803,0.780739735160086,0.464641629087069,3,11,protein homodimerization activity,MF,ACAT1;ABCG1;PTS
2466,GO:0048878,0.781587647308568,0.45917854512583,3,12,chemical homeostasis,BP,RBP4;ABCG1;HNF1A
868,GO:0009891,0.781820221479895,0.458857138374907,3,12,positive regulation of biosynthetic process,BP,ABCG1;FADD;HNF1A
2003,GO:0043167,0.782020218093549,0.358832754948773,11,39,ion binding,MF,HACL1;ACAT1;PXK;ACADVL;NUDT7;ABCG1;ETFDH;PTS;DECR1;ZFYVE21;PEPD
2774,GO:0060627,0.78219230437114,0.628931160911002,1,4,regulation of vesicle-mediated transport,BP,TBC1D14
733,GO:0008284,0.782394545838611,0.519875516873397,2,7,positive regulation of cell proliferation,BP,FADD;FGF18
2109,GO:0044271,0.78316219273782,0.374752367545379,8,28,cellular nitrogen compound biosynthetic process,BP,ACAT1;MRPL14;TSFM;ABCG1;FADD;PSMB10;HNF1A;PTS
1984,GO:0043043,0.783578999804488,0.518213383138247,2,7,peptide biosynthetic process,BP,MRPL14;TSFM
2067,GO:0043604,0.783578999804488,0.518213383138247,2,7,amide biosynthetic process,BP,MRPL14;TSFM
1829,GO:0036094,0.783824431918857,0.389970385313462,6,24,small molecule binding,MF,HACL1;RBP4;ACADVL;ABCG1;ETFDH;DECR1
793,GO:0009108,0.784912652040091,0.507665062618231,2,8,coenzyme biosynthetic process,BP,ACAT1;PTS
1140,GO:0016628,0.785222268357211,0.624724892408354,1,4,oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor,MF,DECR1
627,GO:0007154,0.785800206625398,0.363275444769766,9,33,cell communication,BP,PXK;RBP4;ACADVL;FADD;DEPTOR;PSMB10;LINGO1;FGF18;IFI30
2353,GO:0046889,0.786019313035645,0.623610527104236,1,4,positive regulation of lipid biosynthetic process,BP,ABCG1
2348,GO:0046872,0.78654278436309,0.378538029121012,7,25,metal ion binding,MF,HACL1;ACAT1;NUDT7;ETFDH;PTS;ZFYVE21;PEPD
2806,GO:0065009,0.788548975871555,0.389641652697691,6,20,regulation of molecular function,BP,FADD;DEPTOR;PSMB10;TBC1D14;PTS;FGF18
1339,GO:0023052,0.78999156234809,0.35782667617067,9,33,signaling,BP,PXK;RBP4;ACADVL;FADD;DEPTOR;PSMB10;LINGO1;FGF18;IFI30
2154,GO:0044700,0.78999156234809,0.35782667617067,9,33,single organism signaling,BP,PXK;RBP4;ACADVL;FADD;DEPTOR;PSMB10;LINGO1;FGF18;IFI30
1669,GO:0033043,0.79040050961323,0.617425444589725,1,4,regulation of organelle organization,BP,TBC1D14
2304,GO:0046470,0.791312624739825,0.644484682729184,1,3,phosphatidylcholine metabolic process,BP,PLA2G16
1896,GO:0042304,0.793680047536907,0.612728433972814,1,4,regulation of fatty acid biosynthetic process,BP,ACADVL
2405,GO:0048468,0.795471967949941,0.492469297671499,2,8,cell development,BP,LINGO1;FGF18
2309,GO:0046483,0.795620397983889,0.341325023294445,11,39,heterocycle metabolic process,BP,ACAT1;ARL6IP4;PUS1;NUDT7;TSFM;ABCG1;FADD;PSMB10;LAGE3;HNF1A;PTS
3183,GO:1901615,0.796660265065723,0.442298894788629,3,11,organic hydroxy compound metabolic process,BP,RBP4;ACADVL;ABCG1
1550,GO:0032269,0.79913028716014,0.495870083547761,2,7,negative regulation of cellular protein metabolic process,BP,DEPTOR;PSMB10
351,GO:0005524,0.801146813505118,0.575433170173614,1,6,ATP binding,MF,ABCG1
1206,GO:0017076,0.801146813505118,0.575433170173614,1,6,purine nucleotide binding,MF,ABCG1
1421,GO:0030554,0.801146813505118,0.575433170173614,1,6,adenyl nucleotide binding,MF,ABCG1
1596,GO:0032553,0.801146813505118,0.575433170173614,1,6,ribonucleotide binding,MF,ABCG1
1597,GO:0032555,0.801146813505118,0.575433170173614,1,6,purine ribonucleotide binding,MF,ABCG1
1598,GO:0032559,0.801146813505118,0.575433170173614,1,6,adenyl ribonucleotide binding,MF,ABCG1
1809,GO:0035639,0.801146813505118,0.575433170173614,1,6,purine ribonucleoside triphosphate binding,MF,ABCG1
879,GO:0009966,0.803590405773746,0.400163097447513,4,15,regulation of signal transduction,BP,FADD;DEPTOR;PSMB10;FGF18
182,GO:0002696,0.804968452113122,0.596103724224186,1,4,positive regulation of leukocyte activation,BP,FADD
1655,GO:0032943,0.804968452113122,0.596103724224186,1,4,mononuclear cell proliferation,BP,FADD
1656,GO:0032944,0.804968452113122,0.596103724224186,1,4,regulation of mononuclear cell proliferation,BP,FADD
1657,GO:0032946,0.804968452113122,0.596103724224186,1,4,positive regulation of mononuclear cell proliferation,BP,FADD
2331,GO:0046649,0.804968452113122,0.596103724224186,1,4,lymphocyte activation,BP,FADD
2332,GO:0046651,0.804968452113122,0.596103724224186,1,4,lymphocyte proliferation,BP,FADD
2476,GO:0050670,0.804968452113122,0.596103724224186,1,4,regulation of lymphocyte proliferation,BP,FADD
2477,GO:0050671,0.804968452113122,0.596103724224186,1,4,positive regulation of lymphocyte proliferation,BP,FADD
2532,GO:0050867,0.804968452113122,0.596103724224186,1,4,positive regulation of cell activation,BP,FADD
2606,GO:0051249,0.804968452113122,0.596103724224186,1,4,regulation of lymphocyte activation,BP,FADD
2607,GO:0051251,0.804968452113122,0.596103724224186,1,4,positive regulation of lymphocyte activation,BP,FADD
2856,GO:0070661,0.804968452113122,0.596103724224186,1,4,leukocyte proliferation,BP,FADD
2857,GO:0070663,0.804968452113122,0.596103724224186,1,4,regulation of leukocyte proliferation,BP,FADD
2858,GO:0070665,0.804968452113122,0.596103724224186,1,4,positive regulation of leukocyte proliferation,BP,FADD
417,GO:0006006,0.805595359340823,0.59515901720985,1,4,glucose metabolic process,BP,RBP4
1086,GO:0016125,0.805698522077599,0.477321045052162,2,8,sterol metabolic process,BP,ACADVL;ABCG1
1187,GO:0016860,0.806677393783798,0.593523005674007,1,4,intramolecular oxidoreductase activity,MF,ECI1
107,GO:0001934,0.807332372991456,0.592529316171968,1,4,positive regulation of protein phosphorylation,BP,FGF18
1900,GO:0042327,0.807332372991456,0.592529316171968,1,4,positive regulation of phosphorylation,BP,FGF18
566,GO:0006807,0.809020626545458,0.31242095757185,16,55,nitrogen compound metabolic process,BP,MSRA;ACAT1;MRPL14;ARL6IP4;PUS1;NUDT7;TSFM;ABCG1;FADD;PSMB10;LAGE3;HNF1A;PTS;PLA2G16;CPT1C;PEPD
2536,GO:0050877,0.810008777813081,0.588442144003561,1,4,neurological system process,BP,RBP4
1495,GO:0031347,0.810644149065693,0.469835688792272,2,8,regulation of defense response,BP,FADD;PSMB10
1798,GO:0035556,0.812090754510189,0.387975616559393,4,15,intracellular signal transduction,BP,FADD;DEPTOR;PSMB10;FGF18
2828,GO:0070265,0.814521695148892,0.581451481567318,1,4,necrotic cell death,BP,FADD
781,GO:0009063,0.814647945194107,0.581254100482043,1,4,cellular amino acid catabolic process,BP,ACAT1
2624,GO:0051336,0.81519923518613,0.415190687008803,3,11,regulation of hydrolase activity,BP,FADD;TBC1D14;FGF18
1668,GO:0033036,0.815606304267276,0.364264189330398,5,18,macromolecule localization,BP,RBP4;CNIH4;ABCG1;USE1;TBC1D14
392,GO:0005783,0.815663789278326,0.340381386930669,7,24,endoplasmic reticulum,CC,CNIH4;ABCG1;ALG5;USE1;PLA2G16;CPT1C;DPM3
1417,GO:0030529,0.817546214512336,0.576695263322201,1,4,intracellular ribonucleoprotein complex,CC,MRPL14
3373,GO:1990904,0.817546214512336,0.576695263322201,1,4,ribonucleoprotein complex,CC,MRPL14
2584,GO:0051179,0.817895595626704,0.315816227789312,10,36,localization,BP,RBP4;CNIH4;ABCG1;USE1;FADD;PSMB10;TBC1D14;HNF1A;FGF18;ZFYVE21
2160,GO:0044710,0.818217361892287,0.298944273698075,21,69,single-organism metabolic process,BP,HACL1;MSRA;ACAT1;RBP4;ACADVL;NUDT7;ABCG1;ALG5;ECI1;ETFDH;PSMB10;PTS;PLA2G16;DECR1;FGF18;CPT1C;ZFYVE21;DPM3;PEPD;ETFB;IFI30
1999,GO:0043123,0.819644468399106,0.573361357113435,1,4,positive regulation of I-kappaB kinase/NF-kappaB signaling,BP,FADD
543,GO:0006720,0.820102305580758,0.572630119625736,1,4,isoprenoid metabolic process,BP,RBP4
175,GO:0002683,0.821529393790853,0.570342061818953,1,4,negative regulation of immune system process,BP,FADD
2561,GO:0051050,0.821645092941001,0.452793187967294,2,8,positive regulation of transport,BP,RBP4;ABCG1
691,GO:0008047,0.822015430972395,0.569559745552667,1,4,enzyme activator activity,MF,TBC1D14
603,GO:0006928,0.822580546127213,0.45131818062926,2,8,movement of cell or subcellular component,BP,FADD;FGF18
1854,GO:0040011,0.822580546127213,0.45131818062926,2,8,locomotion,BP,FADD;FGF18
807,GO:0009165,0.824171468526632,0.566070559164329,1,4,nucleotide biosynthetic process,BP,ACAT1
3165,GO:1901293,0.824171468526632,0.566070559164329,1,4,nucleoside phosphate biosynthetic process,BP,ACAT1
87,GO:0001817,0.824449484753568,0.565618379087908,1,4,regulation of cytokine production,BP,FADD
1289,GO:0019867,0.824875895897432,0.564923832912497,1,4,outer membrane,CC,CPT1C
1530,GO:0031968,0.824875895897432,0.564923832912497,1,4,organelle outer membrane,CC,CPT1C
488,GO:0006508,0.827377630515559,0.396689308722949,3,11,proteolysis,BP,FADD;PSMB10;PEPD
2140,GO:0044445,0.827390833577647,0.560802416596401,1,4,cytosolic part,CC,FADD
1756,GO:0034641,0.82917270153157,0.290606660399295,13,46,cellular nitrogen compound metabolic process,BP,ACAT1;MRPL14;ARL6IP4;PUS1;NUDT7;TSFM;ABCG1;FADD;PSMB10;LAGE3;HNF1A;PTS;CPT1C
2448,GO:0048699,0.830512713255431,0.538600852841915,1,5,generation of neurons,BP,LINGO1
631,GO:0007165,0.830993775605759,0.31556148904499,7,27,signal transduction,BP,ACADVL;FADD;DEPTOR;PSMB10;LINGO1;FGF18;IFI30
2588,GO:0051188,0.831323897970393,0.430799074889095,2,9,cofactor biosynthetic process,BP,ACAT1;PTS
2009,GO:0043202,0.831621506479448,0.553770974980918,1,4,lysosomal lumen,CC,IFI30
1574,GO:0032403,0.831792684027197,0.553483834564591,1,4,protein complex binding,MF,FADD
1241,GO:0019216,0.833181638096603,0.427775736916509,2,9,regulation of lipid metabolic process,BP,ACADVL;ABCG1
2354,GO:0046890,0.833181638096603,0.427775736916509,2,9,regulation of lipid biosynthetic process,BP,ACADVL;ABCG1
159,GO:0002520,0.833458593715481,0.550678477576669,1,4,immune system development,BP,FADD
1360,GO:0030097,0.833458593715481,0.550678477576669,1,4,hemopoiesis,BP,FADD
2418,GO:0048534,0.833458593715481,0.550678477576669,1,4,hematopoietic or lymphoid organ development,BP,FADD
211,GO:0003008,0.834010132079144,0.43295320674776,2,8,system process,BP,RBP4;HNF1A
2928,GO:0071495,0.834496345542993,0.520947219550412,1,6,cellular response to endogenous stimulus,BP,FGF18
501,GO:0006575,0.834826321615474,0.531213454137205,1,5,cellular modified amino acid metabolic process,BP,PLA2G16
561,GO:0006790,0.835125115211373,0.374032064103732,3,14,sulfur compound metabolic process,BP,MSRA;ACAT1;NUDT7
407,GO:0005886,0.837183365198636,0.315769727632781,6,24,plasma membrane,CC,PXK;ABCG1;KRT10;FADD;LINGO1;CPT1C
490,GO:0006518,0.838869433210585,0.424945914328868,2,8,peptide metabolic process,BP,MRPL14;TSFM
854,GO:0009725,0.839055622749665,0.413118403937035,2,10,response to hormone,BP,ACAT1;ABCG1
517,GO:0006643,0.839152751441858,0.540937602703076,1,4,membrane lipid metabolic process,BP,DPM3
1333,GO:0022892,0.839313694750808,0.417673319725887,2,9,substrate-specific transporter activity,MF,RBP4;ABCG1
2005,GO:0043169,0.840093847181035,0.30343933906409,7,26,cation binding,MF,HACL1;ACAT1;NUDT7;ETFDH;PTS;ZFYVE21;PEPD
2574,GO:0051129,0.840160092205665,0.539189341720474,1,4,negative regulation of cellular component organization,BP,LINGO1
181,GO:0002694,0.84128590028614,0.519903117550979,1,5,regulation of leukocyte activation,BP,FADD
2531,GO:0050865,0.84128590028614,0.519903117550979,1,5,regulation of cell activation,BP,FADD
2805,GO:0065008,0.841324858918776,0.287470333270314,9,34,regulation of biological quality,BP,RBP4;ACADVL;ABCG1;FADD;DEPTOR;PSMB10;HNF1A;DPM3;IFI30
32,GO:0000902,0.844545568697705,0.514078775521535,1,5,cell morphogenesis,BP,LINGO1
1662,GO:0032989,0.844545568697705,0.514078775521535,1,5,cellular component morphogenesis,BP,LINGO1
252,GO:0004175,0.844593637434003,0.531402748371128,1,4,endopeptidase activity,MF,PSMB10
1045,GO:0015711,0.848472573496838,0.506954215372754,1,5,organic anion transport,BP,ABCG1
115,GO:0001959,0.848769041274742,0.523928691750191,1,4,regulation of cytokine-mediated signaling pathway,BP,FADD
2776,GO:0060759,0.848769041274742,0.523928691750191,1,4,regulation of response to cytokine stimulus,BP,FADD
1961,GO:0042802,0.849160328208577,0.312684280616205,5,19,identical protein binding,MF,HACL1;ACAT1;ABCG1;FADD;PTS
678,GO:0007610,0.849704853178966,0.504693717232188,1,5,behavior,BP,FADD
1551,GO:0032270,0.850799556142135,0.355156888542182,3,12,positive regulation of cellular protein metabolic process,BP,FADD;PSMB10;FGF18
2604,GO:0051247,0.850799556142135,0.355156888542182,3,12,positive regulation of protein metabolic process,BP,FADD;PSMB10;FGF18
2185,GO:0045087,0.851556577953015,0.353913129052236,3,12,innate immune response,BP,FADD;PSMB10;IFI30
201,GO:0002791,0.852475500134353,0.517175643320893,1,4,regulation of peptide secretion,BP,RBP4
202,GO:0002793,0.852475500134353,0.517175643320893,1,4,positive regulation of peptide secretion,BP,RBP4
2488,GO:0050708,0.852475500134353,0.517175643320893,1,4,regulation of protein secretion,BP,RBP4
2489,GO:0050714,0.852475500134353,0.517175643320893,1,4,positive regulation of protein secretion,BP,RBP4
2558,GO:0051046,0.852475500134353,0.517175643320893,1,4,regulation of secretion,BP,RBP4
2559,GO:0051047,0.852475500134353,0.517175643320893,1,4,positive regulation of secretion,BP,RBP4
2595,GO:0051222,0.852475500134353,0.517175643320893,1,4,positive regulation of protein transport,BP,RBP4
3303,GO:1903530,0.852475500134353,0.517175643320893,1,4,regulation of secretion by cell,BP,RBP4
3304,GO:1903532,0.852475500134353,0.517175643320893,1,4,positive regulation of secretion by cell,BP,RBP4
3352,GO:1904951,0.852475500134353,0.517175643320893,1,4,positive regulation of establishment of protein localization,BP,RBP4
1704,GO:0034097,0.854189674393522,0.34616113403287,3,13,response to cytokine,BP,FADD;PSMB10;IFI30
2903,GO:0071345,0.854189674393522,0.34616113403287,3,13,cellular response to cytokine stimulus,BP,FADD;PSMB10;IFI30
3429,GO:2001235,0.855830798628253,0.510963254996421,1,4,positive regulation of apoptotic signaling pathway,BP,FADD
2960,GO:0071944,0.855931864089678,0.286817282615955,6,25,cell periphery,CC,PXK;ABCG1;KRT10;FADD;LINGO1;CPT1C
386,GO:0005773,0.856904011148615,0.387583193733612,2,9,vacuole,CC,TBC1D14;IFI30
910,GO:0010563,0.857964321945017,0.506962682798964,1,4,negative regulation of phosphorus metabolic process,BP,DEPTOR
2261,GO:0045936,0.857964321945017,0.506962682798964,1,4,negative regulation of phosphate metabolic process,BP,DEPTOR
2175,GO:0044877,0.858329627630158,0.48852753767347,1,5,macromolecular complex binding,MF,FADD
1684,GO:0033554,0.859606673567508,0.382804548439342,2,9,cellular response to stress,BP,ACADVL;PSMB10
3184,GO:1901617,0.859762134879767,0.485782147826696,1,5,organic hydroxy compound biosynthetic process,BP,ABCG1
617,GO:0007005,0.860534008724137,0.502091077393308,1,4,mitochondrion organization,BP,PUS1
601,GO:0006919,0.860794818058976,0.501593338651368,1,4,activation of cysteine-type endopeptidase activity involved in apoptotic process,BP,FADD
983,GO:0010950,0.860794818058976,0.501593338651368,1,4,positive regulation of endopeptidase activity,BP,FADD
985,GO:0010952,0.860794818058976,0.501593338651368,1,4,positive regulation of peptidase activity,BP,FADD
2031,GO:0043280,0.860794818058976,0.501593338651368,1,4,positive regulation of cysteine-type endopeptidase activity involved in apoptotic process,BP,FADD
3420,GO:2001056,0.860794818058976,0.501593338651368,1,4,positive regulation of cysteine-type endopeptidase activity,BP,FADD
2605,GO:0051248,0.861244982065987,0.386395468317623,2,8,negative regulation of protein metabolic process,BP,DEPTOR;PSMB10
1673,GO:0033209,0.862941438298388,0.497473212468476,1,4,tumor necrosis factor-mediated signaling pathway,BP,PSMB10
1748,GO:0034612,0.862941438298388,0.497473212468476,1,4,response to tumor necrosis factor,BP,PSMB10
2907,GO:0071356,0.862941438298388,0.497473212468476,1,4,cellular response to tumor necrosis factor,BP,PSMB10
516,GO:0006641,0.863143511672152,0.49708319269354,1,4,triglyceride metabolic process,BP,PLA2G16
1749,GO:0034613,0.864194315771943,0.47717448022522,1,5,cellular protein localization,BP,TBC1D14
2863,GO:0070727,0.864194315771943,0.47717448022522,1,5,cellular macromolecule localization,BP,TBC1D14
3173,GO:1901564,0.865482878885122,0.248296781422308,10,37,organonitrogen compound metabolic process,BP,MSRA;ACAT1;MRPL14;NUDT7;TSFM;PSMB10;PTS;PLA2G16;CPT1C;PEPD
3006,GO:0080090,0.86564623385547,0.256702680810744,8,32,regulation of primary metabolic process,BP,ACADVL;TSFM;ABCG1;FADD;DEPTOR;PSMB10;HNF1A;FGF18
2112,GO:0044281,0.866306076423309,0.234336660619607,16,57,small molecule metabolic process,BP,HACL1;MSRA;ACAT1;RBP4;ACADVL;NUDT7;ABCG1;ECI1;ETFDH;PSMB10;PTS;PLA2G16;DECR1;CPT1C;PEPD;ETFB
75,GO:0001666,0.867016826263753,0.489533792796634,1,4,response to hypoxia,BP,PSMB10
1837,GO:0036293,0.867016826263753,0.489533792796634,1,4,response to decreased oxygen levels,BP,PSMB10
2842,GO:0070482,0.867016826263753,0.489533792796634,1,4,response to oxygen levels,BP,PSMB10
1991,GO:0043086,0.867844727580761,0.374451518398212,2,8,negative regulation of catalytic activity,BP,DEPTOR;PSMB10
2090,GO:0044092,0.867844727580761,0.374451518398212,2,8,negative regulation of molecular function,BP,DEPTOR;PSMB10
555,GO:0006753,0.8701368679036,0.363758741835792,2,9,nucleoside phosphate metabolic process,BP,ACAT1;NUDT7
799,GO:0009117,0.8701368679036,0.363758741835792,2,9,nucleotide metabolic process,BP,ACAT1;NUDT7
915,GO:0010604,0.874474608800611,0.286313495734495,4,17,positive regulation of macromolecule metabolic process,BP,FADD;PSMB10;HNF1A;FGF18
3244,GO:1902589,0.876724381761123,0.451859292094183,1,5,single-organism organelle organization,BP,TBC1D14
1242,GO:0019217,0.877017699069411,0.451248373335813,1,5,regulation of fatty acid metabolic process,BP,ACADVL
86,GO:0001816,0.878589179653385,0.447960364749139,1,5,cytokine production,BP,FADD
2512,GO:0050794,0.878722395287031,0.218409165136075,14,53,regulation of cellular process,BP,PXK;RBP4;ACADVL;TSFM;ABCG1;FADD;DEPTOR;PSMB10;TBC1D14;HNF1A;PLA2G16;LINGO1;FGF18;IFI30
2707,GO:0055086,0.88025987072142,0.33988324050355,2,10,nucleobase-containing small molecule metabolic process,BP,ACAT1;NUDT7
1886,GO:0042180,0.880868575313641,0.343601052663721,2,9,cellular ketone metabolic process,BP,ACADVL;PSMB10
1249,GO:0019318,0.880951554299523,0.44296950732602,1,5,hexose metabolic process,BP,RBP4
2245,GO:0045834,0.881316896570227,0.442192439986267,1,5,positive regulation of lipid metabolic process,BP,ABCG1
2426,GO:0048584,0.881949149117858,0.295650452019085,3,14,positive regulation of response to stimulus,BP,FADD;PSMB10;FGF18
2560,GO:0051049,0.884406676438577,0.293912199786924,3,13,regulation of transport,BP,RBP4;ABCG1;TBC1D14
547,GO:0006732,0.886507452485079,0.287424511958861,3,14,coenzyme metabolic process,BP,ACAT1;NUDT7;PTS
1305,GO:0022008,0.889472100378247,0.413039840657953,1,6,neurogenesis,BP,LINGO1
1759,GO:0034655,0.890692507372601,0.421750994408356,1,5,nucleobase-containing compound catabolic process,BP,NUDT7
3104,GO:0098772,0.892431169572698,0.320951947218106,2,9,molecular function regulator,MF,TBC1D14;FGF18
326,GO:0005215,0.892912599045886,0.315183025932914,2,10,transporter activity,MF,RBP4;ABCG1
3175,GO:1901566,0.893190739347971,0.254051353884237,4,17,organonitrogen compound biosynthetic process,BP,ACAT1;MRPL14;TSFM;PTS
2433,GO:0048608,0.895187174297691,0.411592076433211,1,5,reproductive structure development,BP,RBP4
2798,GO:0061458,0.895187174297691,0.411592076433211,1,5,reproductive system development,BP,RBP4
568,GO:0006810,0.895616427155471,0.210224578652767,8,32,transport,BP,RBP4;CNIH4;ABCG1;USE1;PSMB10;TBC1D14;HNF1A;ZFYVE21
2597,GO:0051234,0.895616427155471,0.210224578652767,8,32,establishment of localization,BP,RBP4;CNIH4;ABCG1;USE1;PSMB10;TBC1D14;HNF1A;ZFYVE21
562,GO:0006793,0.895994551687265,0.210162018666509,8,31,phosphorus metabolic process,BP,ACAT1;NUDT7;DEPTOR;PSMB10;PLA2G16;FGF18;ZFYVE21;DPM3
2110,GO:0044272,0.896269651013802,0.389855253952945,1,7,sulfur compound biosynthetic process,BP,ACAT1
2295,GO:0046434,0.896429924840049,0.408739734298499,1,5,organophosphate catabolic process,BP,NUDT7
705,GO:0008150,0.897392554196317,0.332925430202311,38,120,biological_process,BP,HACL1;MSRA;ACAT1;MRPL14;PXMP2;PXK;RBP4;ACADVL;CNIH4;ARL6IP4;PUS1;NUDT7;TSFM;ABCG1;ALG5;USE1;KRT10;ECI1;ETFDH;LYPLAL1;FADD;DEPTOR;PSMB10;LAGE3;TBC1D14;NUDT6;HNF1A;PTS;PLA2G16;DECR1;LINGO1;FGF18;CPT1C;ZFYVE21;DPM3;PEPD;ETFB;IFI30
1374,GO:0030162,0.897871471832904,0.3099303266067,2,9,regulation of proteolysis,BP,FADD;PSMB10
200,GO:0002790,0.898107164555725,0.404859441592156,1,5,peptide secretion,BP,RBP4
824,GO:0009306,0.898107164555725,0.404859441592156,1,5,protein secretion,BP,RBP4
842,GO:0009605,0.89825662681357,0.260062455582659,3,17,response to external stimulus,BP,ACAT1;FADD;FGF18
2108,GO:0044270,0.899202062943914,0.390859888504592,1,6,cellular nitrogen compound catabolic process,BP,NUDT7
2338,GO:0046700,0.899202062943914,0.390859888504592,1,6,heterocycle catabolic process,BP,NUDT7
2873,GO:0070887,0.901096828134939,0.223861775194988,5,22,cellular response to chemical stimulus,BP,ACADVL;FADD;PSMB10;FGF18;IFI30
387,GO:0005775,0.902122406462255,0.395422796721372,1,5,vacuolar lumen,CC,IFI30
2135,GO:0044437,0.902122406462255,0.395422796721372,1,5,vacuolar part,CC,IFI30
1844,GO:0036477,0.902530524065883,0.383006961969549,1,6,somatodendritic compartment,CC,CPT1C
1986,GO:0043066,0.903352517989665,0.381045615725209,1,6,negative regulation of apoptotic process,BP,FADD
1989,GO:0043069,0.903352517989665,0.381045615725209,1,6,negative regulation of programmed cell death,BP,FADD
2771,GO:0060548,0.903352517989665,0.381045615725209,1,6,negative regulation of cell death,BP,FADD
870,GO:0009893,0.90540898433583,0.217383130890244,5,21,positive regulation of metabolic process,BP,ABCG1;FADD;PSMB10;HNF1A;FGF18
1482,GO:0031326,0.908649848612905,0.200790983158482,6,26,regulation of cellular biosynthetic process,BP,ACADVL;TSFM;ABCG1;FADD;PSMB10;HNF1A
3057,GO:0097190,0.909037103697896,0.286501631533212,2,9,apoptotic signaling pathway,BP,FADD;DEPTOR
2153,GO:0044699,0.909740655352093,0.188486133324153,30,100,single-organism process,BP,HACL1;MSRA;ACAT1;MRPL14;PXK;RBP4;ACADVL;NUDT7;ABCG1;ALG5;USE1;KRT10;ECI1;ETFDH;FADD;DEPTOR;PSMB10;TBC1D14;HNF1A;PTS;PLA2G16;DECR1;LINGO1;FGF18;CPT1C;ZFYVE21;DPM3;PEPD;ETFB;IFI30
2586,GO:0051186,0.910220328791517,0.240429907272676,3,15,cofactor metabolic process,BP,ACAT1;NUDT7;PTS
3007,GO:0080134,0.910674070543007,0.274700600078873,2,11,regulation of response to stress,BP,FADD;PSMB10
916,GO:0010605,0.912353447368175,0.279317213614606,2,9,negative regulation of macromolecule metabolic process,BP,DEPTOR;PSMB10
2115,GO:0044297,0.912365822248719,0.358935392808266,1,6,cell body,CC,FADD
2508,GO:0050789,0.913391577911821,0.164658937200659,15,58,regulation of biological process,BP,PXK;RBP4;ACADVL;TSFM;ABCG1;FADD;DEPTOR;PSMB10;TBC1D14;HNF1A;PTS;PLA2G16;LINGO1;FGF18;IFI30
2032,GO:0043281,0.91460729620925,0.364646042551198,1,5,regulation of cysteine-type endopeptidase activity involved in apoptotic process,BP,FADD
3383,GO:2000116,0.91460729620925,0.364646042551198,1,5,regulation of cysteine-type endopeptidase activity,BP,FADD
2580,GO:0051171,0.914643032181876,0.199764808603909,5,22,regulation of nitrogen compound metabolic process,BP,TSFM;ABCG1;FADD;PSMB10;HNF1A
1484,GO:0031328,0.914707727867959,0.265968694039091,2,11,positive regulation of cellular biosynthetic process,BP,FADD;HNF1A
2602,GO:0051241,0.915581166491245,0.272218154448743,2,9,negative regulation of multicellular organismal process,BP,RBP4;LINGO1
574,GO:0006820,0.915679142310303,0.350513116081097,1,6,anion transport,BP,ABCG1
514,GO:0006638,0.919858644467883,0.350985976062316,1,5,neutral lipid metabolic process,BP,PLA2G16
515,GO:0006639,0.919858644467883,0.350985976062316,1,5,acylglycerol metabolic process,BP,PLA2G16
134,GO:0002252,0.923182235155862,0.24708767198482,2,11,immune effector process,BP,RBP4;FADD
866,GO:0009889,0.926799767941343,0.16789924221145,6,27,regulation of biosynthetic process,BP,ACADVL;TSFM;ABCG1;FADD;PSMB10;HNF1A
1330,GO:0022857,0.928135590076041,0.309658335312405,1,7,transmembrane transporter activity,MF,ABCG1
1245,GO:0019220,0.929281751672218,0.236426128007178,2,10,regulation of phosphate metabolic process,BP,DEPTOR;FGF18
2706,GO:0055085,0.931109549719045,0.225986956954489,2,12,transmembrane transport,BP,ABCG1;PSMB10
416,GO:0005996,0.931706384570215,0.307214618036132,1,6,monosaccharide metabolic process,BP,RBP4
3170,GO:1901362,0.932104276601951,0.152580377184782,7,30,organic cyclic compound biosynthetic process,BP,ACAT1;TSFM;ABCG1;FADD;PSMB10;HNF1A;PTS
668,GO:0007548,0.93221909494068,0.305752001275291,1,6,sex differentiation,BP,RBP4
640,GO:0007249,0.93587564231389,0.295165270437481,1,6,I-kappaB kinase/NF-kappaB signaling,BP,FADD
1998,GO:0043122,0.93587564231389,0.295165270437481,1,6,regulation of I-kappaB kinase/NF-kappaB signaling,BP,FADD
714,GO:0008202,0.936960404283777,0.214637323715371,2,11,steroid metabolic process,BP,ACADVL;ABCG1
510,GO:0006633,0.938982290316941,0.273204816837068,1,8,fatty acid biosynthetic process,BP,ACADVL
1296,GO:0019904,0.939296797917287,0.277597649567096,1,7,protein domain specific binding,MF,FADD
2359,GO:0046914,0.939610870736701,0.208112416973216,2,11,transition metal ion binding,MF,NUDT7;PEPD
2425,GO:0048583,0.939634121736722,0.160382902264465,4,21,regulation of response to stimulus,BP,FADD;DEPTOR;PSMB10;FGF18
1505,GO:0031410,0.940124011716217,0.174932589329197,3,17,cytoplasmic vesicle,CC,ABCG1;TBC1D14;ZFYVE21
3082,GO:0097708,0.940124011716217,0.174932589329197,3,17,intracellular vesicle,CC,ABCG1;TBC1D14;ZFYVE21
2682,GO:0052547,0.940495284838571,0.28137817625551,1,6,regulation of peptidase activity,BP,FADD
2683,GO:0052548,0.940495284838571,0.28137817625551,1,6,regulation of endopeptidase activity,BP,FADD
2114,GO:0044283,0.940680142860983,0.158208482873705,4,21,small molecule biosynthetic process,BP,ACAT1;RBP4;ACADVL;ABCG1
2583,GO:0051174,0.942256087578373,0.201499349756867,2,11,regulation of phosphorus metabolic process,BP,DEPTOR;FGF18
608,GO:0006954,0.942284163318613,0.263299835728649,1,8,inflammatory response,BP,PXK
1696,GO:0033993,0.94288840369846,0.197344465270453,2,12,response to lipid,BP,RBP4;ABCG1
1654,GO:0032940,0.943018090620345,0.199574894844306,2,11,secretion by cell,BP,RBP4;USE1
2356,GO:0046903,0.943018090620345,0.199574894844306,2,11,secretion,BP,RBP4;USE1
2669,GO:0051716,0.94343488197403,0.13048559429145,7,33,cellular response to stimulus,BP,ACADVL;FADD;DEPTOR;PSMB10;LINGO1;FGF18;IFI30
723,GO:0008219,0.943822076391021,0.169405654553488,3,15,cell death,BP,KRT10;FADD;DEPTOR
994,GO:0012501,0.943822076391021,0.169405654553488,3,15,programmed cell death,BP,KRT10;FADD;DEPTOR
2667,GO:0051704,0.944892952380756,0.192274308101349,2,12,multi-organism process,BP,FADD;PSMB10
2010,GO:0043207,0.945238437991215,0.254228056421661,1,8,response to external biotic stimulus,BP,FADD
2668,GO:0051707,0.945238437991215,0.254228056421661,1,8,response to other organism,BP,FADD
2540,GO:0050896,0.945452580674435,0.113381061982731,13,54,response to stimulus,BP,MSRA;ACAT1;PXK;RBP4;ACADVL;ABCG1;ETFDH;FADD;DEPTOR;PSMB10;LINGO1;FGF18;IFI30
2100,GO:0044249,0.94899197390812,0.107332478436753,13,51,cellular biosynthetic process,BP,ACAT1;MRPL14;ACADVL;TSFM;ABCG1;ALG5;FADD;PSMB10;HNF1A;PTS;PLA2G16;FGF18;DPM3
1652,GO:0032880,0.949213302466413,0.253958131415666,1,6,regulation of protein localization,BP,RBP4
2596,GO:0051223,0.949213302466413,0.253958131415666,1,6,regulation of protein transport,BP,RBP4
2819,GO:0070201,0.949213302466413,0.253958131415666,1,6,regulation of establishment of protein localization,BP,RBP4
3015,GO:0090087,0.949213302466413,0.253958131415666,1,6,regulation of peptide transport,BP,RBP4
1394,GO:0030234,0.950447265781672,0.242808071528203,1,7,enzyme regulator activity,MF,TBC1D14
3168,GO:1901360,0.95056533531727,0.105635835434679,12,48,organic cyclic compound metabolic process,BP,ACAT1;ACADVL;ARL6IP4;PUS1;NUDT7;TSFM;ABCG1;FADD;PSMB10;LAGE3;HNF1A;PTS
3179,GO:1901576,0.950973250397386,0.102966168396683,14,54,organic substance biosynthetic process,BP,ACAT1;MRPL14;RBP4;ACADVL;TSFM;ABCG1;ALG5;FADD;PSMB10;HNF1A;PTS;PLA2G16;FGF18;DPM3
3071,GO:0097367,0.950999648748883,0.232099794874474,1,9,carbohydrate derivative binding,MF,ABCG1
2066,GO:0043603,0.951738950440183,0.174469908072598,2,12,cellular amide metabolic process,BP,MRPL14;TSFM
981,GO:0010942,0.951795426002657,0.245443022897965,1,6,positive regulation of cell death,BP,FADD
1985,GO:0043065,0.951795426002657,0.245443022897965,1,6,positive regulation of apoptotic process,BP,FADD
1988,GO:0043068,0.951795426002657,0.245443022897965,1,6,positive regulation of programmed cell death,BP,FADD
148,GO:0002443,0.952378313112236,0.236453503849381,1,7,leukocyte mediated immunity,BP,FADD
3174,GO:1901565,0.95314526773447,0.170711952460173,2,12,organonitrogen compound catabolic process,BP,ACAT1;NUDT7
1122,GO:0016491,0.95332301922817,0.122799065921707,5,24,oxidoreductase activity,MF,MSRA;ACADVL;ETFDH;DECR1;IFI30
759,GO:0008610,0.953578159419011,0.122260078215278,5,24,lipid biosynthetic process,BP,ACADVL;ABCG1;PLA2G16;FGF18;DPM3
995,GO:0012505,0.953637235897804,0.105515965107084,9,37,endomembrane system,CC,CNIH4;ABCG1;ALG5;USE1;TBC1D14;PLA2G16;CPT1C;ZFYVE21;DPM3
1766,GO:0034754,0.954238700146028,0.23022848001474,1,7,cellular hormone metabolic process,BP,RBP4
3156,GO:1901136,0.955239378959441,0.226836635364425,1,7,carbohydrate derivative catabolic process,BP,NUDT7
2515,GO:0050801,0.955255227716643,0.221815414227544,1,8,ion homeostasis,BP,ABCG1
2155,GO:0044702,0.955894588217051,0.224598798494903,1,7,single organism reproductive process,BP,RBP4
209,GO:0003006,0.956183004935358,0.223609393741957,1,7,developmental process involved in reproduction,BP,RBP4
909,GO:0010562,0.957417709849381,0.219343268255695,1,7,positive regulation of phosphorus metabolic process,BP,FGF18
2262,GO:0045937,0.957417709849381,0.219343268255695,1,7,positive regulation of phosphate metabolic process,BP,FGF18
1481,GO:0031325,0.960387379953244,0.115781539849505,4,20,positive regulation of cellular metabolic process,BP,FADD;PSMB10;HNF1A;FGF18
27,GO:0000323,0.96169945244295,0.204144746103791,1,7,lytic vacuole,CC,IFI30
381,GO:0005764,0.96169945244295,0.204144746103791,1,7,lysosome,CC,IFI30
3169,GO:1901361,0.962143157624961,0.197791246598529,1,8,organic cyclic compound catabolic process,BP,NUDT7
3199,GO:1901700,0.962887271285659,0.140354827582428,2,14,response to oxygen-containing compound,BP,RBP4;FADD
1265,GO:0019439,0.963170889701181,0.194064970950205,1,8,aromatic compound catabolic process,BP,NUDT7
893,GO:0010243,0.963918690597707,0.187829450687388,1,9,response to organonitrogen compound,BP,FADD
843,GO:0009607,0.964785285740914,0.184657931574985,1,9,response to biotic stimulus,BP,FADD
2976,GO:0072330,0.966102267033719,0.177122169050141,1,10,monocarboxylic acid biosynthetic process,BP,ACADVL
1890,GO:0042221,0.966123698856749,0.0829173320182253,8,36,response to chemical,BP,ACAT1;RBP4;ACADVL;ABCG1;FADD;PSMB10;FGF18;IFI30
2168,GO:0044765,0.966819587617967,0.0998779583495036,4,21,single-organism transport,BP,RBP4;ABCG1;USE1;HNF1A
3241,GO:1902578,0.966819587617967,0.0998779583495036,4,21,single-organism localization,BP,RBP4;ABCG1;USE1;HNF1A
980,GO:0010941,0.967241186505273,0.130774686004423,2,12,regulation of cell death,BP,FADD;DEPTOR
1968,GO:0042981,0.967241186505273,0.130774686004423,2,12,regulation of apoptotic process,BP,FADD;DEPTOR
1987,GO:0043067,0.967241186505273,0.130774686004423,2,12,regulation of programmed cell death,BP,FADD;DEPTOR
867,GO:0009890,0.967789515968007,0.181312647091589,1,7,negative regulation of biosynthetic process,BP,ACADVL
1483,GO:0031327,0.967789515968007,0.181312647091589,1,7,negative regulation of cellular biosynthetic process,BP,ACADVL
950,GO:0010817,0.967853018724771,0.176560339431439,1,8,regulation of hormone levels,BP,RBP4
1915,GO:0042445,0.967853018724771,0.176560339431439,1,8,hormone metabolic process,BP,RBP4
609,GO:0006955,0.970617013297631,0.100784025259593,3,17,immune response,BP,FADD;PSMB10;IFI30
696,GO:0008092,0.970882613250482,0.164723978612662,1,8,cytoskeletal protein binding,MF,PXK
1,GO:0000003,0.971742402716187,0.161283986966165,1,8,reproduction,BP,RBP4
1314,GO:0022414,0.971742402716187,0.161283986966165,1,8,reproductive process,BP,RBP4
777,GO:0009058,0.972418470869284,0.0631247993253423,14,56,biosynthetic process,BP,ACAT1;MRPL14;RBP4;ACADVL;TSFM;ABCG1;ALG5;FADD;PSMB10;HNF1A;PTS;PLA2G16;FGF18;DPM3
414,GO:0005975,0.972461978625572,0.113152543883335,2,13,carbohydrate metabolic process,BP,RBP4;DPM3
84,GO:0001775,0.9729242809949,0.153319451451098,1,9,cell activation,BP,FADD
2199,GO:0045321,0.9729242809949,0.153319451451098,1,9,leukocyte activation,BP,FADD
3197,GO:1901698,0.974606096712819,0.144046997535392,1,10,response to nitrogen compound,BP,FADD
533,GO:0006694,0.975970437800931,0.140751647362016,1,9,steroid biosynthetic process,BP,ABCG1
2804,GO:0065007,0.980791122045051,0.045872445579287,16,66,biological regulation,BP,PXK;RBP4;ACADVL;TSFM;ABCG1;FADD;DEPTOR;PSMB10;TBC1D14;HNF1A;PTS;PLA2G16;LINGO1;FGF18;DPM3;IFI30
144,GO:0002376,0.981968834361327,0.0605382552431842,4,22,immune system process,BP,RBP4;FADD;PSMB10;IFI30
600,GO:0006915,0.983081101699107,0.0767224705356162,2,14,apoptotic process,BP,FADD;DEPTOR
2161,GO:0044711,0.983366160051251,0.0468374827788225,7,35,single-organism biosynthetic process,BP,ACAT1;RBP4;ACADVL;ABCG1;PLA2G16;FGF18;DPM3
2134,GO:0044433,0.984574813475593,0.0984178053878523,1,11,cytoplasmic vesicle part,CC,ZFYVE21
2413,GO:0048518,0.985135351708118,0.0445988242721094,6,31,positive regulation of biological process,BP,RBP4;ABCG1;FADD;PSMB10;HNF1A;FGF18
1079,GO:0016053,0.986028566718072,0.090186799553761,1,12,organic acid biosynthetic process,BP,ACADVL
2290,GO:0046394,0.986028566718072,0.090186799553761,1,12,carboxylic acid biosynthetic process,BP,ACADVL
2163,GO:0044723,0.988093199305761,0.0823797843517556,1,10,single-organism carbohydrate metabolic process,BP,RBP4
2415,GO:0048522,0.988667211367346,0.0375552129820491,5,28,positive regulation of cellular process,BP,RBP4;FADD;PSMB10;HNF1A;FGF18
569,GO:0006811,0.98897215952788,0.0764379663902375,1,11,ion transport,BP,ABCG1
1135,GO:0016614,1,0.0154985703928749,0,10,oxidoreductase activity, acting on CH-OH group of donors,MF,
3,GO:0000038,1,0.773435048011187,0,1,very long-chain fatty acid metabolic process,BP,
4,GO:0000041,1,0.654612357040219,0,1,transition metal ion transport,BP,
8,GO:0000097,1,0.758087612472411,0,1,sulfur amino acid biosynthetic process,BP,
9,GO:0000122,1,0.578471336067372,0,1,negative regulation of transcription from RNA polymerase II promoter,BP,
13,GO:0000187,1,0.870241843544685,0,1,activation of MAPK activity,BP,
15,GO:0000245,1,0.627020541116027,0,1,spliceosomal complex assembly,BP,
16,GO:0000247,1,0.61159761771495,0,1,C-8 sterol isomerase activity,MF,
17,GO:0000248,1,0.875695093721025,0,1,C-5 sterol desaturase activity,MF,
18,GO:0000255,1,0.870241843544685,0,1,allantoin metabolic process,BP,
22,GO:0000302,1,0.479571854435711,0,2,response to reactive oxygen species,BP,
23,GO:0000303,1,0.665914602464021,0,1,response to superoxide,BP,
24,GO:0000305,1,0.665914602464021,0,1,response to oxygen radical,BP,
28,GO:0000375,1,0.627020541116027,0,1,RNA splicing, via transesterification reactions,BP,
29,GO:0000377,1,0.627020541116027,0,1,RNA splicing, via transesterification reactions with bulged adenosine as nucleophile,BP,
30,GO:0000398,1,0.627020541116027,0,1,mRNA splicing, via spliceosome,BP,
34,GO:0000922,1,0.832354421897545,0,1,spindle pole,CC,
35,GO:0000932,1,0.870241843544685,0,1,P-body,CC,
43,GO:0000988,1,0.37935943284686,0,2,transcription factor activity, protein binding,MF,
44,GO:0000989,1,0.37935943284686,0,2,transcription factor activity, transcription factor binding,MF,
49,GO:0001085,1,0.578471336067372,0,1,RNA polymerase II transcription factor binding,MF,
51,GO:0001102,1,0.578471336067372,0,1,RNA polymerase II activating transcription factor binding,MF,
55,GO:0001504,1,0.805141107601125,0,1,neurotransmitter uptake,BP,
56,GO:0001505,1,0.805141107601125,0,1,regulation of neurotransmitter levels,BP,
57,GO:0001510,1,0.597964029711571,0,1,RNA methylation,BP,
62,GO:0001541,1,0.599713716867655,0,1,ovarian follicle development,BP,
63,GO:0001556,1,0.599713716867655,0,1,oocyte maturation,BP,
66,GO:0001573,1,0.66448681738129,0,1,ganglioside metabolic process,BP,
67,GO:0001608,1,0.715549453301239,0,1,G-protein coupled nucleotide receptor activity,MF,
68,GO:0001614,1,0.715549453301239,0,1,purinergic nucleotide receptor activity,MF,
69,GO:0001650,1,0.758087612472411,0,1,fibrillar center,CC,
77,GO:0001669,1,0.66448681738129,0,1,acrosomal vesicle,CC,
78,GO:0001676,1,0.67645706732307,0,2,long-chain fatty acid metabolic process,BP,
79,GO:0001678,1,0.722624588823278,0,1,cellular glucose homeostasis,BP,
80,GO:0001726,1,0.610116362596827,0,1,ruffle,CC,
83,GO:0001773,1,0.594250321572963,0,1,myeloid dendritic cell activation,BP,
88,GO:0001818,1,0.374703178517604,0,2,negative regulation of cytokine production,BP,
91,GO:0001836,1,0.370515326336158,0,2,release of cytochrome c from mitochondria,BP,
92,GO:0001848,1,0.720126642672929,0,1,complement binding,MF,
93,GO:0001882,1,0.492551844807094,0,2,nucleoside binding,MF,
94,GO:0001883,1,0.703379952013767,0,1,purine nucleoside binding,MF,
96,GO:0001890,1,0.599713716867655,0,1,placenta development,BP,
108,GO:0001935,1,0.599713716867655,0,1,endothelial cell proliferation,BP,
109,GO:0001936,1,0.599713716867655,0,1,regulation of endothelial cell proliferation,BP,
110,GO:0001938,1,0.599713716867655,0,1,positive regulation of endothelial cell proliferation,BP,
111,GO:0001942,1,0.634036220511901,0,1,hair follicle development,BP,
116,GO:0001960,1,0.627020541116027,0,1,negative regulation of cytokine-mediated signaling pathway,BP,
118,GO:0001974,1,0.627020541116027,0,1,blood vessel remodeling,BP,
121,GO:0002028,1,0.570989159824297,0,1,regulation of sodium ion transport,BP,
122,GO:0002054,1,0.702529573849765,0,1,nucleobase binding,MF,
123,GO:0002060,1,0.702529573849765,0,1,purine nucleobase binding,MF,
132,GO:0002237,1,0.101452113891263,0,6,response to molecule of bacterial origin,BP,
137,GO:0002263,1,0.0525450507107165,0,7,cell activation involved in immune response,BP,
138,GO:0002274,1,0.0424181106534814,0,8,myeloid leukocyte activation,BP,
139,GO:0002275,1,0.0525450507107165,0,7,myeloid cell activation involved in immune response,BP,
140,GO:0002277,1,0.594250321572963,0,1,myeloid dendritic cell activation involved in immune response,BP,
141,GO:0002281,1,0.724891980148401,0,1,macrophage activation involved in immune response,BP,
142,GO:0002283,1,0.0741061014299095,0,6,neutrophil activation involved in immune response,BP,
143,GO:0002366,1,0.0525450507107165,0,7,leukocyte activation involved in immune response,BP,
149,GO:0002444,1,0.0741061014299095,0,6,myeloid leukocyte mediated immunity,BP,
150,GO:0002446,1,0.0741061014299095,0,6,neutrophil mediated immunity,BP,
161,GO:0002526,1,0.720126642672929,0,1,acute inflammatory response,BP,
163,GO:0002577,1,0.594250321572963,0,1,regulation of antigen processing and presentation,BP,
164,GO:0002579,1,0.594250321572963,0,1,positive regulation of antigen processing and presentation,BP,
165,GO:0002580,1,0.594250321572963,0,1,regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II,BP,
166,GO:0002582,1,0.594250321572963,0,1,positive regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II,BP,
167,GO:0002583,1,0.594250321572963,0,1,regulation of antigen processing and presentation of peptide antigen,BP,
168,GO:0002585,1,0.594250321572963,0,1,positive regulation of antigen processing and presentation of peptide antigen,BP,
169,GO:0002586,1,0.594250321572963,0,1,regulation of antigen processing and presentation of peptide antigen via MHC class II,BP,
170,GO:0002588,1,0.594250321572963,0,1,positive regulation of antigen processing and presentation of peptide antigen via MHC class II,BP,
173,GO:0002673,1,0.720126642672929,0,1,regulation of acute inflammatory response,BP,
207,GO:0002920,1,0.720126642672929,0,1,regulation of humoral immune response,BP,
208,GO:0002931,1,0.627020541116027,0,1,response to ischemia,BP,
212,GO:0003012,1,0.2192857765104,0,3,muscle system process,BP,
213,GO:0003013,1,0.570989159824297,0,1,circulatory system process,BP,
215,GO:0003015,1,0.570989159824297,0,1,heart process,BP,
218,GO:0003333,1,0.805141107601125,0,1,amino acid transmembrane transport,BP,
224,GO:0003712,1,0.37935943284686,0,2,transcription cofactor activity,MF,
225,GO:0003713,1,0.601567917327783,0,1,transcription coactivator activity,MF,
227,GO:0003729,1,0.730169690081196,0,1,mRNA binding,MF,
228,GO:0003730,1,0.730169690081196,0,1,mRNA 3'-UTR binding,MF,
233,GO:0003854,1,0.652705167196424,0,1,3-beta-hydroxy-delta5-steroid dehydrogenase activity,MF,
234,GO:0003857,1,0.597964029711571,0,1,3-hydroxyacyl-CoA dehydrogenase activity,MF,
235,GO:0003858,1,0.743039914117476,0,1,3-hydroxybutyrate dehydrogenase activity,MF,
237,GO:0003940,1,0.685732886781739,0,1,L-iduronidase activity,MF,
241,GO:0003993,1,0.641058516990934,0,1,acid phosphatase activity,MF,
243,GO:0003996,1,0.483682070560156,0,2,acyl-CoA ligase activity,MF,
244,GO:0004031,1,0.9290546186658,0,1,aldehyde oxidase activity,MF,
245,GO:0004033,1,0.589388163862648,0,1,aldo-keto reductase (NADP) activity,MF,
246,GO:0004064,1,0.645095410017529,0,1,arylesterase activity,MF,
248,GO:0004129,1,0.589388163862648,0,1,cytochrome-c oxidase activity,MF,
249,GO:0004139,1,0.651376974684416,0,1,deoxyribose-phosphate aldolase activity,MF,
256,GO:0004197,1,0.368520729438144,0,2,cysteine-type endopeptidase activity,MF,
257,GO:0004252,1,0.720126642672929,0,1,serine-type endopeptidase activity,MF,
260,GO:0004303,1,0.662077425179723,0,1,estradiol 17-beta-dehydrogenase activity,MF,
261,GO:0004312,1,0.773435048011187,0,1,fatty acid synthase activity,MF,
262,GO:0004321,1,0.703379952013767,0,1,fatty-acyl-CoA synthase activity,MF,
263,GO:0004341,1,0.665914602464021,0,1,gluconolactonase activity,MF,
264,GO:0004364,1,0.587992285191993,0,1,glutathione transferase activity,MF,
265,GO:0004448,1,0.69629877231865,0,1,isocitrate dehydrogenase activity,MF,
266,GO:0004450,1,0.69629877231865,0,1,isocitrate dehydrogenase (NADP+) activity,MF,
267,GO:0004457,1,0.674025502097396,0,1,lactate dehydrogenase activity,MF,
268,GO:0004458,1,0.674025502097396,0,1,D-lactate dehydrogenase (cytochrome) activity,MF,
269,GO:0004464,1,0.587992285191993,0,1,leukotriene-C4 synthase activity,MF,
271,GO:0004470,1,0.619534857753294,0,1,malic enzyme activity,MF,
272,GO:0004497,1,0.262679888468902,0,3,monooxygenase activity,MF,
273,GO:0004505,1,0.601567917327783,0,1,phenylalanine 4-monooxygenase activity,MF,
274,GO:0004508,1,0.661785962438721,0,1,steroid 17-alpha-monooxygenase activity,MF,
275,GO:0004518,1,0.508456912927079,0,2,nuclease activity,MF,
276,GO:0004519,1,0.508456912927079,0,2,endonuclease activity,MF,
277,GO:0004521,1,0.84997168064402,0,1,endoribonuclease activity,MF,
278,GO:0004540,1,0.508456912927079,0,2,ribonuclease activity,MF,
279,GO:0004553,1,0.283297546572572,0,3,hydrolase activity, hydrolyzing O-glycosyl compounds,MF,
280,GO:0004557,1,0.629720466056481,0,1,alpha-galactosidase activity,MF,
281,GO:0004563,1,0.66448681738129,0,1,beta-N-acetylhexosaminidase activity,MF,
285,GO:0004601,1,0.587992285191993,0,1,peroxidase activity,MF,
286,GO:0004602,1,0.587992285191993,0,1,glutathione peroxidase activity,MF,
292,GO:0004721,1,0.580516978001833,0,1,phosphoprotein phosphatase activity,MF,
293,GO:0004725,1,0.580516978001833,0,1,protein tyrosine phosphatase activity,MF,
295,GO:0004731,1,0.702529573849765,0,1,purine-nucleoside phosphorylase activity,MF,
296,GO:0004740,1,0.809126620423613,0,1,pyruvate dehydrogenase (acetyl-transferring) kinase activity,MF,
297,GO:0004769,1,0.397211503167755,0,2,steroid delta-isomerase activity,MF,
298,GO:0004854,1,0.9290546186658,0,1,xanthine dehydrogenase activity,MF,
299,GO:0004857,1,0.24910947904194,0,3,enzyme inhibitor activity,MF,
300,GO:0004859,1,0.56647063732246,0,1,phospholipase inhibitor activity,MF,
301,GO:0004866,1,0.444562996116742,0,2,endopeptidase inhibitor activity,MF,
302,GO:0004867,1,0.711822224064615,0,1,serine-type endopeptidase inhibitor activity,MF,
303,GO:0004869,1,0.627020541116027,0,1,cysteine-type endopeptidase inhibitor activity,MF,
304,GO:0004871,1,0.10440290103681,0,7,signal transducer activity,MF,
305,GO:0004872,1,0.358812520590591,0,4,receptor activity,MF,
306,GO:0004888,1,0.358812520590591,0,4,transmembrane signaling receptor activity,MF,
307,GO:0004896,1,0.870241843544685,0,1,cytokine receptor activity,MF,
308,GO:0004930,1,0.715549453301239,0,1,G-protein coupled receptor activity,MF,
309,GO:0004970,1,0.952324910776072,0,1,ionotropic glutamate receptor activity,MF,
310,GO:0004971,1,0.952324910776072,0,1,AMPA glutamate receptor activity,MF,
311,GO:0005057,1,0.663098539838137,0,1,signal transducer activity, downstream of receptor,MF,
321,GO:0005138,1,0.594250321572963,0,1,interleukin-6 receptor binding,MF,
323,GO:0005158,1,0.663098539838137,0,1,insulin receptor binding,MF,
327,GO:0005216,1,0.54294227948611,0,2,ion channel activity,MF,
328,GO:0005230,1,0.952324910776072,0,1,extracellular ligand-gated ion channel activity,MF,
329,GO:0005231,1,0.952324910776072,0,1,excitatory extracellular ligand-gated ion channel activity,MF,
330,GO:0005234,1,0.952324910776072,0,1,extracellular-glutamate-gated ion channel activity,MF,
331,GO:0005253,1,0.570989159824297,0,1,anion channel activity,MF,
332,GO:0005254,1,0.570989159824297,0,1,chloride channel activity,MF,
333,GO:0005261,1,0.952324910776072,0,1,cation channel activity,MF,
334,GO:0005310,1,0.805141107601125,0,1,dicarboxylic acid transmembrane transporter activity,MF,
335,GO:0005313,1,0.805141107601125,0,1,L-glutamate transmembrane transporter activity,MF,
336,GO:0005314,1,0.805141107601125,0,1,high-affinity glutamate transmembrane transporter activity,MF,
338,GO:0005324,1,0.607633118676714,0,1,long-chain fatty acid transporter activity,MF,
339,GO:0005342,1,0.805141107601125,0,1,organic acid transmembrane transporter activity,MF,
340,GO:0005375,1,0.654612357040219,0,1,copper ion transmembrane transporter activity,MF,
344,GO:0005504,1,0.342005043138806,0,2,fatty acid binding,MF,
345,GO:0005506,1,0.165201746068035,0,5,iron ion binding,MF,
346,GO:0005507,1,0.599713716867655,0,1,copper ion binding,MF,
347,GO:0005509,1,0.17763580977496,0,4,calcium ion binding,MF,
349,GO:0005521,1,0.578471336067372,0,1,lamin binding,MF,
350,GO:0005523,1,0.368254216500185,0,2,tropomyosin binding,MF,
352,GO:0005525,1,0.703379952013767,0,1,GTP binding,MF,
353,GO:0005539,1,0.599713716867655,0,1,glycosaminoglycan binding,MF,
355,GO:0005544,1,0.7161003501605,0,1,calcium-dependent phospholipid binding,MF,
356,GO:0005546,1,0.763267626299272,0,1,phosphatidylinositol-4,5-bisphosphate binding,MF,
361,GO:0005604,1,0.599713716867655,0,1,basement membrane,CC,
362,GO:0005605,1,0.599713716867655,0,1,basal lamina,CC,
367,GO:0005635,1,0.145375095107187,0,4,nuclear envelope,CC,
368,GO:0005637,1,0.578471336067372,0,1,nuclear inner membrane,CC,
369,GO:0005640,1,0.721434029227987,0,1,nuclear outer membrane,CC,
377,GO:0005758,1,0.469993243872978,0,2,mitochondrial intermembrane space,CC,
382,GO:0005766,1,0.24488358065803,0,3,primary lysosome,CC,
384,GO:0005769,1,0.763267626299272,0,1,early endosome,CC,
385,GO:0005770,1,0.654612357040219,0,1,late endosome,CC,
394,GO:0005790,1,0.652705167196424,0,1,smooth endoplasmic reticulum,CC,
397,GO:0005811,1,0.394285612878708,0,2,lipid particle,CC,
399,GO:0005819,1,0.832354421897545,0,1,spindle,CC,
404,GO:0005865,1,0.623232303978104,0,1,striated muscle thin filament,CC,
405,GO:0005874,1,0.832354421897545,0,1,microtubule,CC,
409,GO:0005890,1,0.570989159824297,0,1,sodium:potassium-exchanging ATPase complex,CC,
413,GO:0005938,1,0.832354421897545,0,1,cell cortex,CC,
415,GO:0005984,1,0.685732886781739,0,1,disaccharide metabolic process,BP,
418,GO:0006011,1,0.624056902858297,0,1,UDP-glucose metabolic process,BP,
419,GO:0006012,1,0.624056902858297,0,1,galactose metabolic process,BP,
420,GO:0006022,1,0.378680274718837,0,3,aminoglycan metabolic process,BP,
421,GO:0006023,1,0.837849573162783,0,1,aminoglycan biosynthetic process,BP,
422,GO:0006024,1,0.837849573162783,0,1,glycosaminoglycan biosynthetic process,BP,
423,GO:0006026,1,0.453908529716914,0,2,aminoglycan catabolic process,BP,
424,GO:0006027,1,0.453908529716914,0,2,glycosaminoglycan catabolic process,BP,
425,GO:0006029,1,0.378680274718837,0,3,proteoglycan metabolic process,BP,
427,GO:0006081,1,0.369507241789005,0,3,cellular aldehyde metabolic process,BP,
431,GO:0006086,1,0.809126620423613,0,1,acetyl-CoA biosynthetic process from pyruvate,BP,
432,GO:0006090,1,0.809126620423613,0,1,pyruvate metabolic process,BP,
435,GO:0006097,1,0.69629877231865,0,1,glyoxylate cycle,BP,
436,GO:0006098,1,0.533894405836112,0,2,pentose-phosphate shunt,BP,
437,GO:0006099,1,0.42954976610778,0,2,tricarboxylic acid cycle,BP,
438,GO:0006101,1,0.372359111045872,0,3,citrate metabolic process,BP,
439,GO:0006102,1,0.69629877231865,0,1,isocitrate metabolic process,BP,
440,GO:0006103,1,0.389029020913721,0,3,2-oxoglutarate metabolic process,BP,
441,GO:0006105,1,0.870241843544685,0,1,succinate metabolic process,BP,
442,GO:0006107,1,0.537983829012582,0,2,oxaloacetate metabolic process,BP,
443,GO:0006108,1,0.619534857753294,0,1,malate metabolic process,BP,
444,GO:0006109,1,0.537480666859985,0,2,regulation of carbohydrate metabolic process,BP,
446,GO:0006140,1,0.588770978581337,0,1,regulation of nucleotide metabolic process,BP,
447,GO:0006144,1,0.9290546186658,0,1,purine nucleobase metabolic process,BP,
448,GO:0006145,1,0.9290546186658,0,1,purine nucleobase catabolic process,BP,
449,GO:0006148,1,0.702529573849765,0,1,inosine catabolic process,BP,
450,GO:0006152,1,0.702529573849765,0,1,purine nucleoside catabolic process,BP,
453,GO:0006171,1,0.588770978581337,0,1,cAMP biosynthetic process,BP,
455,GO:0006258,1,0.624056902858297,0,1,UDP-glucose catabolic process,BP,
456,GO:0006259,1,0.405013399991245,0,2,DNA metabolic process,BP,
457,GO:0006260,1,0.611125925797424,0,1,DNA replication,BP,
458,GO:0006308,1,0.665914602464021,0,1,DNA catabolic process,BP,
464,GO:0006364,1,0.84997168064402,0,1,rRNA processing,BP,
467,GO:0006376,1,0.627020541116027,0,1,mRNA splice site selection,BP,
480,GO:0006470,1,0.384563992860105,0,2,protein dephosphorylation,BP,
493,GO:0006536,1,0.805141107601125,0,1,glutamate metabolic process,BP,
494,GO:0006537,1,0.805141107601125,0,1,glutamate biosynthetic process,BP,
498,GO:0006558,1,0.601567917327783,0,1,L-phenylalanine metabolic process,BP,
499,GO:0006559,1,0.601567917327783,0,1,L-phenylalanine catabolic process,BP,
500,GO:0006573,1,0.870241843544685,0,1,valine metabolic process,BP,
502,GO:0006576,1,0.775348239435331,0,1,cellular biogenic amine metabolic process,BP,
504,GO:0006600,1,0.870241843544685,0,1,creatine metabolic process,BP,
505,GO:0006605,1,0.627020541116027,0,1,protein targeting,BP,
506,GO:0006606,1,0.627020541116027,0,1,protein import into nucleus,BP,
507,GO:0006611,1,0.578471336067372,0,1,protein export from nucleus,BP,
512,GO:0006636,1,0.875695093721025,0,1,unsaturated fatty acid biosynthetic process,BP,
520,GO:0006651,1,0.599713716867655,0,1,diacylglycerol biosynthetic process,BP,
521,GO:0006656,1,0.607633118676714,0,1,phosphatidylcholine biosynthetic process,BP,
526,GO:0006665,1,0.289193082017789,0,3,sphingolipid metabolic process,BP,
527,GO:0006672,1,0.289193082017789,0,3,ceramide metabolic process,BP,
528,GO:0006677,1,0.629720466056481,0,1,glycosylceramide metabolic process,BP,
529,GO:0006687,1,0.416537021892388,0,2,glycosphingolipid metabolic process,BP,
530,GO:0006689,1,0.66448681738129,0,1,ganglioside catabolic process,BP,
531,GO:0006690,1,0.328943822256982,0,3,icosanoid metabolic process,BP,
532,GO:0006691,1,0.587992285191993,0,1,leukotriene metabolic process,BP,
535,GO:0006699,1,0.722624588823278,0,1,bile acid biosynthetic process,BP,
536,GO:0006700,1,0.481916244995827,0,2,C21-steroid hormone biosynthetic process,BP,
537,GO:0006702,1,0.260013903787043,0,3,androgen biosynthetic process,BP,
538,GO:0006703,1,0.476789251145117,0,2,estrogen biosynthetic process,BP,
539,GO:0006704,1,0.4300988407249,0,2,glucocorticoid biosynthetic process,BP,
540,GO:0006705,1,0.652705167196424,0,1,mineralocorticoid biosynthetic process,BP,
541,GO:0006706,1,0.662077425179723,0,1,steroid catabolic process,BP,
542,GO:0006710,1,0.662077425179723,0,1,androgen catabolic process,BP,
548,GO:0006733,1,0.0983323875545709,0,6,oxidoreduction coenzyme metabolic process,BP,
549,GO:0006734,1,0.619534857753294,0,1,NADH metabolic process,BP,
550,GO:0006738,1,0.702529573849765,0,1,nicotinamide riboside catabolic process,BP,
551,GO:0006739,1,0.369507241789005,0,3,NADP metabolic process,BP,
552,GO:0006740,1,0.69629877231865,0,1,NADPH regeneration,BP,
553,GO:0006749,1,0.407518757722585,0,2,glutathione metabolic process,BP,
554,GO:0006750,1,0.587992285191993,0,1,glutathione biosynthetic process,BP,
556,GO:0006766,1,0.151063210471522,0,5,vitamin metabolic process,BP,
557,GO:0006767,1,0.22920372011118,0,4,water-soluble vitamin metabolic process,BP,
558,GO:0006771,1,0.641058516990934,0,1,riboflavin metabolic process,BP,
559,GO:0006775,1,0.669147371685357,0,1,fat-soluble vitamin metabolic process,BP,
560,GO:0006778,1,0.743039914117476,0,1,porphyrin-containing compound metabolic process,BP,
564,GO:0006801,1,0.665914602464021,0,1,superoxide metabolic process,BP,
565,GO:0006805,1,0.353995875947602,0,3,xenobiotic metabolic process,BP,
567,GO:0006809,1,0.300423143349393,0,3,nitric oxide biosynthetic process,BP,
570,GO:0006812,1,0.0871208002131022,0,5,cation transport,BP,
571,GO:0006814,1,0.570989159824297,0,1,sodium ion transport,BP,
572,GO:0006816,1,0.4156356908576,0,2,calcium ion transport,BP,
573,GO:0006818,1,0.589388163862648,0,1,hydrogen transport,BP,
575,GO:0006821,1,0.570989159824297,0,1,chloride transport,BP,
576,GO:0006825,1,0.654612357040219,0,1,copper ion transport,BP,
577,GO:0006835,1,0.805141107601125,0,1,dicarboxylic acid transport,BP,
578,GO:0006836,1,0.805141107601125,0,1,neurotransmitter transport,BP,
579,GO:0006839,1,0.472972007825593,0,2,mitochondrial transport,BP,
580,GO:0006853,1,0.756881157205377,0,1,carnitine shuttle,BP,
581,GO:0006855,1,0.61159761771495,0,1,drug transmembrane transport,BP,
582,GO:0006865,1,0.805141107601125,0,1,amino acid transport,BP,
584,GO:0006873,1,0.17681501031885,0,4,cellular ion homeostasis,BP,
585,GO:0006874,1,0.273769155258206,0,3,cellular calcium ion homeostasis,BP,
586,GO:0006875,1,0.17681501031885,0,4,cellular metal ion homeostasis,BP,
587,GO:0006878,1,0.654612357040219,0,1,cellular copper ion homeostasis,BP,
588,GO:0006885,1,0.809126620423613,0,1,regulation of pH,BP,
590,GO:0006887,1,0.0518739633626835,0,7,exocytosis,BP,
593,GO:0006897,1,0.289578441853307,0,3,endocytosis,BP,
594,GO:0006898,1,0.56647063732246,0,1,receptor-mediated endocytosis,BP,
596,GO:0006907,1,0.594250321572963,0,1,pinocytosis,BP,
597,GO:0006909,1,0.594250321572963,0,1,phagocytosis,BP,
598,GO:0006913,1,0.360587210552112,0,2,nucleocytoplasmic transport,BP,
605,GO:0006936,1,0.353707110780339,0,2,muscle contraction,BP,
610,GO:0006956,1,0.720126642672929,0,1,complement activation,BP,
611,GO:0006957,1,0.720126642672929,0,1,complement activation, alternative pathway,BP,
613,GO:0006974,1,0.594250321572963,0,1,cellular response to DNA damage stimulus,BP,
618,GO:0007006,1,0.627020541116027,0,1,mitochondrial membrane organization,BP,
619,GO:0007010,1,0.21825284757342,0,3,cytoskeleton organization,BP,
620,GO:0007015,1,0.21825284757342,0,3,actin filament organization,BP,
624,GO:0007040,1,0.66448681738129,0,1,lysosome organization,BP,
635,GO:0007173,1,0.663098539838137,0,1,epidermal growth factor receptor signaling pathway,BP,
636,GO:0007186,1,0.510887386494527,0,2,G-protein coupled receptor signaling pathway,BP,
637,GO:0007202,1,0.599713716867655,0,1,activation of phospholipase C activity,BP,
638,GO:0007204,1,0.627020541116027,0,1,positive regulation of cytosolic calcium ion concentration,BP,
639,GO:0007215,1,0.952324910776072,0,1,glutamate receptor signaling pathway,BP,
641,GO:0007254,1,0.594250321572963,0,1,JNK cascade,BP,
642,GO:0007259,1,0.550627132808726,0,2,JAK-STAT cascade,BP,
643,GO:0007260,1,0.870241843544685,0,1,tyrosine phosphorylation of STAT protein,BP,
644,GO:0007264,1,0.663098539838137,0,1,small GTPase mediated signal transduction,BP,
645,GO:0007265,1,0.663098539838137,0,1,Ras protein signal transduction,BP,
648,GO:0007272,1,0.66448681738129,0,1,ensheathment of neurons,BP,
650,GO:0007276,1,0.261651310077016,0,3,gamete generation,BP,
651,GO:0007281,1,0.39652754739021,0,2,germ cell development,BP,
652,GO:0007283,1,0.665914602464021,0,1,spermatogenesis,BP,
653,GO:0007292,1,0.39652754739021,0,2,female gamete generation,BP,
654,GO:0007338,1,0.66448681738129,0,1,single fertilization,BP,
655,GO:0007341,1,0.66448681738129,0,1,penetration of zona pellucida,BP,
661,GO:0007411,1,0.663098539838137,0,1,axon guidance,BP,
667,GO:0007519,1,0.610116362596827,0,1,skeletal muscle tissue development,BP,
669,GO:0007568,1,0.665914602464021,0,1,aging,BP,
670,GO:0007584,1,0.722624588823278,0,1,response to nutrient,BP,
672,GO:0007596,1,0.709472138872067,0,2,blood coagulation,BP,
673,GO:0007598,1,0.711822224064615,0,1,blood coagulation, extrinsic pathway,BP,
674,GO:0007599,1,0.709472138872067,0,2,hemostasis,BP,
677,GO:0007605,1,0.53365873865094,0,2,sensory perception of sound,BP,
679,GO:0007611,1,0.610116362596827,0,1,learning or memory,BP,
680,GO:0007613,1,0.610116362596827,0,1,memory,BP,
681,GO:0007617,1,0.66448681738129,0,1,mating behavior,BP,
682,GO:0007618,1,0.66448681738129,0,1,mating,BP,
683,GO:0007619,1,0.66448681738129,0,1,courtship behavior,BP,
684,GO:0007622,1,0.722624588823278,0,1,rhythmic behavior,BP,
685,GO:0007623,1,0.722624588823278,0,1,circadian rhythm,BP,
686,GO:0007626,1,0.66448681738129,0,1,locomotory behavior,BP,
687,GO:0007638,1,0.805141107601125,0,1,mechanosensory behavior,BP,
688,GO:0008015,1,0.570989159824297,0,1,blood circulation,BP,
689,GO:0008016,1,0.570989159824297,0,1,regulation of heart contraction,BP,
692,GO:0008049,1,0.66448681738129,0,1,male courtship behavior,BP,
693,GO:0008064,1,0.368254216500185,0,2,regulation of actin polymerization or depolymerization,BP,
694,GO:0008066,1,0.952324910776072,0,1,glutamate receptor activity,MF,
698,GO:0008108,1,0.624056902858297,0,1,UDP-glucose:hexose-1-phosphate uridylyltransferase activity,MF,
699,GO:0008112,1,0.64063502962645,0,1,nicotinamide N-methyltransferase activity,MF,
701,GO:0008124,1,0.601567917327783,0,1,4-alpha-hydroxytetrahydrobiopterin dehydratase activity,MF,
702,GO:0008134,1,0.578471336067372,0,1,transcription factor binding,MF,
704,GO:0008144,1,0.702529573849765,0,1,drug binding,MF,
707,GO:0008154,1,0.21825284757342,0,3,actin polymerization or depolymerization,BP,
708,GO:0008168,1,0.64063502962645,0,1,methyltransferase activity,MF,
709,GO:0008170,1,0.64063502962645,0,1,N-methyltransferase activity,MF,
711,GO:0008198,1,0.412805705261718,0,2,ferrous iron binding,MF,
712,GO:0008199,1,0.641058516990934,0,1,ferric iron binding,MF,
713,GO:0008201,1,0.599713716867655,0,1,heparin binding,MF,
716,GO:0008206,1,0.722624588823278,0,1,bile acid metabolic process,BP,
717,GO:0008207,1,0.316508729110901,0,3,C21-steroid hormone metabolic process,BP,
718,GO:0008209,1,0.169822191572443,0,4,androgen metabolic process,BP,
719,GO:0008210,1,0.476789251145117,0,2,estrogen metabolic process,BP,
720,GO:0008211,1,0.308612829297389,0,3,glucocorticoid metabolic process,BP,
721,GO:0008212,1,0.652705167196424,0,1,mineralocorticoid metabolic process,BP,
725,GO:0008234,1,0.368520729438144,0,2,cysteine-type peptidase activity,MF,
727,GO:0008236,1,0.720126642672929,0,1,serine-type peptidase activity,MF,
730,GO:0008270,1,0.24978147104869,0,3,zinc ion binding,MF,
731,GO:0008277,1,0.7161003501605,0,1,regulation of G-protein coupled receptor protein signaling pathway,BP,
735,GO:0008286,1,0.809126620423613,0,1,insulin receptor signaling pathway,BP,
737,GO:0008324,1,0.291592547678156,0,4,cation transmembrane transporter activity,MF,
739,GO:0008347,1,0.66448681738129,0,1,glial cell migration,BP,
740,GO:0008360,1,0.403463461522066,0,2,regulation of cell shape,BP,
742,GO:0008366,1,0.66448681738129,0,1,axon ensheathment,BP,
744,GO:0008375,1,0.555521519641525,0,2,acetylglucosaminyltransferase activity,MF,
746,GO:0008385,1,0.594250321572963,0,1,IkappaB kinase complex,CC,
747,GO:0008386,1,0.669147371685357,0,1,cholesterol monooxygenase (side-chain-cleaving) activity,MF,
748,GO:0008395,1,0.441025291167521,0,2,steroid hydroxylase activity,MF,
749,GO:0008406,1,0.298213105951193,0,3,gonad development,BP,
751,GO:0008480,1,0.775348239435331,0,1,sarcosine dehydrogenase activity,MF,
752,GO:0008509,1,0.458205712408007,0,2,anion transmembrane transporter activity,MF,
753,GO:0008514,1,0.805141107601125,0,1,organic anion transmembrane transporter activity,MF,
757,GO:0008584,1,0.722624588823278,0,1,male gonad development,BP,
758,GO:0008585,1,0.415704624109769,0,2,female gonad development,BP,
761,GO:0008630,1,0.594250321572963,0,1,intrinsic apoptotic signaling pathway in response to DNA damage,BP,
762,GO:0008631,1,0.627020541116027,0,1,intrinsic apoptotic signaling pathway in response to oxidative stress,BP,
763,GO:0008637,1,0.370515326336158,0,2,apoptotic mitochondrial changes,BP,
766,GO:0008652,1,0.60925030138103,0,2,cellular amino acid biosynthetic process,BP,
768,GO:0008656,1,0.594250321572963,0,1,cysteine-type endopeptidase activator activity involved in apoptotic process,MF,
770,GO:0008709,1,0.597964029711571,0,1,cholate 7-alpha-dehydrogenase activity,MF,
771,GO:0008757,1,0.64063502962645,0,1,S-adenosylmethionine-dependent methyltransferase activity,MF,
773,GO:0009052,1,0.821650549135252,0,1,pentose-phosphate shunt, non-oxidative branch,BP,
779,GO:0009060,1,0.42954976610778,0,2,aerobic respiration,BP,
782,GO:0009064,1,0.805141107601125,0,1,glutamine family amino acid metabolic process,BP,
784,GO:0009067,1,0.758087612472411,0,1,aspartate family amino acid biosynthetic process,BP,
785,GO:0009072,1,0.601567917327783,0,1,aromatic amino acid family metabolic process,BP,
786,GO:0009074,1,0.601567917327783,0,1,aromatic amino acid family catabolic process,BP,
789,GO:0009084,1,0.805141107601125,0,1,glutamine family amino acid biosynthetic process,BP,
790,GO:0009086,1,0.758087612472411,0,1,methionine biosynthetic process,BP,
795,GO:0009110,1,0.665914602464021,0,1,vitamin biosynthetic process,BP,
796,GO:0009112,1,0.9290546186658,0,1,nucleobase metabolic process,BP,
797,GO:0009115,1,0.9290546186658,0,1,xanthine catabolic process,BP,
798,GO:0009116,1,0.45587639255575,0,2,nucleoside metabolic process,BP,
800,GO:0009119,1,0.702529573849765,0,1,ribonucleoside metabolic process,BP,
801,GO:0009120,1,0.651376974684416,0,1,deoxyribonucleoside metabolic process,BP,
806,GO:0009164,1,0.45587639255575,0,2,nucleoside catabolic process,BP,
809,GO:0009187,1,0.588770978581337,0,1,cyclic nucleotide metabolic process,BP,
810,GO:0009190,1,0.588770978581337,0,1,cyclic nucleotide biosynthetic process,BP,
811,GO:0009225,1,0.624056902858297,0,1,nucleotide-sugar metabolic process,BP,
812,GO:0009227,1,0.624056902858297,0,1,nucleotide-sugar catabolic process,BP,
813,GO:0009237,1,0.743039914117476,0,1,siderophore metabolic process,BP,
818,GO:0009262,1,0.651376974684416,0,1,deoxyribonucleotide metabolic process,BP,
819,GO:0009264,1,0.651376974684416,0,1,deoxyribonucleotide catabolic process,BP,
821,GO:0009267,1,0.70779745864813,0,2,cellular response to starvation,BP,
823,GO:0009303,1,0.599713716867655,0,1,rRNA transcription,BP,
826,GO:0009310,1,0.775348239435331,0,1,amine catabolic process,BP,
827,GO:0009311,1,0.283297546572572,0,3,oligosaccharide metabolic process,BP,
828,GO:0009313,1,0.66448681738129,0,1,oligosaccharide catabolic process,BP,
829,GO:0009314,1,0.580604496498539,0,2,response to radiation,BP,
830,GO:0009395,1,0.392491925960108,0,2,phospholipid catabolic process,BP,
831,GO:0009404,1,0.722624588823278,0,1,toxin metabolic process,BP,
833,GO:0009410,1,0.353995875947602,0,3,response to xenobiotic stimulus,BP,
834,GO:0009416,1,0.805141107601125,0,1,response to light stimulus,BP,
835,GO:0009435,1,0.448303174136672,0,2,NAD biosynthetic process,BP,
837,GO:0009448,1,0.805141107601125,0,1,gamma-aminobutyric acid metabolic process,BP,
838,GO:0009449,1,0.805141107601125,0,1,gamma-aminobutyric acid biosynthetic process,BP,
840,GO:0009566,1,0.66448681738129,0,1,fertilization,BP,
844,GO:0009611,1,0.354488737198381,0,4,response to wounding,BP,
847,GO:0009617,1,0.101452113891263,0,6,response to bacterium,BP,
849,GO:0009635,1,0.722624588823278,0,1,response to herbicide,BP,
850,GO:0009636,1,0.177746145122199,0,4,response to toxic substance,BP,
856,GO:0009743,1,0.722624588823278,0,1,response to carbohydrate,BP,
857,GO:0009746,1,0.722624588823278,0,1,response to hexose,BP,
858,GO:0009749,1,0.722624588823278,0,1,response to glucose,BP,
860,GO:0009791,1,0.721434029227987,0,1,post-embryonic development,BP,
877,GO:0009918,1,0.721434029227987,0,1,sterol delta7 reductase activity,MF,
878,GO:0009922,1,0.773435048011187,0,1,fatty acid elongase activity,MF,
886,GO:0009994,1,0.599713716867655,0,1,oocyte differentiation,BP,
887,GO:0010001,1,0.610116362596827,0,1,glial cell differentiation,BP,
890,GO:0010035,1,0.280001650747517,0,3,response to inorganic substance,BP,
891,GO:0010038,1,0.424098915738386,0,2,response to metal ion,BP,
892,GO:0010212,1,0.722624588823278,0,1,response to ionizing radiation,BP,
894,GO:0010288,1,0.722624588823278,0,1,response to lead ion,BP,
896,GO:0010466,1,0.444562996116742,0,2,negative regulation of peptidase activity,BP,
902,GO:0010508,1,0.724891980148401,0,1,positive regulation of autophagy,BP,
903,GO:0010510,1,0.809126620423613,0,1,regulation of acetyl-CoA biosynthetic process from pyruvate,BP,
904,GO:0010517,1,0.599713716867655,0,1,regulation of phospholipase activity,BP,
905,GO:0010518,1,0.599713716867655,0,1,positive regulation of phospholipase activity,BP,
908,GO:0010558,1,0.141762193319932,0,4,negative regulation of macromolecule biosynthetic process,BP,
919,GO:0010629,1,0.213663529653364,0,3,negative regulation of gene expression,BP,
923,GO:0010638,1,0.594250321572963,0,1,positive regulation of organelle organization,BP,
924,GO:0010639,1,0.388756955475114,0,2,negative regulation of organelle organization,BP,
928,GO:0010656,1,0.627020541116027,0,1,negative regulation of muscle cell apoptotic process,BP,
929,GO:0010657,1,0.627020541116027,0,1,muscle cell apoptotic process,BP,
930,GO:0010658,1,0.627020541116027,0,1,striated muscle cell apoptotic process,BP,
931,GO:0010659,1,0.627020541116027,0,1,cardiac muscle cell apoptotic process,BP,
932,GO:0010660,1,0.627020541116027,0,1,regulation of muscle cell apoptotic process,BP,
933,GO:0010662,1,0.627020541116027,0,1,regulation of striated muscle cell apoptotic process,BP,
934,GO:0010664,1,0.627020541116027,0,1,negative regulation of striated muscle cell apoptotic process,BP,
935,GO:0010665,1,0.627020541116027,0,1,regulation of cardiac muscle cell apoptotic process,BP,
936,GO:0010667,1,0.627020541116027,0,1,negative regulation of cardiac muscle cell apoptotic process,BP,
938,GO:0010675,1,0.537480666859985,0,2,regulation of cellular carbohydrate metabolic process,BP,
939,GO:0010676,1,0.665914602464021,0,1,positive regulation of cellular carbohydrate metabolic process,BP,
940,GO:0010720,1,0.722624588823278,0,1,positive regulation of cell development,BP,
945,GO:0010765,1,0.570989159824297,0,1,positive regulation of sodium ion transport,BP,
948,GO:0010803,1,0.232427908632685,0,3,regulation of tumor necrosis factor-mediated signaling pathway,BP,
949,GO:0010804,1,0.627020541116027,0,1,negative regulation of tumor necrosis factor-mediated signaling pathway,BP,
951,GO:0010821,1,0.370515326336158,0,2,regulation of mitochondrion organization,BP,
952,GO:0010822,1,0.594250321572963,0,1,positive regulation of mitochondrion organization,BP,
953,GO:0010823,1,0.627020541116027,0,1,negative regulation of mitochondrion organization,BP,
954,GO:0010827,1,0.84997168064402,0,1,regulation of glucose transport,BP,
955,GO:0010828,1,0.84997168064402,0,1,positive regulation of glucose transport,BP,
956,GO:0010863,1,0.599713716867655,0,1,positive regulation of phospholipase C activity,BP,
957,GO:0010866,1,0.665914602464021,0,1,regulation of triglyceride biosynthetic process,BP,
958,GO:0010867,1,0.665914602464021,0,1,positive regulation of triglyceride biosynthetic process,BP,
960,GO:0010873,1,0.56647063732246,0,1,positive regulation of cholesterol esterification,BP,
970,GO:0010899,1,0.56647063732246,0,1,regulation of phosphatidylcholine catabolic process,BP,
971,GO:0010900,1,0.56647063732246,0,1,negative regulation of phosphatidylcholine catabolic process,BP,
972,GO:0010906,1,0.537480666859985,0,2,regulation of glucose metabolic process,BP,
973,GO:0010907,1,0.665914602464021,0,1,positive regulation of glucose metabolic process,BP,
974,GO:0010915,1,0.56647063732246,0,1,regulation of very-low-density lipoprotein particle clearance,BP,
975,GO:0010916,1,0.56647063732246,0,1,negative regulation of very-low-density lipoprotein particle clearance,BP,
976,GO:0010921,1,0.665914602464021,0,1,regulation of phosphatase activity,BP,
977,GO:0010922,1,0.665914602464021,0,1,positive regulation of phosphatase activity,BP,
978,GO:0010923,1,0.665914602464021,0,1,negative regulation of phosphatase activity,BP,
984,GO:0010951,1,0.444562996116742,0,2,negative regulation of endopeptidase activity,BP,
986,GO:0010955,1,0.627020541116027,0,1,negative regulation of protein processing,BP,
987,GO:0010959,1,0.24514468681155,0,3,regulation of metal ion transport,BP,
991,GO:0010984,1,0.56647063732246,0,1,regulation of lipoprotein particle clearance,BP,
992,GO:0010985,1,0.56647063732246,0,1,negative regulation of lipoprotein particle clearance,BP,
993,GO:0010996,1,0.805141107601125,0,1,response to auditory stimulus,BP,
996,GO:0012506,1,0.518309011094329,0,3,vesicle membrane,CC,
997,GO:0014047,1,0.805141107601125,0,1,glutamate secretion,BP,
1002,GO:0014074,1,0.722624588823278,0,1,response to purine-containing compound,BP,
1004,GO:0014735,1,0.627020541116027,0,1,regulation of muscle atrophy,BP,
1005,GO:0014736,1,0.627020541116027,0,1,negative regulation of muscle atrophy,BP,
1006,GO:0014745,1,0.627020541116027,0,1,negative regulation of muscle adaptation,BP,
1007,GO:0014808,1,0.627020541116027,0,1,release of sequestered calcium ion into cytosol by sarcoplasmic reticulum,BP,
1008,GO:0014823,1,0.722624588823278,0,1,response to activity,BP,
1010,GO:0014874,1,0.627020541116027,0,1,response to stimulus involved in regulation of muscle adaptation,BP,
1011,GO:0014876,1,0.627020541116027,0,1,response to injury involved in regulation of muscle adaptation,BP,
1012,GO:0014889,1,0.627020541116027,0,1,muscle atrophy,BP,
1013,GO:0015002,1,0.589388163862648,0,1,heme-copper terminal oxidase activity,MF,
1014,GO:0015012,1,0.837849573162783,0,1,heparan sulfate proteoglycan biosynthetic process,BP,
1016,GO:0015065,1,0.715549453301239,0,1,uridine nucleotide receptor activity,MF,
1017,GO:0015075,1,0.163616595797983,0,5,ion transmembrane transporter activity,MF,
1018,GO:0015077,1,0.473049033046135,0,2,monovalent inorganic cation transmembrane transporter activity,MF,
1019,GO:0015078,1,0.589388163862648,0,1,hydrogen ion transmembrane transporter activity,MF,
1020,GO:0015081,1,0.805141107601125,0,1,sodium ion transmembrane transporter activity,MF,
1021,GO:0015103,1,0.570989159824297,0,1,inorganic anion transmembrane transporter activity,MF,
1022,GO:0015108,1,0.570989159824297,0,1,chloride transmembrane transporter activity,MF,
1023,GO:0015171,1,0.805141107601125,0,1,amino acid transmembrane transporter activity,MF,
1024,GO:0015172,1,0.805141107601125,0,1,acidic amino acid transmembrane transporter activity,MF,
1025,GO:0015179,1,0.805141107601125,0,1,L-amino acid transmembrane transporter activity,MF,
1027,GO:0015238,1,0.61159761771495,0,1,drug transmembrane transporter activity,MF,
1028,GO:0015245,1,0.607633118676714,0,1,fatty acid transporter activity,MF,
1030,GO:0015267,1,0.54294227948611,0,2,channel activity,MF,
1031,GO:0015276,1,0.952324910776072,0,1,ligand-gated ion channel activity,MF,
1032,GO:0015291,1,0.805141107601125,0,1,secondary active transmembrane transporter activity,MF,
1033,GO:0015293,1,0.805141107601125,0,1,symporter activity,MF,
1034,GO:0015294,1,0.805141107601125,0,1,solute:cation symporter activity,MF,
1035,GO:0015370,1,0.805141107601125,0,1,solute:sodium symporter activity,MF,
1041,GO:0015631,1,0.832354421897545,0,1,tubulin binding,MF,
1042,GO:0015645,1,0.703379952013767,0,1,fatty acid ligase activity,MF,
1043,GO:0015672,1,0.334298176734486,0,2,monovalent inorganic cation transport,BP,
1044,GO:0015698,1,0.570989159824297,0,1,inorganic anion transport,BP,
1046,GO:0015718,1,0.458258154728783,0,2,monocarboxylic acid transport,BP,
1047,GO:0015740,1,0.805141107601125,0,1,C4-dicarboxylate transport,BP,
1051,GO:0015800,1,0.805141107601125,0,1,acidic amino acid transport,BP,
1052,GO:0015807,1,0.805141107601125,0,1,L-amino acid transport,BP,
1053,GO:0015810,1,0.805141107601125,0,1,aspartate transport,BP,
1054,GO:0015813,1,0.805141107601125,0,1,L-glutamate transport,BP,
1056,GO:0015849,1,0.367165912202571,0,3,organic acid transport,BP,
1058,GO:0015893,1,0.61159761771495,0,1,drug transport,BP,
1059,GO:0015908,1,0.458258154728783,0,2,fatty acid transport,BP,
1060,GO:0015909,1,0.458258154728783,0,2,long-chain fatty acid transport,BP,
1063,GO:0015925,1,0.629720466056481,0,1,galactosidase activity,MF,
1064,GO:0015929,1,0.66448681738129,0,1,hexosaminidase activity,MF,
1070,GO:0015992,1,0.589388163862648,0,1,proton transport,BP,
1078,GO:0016052,1,0.266400988658021,0,3,carbohydrate catabolic process,BP,
1084,GO:0016072,1,0.508456912927079,0,2,rRNA metabolic process,BP,
1088,GO:0016128,1,0.721434029227987,0,1,phytosteroid metabolic process,BP,
1089,GO:0016129,1,0.721434029227987,0,1,phytosteroid biosynthetic process,BP,
1090,GO:0016131,1,0.721434029227987,0,1,brassinosteroid metabolic process,BP,
1091,GO:0016132,1,0.721434029227987,0,1,brassinosteroid biosynthetic process,BP,
1092,GO:0016137,1,0.629720466056481,0,1,glycoside metabolic process,BP,
1093,GO:0016139,1,0.629720466056481,0,1,glycoside catabolic process,BP,
1097,GO:0016209,1,0.587992285191993,0,1,antioxidant activity,MF,
1098,GO:0016229,1,0.153022894816863,0,4,steroid dehydrogenase activity,MF,
1101,GO:0016247,1,0.570989159824297,0,1,channel regulator activity,MF,
1108,GO:0016311,1,0.244046795598593,0,3,dephosphorylation,BP,
1110,GO:0016363,1,0.84997168064402,0,1,nuclear matrix,CC,
1111,GO:0016405,1,0.483682070560156,0,2,CoA-ligase activity,MF,
1123,GO:0016502,1,0.715549453301239,0,1,nucleotide receptor activity,MF,
1124,GO:0016504,1,0.594250321572963,0,1,peptidase activator activity,MF,
1125,GO:0016505,1,0.594250321572963,0,1,peptidase activator activity involved in apoptotic process,MF,
1126,GO:0016528,1,0.378937646944438,0,2,sarcoplasm,CC,
1127,GO:0016529,1,0.627020541116027,0,1,sarcoplasmic reticulum,CC,
1131,GO:0016595,1,0.805141107601125,0,1,glutamate binding,MF,
1132,GO:0016597,1,0.805141107601125,0,1,amino acid binding,MF,
1136,GO:0016615,1,0.619534857753294,0,1,malate dehydrogenase activity,MF,
1137,GO:0016616,1,0.0260422531533258,0,8,oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor,MF,
1138,GO:0016623,1,0.9290546186658,0,1,oxidoreductase activity, acting on the aldehyde or oxo group of donors, oxygen as acceptor,MF,
1146,GO:0016675,1,0.589388163862648,0,1,oxidoreductase activity, acting on a heme group of donors,MF,
1147,GO:0016676,1,0.589388163862648,0,1,oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor,MF,
1148,GO:0016684,1,0.587992285191993,0,1,oxidoreductase activity, acting on peroxide as acceptor,MF,
1149,GO:0016705,1,0.14554312825117,0,5,oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen,MF,
1150,GO:0016706,1,0.646945096935322,0,1,oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, 2-oxoglutarate as one donor, and incorporation of one atom each of oxygen into both donors,MF,
1151,GO:0016713,1,0.669147371685357,0,1,oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced iron-sulfur protein as one donor, and incorporation of one atom of oxygen,MF,
1152,GO:0016714,1,0.601567917327783,0,1,oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced pteridine as one donor, and incorporation of one atom of oxygen,MF,
1153,GO:0016717,1,0.875695093721025,0,1,oxidoreductase activity, acting on paired donors, with oxidation of a pair of donors resulting in the reduction of molecular oxygen to two molecules of water,MF,
1155,GO:0016725,1,0.9290546186658,0,1,oxidoreductase activity, acting on CH or CH2 groups,MF,
1156,GO:0016726,1,0.9290546186658,0,1,oxidoreductase activity, acting on CH or CH2 groups, NAD or NADP as acceptor,MF,
1158,GO:0016741,1,0.64063502962645,0,1,transferase activity, transferring one-carbon groups,MF,
1163,GO:0016763,1,0.702529573849765,0,1,transferase activity, transferring pentosyl groups,MF,
1164,GO:0016765,1,0.587992285191993,0,1,transferase activity, transferring alkyl or aryl (other than methyl) groups,MF,
1167,GO:0016779,1,0.624056902858297,0,1,nucleotidyltransferase activity,MF,
1171,GO:0016791,1,0.370061959698986,0,2,phosphatase activity,MF,
1172,GO:0016798,1,0.283297546572572,0,3,hydrolase activity, acting on glycosyl bonds,MF,
1174,GO:0016810,1,0.699753584737601,0,1,hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds,MF,
1175,GO:0016811,1,0.699753584737601,0,1,hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides,MF,
1181,GO:0016832,1,0.429216306130738,0,2,aldehyde-lyase activity,MF,
1185,GO:0016846,1,0.587992285191993,0,1,carbon-sulfur lyase activity,MF,
1188,GO:0016861,1,0.758087612472411,0,1,intramolecular oxidoreductase activity, interconverting aldoses and ketoses,MF,
1192,GO:0016877,1,0.483682070560156,0,2,ligase activity, forming carbon-sulfur bonds,MF,
1193,GO:0016878,1,0.483682070560156,0,2,acid-thiol ligase activity,MF,
1196,GO:0016898,1,0.674025502097396,0,1,oxidoreductase activity, acting on the CH-OH group of donors, cytochrome as acceptor,MF,
1197,GO:0016903,1,0.9290546186658,0,1,oxidoreductase activity, acting on the aldehyde or oxo group of donors,MF,
1199,GO:0016936,1,0.629720466056481,0,1,galactoside binding,MF,
1201,GO:0017022,1,0.594250321572963,0,1,myosin binding,MF,
1202,GO:0017024,1,0.594250321572963,0,1,myosin I binding,MF,
1203,GO:0017038,1,0.627020541116027,0,1,protein import,BP,
1204,GO:0017040,1,0.699753584737601,0,1,ceramidase activity,MF,
1205,GO:0017046,1,0.870241843544685,0,1,peptide hormone binding,MF,
1207,GO:0017080,1,0.570989159824297,0,1,sodium channel regulator activity,MF,
1208,GO:0017085,1,0.722624588823278,0,1,response to insecticide,BP,
1213,GO:0017143,1,0.722624588823278,0,1,insecticide metabolic process,BP,
1214,GO:0017148,1,0.599713716867655,0,1,negative regulation of translation,BP,
1215,GO:0017156,1,0.7161003501605,0,1,calcium ion regulated exocytosis,BP,
1216,GO:0017157,1,0.7161003501605,0,1,regulation of exocytosis,BP,
1217,GO:0017158,1,0.7161003501605,0,1,regulation of calcium ion-dependent exocytosis,BP,
1218,GO:0017171,1,0.720126642672929,0,1,serine hydrolase activity,MF,
1230,GO:0018879,1,0.722624588823278,0,1,biphenyl metabolic process,BP,
1231,GO:0018894,1,0.722624588823278,0,1,dibenzo-p-dioxin metabolic process,BP,
1233,GO:0018958,1,0.722624588823278,0,1,phenol-containing compound metabolic process,BP,
1234,GO:0018963,1,0.722624588823278,0,1,phthalate metabolic process,BP,
1235,GO:0019001,1,0.703379952013767,0,1,guanyl nucleotide binding,MF,
1236,GO:0019058,1,0.84997168064402,0,1,viral life cycle,BP,
1237,GO:0019079,1,0.84997168064402,0,1,viral genome replication,BP,
1238,GO:0019098,1,0.66448681738129,0,1,reproductive behavior,BP,
1239,GO:0019166,1,0.662223203914035,0,1,trans-2-enoyl-CoA reductase (NADPH) activity,MF,
1240,GO:0019184,1,0.435164809040717,0,2,nonribosomal peptide biosynthetic process,BP,
1248,GO:0019290,1,0.743039914117476,0,1,siderophore biosynthetic process,BP,
1251,GO:0019320,1,0.624056902858297,0,1,hexose catabolic process,BP,
1252,GO:0019359,1,0.448303174136672,0,2,nicotinamide nucleotide biosynthetic process,BP,
1253,GO:0019362,1,0.0983323875545709,0,6,pyridine nucleotide metabolic process,BP,
1254,GO:0019363,1,0.448303174136672,0,2,pyridine nucleotide biosynthetic process,BP,
1255,GO:0019367,1,0.773435048011187,0,1,fatty acid elongation, saturated fatty acid,BP,
1256,GO:0019370,1,0.587992285191993,0,1,leukotriene biosynthetic process,BP,
1257,GO:0019372,1,0.645095410017529,0,1,lipoxygenase pathway,BP,
1258,GO:0019377,1,0.416537021892388,0,2,glycolipid catabolic process,BP,
1259,GO:0019388,1,0.624056902858297,0,1,galactose catabolic process,BP,
1261,GO:0019430,1,0.665914602464021,0,1,removal of superoxide radicals,BP,
1262,GO:0019432,1,0.665914602464021,0,1,triglyceride biosynthetic process,BP,
1263,GO:0019433,1,0.607633118676714,0,1,triglyceride catabolic process,BP,
1266,GO:0019509,1,0.758087612472411,0,1,L-methionine salvage from methylthioadenosine,BP,
1267,GO:0019530,1,0.870241843544685,0,1,taurine metabolic process,BP,
1271,GO:0019674,1,0.275167877807973,0,3,NAD metabolic process,BP,
1272,GO:0019682,1,0.533894405836112,0,2,glyceraldehyde-3-phosphate metabolic process,BP,
1273,GO:0019692,1,0.651376974684416,0,1,deoxyribose phosphate metabolic process,BP,
1275,GO:0019694,1,0.870241843544685,0,1,alkanesulfonate metabolic process,BP,
1276,GO:0019695,1,0.775348239435331,0,1,choline metabolic process,BP,
1277,GO:0019722,1,0.665914602464021,0,1,calcium-mediated signaling,BP,
1278,GO:0019725,1,0.12591514670393,0,5,cellular homeostasis,BP,
1279,GO:0019748,1,0.535523291511761,0,2,secondary metabolic process,BP,
1281,GO:0019825,1,0.661785962438721,0,1,oxygen binding,MF,
1285,GO:0019843,1,0.309301112540155,0,3,rRNA binding,MF,
1286,GO:0019852,1,0.39048982220298,0,2,L-ascorbic acid metabolic process,BP,
1287,GO:0019853,1,0.665914602464021,0,1,L-ascorbic acid biosynthetic process,BP,
1298,GO:0019932,1,0.665914602464021,0,1,second-messenger-mediated signaling,BP,
1300,GO:0019953,1,0.261651310077016,0,3,sexual reproduction,BP,
1301,GO:0020037,1,0.257273381457385,0,3,heme binding,MF,
1302,GO:0021545,1,0.805141107601125,0,1,cranial nerve development,BP,
1303,GO:0021675,1,0.805141107601125,0,1,nerve development,BP,
1304,GO:0021700,1,0.599713716867655,0,1,developmental maturation,BP,
1307,GO:0022404,1,0.634036220511901,0,1,molting cycle process,BP,
1308,GO:0022405,1,0.634036220511901,0,1,hair cycle process,BP,
1311,GO:0022410,1,0.722624588823278,0,1,circadian sleep/wake cycle process,BP,
1313,GO:0022412,1,0.39652754739021,0,2,cellular process involved in reproduction in multicellular organism,BP,
1316,GO:0022602,1,0.599713716867655,0,1,ovulation cycle process,BP,
1321,GO:0022613,1,0.531711858310041,0,2,ribonucleoprotein complex biogenesis,BP,
1322,GO:0022618,1,0.627020541116027,0,1,ribonucleoprotein complex assembly,BP,
1323,GO:0022803,1,0.54294227948611,0,2,passive transmembrane transporter activity,MF,
1325,GO:0022824,1,0.952324910776072,0,1,transmitter-gated ion channel activity,MF,
1326,GO:0022834,1,0.952324910776072,0,1,ligand-gated channel activity,MF,
1327,GO:0022835,1,0.952324910776072,0,1,transmitter-gated channel activity,MF,
1328,GO:0022836,1,0.952324910776072,0,1,gated channel activity,MF,
1329,GO:0022838,1,0.54294227948611,0,2,substrate-specific channel activity,MF,
1331,GO:0022890,1,0.291592547678156,0,4,inorganic cation transmembrane transporter activity,MF,
1332,GO:0022891,1,0.163616595797983,0,5,substrate-specific transmembrane transporter activity,MF,
1334,GO:0022898,1,0.378200365412608,0,2,regulation of transmembrane transporter activity,BP,
1343,GO:0030001,1,0.151325138631537,0,4,metal ion transport,BP,
1344,GO:0030003,1,0.17681501031885,0,4,cellular cation homeostasis,BP,
1345,GO:0030016,1,0.623232303978104,0,1,myofibril,CC,
1346,GO:0030017,1,0.623232303978104,0,1,sarcomere,CC,
1347,GO:0030029,1,0.21825284757342,0,3,actin filament-based process,BP,
1349,GO:0030031,1,0.832354421897545,0,1,cell projection assembly,BP,
1350,GO:0030036,1,0.21825284757342,0,3,actin cytoskeleton organization,BP,
1351,GO:0030041,1,0.21825284757342,0,3,actin filament polymerization,BP,
1352,GO:0030042,1,0.623232303978104,0,1,actin filament depolymerization,BP,
1355,GO:0030060,1,0.619534857753294,0,1,L-malate dehydrogenase activity,MF,
1356,GO:0030061,1,0.722624588823278,0,1,mitochondrial crista,CC,
1363,GO:0030100,1,0.334391351726976,0,2,regulation of endocytosis,BP,
1364,GO:0030101,1,0.724891980148401,0,1,natural killer cell activation,BP,
1366,GO:0030133,1,0.7161003501605,0,1,transport vesicle,CC,
1367,GO:0030135,1,0.685732886781739,0,1,coated vesicle,CC,
1368,GO:0030139,1,0.952324910776072,0,1,endocytic vesicle,CC,
1369,GO:0030141,1,0.0518739633626835,0,7,secretory granule,CC,
1371,GO:0030149,1,0.416537021892388,0,2,sphingolipid catabolic process,BP,
1376,GO:0030166,1,0.837849573162783,0,1,proteoglycan biosynthetic process,BP,
1377,GO:0030170,1,0.673840088392218,0,1,pyridoxal phosphate binding,MF,
1382,GO:0030193,1,0.997322300088831,0,1,regulation of blood coagulation,BP,
1383,GO:0030201,1,0.837849573162783,0,1,heparan sulfate proteoglycan metabolic process,BP,
1384,GO:0030203,1,0.378680274718837,0,3,glycosaminoglycan metabolic process,BP,
1385,GO:0030204,1,0.453908529716914,0,2,chondroitin sulfate metabolic process,BP,
1386,GO:0030205,1,0.685732886781739,0,1,dermatan sulfate metabolic process,BP,
1387,GO:0030207,1,0.453908529716914,0,2,chondroitin sulfate catabolic process,BP,
1388,GO:0030209,1,0.685732886781739,0,1,dermatan sulfate catabolic process,BP,
1389,GO:0030212,1,0.66448681738129,0,1,hyaluronan metabolic process,BP,
1390,GO:0030214,1,0.66448681738129,0,1,hyaluronan catabolic process,BP,
1395,GO:0030246,1,0.646945096935322,0,1,carbohydrate binding,MF,
1397,GO:0030274,1,0.7161003501605,0,1,LIM domain binding,MF,
1400,GO:0030283,1,0.597964029711571,0,1,testosterone dehydrogenase [NAD(P)] activity,MF,
1402,GO:0030317,1,0.665914602464021,0,1,flagellated sperm motility,BP,
1407,GO:0030414,1,0.444562996116742,0,2,peptidase inhibitor activity,MF,
1410,GO:0030426,1,0.599713716867655,0,1,growth cone,CC,
1411,GO:0030427,1,0.599713716867655,0,1,site of polarized growth,CC,
1412,GO:0030431,1,0.722624588823278,0,1,sleep,BP,
1413,GO:0030449,1,0.720126642672929,0,1,regulation of complement activation,BP,
1414,GO:0030488,1,0.597964029711571,0,1,tRNA methylation,BP,
1415,GO:0030497,1,0.773435048011187,0,1,fatty acid elongation,BP,
1419,GO:0030539,1,0.610587287681345,0,1,male genitalia development,BP,
1423,GO:0030594,1,0.952324910776072,0,1,neurotransmitter receptor activity,MF,
1424,GO:0030658,1,0.7161003501605,0,1,transport vesicle membrane,CC,
1425,GO:0030659,1,0.518309011094329,0,3,cytoplasmic vesicle membrane,CC,
1426,GO:0030666,1,0.952324910776072,0,1,endocytic vesicle membrane,CC,
1427,GO:0030667,1,0.7161003501605,0,1,secretory granule membrane,CC,
1428,GO:0030677,1,0.597964029711571,0,1,ribonuclease P complex,CC,
1429,GO:0030678,1,0.597964029711571,0,1,mitochondrial ribonuclease P complex,CC,
1431,GO:0030760,1,0.64063502962645,0,1,pyridine N-methyltransferase activity,MF,
1432,GO:0030799,1,0.588770978581337,0,1,regulation of cyclic nucleotide metabolic process,BP,
1433,GO:0030801,1,0.588770978581337,0,1,positive regulation of cyclic nucleotide metabolic process,BP,
1434,GO:0030802,1,0.588770978581337,0,1,regulation of cyclic nucleotide biosynthetic process,BP,
1435,GO:0030804,1,0.588770978581337,0,1,positive regulation of cyclic nucleotide biosynthetic process,BP,
1436,GO:0030808,1,0.588770978581337,0,1,regulation of nucleotide biosynthetic process,BP,
1437,GO:0030810,1,0.588770978581337,0,1,positive regulation of nucleotide biosynthetic process,BP,
1438,GO:0030814,1,0.588770978581337,0,1,regulation of cAMP metabolic process,BP,
1439,GO:0030816,1,0.588770978581337,0,1,positive regulation of cAMP metabolic process,BP,
1440,GO:0030817,1,0.588770978581337,0,1,regulation of cAMP biosynthetic process,BP,
1441,GO:0030819,1,0.588770978581337,0,1,positive regulation of cAMP biosynthetic process,BP,
1442,GO:0030832,1,0.368254216500185,0,2,regulation of actin filament length,BP,
1443,GO:0030833,1,0.368254216500185,0,2,regulation of actin filament polymerization,BP,
1444,GO:0030834,1,0.623232303978104,0,1,regulation of actin filament depolymerization,BP,
1445,GO:0030835,1,0.623232303978104,0,1,negative regulation of actin filament depolymerization,BP,
1446,GO:0030837,1,0.623232303978104,0,1,negative regulation of actin filament polymerization,BP,
1447,GO:0030838,1,0.594250321572963,0,1,positive regulation of actin filament polymerization,BP,
1449,GO:0030868,1,0.652705167196424,0,1,smooth endoplasmic reticulum membrane,CC,
1450,GO:0030888,1,0.724891980148401,0,1,regulation of B cell proliferation,BP,
1451,GO:0030890,1,0.724891980148401,0,1,positive regulation of B cell proliferation,BP,
1458,GO:0031098,1,0.594250321572963,0,1,stress-activated protein kinase signaling cascade,BP,
1459,GO:0031099,1,0.424735931692201,0,2,regeneration,BP,
1460,GO:0031100,1,0.424735931692201,0,2,animal organ regeneration,BP,
1465,GO:0031210,1,0.56647063732246,0,1,phosphatidylcholine binding,MF,
1466,GO:0031223,1,0.805141107601125,0,1,auditory behavior,BP,
1468,GO:0031225,1,0.711822224064615,0,1,anchored component of membrane,CC,
1471,GO:0031252,1,0.610116362596827,0,1,cell leading edge,CC,
1488,GO:0031333,1,0.623232303978104,0,1,negative regulation of protein complex assembly,BP,
1496,GO:0031348,1,0.634036220511901,0,1,negative regulation of defense response,BP,
1504,GO:0031406,1,0.174580182301854,0,4,carboxylic acid binding,MF,
1506,GO:0031418,1,0.646945096935322,0,1,L-ascorbic acid binding,MF,
1509,GO:0031503,1,0.627020541116027,0,1,protein complex localization,BP,
1512,GO:0031663,1,0.724891980148401,0,1,lipopolysaccharide-mediated signaling pathway,BP,
1514,GO:0031668,1,0.70779745864813,0,2,cellular response to extracellular stimulus,BP,
1515,GO:0031669,1,0.70779745864813,0,2,cellular response to nutrient levels,BP,
1517,GO:0031779,1,0.588770978581337,0,1,melanocortin receptor binding,MF,
1518,GO:0031780,1,0.588770978581337,0,1,corticotropin hormone receptor binding,MF,
1519,GO:0031781,1,0.588770978581337,0,1,type 3 melanocortin receptor binding,MF,
1520,GO:0031782,1,0.588770978581337,0,1,type 4 melanocortin receptor binding,MF,
1521,GO:0031783,1,0.588770978581337,0,1,type 5 melanocortin receptor binding,MF,
1522,GO:0031901,1,0.763267626299272,0,1,early endosome membrane,CC,
1526,GO:0031960,1,0.439119860050815,0,2,response to corticosteroid,BP,
1527,GO:0031965,1,0.41549644932627,0,2,nuclear membrane,CC,
1531,GO:0031970,1,0.469993243872978,0,2,organelle envelope lumen,CC,
1536,GO:0031983,1,0.0741061014299095,0,6,vesicle lumen,CC,
1540,GO:0032088,1,0.594250321572963,0,1,negative regulation of NF-kappaB transcription factor activity,BP,
1541,GO:0032090,1,0.594250321572963,0,1,Pyrin domain binding,MF,
1542,GO:0032092,1,0.724891980148401,0,1,positive regulation of protein binding,BP,
1545,GO:0032147,1,0.520704278273446,0,2,activation of protein kinase activity,BP,
1546,GO:0032148,1,0.599713716867655,0,1,activation of protein kinase B activity,BP,
1548,GO:0032266,1,0.763267626299272,0,1,phosphatidylinositol-3-phosphate binding,MF,
1552,GO:0032271,1,0.368254216500185,0,2,regulation of protein polymerization,BP,
1553,GO:0032272,1,0.623232303978104,0,1,negative regulation of protein polymerization,BP,
1554,GO:0032273,1,0.594250321572963,0,1,positive regulation of protein polymerization,BP,
1556,GO:0032311,1,0.599713716867655,0,1,angiogenin-PRI complex,CC,
1559,GO:0032354,1,0.722624588823278,0,1,response to follicle-stimulating hormone,BP,
1560,GO:0032355,1,0.711822224064615,0,1,response to estradiol,BP,
1565,GO:0032369,1,0.56647063732246,0,1,negative regulation of lipid transport,BP,
1568,GO:0032372,1,0.56647063732246,0,1,negative regulation of sterol transport,BP,
1571,GO:0032375,1,0.56647063732246,0,1,negative regulation of cholesterol transport,BP,
1573,GO:0032386,1,0.360587210552112,0,2,regulation of intracellular transport,BP,
1575,GO:0032409,1,0.378200365412608,0,2,regulation of transporter activity,BP,
1576,GO:0032411,1,0.665914602464021,0,1,positive regulation of transporter activity,BP,
1577,GO:0032412,1,0.378200365412608,0,2,regulation of ion transmembrane transporter activity,BP,
1578,GO:0032414,1,0.665914602464021,0,1,positive regulation of ion transmembrane transporter activity,BP,
1579,GO:0032429,1,0.599713716867655,0,1,regulation of phospholipase A2 activity,BP,
1580,GO:0032430,1,0.599713716867655,0,1,positive regulation of phospholipase A2 activity,BP,
1581,GO:0032431,1,0.599713716867655,0,1,activation of phospholipase A2 activity,BP,
1583,GO:0032479,1,0.269462945980164,0,3,regulation of type I interferon production,BP,
1584,GO:0032480,1,0.374703178517604,0,2,negative regulation of type I interferon production,BP,
1585,GO:0032481,1,0.724891980148401,0,1,positive regulation of type I interferon production,BP,
1586,GO:0032496,1,0.101452113891263,0,6,response to lipopolysaccharide,BP,
1589,GO:0032504,1,0.261651310077016,0,3,multicellular organism reproduction,BP,
1590,GO:0032515,1,0.665914602464021,0,1,negative regulation of phosphoprotein phosphatase activity,BP,
1594,GO:0032549,1,0.703379952013767,0,1,ribonucleoside binding,MF,
1595,GO:0032550,1,0.703379952013767,0,1,purine ribonucleoside binding,MF,
1599,GO:0032561,1,0.703379952013767,0,1,guanyl ribonucleotide binding,MF,
1601,GO:0032602,1,0.428977338147713,0,2,chemokine production,BP,
1602,GO:0032606,1,0.269462945980164,0,3,type I interferon production,BP,
1603,GO:0032607,1,0.634036220511901,0,1,interferon-alpha production,BP,
1604,GO:0032608,1,0.269462945980164,0,3,interferon-beta production,BP,
1606,GO:0032611,1,0.594250321572963,0,1,interleukin-1 beta production,BP,
1607,GO:0032612,1,0.594250321572963,0,1,interleukin-1 production,BP,
1608,GO:0032613,1,0.594250321572963,0,1,interleukin-10 production,BP,
1609,GO:0032623,1,0.702529573849765,0,1,interleukin-2 production,BP,
1610,GO:0032635,1,0.428977338147713,0,2,interleukin-6 production,BP,
1613,GO:0032642,1,0.428977338147713,0,2,regulation of chemokine production,BP,
1614,GO:0032647,1,0.634036220511901,0,1,regulation of interferon-alpha production,BP,
1615,GO:0032648,1,0.269462945980164,0,3,regulation of interferon-beta production,BP,
1617,GO:0032651,1,0.594250321572963,0,1,regulation of interleukin-1 beta production,BP,
1618,GO:0032652,1,0.594250321572963,0,1,regulation of interleukin-1 production,BP,
1619,GO:0032653,1,0.594250321572963,0,1,regulation of interleukin-10 production,BP,
1620,GO:0032675,1,0.428977338147713,0,2,regulation of interleukin-6 production,BP,
1623,GO:0032687,1,0.634036220511901,0,1,negative regulation of interferon-alpha production,BP,
1624,GO:0032688,1,0.374703178517604,0,2,negative regulation of interferon-beta production,BP,
1625,GO:0032722,1,0.428977338147713,0,2,positive regulation of chemokine production,BP,
1626,GO:0032728,1,0.724891980148401,0,1,positive regulation of interferon-beta production,BP,
1628,GO:0032731,1,0.594250321572963,0,1,positive regulation of interleukin-1 beta production,BP,
1629,GO:0032732,1,0.594250321572963,0,1,positive regulation of interleukin-1 production,BP,
1630,GO:0032733,1,0.594250321572963,0,1,positive regulation of interleukin-10 production,BP,
1631,GO:0032755,1,0.428977338147713,0,2,positive regulation of interleukin-6 production,BP,
1635,GO:0032769,1,0.629720466056481,0,1,negative regulation of monooxygenase activity,BP,
1637,GO:0032780,1,0.665914602464021,0,1,negative regulation of ATPase activity,BP,
1638,GO:0032781,1,0.665914602464021,0,1,positive regulation of ATPase activity,BP,
1642,GO:0032814,1,0.724891980148401,0,1,regulation of natural killer cell activation,BP,
1643,GO:0032816,1,0.724891980148401,0,1,positive regulation of natural killer cell activation,BP,
1646,GO:0032868,1,0.297604274052236,0,4,response to insulin,BP,
1647,GO:0032869,1,0.494496044198499,0,3,cellular response to insulin stimulus,BP,
1648,GO:0032870,1,0.428781113323053,0,4,cellular response to hormone stimulus,BP,
1649,GO:0032872,1,0.594250321572963,0,1,regulation of stress-activated MAPK cascade,BP,
1650,GO:0032874,1,0.594250321572963,0,1,positive regulation of stress-activated MAPK cascade,BP,
1658,GO:0032956,1,0.368254216500185,0,2,regulation of actin cytoskeleton organization,BP,
1660,GO:0032970,1,0.368254216500185,0,2,regulation of actin filament-based process,BP,
1665,GO:0032994,1,0.56647063732246,0,1,protein-lipid complex,CC,
1667,GO:0033013,1,0.743039914117476,0,1,tetrapyrrole metabolic process,BP,
1671,GO:0033157,1,0.360587210552112,0,2,regulation of intracellular protein transport,BP,
1674,GO:0033218,1,0.520704278273446,0,2,amide binding,MF,
1676,GO:0033293,1,0.342005043138806,0,2,monocarboxylic acid binding,MF,
1677,GO:0033306,1,0.662223203914035,0,1,phytol metabolic process,BP,
1679,GO:0033365,1,0.627020541116027,0,1,protein localization to organelle,BP,
1680,GO:0033489,1,0.43946118628524,0,2,cholesterol biosynthetic process via desmosterol,BP,
1681,GO:0033490,1,0.43946118628524,0,2,cholesterol biosynthetic process via lathosterol,BP,
1685,GO:0033559,1,0.875695093721025,0,1,unsaturated fatty acid metabolic process,BP,
1687,GO:0033613,1,0.578471336067372,0,1,activating transcription factor binding,MF,
1691,GO:0033764,1,0.153022894816863,0,4,steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor,MF,
1705,GO:0034103,1,0.809126620423613,0,1,regulation of tissue remodeling,BP,
1706,GO:0034121,1,0.724891980148401,0,1,regulation of toll-like receptor signaling pathway,BP,
1707,GO:0034122,1,0.724891980148401,0,1,negative regulation of toll-like receptor signaling pathway,BP,
1708,GO:0034127,1,0.724891980148401,0,1,regulation of MyD88-independent toll-like receptor signaling pathway,BP,
1709,GO:0034128,1,0.724891980148401,0,1,negative regulation of MyD88-independent toll-like receptor signaling pathway,BP,
1710,GO:0034220,1,0.0483785499597115,0,8,ion transmembrane transport,BP,
1712,GO:0034249,1,0.599713716867655,0,1,negative regulation of cellular amide metabolic process,BP,
1713,GO:0034250,1,0.730169690081196,0,1,positive regulation of cellular amide metabolic process,BP,
1714,GO:0034260,1,0.665914602464021,0,1,negative regulation of GTPase activity,BP,
1715,GO:0034284,1,0.722624588823278,0,1,response to monosaccharide,BP,
1717,GO:0034330,1,0.599713716867655,0,1,cell junction organization,BP,
1718,GO:0034332,1,0.599713716867655,0,1,adherens junction organization,BP,
1721,GO:0034356,1,0.448303174136672,0,2,NAD biosynthesis via nicotinamide riboside salvage pathway,BP,
1722,GO:0034358,1,0.56647063732246,0,1,plasma lipoprotein particle,CC,
1723,GO:0034361,1,0.56647063732246,0,1,very-low-density lipoprotein particle,CC,
1724,GO:0034364,1,0.56647063732246,0,1,high-density lipoprotein particle,CC,
1730,GO:0034377,1,0.56647063732246,0,1,plasma lipoprotein particle assembly,BP,
1731,GO:0034379,1,0.56647063732246,0,1,very-low-density lipoprotein particle assembly,BP,
1732,GO:0034381,1,0.56647063732246,0,1,plasma lipoprotein particle clearance,BP,
1733,GO:0034382,1,0.56647063732246,0,1,chylomicron remnant clearance,BP,
1734,GO:0034385,1,0.56647063732246,0,1,triglyceride-rich plasma lipoprotein particle,CC,
1735,GO:0034394,1,0.588770978581337,0,1,protein localization to cell surface,BP,
1736,GO:0034399,1,0.84997168064402,0,1,nuclear periphery,CC,
1737,GO:0034418,1,0.702529573849765,0,1,urate biosynthetic process,BP,
1744,GO:0034447,1,0.56647063732246,0,1,very-low-density lipoprotein particle clearance,BP,
1746,GO:0034504,1,0.627020541116027,0,1,protein localization to nucleus,BP,
1747,GO:0034599,1,0.4156356908576,0,2,cellular response to oxidative stress,BP,
1750,GO:0034614,1,0.665914602464021,0,1,cellular response to reactive oxygen species,BP,
1752,GO:0034622,1,0.134577433575757,0,4,cellular macromolecular complex assembly,BP,
1755,GO:0034638,1,0.56647063732246,0,1,phosphatidylcholine catabolic process,BP,
1761,GO:0034698,1,0.722624588823278,0,1,response to gonadotropin,BP,
1762,GO:0034699,1,0.722624588823278,0,1,response to luteinizing hormone,BP,
1765,GO:0034707,1,0.570989159824297,0,1,chloride channel complex,CC,
1767,GO:0034762,1,0.24514468681155,0,3,regulation of transmembrane transport,BP,
1768,GO:0034764,1,0.378200365412608,0,2,positive regulation of transmembrane transport,BP,
1769,GO:0034765,1,0.24514468681155,0,3,regulation of ion transmembrane transport,BP,
1770,GO:0034767,1,0.378200365412608,0,2,positive regulation of ion transmembrane transport,BP,
1771,GO:0034774,1,0.0741061014299095,0,6,secretory granule lumen,CC,
1775,GO:0035094,1,0.722624588823278,0,1,response to nicotine,BP,
1777,GO:0035235,1,0.952324910776072,0,1,ionotropic glutamate receptor signaling pathway,BP,
1779,GO:0035264,1,0.626850131136504,0,2,multicellular organism growth,BP,
1784,GO:0035303,1,0.665914602464021,0,1,regulation of dephosphorylation,BP,
1785,GO:0035304,1,0.665914602464021,0,1,regulation of protein dephosphorylation,BP,
1786,GO:0035305,1,0.665914602464021,0,1,negative regulation of dephosphorylation,BP,
1787,GO:0035306,1,0.665914602464021,0,1,positive regulation of dephosphorylation,BP,
1788,GO:0035308,1,0.665914602464021,0,1,negative regulation of protein dephosphorylation,BP,
1789,GO:0035335,1,0.580516978001833,0,1,peptidyl-tyrosine dephosphorylation,BP,
1790,GO:0035336,1,0.532244306476539,0,2,long-chain fatty-acyl-CoA metabolic process,BP,
1791,GO:0035337,1,0.532244306476539,0,2,fatty-acyl-CoA metabolic process,BP,
1792,GO:0035338,1,0.532244306476539,0,2,long-chain fatty-acyl-CoA biosynthetic process,BP,
1795,GO:0035434,1,0.654612357040219,0,1,copper ion transmembrane transport,BP,
1796,GO:0035455,1,0.722624588823278,0,1,response to interferon-alpha,BP,
1797,GO:0035457,1,0.722624588823278,0,1,cellular response to interferon-alpha,BP,
1800,GO:0035578,1,0.24488358065803,0,3,azurophil granule lumen,CC,
1801,GO:0035586,1,0.715549453301239,0,1,purinergic receptor activity,MF,
1802,GO:0035587,1,0.715549453301239,0,1,purinergic receptor signaling pathway,BP,
1803,GO:0035588,1,0.715549453301239,0,1,G-protein coupled purinergic receptor signaling pathway,BP,
1804,GO:0035589,1,0.715549453301239,0,1,G-protein coupled purinergic nucleotide receptor signaling pathway,BP,
1805,GO:0035590,1,0.715549453301239,0,1,purinergic nucleotide receptor signaling pathway,BP,
1808,GO:0035637,1,0.570989159824297,0,1,multicellular organismal signaling,BP,
1813,GO:0035725,1,0.570989159824297,0,1,sodium ion transmembrane transport,BP,
1817,GO:0035770,1,0.870241843544685,0,1,ribonucleoprotein granule,CC,
1818,GO:0035795,1,0.627020541116027,0,1,negative regulation of mitochondrial membrane permeability,BP,
1820,GO:0035914,1,0.610116362596827,0,1,skeletal muscle cell differentiation,BP,
1821,GO:0035962,1,0.821650549135252,0,1,response to interleukin-13,BP,
1822,GO:0035963,1,0.821650549135252,0,1,cellular response to interleukin-13,BP,
1825,GO:0036041,1,0.607633118676714,0,1,long-chain fatty acid binding,MF,
1830,GO:0036109,1,0.875695093721025,0,1,alpha-linolenic acid metabolic process,BP,
1836,GO:0036230,1,0.0741061014299095,0,6,granulocyte activation,BP,
1839,GO:0036376,1,0.570989159824297,0,1,sodium ion export from cell,BP,
1840,GO:0036379,1,0.623232303978104,0,1,myofilament,CC,
1842,GO:0036464,1,0.870241843544685,0,1,cytoplasmic ribonucleoprotein granule,CC,
1843,GO:0036473,1,0.627020541116027,0,1,cell death in response to oxidative stress,BP,
1846,GO:0038023,1,0.358812520590591,0,4,signaling receptor activity,MF,
1851,GO:0038127,1,0.663098539838137,0,1,ERBB signaling pathway,BP,
1856,GO:0040013,1,0.665914602464021,0,1,negative regulation of locomotion,BP,
1857,GO:0040014,1,0.870241843544685,0,1,regulation of multicellular organism growth,BP,
1859,GO:0040018,1,0.870241843544685,0,1,positive regulation of multicellular organism growth,BP,
1860,GO:0042033,1,0.724891980148401,0,1,chemokine biosynthetic process,BP,
1861,GO:0042035,1,0.457903252618042,0,2,regulation of cytokine biosynthetic process,BP,
1862,GO:0042036,1,0.634036220511901,0,1,negative regulation of cytokine biosynthetic process,BP,
1863,GO:0042058,1,0.663098539838137,0,1,regulation of epidermal growth factor receptor signaling pathway,BP,
1864,GO:0042060,1,0.709472138872067,0,2,wound healing,BP,
1865,GO:0042063,1,0.403463461522066,0,2,gliogenesis,BP,
1866,GO:0042089,1,0.457903252618042,0,2,cytokine biosynthetic process,BP,
1868,GO:0042100,1,0.724891980148401,0,1,B cell proliferation,BP,
1871,GO:0042107,1,0.457903252618042,0,2,cytokine metabolic process,BP,
1872,GO:0042108,1,0.724891980148401,0,1,positive regulation of cytokine biosynthetic process,BP,
1874,GO:0042113,1,0.724891980148401,0,1,B cell activation,BP,
1875,GO:0042116,1,0.594461822516719,0,2,macrophage activation,BP,
1876,GO:0042119,1,0.0741061014299095,0,6,neutrophil activation,BP,
1883,GO:0042168,1,0.743039914117476,0,1,heme metabolic process,BP,
1887,GO:0042181,1,0.439461162925029,0,2,ketone biosynthetic process,BP,
1888,GO:0042219,1,0.775348239435331,0,1,cellular modified amino acid catabolic process,BP,
1891,GO:0042254,1,0.84997168064402,0,1,ribosome biogenesis,BP,
1892,GO:0042277,1,0.520704278273446,0,2,peptide binding,MF,
1893,GO:0042278,1,0.702529573849765,0,1,purine nucleoside metabolic process,BP,
1894,GO:0042301,1,0.702529573849765,0,1,phosphate ion binding,MF,
1895,GO:0042303,1,0.634036220511901,0,1,molting cycle,BP,
1897,GO:0042306,1,0.627020541116027,0,1,regulation of protein import into nucleus,BP,
1902,GO:0042339,1,0.66448681738129,0,1,keratan sulfate metabolic process,BP,
1903,GO:0042340,1,0.66448681738129,0,1,keratan sulfate catabolic process,BP,
1904,GO:0042345,1,0.627020541116027,0,1,regulation of NF-kappaB import into nucleus,BP,
1905,GO:0042348,1,0.627020541116027,0,1,NF-kappaB import into nucleus,BP,
1906,GO:0042359,1,0.669147371685357,0,1,vitamin D metabolic process,BP,
1907,GO:0042364,1,0.665914602464021,0,1,water-soluble vitamin biosynthetic process,BP,
1909,GO:0042383,1,0.570989159824297,0,1,sarcolemma,CC,
1910,GO:0042391,1,0.54294227948611,0,2,regulation of membrane potential,BP,
1911,GO:0042398,1,0.587992285191993,0,1,cellular modified amino acid biosynthetic process,BP,
1912,GO:0042402,1,0.775348239435331,0,1,cellular biogenic amine catabolic process,BP,
1913,GO:0042426,1,0.775348239435331,0,1,choline catabolic process,BP,
1914,GO:0042440,1,0.743039914117476,0,1,pigment metabolic process,BP,
1916,GO:0042446,1,0.0558949336788127,0,7,hormone biosynthetic process,BP,
1917,GO:0042447,1,0.662077425179723,0,1,hormone catabolic process,BP,
1918,GO:0042448,1,0.661785962438721,0,1,progesterone metabolic process,BP,
1919,GO:0042454,1,0.702529573849765,0,1,ribonucleoside catabolic process,BP,
1920,GO:0042493,1,0.0643973730135525,0,7,response to drug,BP,
1921,GO:0042503,1,0.870241843544685,0,1,tyrosine phosphorylation of Stat3 protein,BP,
1922,GO:0042506,1,0.870241843544685,0,1,tyrosine phosphorylation of Stat5 protein,BP,
1923,GO:0042509,1,0.870241843544685,0,1,regulation of tyrosine phosphorylation of STAT protein,BP,
1924,GO:0042516,1,0.870241843544685,0,1,regulation of tyrosine phosphorylation of Stat3 protein,BP,
1925,GO:0042517,1,0.870241843544685,0,1,positive regulation of tyrosine phosphorylation of Stat3 protein,BP,
1926,GO:0042522,1,0.870241843544685,0,1,regulation of tyrosine phosphorylation of Stat5 protein,BP,
1927,GO:0042523,1,0.870241843544685,0,1,positive regulation of tyrosine phosphorylation of Stat5 protein,BP,
1928,GO:0042531,1,0.870241843544685,0,1,positive regulation of tyrosine phosphorylation of STAT protein,BP,
1929,GO:0042537,1,0.722624588823278,0,1,benzene-containing compound metabolic process,BP,
1930,GO:0042542,1,0.722624588823278,0,1,response to hydrogen peroxide,BP,
1931,GO:0042552,1,0.66448681738129,0,1,myelination,BP,
1934,GO:0042562,1,0.870241843544685,0,1,hormone binding,MF,
1936,GO:0042578,1,0.370061959698986,0,2,phosphoric ester hydrolase activity,MF,
1938,GO:0042582,1,0.24488358065803,0,3,azurophil granule,CC,
1945,GO:0042627,1,0.56647063732246,0,1,chylomicron,CC,
1947,GO:0042633,1,0.634036220511901,0,1,hair cycle,BP,
1948,GO:0042634,1,0.634036220511901,0,1,regulation of hair cycle,BP,
1949,GO:0042635,1,0.634036220511901,0,1,positive regulation of hair cycle,BP,
1951,GO:0042698,1,0.599713716867655,0,1,ovulation cycle,BP,
1952,GO:0042726,1,0.641058516990934,0,1,flavin-containing compound metabolic process,BP,
1953,GO:0042742,1,0.594250321572963,0,1,defense response to bacterium,BP,
1954,GO:0042745,1,0.722624588823278,0,1,circadian sleep/wake cycle,BP,
1955,GO:0042747,1,0.722624588823278,0,1,circadian sleep/wake cycle, REM sleep,BP,
1956,GO:0042759,1,0.773435048011187,0,1,long-chain fatty acid biosynthetic process,BP,
1957,GO:0042761,1,0.773435048011187,0,1,very long-chain fatty acid biosynthetic process,BP,
1958,GO:0042762,1,0.809126620423613,0,1,regulation of sulfur metabolic process,BP,
1959,GO:0042771,1,0.594250321572963,0,1,intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator,BP,
1963,GO:0042816,1,0.9290546186658,0,1,vitamin B6 metabolic process,BP,
1965,GO:0042940,1,0.805141107601125,0,1,D-amino acid transport,BP,
1966,GO:0042976,1,0.870241843544685,0,1,activation of Janus kinase activity,BP,
1967,GO:0042977,1,0.870241843544685,0,1,activation of JAK2 kinase activity,BP,
1971,GO:0042990,1,0.627020541116027,0,1,regulation of transcription factor import into nucleus,BP,
1972,GO:0042991,1,0.627020541116027,0,1,transcription factor import into nucleus,BP,
1977,GO:0043014,1,0.832354421897545,0,1,alpha-tubulin binding,MF,
1978,GO:0043021,1,0.84997168064402,0,1,ribonucleoprotein complex binding,MF,
1979,GO:0043025,1,0.135537164283188,0,5,neuronal cell body,CC,
1980,GO:0043027,1,0.627020541116027,0,1,cysteine-type endopeptidase inhibitor activity involved in apoptotic process,MF,
1981,GO:0043028,1,0.370515326336158,0,2,cysteine-type endopeptidase regulator activity involved in apoptotic process,MF,
1983,GO:0043030,1,0.821650549135252,0,1,regulation of macrophage activation,BP,
1993,GO:0043090,1,0.805141107601125,0,1,amino acid import,BP,
1994,GO:0043092,1,0.805141107601125,0,1,L-amino acid import,BP,
1995,GO:0043094,1,0.531156155360391,0,2,cellular metabolic compound salvage,BP,
1996,GO:0043101,1,0.702529573849765,0,1,purine-containing compound salvage,BP,
1997,GO:0043102,1,0.758087612472411,0,1,amino acid salvage,BP,
2000,GO:0043124,1,0.594250321572963,0,1,negative regulation of I-kappaB kinase/NF-kappaB signaling,BP,
2001,GO:0043154,1,0.627020541116027,0,1,negative regulation of cysteine-type endopeptidase activity involved in apoptotic process,BP,
2007,GO:0043177,1,0.174580182301854,0,4,organic acid binding,MF,
2011,GO:0043209,1,0.619534857753294,0,1,myelin sheath,CC,
2023,GO:0043242,1,0.623232303978104,0,1,negative regulation of protein complex disassembly,BP,
2024,GO:0043244,1,0.623232303978104,0,1,regulation of protein complex disassembly,BP,
2026,GO:0043269,1,0.24514468681155,0,3,regulation of ion transport,BP,
2027,GO:0043270,1,0.378200365412608,0,2,positive regulation of ion transport,BP,
2028,GO:0043276,1,0.809126620423613,0,1,anoikis,BP,
2033,GO:0043292,1,0.623232303978104,0,1,contractile fiber,CC,
2034,GO:0043299,1,0.0741061014299095,0,6,leukocyte degranulation,BP,
2035,GO:0043312,1,0.0741061014299095,0,6,neutrophil degranulation,BP,
2036,GO:0043330,1,0.724891980148401,0,1,response to exogenous dsRNA,BP,
2037,GO:0043331,1,0.724891980148401,0,1,response to dsRNA,BP,
2038,GO:0043393,1,0.434296551820856,0,2,regulation of protein binding,BP,
2046,GO:0043433,1,0.594250321572963,0,1,negative regulation of sequence-specific DNA binding transcription factor activity,BP,
2047,GO:0043434,1,0.257447524930029,0,5,response to peptide hormone,BP,
2049,GO:0043462,1,0.665914602464021,0,1,regulation of ATPase activity,BP,
2052,GO:0043491,1,0.832354421897545,0,1,protein kinase B signaling,BP,
2054,GO:0043496,1,0.434296551820856,0,2,regulation of protein homodimerization activity,BP,
2055,GO:0043500,1,0.627020541116027,0,1,muscle adaptation,BP,
2056,GO:0043502,1,0.627020541116027,0,1,regulation of muscle adaptation,BP,
2057,GO:0043523,1,0.722624588823278,0,1,regulation of neuron apoptotic process,BP,
2058,GO:0043524,1,0.722624588823278,0,1,negative regulation of neuron apoptotic process,BP,
2061,GO:0043546,1,0.9290546186658,0,1,molybdopterin cofactor binding,MF,
2068,GO:0043615,1,0.66448681738129,0,1,astrocyte cell migration,BP,
2071,GO:0043623,1,0.21825284757342,0,3,cellular protein complex assembly,BP,
2073,GO:0043627,1,0.722624588823278,0,1,response to estrogen,BP,
2075,GO:0043648,1,0.135328798927545,0,6,dicarboxylic acid metabolic process,BP,
2076,GO:0043650,1,0.805141107601125,0,1,dicarboxylic acid biosynthetic process,BP,
2077,GO:0043651,1,0.875695093721025,0,1,linoleic acid metabolic process,BP,
2078,GO:0043666,1,0.665914602464021,0,1,regulation of phosphoprotein phosphatase activity,BP,
2081,GO:0043900,1,0.84997168064402,0,1,regulation of multi-organism process,BP,
2082,GO:0043901,1,0.84997168064402,0,1,negative regulation of multi-organism process,BP,
2083,GO:0043903,1,0.84997168064402,0,1,regulation of symbiosis, encompassing mutualism through parasitism,BP,
2085,GO:0044057,1,0.355880293265607,0,2,regulation of system process,BP,
2105,GO:0044262,1,0.252605654020338,0,4,cellular carbohydrate metabolic process,BP,
2116,GO:0044321,1,0.722624588823278,0,1,response to leptin,BP,
2117,GO:0044325,1,0.570989159824297,0,1,ion channel binding,MF,
2119,GO:0044351,1,0.594250321572963,0,1,macropinocytosis,BP,
2120,GO:0044381,1,0.84997168064402,0,1,glucose import in response to insulin stimulus,BP,
2124,GO:0044420,1,0.599713716867655,0,1,extracellular matrix component,CC,
2142,GO:0044449,1,0.623232303978104,0,1,contractile fiber part,CC,
2144,GO:0044452,1,0.758087612472411,0,1,nucleolar part,CC,
2146,GO:0044456,1,0.952324910776072,0,1,synapse part,CC,
2148,GO:0044463,1,0.599713716867655,0,1,cell projection part,CC,
2150,GO:0044539,1,0.607633118676714,0,1,long-chain fatty acid import,BP,
2151,GO:0044548,1,0.610116362596827,0,1,S100 protein binding,MF,
2152,GO:0044550,1,0.743039914117476,0,1,secondary metabolite biosynthetic process,BP,
2156,GO:0044703,1,0.261651310077016,0,3,multi-organism reproductive process,BP,
2157,GO:0044706,1,0.66448681738129,0,1,multi-multicellular organism process,BP,
2164,GO:0044724,1,0.412759765051976,0,2,single-organism carbohydrate catabolic process,BP,
2165,GO:0044744,1,0.627020541116027,0,1,protein targeting to nucleus,BP,
2177,GO:0045019,1,0.417440256616709,0,2,negative regulation of nitric oxide biosynthetic process,BP,
2178,GO:0045028,1,0.715549453301239,0,1,G-protein coupled purinergic nucleotide receptor activity,MF,
2179,GO:0045029,1,0.715549453301239,0,1,UDP-activated nucleotide receptor activity,MF,
2180,GO:0045055,1,0.0518739633626835,0,7,regulated exocytosis,BP,
2181,GO:0045069,1,0.84997168064402,0,1,regulation of viral genome replication,BP,
2182,GO:0045071,1,0.84997168064402,0,1,negative regulation of viral genome replication,BP,
2183,GO:0045073,1,0.724891980148401,0,1,regulation of chemokine biosynthetic process,BP,
2184,GO:0045080,1,0.724891980148401,0,1,positive regulation of chemokine biosynthetic process,BP,
2191,GO:0045124,1,0.809126620423613,0,1,regulation of bone resorption,BP,
2192,GO:0045137,1,0.298213105951193,0,3,development of primary sexual characteristics,BP,
2195,GO:0045211,1,0.952324910776072,0,1,postsynaptic membrane,CC,
2196,GO:0045216,1,0.599713716867655,0,1,cell-cell junction organization,BP,
2198,GO:0045296,1,0.69629877231865,0,1,cadherin binding,MF,
2201,GO:0045349,1,0.634036220511901,0,1,interferon-alpha biosynthetic process,BP,
2202,GO:0045350,1,0.457903252618042,0,2,interferon-beta biosynthetic process,BP,
2203,GO:0045351,1,0.457903252618042,0,2,type I interferon biosynthetic process,BP,
2204,GO:0045354,1,0.634036220511901,0,1,regulation of interferon-alpha biosynthetic process,BP,
2205,GO:0045355,1,0.634036220511901,0,1,negative regulation of interferon-alpha biosynthetic process,BP,
2206,GO:0045357,1,0.457903252618042,0,2,regulation of interferon-beta biosynthetic process,BP,
2207,GO:0045358,1,0.634036220511901,0,1,negative regulation of interferon-beta biosynthetic process,BP,
2208,GO:0045359,1,0.724891980148401,0,1,positive regulation of interferon-beta biosynthetic process,BP,
2209,GO:0045428,1,0.300423143349393,0,3,regulation of nitric oxide biosynthetic process,BP,
2210,GO:0045429,1,0.724891980148401,0,1,positive regulation of nitric oxide biosynthetic process,BP,
2212,GO:0045453,1,0.809126620423613,0,1,bone resorption,BP,
2214,GO:0045485,1,0.875695093721025,0,1,omega-6 fatty acid desaturase activity,MF,
2217,GO:0045580,1,0.702529573849765,0,1,regulation of T cell differentiation,BP,
2218,GO:0045582,1,0.702529573849765,0,1,positive regulation of T cell differentiation,BP,
2222,GO:0045619,1,0.702529573849765,0,1,regulation of lymphocyte differentiation,BP,
2223,GO:0045621,1,0.702529573849765,0,1,positive regulation of lymphocyte differentiation,BP,
2230,GO:0045682,1,0.634036220511901,0,1,regulation of epidermis development,BP,
2231,GO:0045684,1,0.634036220511901,0,1,positive regulation of epidermis development,BP,
2233,GO:0045723,1,0.665914602464021,0,1,positive regulation of fatty acid biosynthetic process,BP,
2234,GO:0045727,1,0.730169690081196,0,1,positive regulation of translation,BP,
2236,GO:0045742,1,0.663098539838137,0,1,positive regulation of epidermal growth factor receptor signaling pathway,BP,
2237,GO:0045744,1,0.7161003501605,0,1,negative regulation of G-protein coupled receptor protein signaling pathway,BP,
2241,GO:0045806,1,0.56647063732246,0,1,negative regulation of endocytosis,BP,
2242,GO:0045807,1,0.594250321572963,0,1,positive regulation of endocytosis,BP,
2243,GO:0045824,1,0.634036220511901,0,1,negative regulation of innate immune response,BP,
2249,GO:0045861,1,0.444562996116742,0,2,negative regulation of proteolysis,BP,
2251,GO:0045892,1,0.578471336067372,0,1,negative regulation of transcription, DNA-templated,BP,
2253,GO:0045913,1,0.665914602464021,0,1,positive regulation of carbohydrate metabolic process,BP,
2255,GO:0045923,1,0.665914602464021,0,1,positive regulation of fatty acid metabolic process,BP,
2257,GO:0045927,1,0.870241843544685,0,1,positive regulation of growth,BP,
2259,GO:0045934,1,0.383197636779896,0,2,negative regulation of nucleobase-containing compound metabolic process,BP,
2265,GO:0045981,1,0.588770978581337,0,1,positive regulation of nucleotide metabolic process,BP,
2267,GO:0046058,1,0.588770978581337,0,1,cAMP metabolic process,BP,
2268,GO:0046102,1,0.702529573849765,0,1,inosine metabolic process,BP,
2269,GO:0046110,1,0.9290546186658,0,1,xanthine metabolic process,BP,
2270,GO:0046113,1,0.9290546186658,0,1,nucleobase catabolic process,BP,
2271,GO:0046121,1,0.651376974684416,0,1,deoxyribonucleoside catabolic process,BP,
2272,GO:0046128,1,0.702529573849765,0,1,purine ribonucleoside metabolic process,BP,
2273,GO:0046130,1,0.702529573849765,0,1,purine ribonucleoside catabolic process,BP,
2276,GO:0046209,1,0.300423143349393,0,3,nitric oxide metabolic process,BP,
2280,GO:0046324,1,0.84997168064402,0,1,regulation of glucose import,BP,
2281,GO:0046326,1,0.84997168064402,0,1,positive regulation of glucose import,BP,
2282,GO:0046328,1,0.594250321572963,0,1,regulation of JNK cascade,BP,
2283,GO:0046330,1,0.594250321572963,0,1,positive regulation of JNK cascade,BP,
2284,GO:0046339,1,0.599713716867655,0,1,diacylglycerol metabolic process,BP,
2287,GO:0046365,1,0.624056902858297,0,1,monosaccharide catabolic process,BP,
2288,GO:0046386,1,0.651376974684416,0,1,deoxyribose phosphate catabolic process,BP,
2292,GO:0046415,1,0.702529573849765,0,1,urate metabolic process,BP,
2293,GO:0046425,1,0.870241843544685,0,1,regulation of JAK-STAT cascade,BP,
2294,GO:0046427,1,0.870241843544685,0,1,positive regulation of JAK-STAT cascade,BP,
2296,GO:0046449,1,0.870241843544685,0,1,creatinine metabolic process,BP,
2297,GO:0046456,1,0.513718623263497,0,2,icosanoid biosynthetic process,BP,
2298,GO:0046460,1,0.397388064236748,0,2,neutral lipid biosynthetic process,BP,
2299,GO:0046461,1,0.607633118676714,0,1,neutral lipid catabolic process,BP,
2300,GO:0046463,1,0.397388064236748,0,2,acylglycerol biosynthetic process,BP,
2301,GO:0046464,1,0.607633118676714,0,1,acylglycerol catabolic process,BP,
2302,GO:0046466,1,0.416537021892388,0,2,membrane lipid catabolic process,BP,
2306,GO:0046475,1,0.56647063732246,0,1,glycerophospholipid catabolic process,BP,
2307,GO:0046477,1,0.629720466056481,0,1,glycosylceramide catabolic process,BP,
2308,GO:0046479,1,0.416537021892388,0,2,glycosphingolipid catabolic process,BP,
2312,GO:0046487,1,0.69629877231865,0,1,glyoxylate metabolic process,BP,
2314,GO:0046495,1,0.702529573849765,0,1,nicotinamide riboside metabolic process,BP,
2315,GO:0046496,1,0.0983323875545709,0,6,nicotinamide nucleotide metabolic process,BP,
2316,GO:0046503,1,0.342005043138806,0,2,glycerolipid catabolic process,BP,
2317,GO:0046514,1,0.416537021892388,0,2,ceramide catabolic process,BP,
2318,GO:0046523,1,0.758087612472411,0,1,S-methyl-5-thioribose-1-phosphate isomerase activity,MF,
2320,GO:0046545,1,0.415704624109769,0,2,development of primary female sexual characteristics,BP,
2321,GO:0046546,1,0.722624588823278,0,1,development of primary male sexual characteristics,BP,
2322,GO:0046573,1,0.645095410017529,0,1,lactonohydrolase activity,MF,
2325,GO:0046631,1,0.702529573849765,0,1,alpha-beta T cell activation,BP,
2326,GO:0046632,1,0.702529573849765,0,1,alpha-beta T cell differentiation,BP,
2327,GO:0046634,1,0.702529573849765,0,1,regulation of alpha-beta T cell activation,BP,
2328,GO:0046635,1,0.702529573849765,0,1,positive regulation of alpha-beta T cell activation,BP,
2329,GO:0046637,1,0.702529573849765,0,1,regulation of alpha-beta T cell differentiation,BP,
2330,GO:0046638,1,0.702529573849765,0,1,positive regulation of alpha-beta T cell differentiation,BP,
2334,GO:0046661,1,0.439461162925029,0,2,male sex differentiation,BP,
2335,GO:0046677,1,0.580604496498539,0,2,response to antibiotic,BP,
2336,GO:0046683,1,0.722624588823278,0,1,response to organophosphorus,BP,
2337,GO:0046686,1,0.424098915738386,0,2,response to cadmium ion,BP,
2339,GO:0046717,1,0.805141107601125,0,1,acid secretion,BP,
2340,GO:0046822,1,0.360587210552112,0,2,regulation of nucleocytoplasmic transport,BP,
2341,GO:0046825,1,0.578471336067372,0,1,regulation of protein export from nucleus,BP,
2343,GO:0046849,1,0.809126620423613,0,1,bone remodeling,BP,
2344,GO:0046850,1,0.809126620423613,0,1,regulation of bone remodeling,BP,
2349,GO:0046873,1,0.525687260325734,0,2,metal ion transmembrane transporter activity,MF,
2355,GO:0046902,1,0.627020541116027,0,1,regulation of mitochondrial membrane permeability,BP,
2357,GO:0046906,1,0.257273381457385,0,3,tetrapyrrole binding,MF,
2360,GO:0046915,1,0.654612357040219,0,1,transition metal ion transmembrane transporter activity,MF,
2361,GO:0046916,1,0.654612357040219,0,1,cellular transition metal ion homeostasis,BP,
2363,GO:0046942,1,0.367165912202571,0,3,carboxylic acid transport,BP,
2364,GO:0046943,1,0.805141107601125,0,1,carboxylic acid transmembrane transporter activity,MF,
2365,GO:0046949,1,0.532244306476539,0,2,fatty-acyl-CoA biosynthetic process,BP,
2371,GO:0046997,1,0.775348239435331,0,1,oxidoreductase activity, acting on the CH-NH group of donors, flavin as acceptor,MF,
2372,GO:0047015,1,0.597964029711571,0,1,3-hydroxy-2-methylbutyryl-CoA dehydrogenase activity,MF,
2373,GO:0047035,1,0.610587287681345,0,1,testosterone dehydrogenase (NAD+) activity,MF,
2374,GO:0047045,1,0.610587287681345,0,1,testosterone 17-beta-dehydrogenase (NADP+) activity,MF,
2375,GO:0047442,1,0.661785962438721,0,1,17-alpha-hydroxyprogesterone aldolase activity,MF,
2376,GO:0047598,1,0.721434029227987,0,1,7-dehydrocholesterol reductase activity,MF,
2377,GO:0047750,1,0.61159761771495,0,1,cholestenol delta-isomerase activity,MF,
2378,GO:0047760,1,0.703379952013767,0,1,butyrate-CoA ligase activity,MF,
2379,GO:0047860,1,0.619534857753294,0,1,diiodophenylpyruvate reductase activity,MF,
2381,GO:0048009,1,0.870241843544685,0,1,insulin-like growth factor receptor signaling pathway,BP,
2386,GO:0048029,1,0.646945096935322,0,1,monosaccharide binding,MF,
2394,GO:0048156,1,0.610116362596827,0,1,tau protein binding,MF,
2395,GO:0048167,1,0.439119860050815,0,2,regulation of synaptic plasticity,BP,
2396,GO:0048168,1,0.439119860050815,0,2,regulation of neuronal synaptic plasticity,BP,
2398,GO:0048232,1,0.665914602464021,0,1,male gamete generation,BP,
2399,GO:0048244,1,0.646945096935322,0,1,phytanoyl-CoA dioxygenase activity,MF,
2400,GO:0048259,1,0.56647063732246,0,1,regulation of receptor-mediated endocytosis,BP,
2401,GO:0048261,1,0.56647063732246,0,1,negative regulation of receptor-mediated endocytosis,BP,
2404,GO:0048306,1,0.610116362596827,0,1,calcium-dependent protein binding,MF,
2406,GO:0048469,1,0.599713716867655,0,1,cell maturation,BP,
2408,GO:0048477,1,0.39652754739021,0,2,oogenesis,BP,
2409,GO:0048511,1,0.431581008649135,0,2,rhythmic process,BP,
2410,GO:0048512,1,0.722624588823278,0,1,circadian behavior,BP,
2417,GO:0048525,1,0.84997168064402,0,1,negative regulation of viral process,BP,
2422,GO:0048545,1,0.303462340441845,0,3,response to steroid hormone,BP,
2432,GO:0048599,1,0.599713716867655,0,1,oocyte development,BP,
2434,GO:0048609,1,0.261651310077016,0,3,multicellular organismal reproductive process,BP,
2438,GO:0048639,1,0.870241843544685,0,1,positive regulation of developmental growth,BP,
2440,GO:0048641,1,0.610116362596827,0,1,regulation of skeletal muscle tissue development,BP,
2441,GO:0048642,1,0.610116362596827,0,1,negative regulation of skeletal muscle tissue development,BP,
2443,GO:0048659,1,0.599713716867655,0,1,smooth muscle cell proliferation,BP,
2444,GO:0048660,1,0.599713716867655,0,1,regulation of smooth muscle cell proliferation,BP,
2445,GO:0048662,1,0.599713716867655,0,1,negative regulation of smooth muscle cell proliferation,BP,
2451,GO:0048708,1,0.610116362596827,0,1,astrocyte differentiation,BP,
2456,GO:0048771,1,0.505931170636085,0,2,tissue remodeling,BP,
2467,GO:0050277,1,0.821650549135252,0,1,sedoheptulokinase activity,MF,
2468,GO:0050508,1,0.837849573162783,0,1,glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity,MF,
2469,GO:0050543,1,0.607633118676714,0,1,icosatetraenoic acid binding,MF,
2470,GO:0050654,1,0.453908529716914,0,2,chondroitin sulfate proteoglycan metabolic process,BP,
2471,GO:0050655,1,0.685732886781739,0,1,dermatan sulfate proteoglycan metabolic process,BP,
2475,GO:0050663,1,0.415612183063192,0,2,cytokine secretion,BP,
2478,GO:0050673,1,0.397388064236748,0,2,epithelial cell proliferation,BP,
2479,GO:0050678,1,0.397388064236748,0,2,regulation of epithelial cell proliferation,BP,
2480,GO:0050679,1,0.599713716867655,0,1,positive regulation of epithelial cell proliferation,BP,
2481,GO:0050680,1,0.665914602464021,0,1,negative regulation of epithelial cell proliferation,BP,
2482,GO:0050699,1,0.612204605232657,0,1,WW domain binding,MF,
2483,GO:0050701,1,0.594250321572963,0,1,interleukin-1 secretion,BP,
2484,GO:0050702,1,0.594250321572963,0,1,interleukin-1 beta secretion,BP,
2485,GO:0050704,1,0.594250321572963,0,1,regulation of interleukin-1 secretion,BP,
2486,GO:0050706,1,0.594250321572963,0,1,regulation of interleukin-1 beta secretion,BP,
2487,GO:0050707,1,0.594250321572963,0,1,regulation of cytokine secretion,BP,
2490,GO:0050715,1,0.594250321572963,0,1,positive regulation of cytokine secretion,BP,
2491,GO:0050716,1,0.594250321572963,0,1,positive regulation of interleukin-1 secretion,BP,
2492,GO:0050718,1,0.594250321572963,0,1,positive regulation of interleukin-1 beta secretion,BP,
2493,GO:0050727,1,0.365878756007525,0,3,regulation of inflammatory response,BP,
2494,GO:0050730,1,0.870241843544685,0,1,regulation of peptidyl-tyrosine phosphorylation,BP,
2495,GO:0050731,1,0.870241843544685,0,1,positive regulation of peptidyl-tyrosine phosphorylation,BP,
2496,GO:0050755,1,0.724891980148401,0,1,chemokine metabolic process,BP,
2497,GO:0050764,1,0.594250321572963,0,1,regulation of phagocytosis,BP,
2498,GO:0050766,1,0.594250321572963,0,1,positive regulation of phagocytosis,BP,
2501,GO:0050769,1,0.722624588823278,0,1,positive regulation of neurogenesis,BP,
2505,GO:0050777,1,0.634036220511901,0,1,negative regulation of immune response,BP,
2507,GO:0050786,1,0.610116362596827,0,1,RAGE receptor binding,MF,
2510,GO:0050792,1,0.84997168064402,0,1,regulation of viral process,BP,
2516,GO:0050802,1,0.722624588823278,0,1,circadian sleep/wake cycle, sleep,BP,
2518,GO:0050806,1,0.489774297889947,0,2,positive regulation of synaptic transmission,BP,
2520,GO:0050812,1,0.809126620423613,0,1,regulation of acyl-CoA biosynthetic process,BP,
2521,GO:0050817,1,0.709472138872067,0,2,coagulation,BP,
2522,GO:0050818,1,0.997322300088831,0,1,regulation of coagulation,BP,
2524,GO:0050829,1,0.594250321572963,0,1,defense response to Gram-negative bacterium,BP,
2525,GO:0050839,1,0.69629877231865,0,1,cell adhesion molecule binding,MF,
2526,GO:0050848,1,0.665914602464021,0,1,regulation of calcium-mediated signaling,BP,
2530,GO:0050864,1,0.724891980148401,0,1,regulation of B cell activation,BP,
2534,GO:0050871,1,0.724891980148401,0,1,positive regulation of B cell activation,BP,
2537,GO:0050878,1,0.709472138872067,0,2,regulation of body fluid levels,BP,
2538,GO:0050885,1,0.53365873865094,0,2,neuromuscular process controlling balance,BP,
2539,GO:0050890,1,0.610116362596827,0,1,cognition,BP,
2542,GO:0050905,1,0.53365873865094,0,2,neuromuscular process,BP,
2546,GO:0050954,1,0.53365873865094,0,2,sensory perception of mechanical stimulus,BP,
2547,GO:0050994,1,0.392491925960108,0,2,regulation of lipid catabolic process,BP,
2548,GO:0050995,1,0.56647063732246,0,1,negative regulation of lipid catabolic process,BP,
2549,GO:0050997,1,0.56647063732246,0,1,quaternary ammonium group binding,MF,
2551,GO:0051001,1,0.629720466056481,0,1,negative regulation of nitric-oxide synthase activity,BP,
2552,GO:0051004,1,0.56647063732246,0,1,regulation of lipoprotein lipase activity,BP,
2553,GO:0051005,1,0.56647063732246,0,1,negative regulation of lipoprotein lipase activity,BP,
2554,GO:0051015,1,0.623232303978104,0,1,actin filament binding,MF,
2562,GO:0051051,1,0.56647063732246,0,1,negative regulation of transport,BP,
2563,GO:0051052,1,0.665914602464021,0,1,regulation of DNA metabolic process,BP,
2564,GO:0051053,1,0.665914602464021,0,1,negative regulation of DNA metabolic process,BP,
2566,GO:0051090,1,0.269462945980164,0,3,regulation of sequence-specific DNA binding transcription factor activity,BP,
2567,GO:0051091,1,0.269462945980164,0,3,positive regulation of sequence-specific DNA binding transcription factor activity,BP,
2568,GO:0051092,1,0.269462945980164,0,3,positive regulation of NF-kappaB transcription factor activity,BP,
2571,GO:0051098,1,0.434296551820856,0,2,regulation of binding,BP,
2572,GO:0051099,1,0.724891980148401,0,1,positive regulation of binding,BP,
2576,GO:0051156,1,0.533894405836112,0,2,glucose 6-phosphate metabolic process,BP,
2577,GO:0051168,1,0.578471336067372,0,1,nuclear export,BP,
2578,GO:0051169,1,0.360587210552112,0,2,nuclear transport,BP,
2579,GO:0051170,1,0.627020541116027,0,1,nuclear import,BP,
2581,GO:0051172,1,0.0777118951231556,0,5,negative regulation of nitrogen compound metabolic process,BP,
2589,GO:0051193,1,0.809126620423613,0,1,regulation of cofactor metabolic process,BP,
2590,GO:0051196,1,0.809126620423613,0,1,regulation of coenzyme metabolic process,BP,
2591,GO:0051208,1,0.627020541116027,0,1,sequestering of calcium ion,BP,
2592,GO:0051209,1,0.627020541116027,0,1,release of sequestered calcium ion into cytosol,BP,
2593,GO:0051213,1,0.646945096935322,0,1,dioxygenase activity,MF,
2599,GO:0051238,1,0.627020541116027,0,1,sequestering of metal ion,BP,
2609,GO:0051253,1,0.383197636779896,0,2,negative regulation of RNA metabolic process,BP,
2611,GO:0051258,1,0.21825284757342,0,3,protein polymerization,BP,
2614,GO:0051261,1,0.623232303978104,0,1,protein depolymerization,BP,
2617,GO:0051271,1,0.665914602464021,0,1,negative regulation of cellular component movement,BP,
2619,GO:0051282,1,0.627020541116027,0,1,regulation of sequestering of calcium ion,BP,
2620,GO:0051283,1,0.627020541116027,0,1,negative regulation of sequestering of calcium ion,BP,
2621,GO:0051287,1,0.29344687252693,0,4,NAD binding,MF,
2623,GO:0051291,1,0.37935943284686,0,2,protein heterooligomerization,BP,
2626,GO:0051340,1,0.665914602464021,0,1,regulation of ligase activity,BP,
2628,GO:0051342,1,0.665914602464021,0,1,regulation of cyclic-nucleotide phosphodiesterase activity,BP,
2629,GO:0051344,1,0.665914602464021,0,1,negative regulation of cyclic-nucleotide phosphodiesterase activity,BP,
2631,GO:0051346,1,0.163609704987404,0,4,negative regulation of hydrolase activity,BP,
2634,GO:0051352,1,0.665914602464021,0,1,negative regulation of ligase activity,BP,
2635,GO:0051353,1,0.665914602464021,0,1,positive regulation of oxidoreductase activity,BP,
2636,GO:0051354,1,0.629720466056481,0,1,negative regulation of oxidoreductase activity,BP,
2637,GO:0051384,1,0.439119860050815,0,2,response to glucocorticoid,BP,
2638,GO:0051385,1,0.722624588823278,0,1,response to mineralocorticoid,BP,
2640,GO:0051403,1,0.594250321572963,0,1,stress-activated MAPK cascade,BP,
2641,GO:0051412,1,0.722624588823278,0,1,response to corticosterone,BP,
2648,GO:0051480,1,0.627020541116027,0,1,regulation of cytosolic calcium ion concentration,BP,
2649,GO:0051493,1,0.368254216500185,0,2,regulation of cytoskeleton organization,BP,
2650,GO:0051494,1,0.623232303978104,0,1,negative regulation of cytoskeleton organization,BP,
2651,GO:0051495,1,0.594250321572963,0,1,positive regulation of cytoskeleton organization,BP,
2653,GO:0051537,1,0.9290546186658,0,1,2 iron, 2 sulfur cluster binding,MF,
2656,GO:0051591,1,0.722624588823278,0,1,response to cAMP,BP,
2657,GO:0051597,1,0.610116362596827,0,1,response to methylmercury,BP,
2665,GO:0051693,1,0.623232303978104,0,1,actin filament capping,BP,
2666,GO:0051694,1,0.623232303978104,0,1,pointed-end actin filament capping,BP,
2671,GO:0051797,1,0.634036220511901,0,1,regulation of hair follicle development,BP,
2672,GO:0051798,1,0.634036220511901,0,1,positive regulation of hair follicle development,BP,
2673,GO:0051896,1,0.832354421897545,0,1,regulation of protein kinase B signaling,BP,
2674,GO:0051897,1,0.832354421897545,0,1,positive regulation of protein kinase B signaling,BP,
2675,GO:0051924,1,0.665914602464021,0,1,regulation of calcium ion transport,BP,
2676,GO:0051928,1,0.665914602464021,0,1,positive regulation of calcium ion transport,BP,
2677,GO:0051938,1,0.805141107601125,0,1,L-glutamate import,BP,
2680,GO:0051962,1,0.722624588823278,0,1,positive regulation of nervous system development,BP,
2681,GO:0051990,1,0.69629877231865,0,1,(R)-2-hydroxyglutarate dehydrogenase activity,MF,
2684,GO:0052652,1,0.588770978581337,0,1,cyclic purine nucleotide metabolic process,BP,
2686,GO:0052692,1,0.629720466056481,0,1,raffinose alpha-galactosidase activity,MF,
2697,GO:0055065,1,0.129599595414226,0,5,metal ion homeostasis,BP,
2698,GO:0055067,1,0.809126620423613,0,1,monovalent inorganic cation homeostasis,BP,
2699,GO:0055070,1,0.654612357040219,0,1,copper ion homeostasis,BP,
2700,GO:0055072,1,0.743039914117476,0,1,iron ion homeostasis,BP,
2701,GO:0055074,1,0.273769155258206,0,3,calcium ion homeostasis,BP,
2702,GO:0055076,1,0.484808562584338,0,2,transition metal ion homeostasis,BP,
2703,GO:0055080,1,0.103533116489244,0,6,cation homeostasis,BP,
2705,GO:0055082,1,0.12591514670393,0,5,cellular chemical homeostasis,BP,
2713,GO:0055102,1,0.56647063732246,0,1,lipase inhibitor activity,MF,
2720,GO:0060047,1,0.570989159824297,0,1,heart contraction,BP,
2726,GO:0060078,1,0.952324910776072,0,1,regulation of postsynaptic membrane potential,BP,
2727,GO:0060079,1,0.952324910776072,0,1,excitatory postsynaptic potential,BP,
2728,GO:0060089,1,0.358812520590591,0,4,molecular transducer activity,MF,
2729,GO:0060090,1,0.634036220511901,0,1,binding, bridging,MF,
2731,GO:0060179,1,0.66448681738129,0,1,male mating behavior,BP,
2732,GO:0060191,1,0.337499347144934,0,2,regulation of lipase activity,BP,
2733,GO:0060192,1,0.56647063732246,0,1,negative regulation of lipase activity,BP,
2734,GO:0060193,1,0.599713716867655,0,1,positive regulation of lipase activity,BP,
2735,GO:0060205,1,0.0741061014299095,0,6,cytoplasmic vesicle lumen,CC,
2736,GO:0060228,1,0.56647063732246,0,1,phosphatidylcholine-sterol O-acyltransferase activator activity,MF,
2742,GO:0060291,1,0.610116362596827,0,1,long-term synaptic potentiation,BP,
2749,GO:0060341,1,0.360587210552112,0,2,regulation of cellular localization,BP,
2756,GO:0060396,1,0.870241843544685,0,1,growth hormone receptor signaling pathway,BP,
2757,GO:0060397,1,0.870241843544685,0,1,JAK-STAT cascade involved in growth hormone signaling pathway,BP,
2758,GO:0060401,1,0.627020541116027,0,1,cytosolic calcium ion transport,BP,
2759,GO:0060402,1,0.627020541116027,0,1,calcium ion transport into cytosol,BP,
2760,GO:0060416,1,0.627888728144946,0,2,response to growth hormone,BP,
2764,GO:0060491,1,0.832354421897545,0,1,regulation of cell projection assembly,BP,
2766,GO:0060538,1,0.610116362596827,0,1,skeletal muscle organ development,BP,
2775,GO:0060696,1,0.392491925960108,0,2,regulation of phospholipid catabolic process,BP,
2778,GO:0060761,1,0.627020541116027,0,1,negative regulation of response to cytokine stimulus,BP,
2780,GO:0060992,1,0.722624588823278,0,1,response to fungicide,BP,
2786,GO:0061041,1,0.997322300088831,0,1,regulation of wound healing,BP,
2789,GO:0061134,1,0.261533780820169,0,3,peptidase regulator activity,MF,
2790,GO:0061135,1,0.444562996116742,0,2,endopeptidase regulator activity,MF,
2792,GO:0061337,1,0.570989159824297,0,1,cardiac conduction,BP,
2793,GO:0061370,1,0.439461162925029,0,2,testosterone biosynthetic process,BP,
2800,GO:0061695,1,0.594250321572963,0,1,transferase complex, transferring phosphorus-containing groups,CC,
2801,GO:0061702,1,0.368520729438144,0,2,inflammasome complex,CC,
2803,GO:0065005,1,0.56647063732246,0,1,protein-lipid complex assembly,BP,
2810,GO:0070059,1,0.623678828523659,0,1,intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress,BP,
2812,GO:0070064,1,0.870241843544685,0,1,proline-rich region binding,MF,
2818,GO:0070195,1,0.870241843544685,0,1,growth hormone receptor complex,CC,
2832,GO:0070279,1,0.673840088392218,0,1,vitamin B6 binding,MF,
2834,GO:0070296,1,0.627020541116027,0,1,sarcoplasmic reticulum calcium ion transport,BP,
2835,GO:0070302,1,0.594250321572963,0,1,regulation of stress-activated protein kinase signaling cascade,BP,
2836,GO:0070304,1,0.594250321572963,0,1,positive regulation of stress-activated protein kinase signaling cascade,BP,
2841,GO:0070405,1,0.56647063732246,0,1,ammonium ion binding,MF,
2843,GO:0070509,1,0.627020541116027,0,1,calcium ion import,BP,
2844,GO:0070513,1,0.634036220511901,0,1,death domain binding,MF,
2846,GO:0070538,1,0.607633118676714,0,1,oleic acid binding,MF,
2847,GO:0070542,1,0.490208469702314,0,2,response to fatty acid,BP,
2848,GO:0070555,1,0.421165540245385,0,2,response to interleukin-1,BP,
2849,GO:0070569,1,0.624056902858297,0,1,uridylyltransferase activity,MF,
2850,GO:0070588,1,0.4156356908576,0,2,calcium ion transmembrane transport,BP,
2851,GO:0070613,1,0.449797616968255,0,2,regulation of protein processing,BP,
2852,GO:0070637,1,0.702529573849765,0,1,pyridine nucleoside metabolic process,BP,
2853,GO:0070638,1,0.702529573849765,0,1,pyridine nucleoside catabolic process,BP,
2859,GO:0070670,1,0.821650549135252,0,1,response to interleukin-4,BP,
2860,GO:0070696,1,0.594250321572963,0,1,transmembrane receptor protein serine/threonine kinase binding,MF,
2861,GO:0070700,1,0.594250321572963,0,1,BMP receptor binding,MF,
2862,GO:0070704,1,0.875695093721025,0,1,sterol desaturase activity,MF,
2864,GO:0070742,1,0.962487671625505,0,1,C2H2 zinc finger domain binding,MF,
2865,GO:0070777,1,0.805141107601125,0,1,D-aspartate transport,BP,
2866,GO:0070779,1,0.805141107601125,0,1,D-aspartate import,BP,
2867,GO:0070820,1,0.69629877231865,0,1,tertiary granule,CC,
2868,GO:0070838,1,0.4156356908576,0,2,divalent metal ion transport,BP,
2871,GO:0070857,1,0.722624588823278,0,1,regulation of bile acid biosynthetic process,BP,
2872,GO:0070859,1,0.722624588823278,0,1,positive regulation of bile acid biosynthetic process,BP,
2875,GO:0070901,1,0.597964029711571,0,1,mitochondrial tRNA methylation,BP,
2878,GO:0070936,1,0.634036220511901,0,1,protein K48-linked ubiquitination,BP,
2879,GO:0070970,1,0.702529573849765,0,1,interleukin-2 secretion,BP,
2880,GO:0070996,1,0.588770978581337,0,1,type 1 melanocortin receptor binding,MF,
2882,GO:0071071,1,0.421235953322651,0,2,regulation of phospholipid biosynthetic process,BP,
2883,GO:0071073,1,0.607633118676714,0,1,positive regulation of phospholipid biosynthetic process,BP,
2885,GO:0071216,1,0.176548685694985,0,5,cellular response to biotic stimulus,BP,
2886,GO:0071219,1,0.176548685694985,0,5,cellular response to molecule of bacterial origin,BP,
2887,GO:0071222,1,0.176548685694985,0,5,cellular response to lipopolysaccharide,BP,
2888,GO:0071229,1,0.809126620423613,0,1,cellular response to acid chemical,BP,
2889,GO:0071236,1,0.722624588823278,0,1,cellular response to antibiotic,BP,
2890,GO:0071241,1,0.722624588823278,0,1,cellular response to inorganic substance,BP,
2891,GO:0071248,1,0.722624588823278,0,1,cellular response to metal ion,BP,
2893,GO:0071265,1,0.758087612472411,0,1,L-methionine biosynthetic process,BP,
2894,GO:0071267,1,0.758087612472411,0,1,L-methionine salvage,BP,
2895,GO:0071276,1,0.722624588823278,0,1,cellular response to cadmium ion,BP,
2897,GO:0071312,1,0.722624588823278,0,1,cellular response to alkaloid,BP,
2898,GO:0071320,1,0.722624588823278,0,1,cellular response to cAMP,BP,
2899,GO:0071322,1,0.722624588823278,0,1,cellular response to carbohydrate stimulus,BP,
2900,GO:0071326,1,0.722624588823278,0,1,cellular response to monosaccharide stimulus,BP,
2901,GO:0071331,1,0.722624588823278,0,1,cellular response to hexose stimulus,BP,
2902,GO:0071333,1,0.722624588823278,0,1,cellular response to glucose stimulus,BP,
2905,GO:0071347,1,0.421165540245385,0,2,cellular response to interleukin-1,BP,
2906,GO:0071353,1,0.821650549135252,0,1,cellular response to interleukin-4,BP,
2910,GO:0071371,1,0.722624588823278,0,1,cellular response to gonadotropin stimulus,BP,
2911,GO:0071372,1,0.722624588823278,0,1,cellular response to follicle-stimulating hormone stimulus,BP,
2912,GO:0071373,1,0.722624588823278,0,1,cellular response to luteinizing hormone stimulus,BP,
2913,GO:0071375,1,0.428781113323053,0,4,cellular response to peptide hormone stimulus,BP,
2914,GO:0071378,1,0.627888728144946,0,2,cellular response to growth hormone stimulus,BP,
2915,GO:0071383,1,0.722624588823278,0,1,cellular response to steroid hormone stimulus,BP,
2916,GO:0071384,1,0.722624588823278,0,1,cellular response to corticosteroid stimulus,BP,
2917,GO:0071385,1,0.722624588823278,0,1,cellular response to glucocorticoid stimulus,BP,
2918,GO:0071396,1,0.141271234083399,0,6,cellular response to lipid,BP,
2919,GO:0071398,1,0.809126620423613,0,1,cellular response to fatty acid,BP,
2920,GO:0071407,1,0.722624588823278,0,1,cellular response to organic cyclic compound,BP,
2921,GO:0071417,1,0.264389417920476,0,5,cellular response to organonitrogen compound,BP,
2922,GO:0071436,1,0.570989159824297,0,1,sodium ion export,BP,
2923,GO:0071450,1,0.665914602464021,0,1,cellular response to oxygen radical,BP,
2924,GO:0071451,1,0.665914602464021,0,1,cellular response to superoxide,BP,
2927,GO:0071466,1,0.353995875947602,0,3,cellular response to xenobiotic stimulus,BP,
2930,GO:0071548,1,0.722624588823278,0,1,response to dexamethasone,BP,
2931,GO:0071549,1,0.722624588823278,0,1,cellular response to dexamethasone stimulus,BP,
2933,GO:0071553,1,0.715549453301239,0,1,G-protein coupled pyrimidinergic nucleotide receptor activity,MF,
2934,GO:0071559,1,0.722624588823278,0,1,response to transforming growth factor beta,BP,
2935,GO:0071560,1,0.722624588823278,0,1,cellular response to transforming growth factor beta stimulus,BP,
2944,GO:0071826,1,0.627020541116027,0,1,ribonucleoprotein complex subunit organization,BP,
2946,GO:0071830,1,0.56647063732246,0,1,triglyceride-rich lipoprotein particle clearance,BP,
2948,GO:0071855,1,0.588770978581337,0,1,neuropeptide receptor binding,MF,
2949,GO:0071867,1,0.722624588823278,0,1,response to monoamine,BP,
2950,GO:0071868,1,0.722624588823278,0,1,cellular response to monoamine stimulus,BP,
2951,GO:0071869,1,0.722624588823278,0,1,response to catecholamine,BP,
2952,GO:0071870,1,0.722624588823278,0,1,cellular response to catecholamine stimulus,BP,
2953,GO:0071871,1,0.722624588823278,0,1,response to epinephrine,BP,
2954,GO:0071872,1,0.722624588823278,0,1,cellular response to epinephrine stimulus,BP,
2956,GO:0071897,1,0.665914602464021,0,1,DNA biosynthetic process,BP,
2958,GO:0071901,1,0.594250321572963,0,1,negative regulation of protein serine/threonine kinase activity,BP,
2977,GO:0072331,1,0.594250321572963,0,1,signal transduction by p53 class mediator,BP,
2978,GO:0072332,1,0.594250321572963,0,1,intrinsic apoptotic signaling pathway by p53 class mediator,BP,
2979,GO:0072338,1,0.870241843544685,0,1,cellular lactam metabolic process,BP,
2980,GO:0072350,1,0.372359111045872,0,3,tricarboxylic acid metabolic process,BP,
2983,GO:0072376,1,0.511085405125141,0,2,protein activation cascade,BP,
2984,GO:0072378,1,0.711822224064615,0,1,blood coagulation, fibrin clot formation,BP,
2985,GO:0072503,1,0.273769155258206,0,3,cellular divalent inorganic cation homeostasis,BP,
2986,GO:0072507,1,0.273769155258206,0,3,divalent inorganic cation homeostasis,BP,
2987,GO:0072511,1,0.4156356908576,0,2,divalent inorganic cation transport,BP,
2991,GO:0072524,1,0.0906276373455396,0,7,pyridine-containing compound metabolic process,BP,
2992,GO:0072525,1,0.448303174136672,0,2,pyridine-containing compound biosynthetic process,BP,
2993,GO:0072526,1,0.702529573849765,0,1,pyridine-containing compound catabolic process,BP,
2994,GO:0072557,1,0.623678828523659,0,1,IPAF inflammasome complex,CC,
2995,GO:0072558,1,0.594250321572963,0,1,NLRP1 inflammasome complex,CC,
2996,GO:0072559,1,0.368520729438144,0,2,NLRP3 inflammasome complex,CC,
2997,GO:0072562,1,0.720126642672929,0,1,blood microparticle,CC,
2998,GO:0072593,1,0.223078860970488,0,5,reactive oxygen species metabolic process,BP,
2999,GO:0072594,1,0.627020541116027,0,1,establishment of protein localization to organelle,BP,
3000,GO:0072604,1,0.594250321572963,0,1,interleukin-6 secretion,BP,
3001,GO:0072606,1,0.594250321572963,0,1,interleukin-8 secretion,BP,
3002,GO:0072608,1,0.594250321572963,0,1,interleukin-10 secretion,BP,
3008,GO:0080135,1,0.244348283158149,0,3,regulation of cellular response to stress,BP,
3009,GO:0080171,1,0.66448681738129,0,1,lytic vacuole organization,BP,
3010,GO:0086036,1,0.570989159824297,0,1,regulation of cardiac muscle cell membrane potential,BP,
3011,GO:0089711,1,0.805141107601125,0,1,L-glutamate transmembrane transport,BP,
3022,GO:0090195,1,0.594250321572963,0,1,chemokine secretion,BP,
3023,GO:0090196,1,0.594250321572963,0,1,regulation of chemokine secretion,BP,
3024,GO:0090197,1,0.594250321572963,0,1,positive regulation of chemokine secretion,BP,
3025,GO:0090199,1,0.370515326336158,0,2,regulation of release of cytochrome c from mitochondria,BP,
3026,GO:0090200,1,0.594250321572963,0,1,positive regulation of release of cytochrome c from mitochondria,BP,
3027,GO:0090201,1,0.627020541116027,0,1,negative regulation of release of cytochrome c from mitochondria,BP,
3029,GO:0090207,1,0.665914602464021,0,1,regulation of triglyceride metabolic process,BP,
3030,GO:0090208,1,0.665914602464021,0,1,positive regulation of triglyceride metabolic process,BP,
3031,GO:0090257,1,0.627020541116027,0,1,regulation of muscle system process,BP,
3037,GO:0090305,1,0.508456912927079,0,2,nucleic acid phosphodiester bond hydrolysis,BP,
3038,GO:0090322,1,0.665914602464021,0,1,regulation of superoxide metabolic process,BP,
3040,GO:0090484,1,0.61159761771495,0,1,drug transporter activity,MF,
3041,GO:0090501,1,0.508456912927079,0,2,RNA phosphodiester bond hydrolysis,BP,
3042,GO:0090502,1,0.84997168064402,0,1,RNA phosphodiester bond hydrolysis, endonucleolytic,BP,
3043,GO:0090533,1,0.570989159824297,0,1,cation-transporting ATPase complex,CC,
3044,GO:0090559,1,0.627020541116027,0,1,regulation of membrane permeability,BP,
3049,GO:0097028,1,0.603893603401742,0,1,dendritic cell differentiation,BP,
3051,GO:0097060,1,0.952324910776072,0,1,synaptic membrane,CC,
3052,GO:0097089,1,0.646945096935322,0,1,methyl-branched fatty acid metabolic process,BP,
3053,GO:0097153,1,0.368520729438144,0,2,cysteine-type endopeptidase activity involved in apoptotic process,MF,
3056,GO:0097169,1,0.368520729438144,0,2,AIM2 inflammasome complex,CC,
3060,GO:0097193,1,0.228557389164146,0,3,intrinsic apoptotic signaling pathway,BP,
3061,GO:0097194,1,0.623678828523659,0,1,execution phase of apoptosis,BP,
3062,GO:0097200,1,0.623678828523659,0,1,cysteine-type endopeptidase activity involved in execution phase of apoptosis,MF,
3064,GO:0097223,1,0.66448681738129,0,1,sperm part,CC,
3068,GO:0097340,1,0.627020541116027,0,1,inhibition of cysteine-type endopeptidase activity,BP,
3069,GO:0097341,1,0.627020541116027,0,1,zymogen inhibition,BP,
3072,GO:0097421,1,0.665914602464021,0,1,liver regeneration,BP,
3073,GO:0097425,1,0.652705167196424,0,1,smooth endoplasmic reticulum part,CC,
3074,GO:0097435,1,0.21825284757342,0,3,supramolecular fiber organization,BP,
3076,GO:0097485,1,0.663098539838137,0,1,neuron projection guidance,BP,
3079,GO:0097553,1,0.627020541116027,0,1,calcium ion transmembrane import into cytosol,BP,
3081,GO:0097696,1,0.550627132808726,0,2,STAT cascade,BP,
3083,GO:0097722,1,0.665914602464021,0,1,sperm motility,BP,
3084,GO:0098533,1,0.570989159824297,0,1,ATPase dependent transmembrane transport complex,CC,
3090,GO:0098590,1,0.952324910776072,0,1,plasma membrane region,CC,
3094,GO:0098655,1,0.0871208002131022,0,5,cation transmembrane transport,BP,
3095,GO:0098656,1,0.344776170139228,0,3,anion transmembrane transport,BP,
3096,GO:0098657,1,0.805141107601125,0,1,import into cell,BP,
3097,GO:0098660,1,0.0871208002131022,0,5,inorganic ion transmembrane transport,BP,
3098,GO:0098661,1,0.570989159824297,0,1,inorganic anion transmembrane transport,BP,
3099,GO:0098662,1,0.0871208002131022,0,5,inorganic cation transmembrane transport,BP,
3102,GO:0098754,1,0.389557346055208,0,2,detoxification,BP,
3103,GO:0098771,1,0.103533116489244,0,6,inorganic ion homeostasis,BP,
3106,GO:0098781,1,0.599713716867655,0,1,ncRNA transcription,BP,
3107,GO:0098794,1,0.952324910776072,0,1,postsynapse,CC,
3114,GO:0098869,1,0.389557346055208,0,2,cellular oxidant detoxification,BP,
3119,GO:0099094,1,0.952324910776072,0,1,ligand-gated cation channel activity,MF,
3120,GO:0099503,1,0.0518739633626835,0,7,secretory vesicle,CC,
3125,GO:0099565,1,0.952324910776072,0,1,chemical synaptic transmission, postsynaptic,BP,
3126,GO:0099568,1,0.832354421897545,0,1,cytoplasmic region,CC,
3127,GO:0099600,1,0.358812520590591,0,4,transmembrane receptor activity,MF,
3128,GO:0101002,1,0.315132169877643,0,3,ficolin-1-rich granule,CC,
3129,GO:0102007,1,0.645095410017529,0,1,acyl-L-homoserine-lactone lactonohydrolase activity,MF,
3131,GO:0102336,1,0.773435048011187,0,1,3-oxo-arachidoyl-CoA synthase activity,MF,
3132,GO:0102337,1,0.773435048011187,0,1,3-oxo-cerotoyl-CoA synthase activity,MF,
3133,GO:0102338,1,0.773435048011187,0,1,3-oxo-lignoceronyl-CoA synthase activity,MF,
3136,GO:1900046,1,0.997322300088831,0,1,regulation of hemostasis,BP,
3137,GO:1900076,1,0.84997168064402,0,1,regulation of cellular response to insulin stimulus,BP,
3138,GO:1900078,1,0.84997168064402,0,1,positive regulation of cellular response to insulin stimulus,BP,
3139,GO:1900180,1,0.627020541116027,0,1,regulation of protein localization to nucleus,BP,
3140,GO:1900274,1,0.599713716867655,0,1,regulation of phospholipase C activity,BP,
3141,GO:1900371,1,0.588770978581337,0,1,regulation of purine nucleotide biosynthetic process,BP,
3142,GO:1900373,1,0.588770978581337,0,1,positive regulation of purine nucleotide biosynthetic process,BP,
3143,GO:1900407,1,0.4156356908576,0,2,regulation of cellular response to oxidative stress,BP,
3144,GO:1900408,1,0.627020541116027,0,1,negative regulation of cellular response to oxidative stress,BP,
3145,GO:1900409,1,0.665914602464021,0,1,positive regulation of cellular response to oxidative stress,BP,
3146,GO:1900542,1,0.588770978581337,0,1,regulation of purine nucleotide metabolic process,BP,
3147,GO:1900544,1,0.588770978581337,0,1,positive regulation of purine nucleotide metabolic process,BP,
3149,GO:1901019,1,0.665914602464021,0,1,regulation of calcium ion transmembrane transporter activity,BP,
3150,GO:1901021,1,0.665914602464021,0,1,positive regulation of calcium ion transmembrane transporter activity,BP,
3151,GO:1901031,1,0.665914602464021,0,1,regulation of response to reactive oxygen species,BP,
3152,GO:1901033,1,0.665914602464021,0,1,positive regulation of response to reactive oxygen species,BP,
3153,GO:1901052,1,0.775348239435331,0,1,sarcosine metabolic process,BP,
3154,GO:1901053,1,0.775348239435331,0,1,sarcosine catabolic process,BP,
3158,GO:1901184,1,0.663098539838137,0,1,regulation of ERBB signaling pathway,BP,
3159,GO:1901186,1,0.663098539838137,0,1,positive regulation of ERBB signaling pathway,BP,
3160,GO:1901214,1,0.722624588823278,0,1,regulation of neuron death,BP,
3161,GO:1901215,1,0.722624588823278,0,1,negative regulation of neuron death,BP,
3166,GO:1901317,1,0.665914602464021,0,1,regulation of flagellated sperm motility,BP,
3167,GO:1901318,1,0.665914602464021,0,1,negative regulation of flagellated sperm motility,BP,
3176,GO:1901568,1,0.328943822256982,0,3,fatty acid derivative metabolic process,BP,
3177,GO:1901570,1,0.513718623263497,0,2,fatty acid derivative biosynthetic process,BP,
3182,GO:1901607,1,0.60925030138103,0,2,alpha-amino acid biosynthetic process,BP,
3186,GO:1901652,1,0.157831239861515,0,6,response to peptide,BP,
3187,GO:1901653,1,0.264389417920476,0,5,cellular response to peptide,BP,
3188,GO:1901654,1,0.722624588823278,0,1,response to ketone,BP,
3189,GO:1901655,1,0.722624588823278,0,1,cellular response to ketone,BP,
3190,GO:1901657,1,0.284537128330972,0,3,glycosyl compound metabolic process,BP,
3191,GO:1901658,1,0.284537128330972,0,3,glycosyl compound catabolic process,BP,
3192,GO:1901668,1,0.665914602464021,0,1,regulation of superoxide dismutase activity,BP,
3193,GO:1901671,1,0.665914602464021,0,1,positive regulation of superoxide dismutase activity,BP,
3195,GO:1901685,1,0.587992285191993,0,1,glutathione derivative metabolic process,BP,
3196,GO:1901687,1,0.587992285191993,0,1,glutathione derivative biosynthetic process,BP,
3198,GO:1901699,1,0.264389417920476,0,5,cellular response to nitrogen compound,BP,
3200,GO:1901701,1,0.0400115472015454,0,10,cellular response to oxygen-containing compound,BP,
3203,GO:1901879,1,0.623232303978104,0,1,regulation of protein depolymerization,BP,
3204,GO:1901880,1,0.623232303978104,0,1,negative regulation of protein depolymerization,BP,
3205,GO:1901894,1,0.665914602464021,0,1,regulation of calcium-transporting ATPase activity,BP,
3206,GO:1901896,1,0.665914602464021,0,1,positive regulation of calcium-transporting ATPase activity,BP,
3207,GO:1901981,1,0.763267626299272,0,1,phosphatidylinositol phosphate binding,MF,
3213,GO:1902001,1,0.756881157205377,0,1,fatty acid transmembrane transport,BP,
3218,GO:1902106,1,0.603893603401742,0,1,negative regulation of leukocyte differentiation,BP,
3220,GO:1902108,1,0.627020541116027,0,1,regulation of mitochondrial membrane permeability involved in apoptotic process,BP,
3221,GO:1902109,1,0.627020541116027,0,1,negative regulation of mitochondrial membrane permeability involved in apoptotic process,BP,
3223,GO:1902175,1,0.627020541116027,0,1,regulation of oxidative stress-induced intrinsic apoptotic signaling pathway,BP,
3224,GO:1902176,1,0.627020541116027,0,1,negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway,BP,
3225,GO:1902221,1,0.601567917327783,0,1,erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process,BP,
3226,GO:1902222,1,0.601567917327783,0,1,erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process,BP,
3228,GO:1902305,1,0.570989159824297,0,1,regulation of sodium ion transmembrane transport,BP,
3229,GO:1902307,1,0.570989159824297,0,1,positive regulation of sodium ion transmembrane transport,BP,
3230,GO:1902311,1,0.654612357040219,0,1,regulation of copper ion transmembrane transport,BP,
3231,GO:1902475,1,0.805141107601125,0,1,L-alpha-amino acid transmembrane transport,BP,
3232,GO:1902476,1,0.570989159824297,0,1,chloride transmembrane transport,BP,
3235,GO:1902524,1,0.634036220511901,0,1,positive regulation of protein K48-linked ubiquitination,BP,
3239,GO:1902554,1,0.594250321572963,0,1,serine/threonine protein kinase complex,CC,
3240,GO:1902555,1,0.597964029711571,0,1,endoribonuclease complex,CC,
3245,GO:1902593,1,0.627020541116027,0,1,single-organism nuclear import,BP,
3246,GO:1902600,1,0.589388163862648,0,1,hydrogen ion transmembrane transport,BP,
3249,GO:1902656,1,0.627020541116027,0,1,calcium ion import into cytosol,BP,
3250,GO:1902679,1,0.383197636779896,0,2,negative regulation of RNA biosynthetic process,BP,
3256,GO:1902882,1,0.4156356908576,0,2,regulation of response to oxidative stress,BP,
3257,GO:1902883,1,0.627020541116027,0,1,negative regulation of response to oxidative stress,BP,
3258,GO:1902884,1,0.665914602464021,0,1,positive regulation of response to oxidative stress,BP,
3259,GO:1902903,1,0.368254216500185,0,2,regulation of supramolecular fiber organization,BP,
3260,GO:1902904,1,0.623232303978104,0,1,negative regulation of supramolecular fiber organization,BP,
3261,GO:1902905,1,0.594250321572963,0,1,positive regulation of supramolecular fiber organization,BP,
3262,GO:1902911,1,0.594250321572963,0,1,protein kinase complex,CC,
3263,GO:1902914,1,0.634036220511901,0,1,regulation of protein polyubiquitination,BP,
3264,GO:1902916,1,0.634036220511901,0,1,positive regulation of protein polyubiquitination,BP,
3267,GO:1902936,1,0.763267626299272,0,1,phosphatidylinositol bisphosphate binding,MF,
3268,GO:1903010,1,0.665914602464021,0,1,regulation of bone development,BP,
3269,GO:1903011,1,0.665914602464021,0,1,negative regulation of bone development,BP,
3270,GO:1903034,1,0.997322300088831,0,1,regulation of response to wounding,BP,
3276,GO:1903169,1,0.665914602464021,0,1,regulation of calcium ion transmembrane transport,BP,
3277,GO:1903173,1,0.662223203914035,0,1,fatty alcohol metabolic process,BP,
3278,GO:1903201,1,0.627020541116027,0,1,regulation of oxidative stress-induced cell death,BP,
3279,GO:1903202,1,0.627020541116027,0,1,negative regulation of oxidative stress-induced cell death,BP,
3280,GO:1903273,1,0.570989159824297,0,1,regulation of sodium ion export,BP,
3281,GO:1903275,1,0.570989159824297,0,1,positive regulation of sodium ion export,BP,
3282,GO:1903276,1,0.570989159824297,0,1,regulation of sodium ion export from cell,BP,
3283,GO:1903278,1,0.570989159824297,0,1,positive regulation of sodium ion export from cell,BP,
3284,GO:1903305,1,0.7161003501605,0,1,regulation of regulated secretory pathway,BP,
3285,GO:1903317,1,0.449797616968255,0,2,regulation of protein maturation,BP,
3286,GO:1903318,1,0.627020541116027,0,1,negative regulation of protein maturation,BP,
3292,GO:1903409,1,0.300423143349393,0,3,reactive oxygen species biosynthetic process,BP,
3293,GO:1903426,1,0.300423143349393,0,3,regulation of reactive oxygen species biosynthetic process,BP,
3294,GO:1903427,1,0.417440256616709,0,2,negative regulation of reactive oxygen species biosynthetic process,BP,
3295,GO:1903428,1,0.724891980148401,0,1,positive regulation of reactive oxygen species biosynthetic process,BP,
3297,GO:1903507,1,0.578471336067372,0,1,negative regulation of nucleic acid-templated transcription,BP,
3300,GO:1903510,1,0.453908529716914,0,2,mucopolysaccharide metabolic process,BP,
3301,GO:1903514,1,0.627020541116027,0,1,calcium ion transport from endoplasmic reticulum to cytosol,BP,
3302,GO:1903522,1,0.570989159824297,0,1,regulation of blood circulation,BP,
3305,GO:1903533,1,0.627020541116027,0,1,regulation of protein targeting,BP,
3309,GO:1903610,1,0.665914602464021,0,1,regulation of calcium-dependent ATPase activity,BP,
3310,GO:1903611,1,0.665914602464021,0,1,negative regulation of calcium-dependent ATPase activity,BP,
3311,GO:1903624,1,0.665914602464021,0,1,regulation of DNA catabolic process,BP,
3312,GO:1903625,1,0.665914602464021,0,1,negative regulation of DNA catabolic process,BP,
3313,GO:1903627,1,0.665914602464021,0,1,regulation of dUTP diphosphatase activity,BP,
3314,GO:1903629,1,0.665914602464021,0,1,positive regulation of dUTP diphosphatase activity,BP,
3315,GO:1903630,1,0.665914602464021,0,1,regulation of aminoacyl-tRNA ligase activity,BP,
3316,GO:1903631,1,0.665914602464021,0,1,negative regulation of aminoacyl-tRNA ligase activity,BP,
3317,GO:1903633,1,0.665914602464021,0,1,regulation of leucine-tRNA ligase activity,BP,
3318,GO:1903634,1,0.665914602464021,0,1,negative regulation of leucine-tRNA ligase activity,BP,
3320,GO:1903707,1,0.603893603401742,0,1,negative regulation of hemopoiesis,BP,
3322,GO:1903725,1,0.235898620024342,0,3,regulation of phospholipid metabolic process,BP,
3323,GO:1903726,1,0.56647063732246,0,1,negative regulation of phospholipid metabolic process,BP,
3324,GO:1903727,1,0.607633118676714,0,1,positive regulation of phospholipid metabolic process,BP,
3325,GO:1903779,1,0.570989159824297,0,1,regulation of cardiac conduction,BP,
3326,GO:1903825,1,0.608275652648745,0,2,organic acid transmembrane transport,BP,
3327,GO:1903827,1,0.360587210552112,0,2,regulation of cellular protein localization,BP,
3328,GO:1903900,1,0.84997168064402,0,1,regulation of viral life cycle,BP,
3329,GO:1903901,1,0.84997168064402,0,1,negative regulation of viral life cycle,BP,
3330,GO:1904062,1,0.24514468681155,0,3,regulation of cation transmembrane transport,BP,
3331,GO:1904064,1,0.378200365412608,0,2,positive regulation of cation transmembrane transport,BP,
3333,GO:1904251,1,0.722624588823278,0,1,regulation of bile acid metabolic process,BP,
3334,GO:1904253,1,0.722624588823278,0,1,positive regulation of bile acid metabolic process,BP,
3335,GO:1904406,1,0.417440256616709,0,2,negative regulation of nitric oxide metabolic process,BP,
3336,GO:1904407,1,0.724891980148401,0,1,positive regulation of nitric oxide metabolic process,BP,
3337,GO:1904427,1,0.665914602464021,0,1,positive regulation of calcium ion transmembrane transport,BP,
3338,GO:1904589,1,0.627020541116027,0,1,regulation of protein import,BP,
3339,GO:1904645,1,0.623678828523659,0,1,response to beta-amyloid,BP,
3340,GO:1904646,1,0.623678828523659,0,1,cellular response to beta-amyloid,BP,
3344,GO:1904724,1,0.69629877231865,0,1,tertiary granule lumen,CC,
3345,GO:1904813,1,0.315132169877643,0,3,ficolin-1-rich granule lumen,CC,
3346,GO:1904833,1,0.665914602464021,0,1,positive regulation of removal of superoxide radicals,BP,
3349,GO:1904892,1,0.870241843544685,0,1,regulation of STAT cascade,BP,
3350,GO:1904894,1,0.870241843544685,0,1,positive regulation of STAT cascade,BP,
3351,GO:1904949,1,0.570989159824297,0,1,ATPase complex,CC,
3354,GO:1905039,1,0.608275652648745,0,2,carboxylic acid transmembrane transport,BP,
3357,GO:1905348,1,0.597964029711571,0,1,endonuclease complex,CC,
3360,GO:1905709,1,0.627020541116027,0,1,negative regulation of membrane permeability,BP,
3364,GO:1990001,1,0.627020541116027,0,1,inhibition of cysteine-type endopeptidase activity involved in apoptotic process,BP,
3369,GO:1990542,1,0.756881157205377,0,1,mitochondrial transmembrane transport,BP,
3370,GO:1990748,1,0.389557346055208,0,2,cellular detoxification,BP,
3371,GO:1990777,1,0.56647063732246,0,1,lipoprotein particle,CC,
3374,GO:2000021,1,0.627020541116027,0,1,regulation of ion homeostasis,BP,
3382,GO:2000113,1,0.227200382972737,0,3,negative regulation of cellular macromolecule biosynthetic process,BP,
3384,GO:2000117,1,0.627020541116027,0,1,negative regulation of cysteine-type endopeptidase activity,BP,
3385,GO:2000121,1,0.665914602464021,0,1,regulation of removal of superoxide radicals,BP,
3389,GO:2000146,1,0.665914602464021,0,1,negative regulation of cell motility,BP,
3391,GO:2000209,1,0.809126620423613,0,1,regulation of anoikis,BP,
3392,GO:2000257,1,0.720126642672929,0,1,regulation of protein activation cascade,BP,
3393,GO:2000278,1,0.665914602464021,0,1,regulation of DNA biosynthetic process,BP,
3394,GO:2000279,1,0.665914602464021,0,1,negative regulation of DNA biosynthetic process,BP,
3395,GO:2000377,1,0.300423143349393,0,3,regulation of reactive oxygen species metabolic process,BP,
3396,GO:2000378,1,0.417440256616709,0,2,negative regulation of reactive oxygen species metabolic process,BP,
3397,GO:2000379,1,0.481089069304752,0,2,positive regulation of reactive oxygen species metabolic process,BP,
3408,GO:2000482,1,0.594250321572963,0,1,regulation of interleukin-8 secretion,BP,
3409,GO:2000484,1,0.594250321572963,0,1,positive regulation of interleukin-8 secretion,BP,
3412,GO:2000649,1,0.570989159824297,0,1,regulation of sodium ion transmembrane transporter activity,BP,
3413,GO:2000778,1,0.594250321572963,0,1,positive regulation of interleukin-6 secretion,BP,
3415,GO:2000811,1,0.809126620423613,0,1,negative regulation of anoikis,BP,
3416,GO:2001014,1,0.610116362596827,0,1,regulation of skeletal muscle cell differentiation,BP,
3417,GO:2001015,1,0.610116362596827,0,1,negative regulation of skeletal muscle cell differentiation,BP,
3421,GO:2001057,1,0.300423143349393,0,3,reactive nitrogen species metabolic process,BP,
3423,GO:2001179,1,0.594250321572963,0,1,regulation of interleukin-10 secretion,BP,
3424,GO:2001181,1,0.594250321572963,0,1,positive regulation of interleukin-10 secretion,BP,
3425,GO:2001198,1,0.603893603401742,0,1,regulation of dendritic cell differentiation,BP,
3426,GO:2001199,1,0.603893603401742,0,1,negative regulation of dendritic cell differentiation,BP,
3433,GO:2001242,1,0.370515326336158,0,2,regulation of intrinsic apoptotic signaling pathway,BP,
3434,GO:2001243,1,0.627020541116027,0,1,negative regulation of intrinsic apoptotic signaling pathway,BP,
3435,GO:2001245,1,0.607633118676714,0,1,regulation of phosphatidylcholine biosynthetic process,BP,
3438,GO:2001273,1,0.84997168064402,0,1,regulation of glucose import in response to insulin stimulus,BP,
3439,GO:2001275,1,0.84997168064402,0,1,positive regulation of glucose import in response to insulin stimulus,BP,
